エドガーで原本を確認する
__________________________________________________________________________________________________________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________
FORM 10-Q
_________________
(Mark One)
x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended September 30, 2023
OR
¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from ______ to ______
Commission File Number: 1-6028
_________________
LINCOLN NATIONAL CORPORATION
(Exact name of registrant as specified in its charter)
_________________
|
|
|
|
Indiana |
35-1140070 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
|
|
150 N. Radnor-Chester Road, Suite A305, Radnor, Pennsylvania |
19087 |
(Address of principal executive offices) |
(Zip Code) |
(484) 583-1400
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
__________________________________
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class |
Trading symbol(s) |
Name of each exchange on which registered |
Common Stock |
LNC |
New York Stock Exchange |
Depositary Shares, each representing a 1/1000th interest in a share of 9.000% Non-Cumulative Preferred Stock, Series D |
LNC PRD |
New York Stock Exchange |
__________________________________
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
|
|
|
|
|
|
Large Accelerated Filer |
x |
|
Accelerated Filer |
¨ |
|
Non-accelerated Filer |
¨ |
|
Smaller Reporting Company |
¨ |
|
|
|
|
Emerging Growth Company |
¨ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨No x
As of October 30, 2023, there were 169,661,872 shares of the registrant’s common stock outstanding.
_________________________________________________________________________________________________________
Lincoln National Corporation
Table of Contents
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
LINCOLN NATIONAL CORPORATION
CONSOLIDATED BALANCE SHEETS
(in millions, except share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
As of |
|
||
|
September 30, |
December 31, |
||||||
|
|
2023 |
|
|
2022 |
|
||
|
|
|
|
|
|
|
|
|
|
(Unaudited) |
|
|
|
|
|||
ASSETS |
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
Fixed maturity available-for-sale securities, at fair value |
|
|
|
|
|
|
|
|
(amortized cost: 2023 - $112,034; 2022 - $111,707; allowance for credit losses: 2023 - $21; 2022 - $22) |
|
$ |
97,804 |
|
|
$ |
99,736 |
|
Trading securities |
|
|
2,788 |
|
|
|
3,498 |
|
Equity securities |
|
|
383 |
|
|
|
427 |
|
Mortgage loans on real estate, net of allowance for credit losses |
|
|
|
|
|
|
|
|
(portion at fair value: 2023 - $315; 2022 - $487) |
|
|
18,751 |
|
|
|
18,301 |
|
Policy loans |
|
|
2,428 |
|
|
|
2,359 |
|
Derivative investments |
|
|
5,790 |
|
|
|
3,594 |
|
Other investments |
|
|
4,551 |
|
|
|
3,739 |
|
Total investments |
|
|
132,495 |
|
|
|
131,654 |
|
Cash and invested cash |
|
|
2,529 |
|
|
|
3,343 |
|
Deferred acquisition costs, value of business acquired and deferred sales inducements |
|
|
12,341 |
|
|
|
12,235 |
|
Reinsurance recoverables, net of allowance for credit losses |
|
|
18,389 |
|
|
|
19,443 |
|
Market risk benefit assets |
|
|
4,108 |
|
|
|
2,807 |
|
Accrued investment income |
|
|
1,372 |
|
|
|
1,253 |
|
Goodwill |
|
|
1,144 |
|
|
|
1,144 |
|
Other assets |
|
|
20,223 |
|
|
|
18,802 |
|
Separate account assets |
|
|
145,810 |
|
|
|
143,536 |
|
Total assets |
|
$ |
338,411 |
|
|
$ |
334,217 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
Policyholder account balances |
|
$ |
117,210 |
|
|
$ |
114,435 |
|
Future contract benefits |
|
|
39,362 |
|
|
|
38,826 |
|
Market risk benefit liabilities |
|
|
1,385 |
|
|
|
2,078 |
|
Deferred front-end loads |
|
|
5,653 |
|
|
|
5,052 |
|
Payables for collateral on investments |
|
|
8,046 |
|
|
|
6,712 |
|
Short-term debt |
|
|
- |
|
|
|
500 |
|
Long-term debt |
|
|
5,905 |
|
|
|
5,955 |
|
Other liabilities |
|
|
11,841 |
|
|
|
12,021 |
|
Separate account liabilities |
|
|
145,810 |
|
|
|
143,536 |
|
Total liabilities |
|
|
335,212 |
|
|
|
329,115 |
|
|
|
|
|
|
|
|
|
|
Contingencies and Commitments (See Note 15) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Equity |
|
|
|
|
|
|
|
|
Preferred stock – 10,000,000 shares authorized: |
|
|
|
|
|
|
|
|
Series C preferred stock – 20,000 shares authorized, issued and outstanding |
|
|
|
|
|
|
|
|
as of September 30, 2023, and December 31, 2022 |
|
|
493 |
|
|
|
493 |
|
Series D preferred stock – 20,000 shares authorized, issued and outstanding |
|
|
|
|
|
|
|
|
as of September 30, 2023, and December 31, 2022 |
|
|
493 |
|
|
|
493 |
|
Common stock – 800,000,000 shares authorized; 169,658,271 and 169,220,511 shares |
|
|
|
|
|
|
|
|
issued and outstanding as of September 30, 2023, and December 31, 2022, respectively |
|
|
4,591 |
|
|
|
4,544 |
|
Retained earnings |
|
|
6,102 |
|
|
|
5,924 |
|
Accumulated other comprehensive income (loss) |
|
|
(8,480 |
) |
|
|
(6,352 |
) |
Total stockholders’ equity |
|
|
3,199 |
|
|
|
5,102 |
|
Total liabilities and stockholders’ equity |
|
$ |
338,411 |
|
|
$ |
334,217 |
|
LINCOLN NATIONAL CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited, in millions, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
Insurance premiums |
$ |
1,566 |
|
$ |
1,548 |
|
$ |
4,757 |
|
$ |
4,523 |
|
Fee income |
|
1,363 |
|
|
1,381 |
|
|
4,107 |
|
|
4,249 |
|
Net investment income |
|
1,494 |
|
|
1,295 |
|
|
4,468 |
|
|
4,105 |
|
Realized gain (loss) |
|
(453 |
) |
|
249 |
|
|
(3,066 |
) |
|
1,531 |
|
Amortization of deferred gain on business sold through reinsurance |
|
15 |
|
|
10 |
|
|
34 |
|
|
31 |
|
Other revenues |
|
218 |
|
|
189 |
|
|
646 |
|
|
530 |
|
Total revenues |
|
4,203 |
|
|
4,672 |
|
|
10,946 |
|
|
14,969 |
|
Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
Benefits |
|
2,152 |
|
|
2,149 |
|
|
6,635 |
|
|
6,259 |
|
Interest credited |
|
831 |
|
|
726 |
|
|
2,424 |
|
|
2,133 |
|
Market risk benefit (gain) loss |
|
(1,428 |
) |
|
(798 |
) |
|
(2,832 |
) |
|
(1,679 |
) |
Policyholder liability remeasurement (gain) loss |
|
159 |
|
|
2,692 |
|
|
(68 |
) |
|
2,818 |
|
Commissions and other expenses |
|
1,335 |
|
|
1,280 |
|
|
3,970 |
|
|
3,741 |
|
Interest and debt expense |
|
84 |
|
|
71 |
|
|
250 |
|
|
205 |
|
Spark program expense |
|
36 |
|
|
44 |
|
|
101 |
|
|
118 |
|
Impairment of intangibles |
|
- |
|
|
634 |
|
|
- |
|
|
634 |
|
Total expenses |
|
3,169 |
|
|
6,798 |
|
|
10,480 |
|
|
14,229 |
|
Income (loss) before taxes |
|
1,034 |
|
|
(2,126 |
) |
|
466 |
|
|
740 |
|
Federal income tax expense (benefit) |
|
181 |
|
|
(350 |
) |
|
(17 |
) |
|
195 |
|
Net income (loss) |
|
853 |
|
|
(1,776 |
) |
|
483 |
|
|
545 |
|
Other comprehensive income (loss), net of tax: |
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized investment gain (loss) |
|
(2,896 |
) |
|
(5,055 |
) |
|
(1,635 |
) |
|
(19,207 |
) |
Market risk benefit non-performance risk gain (loss) |
|
(844 |
) |
|
(150 |
) |
|
(742 |
) |
|
224 |
|
Policyholder liability discount rate remeasurement gain (loss) |
|
364 |
|
|
549 |
|
|
274 |
|
|
2,070 |
|
Foreign currency translation adjustment |
|
(6 |
) |
|
(13 |
) |
|
1 |
|
|
(33 |
) |
Funded status of employee benefit plans |
|
6 |
|
|
9 |
|
|
(26 |
) |
|
22 |
|
Total other comprehensive income (loss), net of tax |
|
(3,376 |
) |
|
(4,660 |
) |
|
(2,128 |
) |
|
(16,924 |
) |
Comprehensive income (loss) |
$ |
(2,523 |
) |
$ |
(6,436 |
) |
$ |
(1,645 |
) |
$ |
(16,379 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (Loss) Available to Common Stockholders |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
$ |
853 |
|
$ |
(1,776 |
) |
$ |
483 |
|
$ |
545 |
|
Preferred stock dividends declared |
|
(34 |
) |
|
- |
|
|
(71 |
) |
|
- |
|
Deferred units of LNC stock in our deferred compensation plans |
|
- |
|
|
(1 |
) |
|
(2 |
) |
|
(8 |
) |
Net income (loss) available to common stockholders |
$ |
819 |
|
$ |
(1,777 |
) |
$ |
410 |
|
$ |
537 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (Loss) Per Common Share |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
$ |
4.82 |
|
$ |
(10.46 |
) |
$ |
2.43 |
|
$ |
3.18 |
|
Diluted |
|
4.79 |
|
|
(10.47 |
) |
|
2.40 |
|
|
3.10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Dividends Declared Per Preferred Share |
|
|
|
|
|
|
|
|
|
|
|
|
Series C preferred stock |
$ |
1,156.25 |
|
$ |
- |
|
$ |
1,792.19 |
|
$ |
- |
|
Series D preferred stock |
|
562.50 |
|
|
- |
|
|
1,743.75 |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Dividends Declared Per Common Share |
$ |
0.45 |
|
$ |
0.45 |
|
$ |
1.35 |
|
$ |
1.35 |
|
LINCOLN NATIONAL CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Unaudited, in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of beginning-of-period |
$ |
986 |
|
$ |
- |
|
$ |
986 |
|
$ |
- |
|
Balance as of end-of-period |
|
986 |
|
|
- |
|
|
986 |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of beginning-of-period |
|
4,575 |
|
|
4,546 |
|
|
4,544 |
|
|
4,735 |
|
Stock compensation/issued for benefit plans |
|
16 |
|
|
15 |
|
|
47 |
|
|
30 |
|
Retirement of common stock/cancellation of shares |
|
- |
|
|
(27 |
) |
|
- |
|
|
(231 |
) |
Balance as of end-of-period |
|
4,591 |
|
|
4,534 |
|
|
4,591 |
|
|
4,534 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retained Earnings |
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of beginning-of-period |
|
5,362 |
|
|
7,065 |
|
|
5,924 |
|
|
5,196 |
|
Net income (loss) |
|
853 |
|
|
(1,776 |
) |
|
483 |
|
|
545 |
|
Retirement of common stock |
|
- |
|
|
(23 |
) |
|
- |
|
|
(319 |
) |
Preferred stock dividends declared |
|
(34 |
) |
|
- |
|
|
(71 |
) |
|
- |
|
Common stock dividends declared |
|
(79 |
) |
|
(77 |
) |
|
(234 |
) |
|
(233 |
) |
Balance as of end-of-period |
|
6,102 |
|
|
5,189 |
|
|
6,102 |
|
|
5,189 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) |
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of beginning-of-period |
|
(5,104 |
) |
|
(2,280 |
) |
|
(6,352 |
) |
|
9,984 |
|
Other comprehensive income (loss), net of tax |
|
(3,376 |
) |
|
(4,660 |
) |
|
(2,128 |
) |
|
(16,924 |
) |
Balance as of end-of-period |
|
(8,480 |
) |
|
(6,940 |
) |
|
(8,480 |
) |
|
(6,940 |
) |
Total stockholders’ equity as of end-of-period |
$ |
3,199 |
|
$ |
2,783 |
|
$ |
3,199 |
|
$ |
2,783 |
|
LINCOLN NATIONAL CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine |
|
||||
|
Months Ended |
|
||||
|
September 30, |
|
||||
|
2023 |
|
2022 |
|
||
Cash Flows from Operating Activities |
|
|
|
|
|
|
Net income (loss) |
$ |
483 |
|
$ |
545 |
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) |
|
|
|
|
|
|
operating activities: |
|
|
|
|
|
|
Realized (gain) loss |
|
3,066 |
|
|
(1,531 |
) |
Market risk benefit (gain) loss |
|
(2,832 |
) |
|
(1,679 |
) |
Sales and maturities (purchases) of trading securities, net |
|
703 |
|
|
163 |
|
Amortization of deferred gain on business sold through reinsurance |
|
(34 |
) |
|
(31 |
) |
Impairment of intangibles |
|
- |
|
|
634 |
|
Change in: |
|
|
|
|
|
|
Deferred acquisition costs, value of business acquired, deferred sales inducements |
|
|
|
|
|
|
and deferred front-end loads |
|
495 |
|
|
365 |
|
Accrued investment income |
|
(77 |
) |
|
(80 |
) |
Insurance liabilities and reinsurance-related balances |
|
(1,804 |
) |
|
4,463 |
|
Accrued expenses |
|
(19 |
) |
|
(407 |
) |
Federal income tax accruals |
|
(17 |
) |
|
249 |
|
Other |
|
(170 |
) |
|
324 |
|
Net cash provided by (used in) operating activities |
|
(206 |
) |
|
3,015 |
|
Cash Flows from Investing Activities |
|
|
|
|
|
|
Purchases of available-for-sale securities and equity securities |
|
(8,248 |
) |
|
(12,008 |
) |
Sales of available-for-sale securities and equity securities |
|
2,838 |
|
|
1,196 |
|
Maturities of available-for-sale securities |
|
4,086 |
|
|
4,333 |
|
Purchases of alternative investments |
|
(426 |
) |
|
(484 |
) |
Sales and repayments of alternative investments |
|
103 |
|
|
383 |
|
Issuance of mortgage loans on real estate |
|
(1,377 |
) |
|
(1,924 |
) |
Repayment and maturities of mortgage loans on real estate |
|
908 |
|
|
1,872 |
|
Repayment (issuance) of policy loans, net |
|
(72 |
) |
|
17 |
|
Net change in collateral on investments, certain derivatives and related settlements |
|
(205 |
) |
|
(3,155 |
) |
Other |
|
(227 |
) |
|
(93 |
) |
Net cash provided by (used in) investing activities |
|
(2,620 |
) |
|
(9,863 |
) |
Cash Flows from Financing Activities |
|
|
|
|
|
|
Payment of long-term debt, including current maturities |
|
(500 |
) |
|
(300 |
) |
Issuance of long-term debt, net of issuance costs |
|
- |
|
|
296 |
|
Payment related to sale-leaseback transactions |
|
(63 |
) |
|
(52 |
) |
Proceeds from certain financing arrangements |
|
65 |
|
|
53 |
|
Payment related to certain financing arrangements |
|
(35 |
) |
|
- |
|
Deposits of fixed account balances |
|
11,129 |
|
|
11,845 |
|
Withdrawals of fixed account balances |
|
(7,759 |
) |
|
(5,435 |
) |
Transfers from (to) separate accounts, net |
|
(519 |
) |
|
101 |
|
Common stock issued for benefit plans |
|
(6 |
) |
|
(15 |
) |
Repurchase of common stock |
|
- |
|
|
(550 |
) |
Dividends paid to preferred stockholders |
|
(71 |
) |
|
- |
|
Dividends paid to common stockholders |
|
(229 |
) |
|
(234 |
) |
Other |
|
- |
|
|
(1 |
) |
Net cash provided by (used in) financing activities |
|
2,012 |
|
|
5,708 |
|
Net increase (decrease) in cash, invested cash and restricted cash |
|
(814 |
) |
|
(1,140 |
) |
Cash, invested cash and restricted cash as of beginning-of-year |
|
3,343 |
|
|
2,612 |
|
Cash, invested cash and restricted cash as of end-of-period |
$ |
2,529 |
|
$ |
1,472 |
|
LINCOLN NATIONAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies
Nature of Operations
Lincoln National Corporation and its subsidiaries (“LNC” or the “Company,” which also may be referred to as “we,” “our” or “us”) operate multiple insurance businesses through four business segments: Annuities, Life Insurance, Group Protection and Retirement Plan Services. In addition, we include financial data for operations that are not directly related to our business segments in Other Operations. The collective group of businesses uses “Lincoln Financial Group” as its marketing identity. Through our business segments, we sell a wide range of wealth accumulation, wealth protection, group protection and retirement income products and solutions. These products primarily include fixed and variable annuities, fixed indexed annuities, indexed variable annuities, also referred to as registered index-linked annuities (“RILA”), universal life insurance (“UL”), variable universal life insurance (“VUL”), linked-benefit UL and VUL, indexed universal life insurance (“IUL”), term life insurance, group life, disability and dental and employer-sponsored retirement plans and services. For more information on our segments and the products and solutions we provide, see Note 17.
Basis of Presentation
The accompanying unaudited consolidated financial statements are prepared in accordance with United States of America generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions for the Securities and Exchange Commission (“SEC”) Quarterly Report on Form 10-Q, including Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. The information contained in the Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K/A for the year ended December 31, 2022 (“2022 Form 10-K/A”), as updated by our Current Report on Form 8-K filed with the SEC on May 22, 2023 (the “May 2023 Form 8-K”), should be read in connection with the reading of these interim unaudited consolidated financial statements. Certain GAAP policies, which significantly affect the determination of financial condition, results of operations and cash flows, are summarized below.
In the opinion of management, these statements include all normal recurring adjustments necessary for a fair presentation of the Company’s results. Interim results for the nine months ended September 30, 2023, are not necessarily indicative of the results that may be expected for the full year ending December 31, 2023. All material inter-company accounts and transactions have been eliminated in consolidation.
Certain amounts reported in prior periods’ consolidated financial statements have been reclassified to conform to the presentation adopted in the current period.
We present disaggregated disclosures in the Notes below for long-duration insurance balances, applying the level of aggregation by reportable segment as follows:
|
|
|
Reportable Segment |
Level of Aggregation |
|
Annuities |
Variable Annuities |
|
|
Fixed Annuities |
|
|
Payout Annuities |
|
Life Insurance |
Traditional Life |
|
|
UL and Other |
|
Group Protection |
Group Protection |
|
Retirement Plan Services |
Retirement Plan Services |
|
The fixed annuities level of aggregation represents deferred fixed annuities. We have excluded amounts reported in Other Operations from our disaggregated disclosures that are attributable to the indemnity reinsurance agreements with Protective Life Insurance Company (“Protective”) and Swiss Re Life & Health America, Inc (“Swiss Re”) as these contracts are fully reinsured, run-off institutional pension business in the form of group annuity and the results of certain disability income business and not reflected in the results of the reportable segments listed above.
Summary of Significant Accounting Policies
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of LNC and all other entities in which we have a controlling financial interest and any variable interest entities (“VIEs”) in which we are the primary beneficiary. We use the equity method of accounting to recognize all of our investments in limited liability partnerships.
All material inter-company accounts and transactions have been eliminated in consolidation.
Our involvement with VIEs is primarily to invest in assets that allow us to gain exposure to a broadly diversified portfolio of asset classes. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support or where investors lack certain characteristics of a controlling financial interest. We assess our contractual, ownership or other interests in a VIE to determine if our interest participates in the variability the VIE was designed to absorb and pass onto variable interest holders. We perform an ongoing qualitative assessment of our variable interests in VIEs to determine whether we have a controlling financial interest and would therefore be considered the primary beneficiary of the VIE. If we determine we are the primary beneficiary of a VIE, we consolidate the assets and liabilities of the VIE in the consolidated financial statements.
Accounting Estimates and Assumptions
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions affecting the reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses for the reporting period. In applying these estimates and assumptions, management makes subjective and complex judgments that frequently require assumptions about matters that are uncertain and inherently subject to change, including matters related to or impacted by the COVID-19 pandemic. Actual results could differ from these estimates and assumptions. Included among the material (or potentially material) reported amounts and disclosures that require use of estimates are: fair value of certain financial assets, derivatives, allowances for credit losses, deferred acquisition costs (“DAC”), value of business acquired (“VOBA”), deferred sales inducements (“DSI”), goodwill and other intangibles, market risk benefits (“MRBs”), future contract benefits, deferred front-end loads (“DFEL”), pension plans, stock-based incentive compensation, income taxes including the recoverability of our deferred tax assets, and the potential effects of resolving litigated matters.
Business Combinations
We use the acquisition method of accounting for all business combination transactions, and accordingly, recognize the fair values of assets acquired, liabilities assumed and any noncontrolling interests in the consolidated financial statements. The allocation of fair values may be subject to adjustment after the initial allocation for up to a one-year period as more information becomes available relative to the fair values as of the acquisition date. The consolidated financial statements include the results of operations of any acquired company since the acquisition date.
Fair Value Measurement
Our measurement of fair value is based on assumptions used by market participants in pricing the asset or liability, which may include inherent risk, restrictions on the sale or use of an asset or non-performance risk, which would include our own credit risk. Our estimate of an exchange price is the price in an orderly transaction between market participants to sell the asset or transfer the liability (“exit price”) in the principal market, or the most advantageous market in the absence of a principal market, for that asset or liability, as opposed to the price that would be paid to acquire the asset or receive a liability (“entry price”). Pursuant to the Fair Value Measurements and Disclosures Topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards CodificationTM (“ASC”), we categorize our financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique. The three-level hierarchy for fair value measurement is defined as follows:
Level 1 – inputs to the valuation methodology are quoted prices available in active markets for identical investments as of the reporting date, except for large holdings subject to “blockage discounts” that are excluded;
Level 2 – inputs to the valuation methodology are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date, and fair value can be determined through the use of models or other valuation methodologies; and
Level 3 – inputs to the valuation methodology are unobservable inputs in situations where there is little or no market activity for the asset or liability, and we make estimates and assumptions related to the pricing of the asset or liability, including assumptions regarding risk.
In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.
When a determination is made to classify an asset or liability within Level 3 of the fair value hierarchy, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. Because certain securities trade in less liquid or illiquid markets with limited or no pricing information, the determination of fair value for these securities is inherently more difficult. However, Level 3 fair value investments may include, in addition to the unobservable or Level 3 inputs, observable components, which are components that are actively quoted or can be validated to market-based sources.
Fixed Maturity Available-For-Sale Securities – Fair Valuation Methodologies and Associated Inputs
Securities classified as available-for-sale (“AFS”) consist of fixed maturity securities and are stated at fair value with unrealized gains and losses included within accumulated other comprehensive income (loss) (“AOCI”), net of the effect on future contract benefits and policyholder account balances that would result from the realization of the unrealized gains and losses. We measure the fair value of our securities classified as fixed maturity AFS based on assumptions used by market participants in pricing the security. The most appropriate valuation methodology is selected based on the specific characteristics of the fixed maturity security, and we consistently apply the valuation methodology to measure the security’s fair value. Our fair value measurement is based on a market approach that utilizes prices and other relevant information generated by market transactions involving identical or comparable securities. Sources of inputs to the market approach primarily include third-party pricing services, independent broker quotations or pricing matrices. We do not adjust prices received from third parties; however, we do analyze the third-party pricing services’ valuation methodologies and related inputs and perform additional evaluation to determine the appropriate level within the fair value hierarchy.
The observable and unobservable inputs to our valuation methodologies are based on a set of standard inputs that we generally use to evaluate all of our fixed maturity AFS securities. Observable inputs include benchmark yields, reported trades, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data. In addition, market indicators, industry and economic events are monitored, and further market data is acquired if certain triggers are met. For certain security types, additional inputs may be used, or some of the inputs described above may not be applicable. For private placement securities, we use pricing matrices that utilize observable pricing inputs of similar public securities and Treasury yields as inputs to the fair value measurement. Depending on the type of security or the daily market activity, standard inputs may be prioritized differently or may not be available for all fixed maturity AFS securities on any given day. For broker-quoted only securities, non-binding quotes from market makers or broker-dealers are obtained from sources recognized as market participants. For securities trading in less liquid or illiquid markets with limited or no pricing information, we use unobservable inputs to measure fair value.
The following summarizes our fair valuation methodologies and associated inputs, which are particular to the specified security type and are in addition to the defined standard inputs to our valuation methodologies for all of our fixed maturity AFS securities discussed above:
Corporate bonds and U.S. government bonds – We also use Trade Reporting and Compliance EngineTM reported tables for our corporate bonds and vendor trading platform data for our U.S. government bonds.
Mortgage- and asset-backed securities (“ABS”) – We also utilize additional inputs, which include new issues data, monthly payment information and monthly collateral performance, including prepayments, severity, delinquencies, step-down features and over collateralization features for each of our mortgage-backed securities (“MBS”), which include collateralized mortgage obligations and mortgage pass through securities backed by residential mortgages (“RMBS”), commercial mortgage-backed securities (“CMBS”) and collateralized loan obligations (“CLOs”).
State and municipal bonds – We also use additional inputs that include information from the Municipal Securities Rule Making Board, as well as material event notices, new issue data, issuer financial statements and Municipal Market Data benchmark yields for our state and municipal bonds.
Hybrid and redeemable preferred securities – We also utilize additional inputs of exchange prices (underlying and common stock of the same issuer) for our hybrid and redeemable preferred securities.
In order to validate the pricing information and broker-dealer quotes, we employ, where possible, procedures that include comparisons with similar observable positions, comparisons with subsequent sales and observations of general market movements for those security classes. We have policies and procedures in place to review the process that is utilized by our third-party pricing service and the output that is provided to us by the pricing service. On a periodic basis, we test the pricing for a sample of securities to evaluate the inputs and assumptions used by the pricing service, and we perform a comparison of the pricing service output to an alternative pricing source. We also evaluate prices provided by our primary pricing service to ensure that they are not stale or unreasonable by reviewing the prices for unusual changes from period to period based on certain parameters or for lack of change from one period to the next.
Fixed Maturity AFS Securities – Evaluation for Recovery of Amortized Cost
We regularly review our fixed maturity AFS securities (also referred to as “debt securities”) for declines in fair value that we determine to be impairment-related, including those attributable to credit risk factors that may require a credit loss allowance. For our debt securities, we generally consider the following to determine whether our debt securities with unrealized losses are credit impaired:
The estimated range and average period until recovery;
The estimated range and average holding period to maturity;
Remaining payment terms of the security;
Current delinquencies and nonperforming assets of underlying collateral;
Expected future default rates;
Collateral value by vintage, geographic region, industry concentration or property type;
Subordination levels or other credit enhancements as of the balance sheet date as compared to origination; and
Contractual and regulatory cash obligations.
For a debt security, if we intend to sell a security, or it is more likely than not we will be required to sell a debt security before recovery of its amortized cost basis and the fair value of the debt security is below amortized cost, we conclude that an impairment has occurred and the amortized cost is written down to current fair value, with a corresponding charge to realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss). If we do not intend to sell a debt security, or it is not more likely than not we will be required to sell a debt security before recovery of its amortized cost basis but the present value of the cash flows expected to be collected is less than the amortized cost of the debt security (referred to as the credit loss), we conclude that an impairment has occurred, and a credit loss allowance is recorded, with a corresponding charge to realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss). The remainder of the decline to fair value related to factors other than credit loss is recorded in other comprehensive income (“OCI”) to unrealized losses on fixed maturity AFS securities on the Consolidated Statements of Stockholders’ Equity, as this amount is considered a noncredit impairment.
When assessing our intent to sell a debt security, or if it is more likely than not we will be required to sell a debt security before recovery of its cost basis, we evaluate facts and circumstances such as, but not limited to, decisions to reposition our security portfolio, sales of securities to meet cash flow needs and sales of securities to capitalize on favorable pricing. Management considers the following as part of the evaluation:
The current economic environment and market conditions;
Our business strategy and current business plans;
The nature and type of security, including expected maturities and exposure to general credit, liquidity, market and interest rate risk;
Our analysis of data from financial models and other internal and industry sources to evaluate the current effectiveness of our hedging and overall risk management strategies;
The current and expected timing of contractual maturities of our assets and liabilities, expectations of prepayments on investments and expectations for surrenders and withdrawals of annuity contracts and life insurance policies;
The capital risk limits approved by management; and
Our current financial condition and liquidity demands.
In order to determine the amount of the credit loss for a debt security, we calculate the recovery value by performing a discounted cash flow analysis based on the current cash flows and future cash flows we expect to recover. The discount rate is the effective interest rate implicit in the underlying debt security. The effective interest rate is the original yield, or the coupon if the debt security was previously impaired. See the discussion below for additional information on the methodology and significant inputs, by security type, that we use to determine the amount of a credit loss.
To determine the recovery period of a debt security, we consider the facts and circumstances surrounding the underlying issuer including, but not limited to, the following:
Historical and implied volatility of the security;
The extent to which the fair value has been less than amortized cost;
Adverse conditions specifically related to the security or to specific conditions in an industry or geographic area;
Failure, if any, of the issuer of the security to make scheduled payments; and
Recoveries or additional declines in fair value subsequent to the balance sheet date.
In periods subsequent to the recognition of a credit loss impairment through a credit loss allowance, we continue to reassess the expected cash flows of the debt security at each subsequent measurement date as necessary. If the measurement of credit loss changes, we recognize a provision for (or reversal of) credit loss expense through realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss), limited by the amount that amortized cost exceeds fair value. Losses are charged against the allowance for credit losses when management believes the uncollectibility of a debt security is confirmed or when either of the criteria regarding intent or requirement to sell is met. Accrued interest on debt securities is written-off through net investment income on the Consolidated Statements of Comprehensive Income (Loss) when deemed uncollectible.
To determine the recovery value of a corporate bond or CLO, we perform additional analysis related to the underlying issuer including, but not limited to, the following:
Fundamentals of the issuer to determine what we would recover if they were to file bankruptcy versus the price at which the market is trading;
Fundamentals of the industry in which the issuer operates;
Earnings multiples for the given industry or sector of an industry that the underlying issuer operates within, divided by the outstanding debt to determine an expected recovery value of the security in the case of a liquidation;
Expected cash flows of the issuer (e.g., whether the issuer has cash flows in excess of what is required to fund its operations);
Expectations regarding defaults and recovery rates;
Changes to the rating of the security by a rating agency; and
Additional market information (e.g., if there has been a replacement of the corporate debt security).
Each quarter, we review the cash flows for the MBS portfolio, including current credit enhancements and trends in the underlying collateral performance to determine whether or not they are sufficient to provide for the recovery of our amortized cost. To determine recovery value of a MBS, we perform additional analysis related to the underlying issuer including, but not limited to, the following:
Discounted cash flow analysis based on the current cash flows and future cash flows we expect to recover;
Level of borrower creditworthiness of the home equity loans or residential mortgages that back an RMBS or commercial mortgages that back a CMBS;
Susceptibility to fair value fluctuations for changes in the interest rate environment;
Susceptibility to reinvestment risks, in cases where market yields are lower than the securities’ book yield earned;
Susceptibility to reinvestment risks, in cases where market yields are higher than the book yields earned on a security;
Expectations of sale of such a security where market yields are higher than the book yields earned on a security; and
Susceptibility to variability of prepayments.
When evaluating MBS and mortgage-related ABS, we consider a number of pool-specific factors as well as market level factors when determining whether or not the impairment on the security requires a credit loss allowance. The most important factor is the performance of the underlying collateral in the security and the trends of that performance in the prior periods. We use this information about the collateral to forecast the timing and rate of mortgage loan defaults, including making projections for loans that are already delinquent and for those loans that are currently performing but may become delinquent in the future. Other factors used in this analysis include the credit characteristics of borrowers, geographic distribution of underlying loans and timing of liquidations by state. Once default rates and timing assumptions are determined, we then make assumptions regarding the severity of a default if it were to occur. Factors that impact the severity assumption include expectations for future home price appreciation or depreciation, loan size, first lien versus second lien, existence of loan level private mortgage insurance, type of occupancy and geographic distribution of loans. Once default and severity assumptions are determined for the security in question, cash flows for the underlying collateral are projected including expected defaults and prepayments. These cash flows on the collateral are then translated to cash flows on our tranche based on the cash flow waterfall of the entire capital security structure. If this analysis indicates the entire principal on a particular security will not be returned, the security is reviewed for a credit loss by comparing the expected cash flows to amortized cost. To the extent that the security has already been impaired through a credit loss allowance or was purchased at a discount, such that the amortized cost of the security is less than or equal to the present value of cash flows expected to be collected, no credit loss allowance is required. Otherwise, if the amortized cost of the security is greater than the present value of the cash flows expected to be collected, and the security was not purchased at a discount greater than the expected principal loss, then an impairment through a credit loss allowance is recognized.
We further monitor the cash flows of all of our debt securities backed by mortgages on an ongoing basis. We also perform detailed analysis on all of our subprime, Alt-A, non-agency residential MBS and on a significant percentage of our debt securities backed by pools of commercial mortgages. The detailed analysis includes revising projected cash flows by updating the cash flows for actual cash received and applying assumptions with respect to expected defaults, foreclosures and recoveries in the future. These revised projected cash flows are then compared to the amount of credit enhancement (subordination) in the structure to determine whether the amortized cost of the security is recoverable. If it is not recoverable, we record an impairment through a credit loss allowance for the security.
Trading Securities
Trading securities consist of fixed maturity securities in designated portfolios, some of which support modified coinsurance and coinsurance with funds withheld reinsurance agreements. Investment results for the portfolios that support modified coinsurance and coinsurance with funds withheld reinsurance agreements, including gains and losses from sales, are passed directly to the reinsurers pursuant to contractual terms of the reinsurance agreements. Trading securities are carried at fair value, and changes in fair value and changes in the fair value of embedded derivative liabilities associated with the underlying reinsurance agreements are recorded in realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss) as they occur.
Equity Securities
Equity securities are carried at fair value, and changes in fair value are recorded in realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss) as they occur. Equity securities consist primarily of common stock of publicly-traded companies, privately placed securities and mutual fund shares. We measure the fair value of our equity securities based on assumptions used by market participants in pricing the security. The most appropriate valuation methodology is selected based on the specific characteristics of the equity security. Fair values of publicly-traded equity securities are determined using quoted prices in active markets for identical or comparable securities. When quoted prices are not available, we use valuation methodologies most appropriate for the specific asset. Fair values for private placement securities are determined using discounted cash flow, earnings multiple and other valuation models. The fair values of mutual fund shares that transact regularly are based on transaction prices of identical fund shares.
Mortgage Loans on Real Estate
Mortgage loans on real estate consist of commercial and residential mortgage loans and are generally carried at unpaid principal balances adjusted for amortization of premiums and accretion of discounts and are net of allowance for credit losses. We carry certain mortgage loans associated with modified coinsurance agreements at fair value where the fair value option has been elected. Interest income is accrued on the principal balance of the loan based on the loan’s contractual interest rate.
Premiums and discounts are amortized using the effective yield method over the life of the loan. Interest income and amortization of premiums and discounts are reported in net investment income on the Consolidated Statements of Comprehensive Income (Loss) along with mortgage loan fees, which are recorded as they are incurred.
Our policy for commercial mortgage loans is to report loans that are 60 or more days past due, which equates to two or more payments missed, as delinquent. Our policy for residential mortgage loans is to report loans that are 90 or more days past due, which equates to three or more payments missed, as delinquent. We do not accrue interest on loans 90 days past due, and any interest received on these loans is either applied to the principal or recorded in net investment income on the Consolidated Statements of Comprehensive Income (Loss) when received, depending on the assessment of the collectability of the loan. We resume accruing interest once a loan complies with all of its original terms or restructured terms. Mortgage loans deemed uncollectible are charged against the allowance for credit losses, and subsequent recoveries, if any, are likewise credited to the allowance for credit losses. Accrued interest on mortgage loans is written-off when deemed uncollectible.
In connection with our recognition of an allowance for credit losses for mortgage loans on real estate, we perform a quantitative analysis using a probability of default/loss given default/exposure at default approach to estimate expected credit losses in our mortgage loan portfolio as well as unfunded commitments related to commercial mortgage loans, exclusive of certain mortgage loans held at fair value. Our model estimates expected credit losses over the contractual terms of the loans, which are the periods over which we are exposed to credit risk, adjusted for expected prepayments. Credit loss estimates are segmented by commercial mortgage loans, residential mortgage loans, and unfunded commitments related to commercial mortgage loans.
The allowance for credit losses for pooled loans of similar risk (i.e., commercial and residential mortgage loans) is estimated using relevant historical credit loss information adjusted for current conditions and reasonable and supportable forecasts of future conditions. Historical credit loss experience provides the basis for the estimation of expected credit losses with adjustments for differences in current loan-specific risk characteristics, such as differences in underwriting standards, portfolio mix, delinquency level, or term lengths as well as adjustments for changes in environmental conditions, such as unemployment rates, property values, or other factors that management deems relevant. We apply probability weights to the positive, base and adverse scenarios we use. For periods beyond our reasonable and supportable forecast, we use implicit mean reversion over the remaining life of the recoverable, meaning our model will inherently revert to the baseline scenario as the baseline is representative of the historical average over a longer period of time.
Loans are considered impaired when it is probable that, based upon current information and events, we will be unable to collect all amounts due under the contractual terms of the loan agreement. When we determine that a loan is impaired, a specific credit loss allowance is established for the excess carrying value of the loan over its estimated value. The loan’s estimated value is based on: the present value of expected future cash flows discounted at the loan’s effective interest rate; the loan’s observable market price; or the fair value of the loan’s collateral.
Allowance for credit losses are maintained at a level we believe is adequate to absorb current expected lifetime credit losses. Our periodic evaluation of the adequacy of the allowance for credit losses is based on historical loss experience, known and inherent risks in the portfolio, adverse situations that may affect the borrower’s ability to repay (including the timing of future payments), the estimated value of the underlying collateral, composition of the loan portfolio, current economic conditions, reasonable and supportable forecasts about the future and other relevant factors.
Mortgage loans on real estate are presented net of the allowance for credit losses on the Consolidated Balance Sheets. Changes in the allowance are reported in realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss). Mortgage loans on real estate deemed uncollectible are charged against the allowance for credit losses, and subsequent recoveries, if any, are credited to the allowance for credit losses, limited to the aggregate of amounts previously charged-off and expected to be charged-off.
Our commercial loan portfolio is primarily comprised of long-term loans secured by existing commercial real estate. We believe all of the commercial loans in our portfolio share three primary risks: borrower credit worthiness; sustainability of the cash flow of the property; and market risk; therefore, our methods of monitoring and assessing credit risk are consistent for our entire portfolio.
For our commercial mortgage loan portfolio, trends in market vacancy and rental rates are incorporated into the analysis that we perform for monitored loans and may contribute to the establishment of (or an increase or decrease in) an allowance for credit losses. In addition, we review each loan individually in our commercial mortgage loan portfolio on an annual basis to identify emerging risks. We focus on properties that experienced a reduction in debt-service coverage or that have significant exposure to tenants with deteriorating credit profiles. Where warranted, we establish or increase a credit loss allowance for a specific loan based upon this analysis.
We measure and assess the credit quality of our commercial mortgage loans by using loan-to-value and debt-service coverage ratios. The loan-to-value ratio compares the principal amount of the loan to the fair value at origination of the underlying property collateralizing the loan and is commonly expressed as a percentage. Loan-to-value ratios greater than 100% indicate that the principal amount is greater than the collateral value. Therefore, all else being equal, a lower loan-to-value ratio generally indicates a higher quality loan. The debt-service coverage ratio compares a property’s net operating income to its debt-service payments. Debt-service coverage ratios of less than 1.0 indicate that property operations do not generate enough income to cover its current debt payments. Therefore, all else being equal, a higher debt-service coverage ratio generally indicates a higher quality loan.
These credit quality metrics are monitored and reviewed at least annually.
We have off-balance sheet commitments related to commercial mortgage loans. As such, an allowance for credit losses is developed based on the commercial mortgage loan process outlined above, along with an internally developed conversion factor.
Our residential loan portfolio is primarily comprised of first lien mortgages secured by existing residential real estate. In contrast to the commercial mortgage loan portfolio, residential mortgage loans are primarily smaller-balance homogenous loans that share similar risk characteristics. Therefore, these pools of loans are collectively evaluated for inherent credit losses. Such evaluations consider numerous factors, including, but not limited to borrower credit scores, collateral values, loss forecasts, geographic location, delinquency rates and economic trends. These evaluations and assessments are revised as conditions change and new information becomes available, including updated forecasts, which can cause the allowance for credit losses to increase or decrease over time as such evaluations are revised. Generally, residential mortgage loan pools exclude loans that are nonperforming, as those loans are evaluated individually using the evaluation framework for specific allowance for credit losses described above.
For residential mortgage loans, our primary credit quality indicator is whether the loan is performing or nonperforming. We generally define nonperforming residential mortgage loans as those that are 90 or more days past due and/or in nonaccrual status. There is generally a higher risk of experiencing credit losses when a residential mortgage loan is nonperforming. We monitor and update aging schedules and nonaccrual status on a monthly basis.
Policy Loans
Policy loans represent loans we issue to policyholders that use the cash surrender value of their life insurance policy as collateral. Policy loans are carried at unpaid principal balances.
Derivative Instruments
We hedge certain portions of our exposure to interest rate risk, foreign currency exchange risk, equity market risk, basis risk, commodity risk and credit risk by entering into derivative transactions. Our derivative instruments are recognized as either assets or liabilities on the Consolidated Balance Sheets at estimated fair value. We have master netting agreements with each of our derivative counterparties that allow for the netting of our derivative asset and liability positions by counterparty. We categorize derivatives into a three-level hierarchy, based on the priority of the inputs to the respective valuation technique as discussed above in “Fair Value Measurement.” The accounting for changes in the estimated fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship, and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, we designate the hedging instrument based upon the exposure being hedged: as a cash flow hedge or a fair value hedge.
For derivative instruments that are designated and qualify as a cash flow hedge, the gain or loss on the derivative instrument is reported as a component of AOCI and reclassified into net income in the same period or periods during which the hedged transaction affects net income. For derivative instruments that are designated and qualify as a fair value hedge, the gain or loss on the derivative instrument, as well as the offsetting gain or loss on the hedged item attributable to the hedged risk are recognized in net income during the period of change in estimated fair values. For derivative instruments not designated as hedging instruments, but that are economic hedges, the gain or loss is recognized in net income.
We purchase and issue financial instruments and products that contain embedded derivative instruments that are recorded with the associated host contract. When it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is bifurcated from the host for measurement purposes and reported within other assets or other liabilities on the Consolidated Balance Sheets. The embedded derivative is carried at fair value with changes in fair value recognized in net income during the period of change.
We employ several different methods for determining the fair value of our derivative instruments. The fair value of our derivative contracts are measured based on current settlement values, which are based on quoted market prices, industry standard models that are commercially available and broker quotes. These techniques project cash flows of the derivatives using current and implied future market conditions. We calculate the present value of the cash flows to measure the current fair market value of the derivative.
Other Investments
Other investments consist primarily of alternative investments, cash collateral receivables related to our derivative instruments, Federal Home Loan Bank (“FHLB”) common stock and short-term investments.
Alternative investments consist primarily of investments in limited partnerships (“LPs”). We account for our investments in LPs using the equity method to determine the carrying value. Recognition of alternative investment income is delayed due to the availability of the related financial statements, which are generally obtained from the partnerships’ general partners. As a result, our private equity investments are generally on a three-month delay and our hedge funds are on a one-month delay.
In addition, the impact of audit adjustments related to completion of calendar-year financial statement audits of the investees are typically received during the second quarter of each calendar year. Accordingly, our investment income from alternative investments for any calendar-year period may not include the complete impact of the change in the underlying net assets for the partnership for that calendar-year period.
In uncleared derivative transactions, we and the counterparty enter into a credit support annex requiring either party to post collateral, which may be in the form of cash, equal to the net derivative exposure. Cash collateral we have posted to a counterparty is recorded within other investments. Cash collateral a counterparty has posted is recorded within payables for collateral on investments. We also have investments in FHLB common stock, carried at cost, that enable access to the FHLB lending program. For more information on our collateralized financing arrangements, see “Payables for Collateral on Investments” below.
Short-term investments consist of securities with original maturities of one year or less, but greater than three months. Securities included in short-term investments are carried at fair value, with valuation methods and inputs consistent with those applied to fixed maturity AFS securities.
Cash and Invested Cash
Cash and invested cash is carried at cost and includes all highly liquid debt instruments purchased with an original maturity of three months or less.
DAC, VOBA, DSI and DFEL
Acquisition costs directly related to successful contract acquisitions or renewals of annuities, UL, VUL, traditional life insurance, group life and disability insurance, and other investment contracts have been deferred (i.e., DAC). Such acquisition costs are capitalized in the period they are incurred and primarily include commissions, certain bonuses, a portion of total compensation and benefits of certain employees involved in the acquisition process and medical and inspection fees. VOBA is an intangible asset that reflects the estimated fair value of in-force contracts in a life insurance company acquisition and represents the portion of the purchase price that is allocated to the value of the right to receive future cash flows from the business in force at the acquisition date. Bonus credits and excess interest for dollar cost averaging contracts are considered DSI and reported in deferred acquisition costs, value of business acquired and deferred sales inducements on the Consolidated Balance Sheets. Contract sales charges that are collected in the early years of an insurance contract are deferred and reported as deferred front-end loads (i.e., DFEL) on the Consolidated Balance Sheets.
DAC, VOBA, DSI and DFEL amortization is reported within the following financial statement line items on the Consolidated Statements of Comprehensive Income (Loss):
DAC and VOBA – commissions and other expenses
DSI – interest credited
DFEL – fee income
DAC, VOBA, DSI and DFEL are amortized on a constant level basis relative to the insurance in force over the expected term of the related contracts using the groupings and actuarial assumptions that are consistent with those used for calculating the related policyholder liability balances. Actuarial assumptions include, but are not limited to, mortality, morbidity and certain policyholder behaviors such as persistency, which are adjusted for emerging experience and expected trends of the related long-duration insurance contracts and certain investment contracts by each reportable segment. During the third quarter of each year, we conduct our comprehensive review and update these actuarial assumptions. We may update our actuarial assumptions in other quarters as we become aware of information that warrants updating outside of our comprehensive review. These resulting changes are applied prospectively.
The following provides a summary of our DAC, VOBA, DSI and DFEL amortization basis and expected amortization period by reportable segment:
|
|
|
Reportable Segment |
Amortization Basis |
Expected Amortization Period |
Annuities |
Total deposits paid to date on policies in force |
Between 30 to 40 years |
Life Insurance |
Policy count of policies in force |
On average 60 years |
Group Protection |
Group certificate contracts in force |
4 years |
Retirement Plan Services |
Lives in force |
Between 40 to 50 years |
We account for modifications of insurance contracts that result in a substantially unchanged contract as a continuation of the replaced contract. We account for modifications of insurance contracts that result in a substantially changed contract as an extinguishment of the replaced contract.
For reinsurance transactions where we receive proceeds that represent recovery of our previously incurred acquisition costs, we reduce the applicable unamortized acquisition cost such that net acquisition costs are capitalized and charged to commissions and other expenses.
Reinsurance
Our insurance subsidiaries enter into reinsurance agreements in the normal course of business to limit our exposure to the risk of loss and to enhance our capital management.
In order for a reinsurance agreement to qualify for reinsurance accounting, the agreement must satisfy certain risk transfer conditions that include, among other items, a reasonable possibility of a significant loss for the assuming entity. When we apply reinsurance accounting, premiums, benefits and DAC amortization are reported net of reinsurance ceded, as applicable, on the Consolidated Statements of Comprehensive Income (Loss). Amounts currently recoverable, such as ceded reserves, other than ceded MRBs, are reported in reinsurance recoverables, and amounts currently payable to the reinsurers, such as premiums, are included in other liabilities on the Consolidated Balance Sheets.
We use deposit accounting to recognize reinsurance agreements that do not transfer significant insurance risk. This accounting treatment results in amounts paid or received by our insurance subsidiaries to be considered on deposit with the reinsurer and such amounts are reported in other assets and other liabilities, respectively, on the Consolidated Balance Sheets. As amounts are paid or received, consistent with the underlying contracts, deposit assets or liabilities are adjusted. When there is a contractual right of offset, assets and liabilities and revenues and expenses from certain reinsurance contracts that grant statutory surplus relief to our insurance companies are netted on the Consolidated Balance Sheets and Consolidated Statements of Comprehensive Income (Loss), respectively.
Reinsurance recoverables are measured and recognized consistent with the liabilities related to the underlying contracts. The interest assumption used for discounting reinsurance recoverables associated with non-participating traditional life insurance contracts and limited payment life-contingent annuity contracts is the upper-medium grade fixed income instrument (“single-A”) interest rate locked-in at the reinsurance contract issuance date. We remeasure reinsurance recoverables associated with non-participating traditional life insurance contracts and limited payment life-contingent annuity contracts with the current single-A interest rate as of the end of each reporting period. Ceded MRBs are accounted for separately from reinsurance recoverables. See “MRBs” below for additional information. The cost of reinsurance related to long-duration contracts is accounted for over the life of the underlying reinsured policies using assumptions consistent with those used to account for the underlying policies and is reported within other assets on the Consolidated Balance Sheets.
We estimated an allowance for credit losses for all reinsurance recoverables and related reinsurance deposit assets held by our subsidiaries, other than ceded MRB assets. As such, we performed a quantitative analysis using a probability of loss model approach to estimate expected credit losses for reinsurance recoverables, inclusive of similar assets recognized using the deposit method of accounting. The credit loss allowance is a general allowance for pools of receivables with similar risk characteristics segmented by credit risk ratings and receivables assessed on an individual basis that do not share similar risk characteristics where we anticipate a credit loss over the life of reinsurance-related assets, other than ceded MRB assets.
Our model uses relevant internal or external historical loss information adjusted for current conditions and reasonable and supportable forecasts of future events and conditions in developing our credit loss estimate. We utilized historical credit rating data to form an estimation of probability of default of counterparties by means of a transition matrix that provides the rates of credit migration for credit ratings transitioning to impairment. We updated reinsurer credit ratings during the period to incorporate the most up-to-date information on the current state of the financial stability of our reinsurers. To simulate changes in economic conditions, we used positive, base and adverse scenarios that include varying levels of loss given default assumptions to reflect the impact of changes in severity of losses. We applied probability weights to the positive, base and adverse scenarios. For periods beyond our reasonable and supportable forecasts, we used implicit mean reversion over the remaining life of the recoverable. Additionally, we considered factors that impact our exposure at default that are driven by actuarial expectations around term assumptions rather than being directly driven by market or economic environment.
Our model estimates the expected credit losses over the life of the reinsurance asset. Credit loss estimates are segmented based on counterparty credit risk. Our modeling process utilizes counterparty credit ratings, collateral types and amounts, and term and run-off assumptions. For reinsurance recoverables that do not share similar risk characteristics, we assessed on an individual basis to determine a specific credit loss allowance.
We estimated expected credit losses over the contractual term of the recoverable, which is the period during which we are exposed to the credit risk. Reinsurance recoverables may not have explicit contractual lives, but are tied to the underlying insurance products; as a result, we estimated the contractual life by utilizing actuarial estimates of the timing of payouts related to those underlying products.
Reinsurance agreements often require the reinsurer to collateralize the recoverable with funds in a trust account or with a letter of credit for the benefit of the ceding insurance entity that can reduce the expected credit losses on a given agreement. As such, we review reinsurance collateral by individual agreement to sensitize risk of loss based on level of collateralization. This review is driven by the assumption that non-collateralized reinsurance recoverables would have materially higher losses in times of default. Therefore, reinsurance recoverables are pooled as either fully-collateralized or non-collateralized.
Reinsurance recoverables are presented net of the allowance for credit losses on the Consolidated Balance Sheets. Changes in the allowance for credit losses are reported in realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).
Reinsurance recoverables deemed uncollectible are charged against the allowance for credit losses, and subsequent recoveries, if any, are credited to the allowance for credit losses, limited to the aggregate of amounts previously charged-off and expected to be charged-off.
Goodwill
We recognize the excess of the purchase price, plus the fair value of any noncontrolling interest in the acquiree, over the fair value of identifiable net assets acquired as goodwill. Goodwill is not amortized, but is reviewed for impairment annually as of October 1 and more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value.
We perform a quantitative goodwill impairment test where the fair value of the reporting unit is determined and compared to the carrying value of the reporting unit. If the carrying value of the reporting unit is greater than the reporting unit’s fair value, goodwill is impaired and written down to the reporting unit’s fair value; and a charge is reported in impairment of intangibles on the Consolidated Statements of Comprehensive Income (Loss). The results of one goodwill impairment test on one reporting unit cannot subsidize the results of another reporting unit.
Other Assets and Other Liabilities
Other assets consist primarily of certain reinsurance assets, net of allowance for credit losses, current and deferred taxes, premiums and fees receivable, property and equipment, balances associated with corporate-owned and bank-owned life insurance, receivables resulting from sales of securities that had not yet settled as of the balance sheet date, specifically identifiable intangible assets, operating lease right-of-use (“ROU”) assets, finance lease assets, ceded MRB liabilities and other receivables and prepaid expenses. Other liabilities consist primarily of certain reinsurance payables, pension and other employee benefit liabilities, certain financing arrangements, derivative instrument liabilities, ceded MRB assets, other policyholder liabilities, deferred gain on business sold through reinsurance, long-term operating lease liabilities, payables resulting from purchases of securities that had not yet settled as of the balance sheet date, finance lease liabilities and other accrued expenses.
The carrying values of specifically identifiable intangible assets are reviewed at least annually for indicators of impairment in value that are related to credit loss or non-credit, including unexpected or adverse changes in the following: the economic or competitive environments in which the company operates; profitability analyses; cash flow analyses; and the fair value of the relevant business operation. If there was an indication of impairment, then the discounted cash flow method would be used to measure the impairment, and the carrying value would be adjusted as necessary and reported in impairment of intangibles on the Consolidated Statements of Comprehensive Income (Loss). Sales force intangibles are attributable to the value of the new business distribution system acquired through business combinations. These assets are amortized on a straight-line basis over their useful life of 25 years. Specifically identifiable intangible assets also includes the value of customer relationships acquired (“VOCRA”) and value of distribution agreements (“VODA”). The carrying values of VOCRA and VODA are amortized using a straight-line basis over their weighted average life of 20 years and 13 years, respectively.
Property and equipment owned for company use is carried at cost less allowances for depreciation. Provisions for depreciation of investment real estate and property and equipment owned for company use are computed principally on the straight-line method over the estimated useful lives of the assets, which include buildings, computer hardware and software and other property and equipment. Certain assets on the Consolidated Balance Sheets are related to finance leases and certain financing arrangements and are depreciated in a manner consistent with our current depreciation policy for owned assets. We periodically review the carrying value of our long-lived assets, including property and equipment, for impairment whenever events or circumstances indicate that the carrying amount of such assets may not be fully recoverable. For long-lived assets to be held and used, impairments are recognized when the carrying amount of a long-lived asset is not recoverable and exceeds its fair value. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. An impairment loss is measured as the amount by which the carrying amount of a long-lived asset exceeds its fair value.
Long-lived assets to be disposed of by abandonment or in an exchange for a similar productive long-lived asset are classified as held-for-use until they are disposed. Long-lived assets to be sold are classified as held-for-sale and are no longer depreciated. Certain criteria have to be met in order for the long-lived asset to be classified as held-for-sale, including that a sale is probable and expected to occur within one year. Long-lived assets classified as held-for-sale are recorded at the lower of their carrying amount or fair value less cost to sell.
We lease office space and certain equipment under various long-term lease agreements. We determine if an arrangement is a lease at inception. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. Our leases do not provide an implicit rate; therefore, we use our incremental borrowing rate at the commencement date in determining the present value of future payments. The ROU asset is calculated using the lease liability carrying amount, plus or minus prepaid/accrued lease payments, minus the unamortized balance of lease incentives received, plus unamortized initial direct costs. Lease terms used to calculate our lease obligation include options when we are reasonably certain that we will exercise such options. Our lease agreements may contain both lease and non-lease components, which are accounted for separately. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.
Other liabilities includes deferred gains on business sold through reinsurance. Effective October 1, 2021, we entered into a reinsurance agreement with Security Life of Denver Insurance Company (a subsidiary of Resolution Life that we refer to herein as “Resolution Life”). We are recognizing the gain related to this transaction over the projected life of the policies, or 30 years. Effective January 1, 2020, we entered into a reinsurance agreement with Swiss Re. We are recognizing the gain related to this transaction over the period in which the in-force policies are expected to run off, or 15 years. Effective October 1, 2018, we entered into a reinsurance agreement with Athene Holding Ltd. We are recognizing the gain related to this transaction over the period in which the majority of account balances is expected to run off, or 20 years.
Separate Account Assets and Liabilities
Separate accounts represent segregated funds that are maintained to meet specific investment objectives of policyholders who direct the investments and bear the investment risk, except to the extent of minimum guarantees made by the Company with respect to certain accounts. The assets of each account are legally segregated and are not subject to claims that arise out of any other business of the Company.
We report separate account assets as a summary total on the Consolidated Balance Sheets based on the fair value of the underlying investments. The underlying investments consist primarily of mutual funds, fixed maturity AFS securities, short-term investments and cash. Investment income and net realized and unrealized gains (losses) of the separate accounts generally accrue directly to the policyholders; therefore, they are not reflected on the Consolidated Statements of Comprehensive Income (Loss), and the Consolidated Statements of Cash Flows do not reflect investment activity of the separate accounts. Asset-based fees and contract administration charges (collectively referred to as “policyholder assessments”) are assessed against the accounts and included within fee income on the Consolidated Statements of Comprehensive Income (Loss). An amount equivalent to the separate account assets is recorded as separate account liabilities, representing the account balance obligated to be returned to the policyholder.
Future Contract Benefits
Future contract benefits represent liability reserves, including liability for future policy benefits (“LFPB”), liability for future claims reserves and additional liability for other insurance benefits that we have established and carry based on estimates of how much we will need to pay for future benefits and claims.
The LFPB associated with non-participating traditional life insurance contracts and limited payment life-contingent annuity contracts is measured using a net premium ratio approach. This approach accrues expected benefits and claims in proportion to the premium revenue recognized. For life-contingent payout annuity contracts with limited premium payments, as premium collection is not the completion of the earnings process, gross premiums in excess of net premiums are deferred. This excess of gross premiums received over the related net premiums is referred to as the deferred profit liability (“DPL”). The DPL is included in the LFPB, and profits are recognized over the life of the contracts.
In measuring our LFPB, we establish cohorts, which are groupings of long-duration contracts. Factors that we consider in determining cohorts include, but are not limited to, our contract classification and issue year requirements, product risk characteristics, assumptions and modeling level used in the valuation systems. The net premium ratio is capped at 100% at the individual cohort level. Expected benefits and claims in excess of premium revenue recognized are expensed immediately.
We use actuarial assumptions to best estimate future premium and benefit cash flows (“cash flow assumptions”) as well as the actual historical cash flows received and paid to derive a net premium ratio in measuring the LFPB. These actuarial assumptions include mortality rates, morbidity, policyholder behavior (e.g., persistency) and withdrawals based principally on generally accepted actuarial methods and assumptions. During the third quarter of each year, we conduct our comprehensive review of the cash flow assumptions and projection models used in estimating these liabilities and update these assumptions (excluding the claims settlement expense assumption that is locked in at inception) in the calculation of the net premium ratio. We may also update these assumptions in other quarters as we become aware of information that is indicative of such update. On a quarterly basis, we retrospectively update the net premium ratio for actual experience. The remeasurement of LFPB for both assumption updates and actual experience are reported within policyholder liability remeasurement gain (loss) on the Consolidated Statements of Comprehensive Income (Loss). For all contract cohorts issued after January 1, 2021, interest is accrued on LFPB at the single-A interest rate on the contract cohort inception date. For contract cohorts issued prior to January 1, 2021, interest remains accruing at the original discount rate in effect on the contract cohort inception date due to the modified retrospective transition method. We also remeasure the LFPB using the single-A interest rate as of the end of each reporting period, which is reported within policyholder liability discount rate remeasurement gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).
We evaluate the liability for future claims on our long-term life and disability group products. Given the term and renewal features of our product and funding nature of the associated premiums, we have determined that the liability value is generally zero for policies that are not on claim. Therefore, the liability for future claims represents future payments on claims for which a disability event has occurred as of the valuation date. In measuring the liability for future claims, we establish cohorts similar to the process described above and use actuarial assumptions primarily based on claim termination rates, offsets for other insurance including social security and long-term disability incidence and severity assumptions. Cash flow assumptions are subject to the comprehensive review process discussed above. On a quarterly basis, the liability for future claims is updated for actual claims experience. The remeasurement of the liability for future claims for both assumption updates and actual experience are reported within policyholder liability remeasurement gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).
We remeasure the liability for future claims using a single-A interest rate as of the end of each reporting period, which is reported within policyholder liability discount rate remeasurement gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).
We use the single-A interest rate curve to discount cash flows used to calculate the LFPB and the liability for future claims. This curve is developed using the upper-medium grade (low credit risk) fixed-income instrument yields that are intended to reflect the duration characteristics of the applicable insurance liabilities.
We issue UL contracts with separate accounts that may include various types of guaranteed benefits that are not accounted for as MRBs or embedded derivatives. These guaranteed benefits require an additional liability that is calculated by estimating the present value of total expected benefit payments over the life of the contract from inception divided by the present value of total expected assessments over the life of the contract (“benefit ratio”) multiplied by the cumulative assessments recorded from the contract inception through the balance sheet date less the cumulative payments plus interest on the liability. Cash flow assumptions incorporated in a benefit ratio in measuring these additional liabilities for other insurance benefits include mortality rates, morbidity, policyholder behavior (e.g., persistency) and withdrawals based principally on generally accepted actuarial methods and assumptions. During the third quarter of each year, we conduct our comprehensive review of the cash flow assumptions and projection models used in estimating these liabilities and update these assumptions in the calculation of the benefit ratio. We may also update these assumptions in other quarters as we become aware of information that is indicative of such update. On a quarterly basis, we retrospectively update the benefit ratio for actual experience. The remeasurement of additional liability for both assumptions and actual experience are reported within policyholder liability remeasurement gain (loss) on the Consolidated Statements of Comprehensive Income (Loss). As future cash flow assumption and experience updates result in changes in expected benefit payments or assessments, the benefit ratio is recalculated using the updated expected benefit payments and assessments over the life of the contract since inception. The revised benefit ratio is then applied to the liability calculation described above.
Premium deficiency testing is performed for interest-sensitive life products periodically using best estimate assumptions as of the testing date to test the adequacy and appropriateness of the established net reserve (i.e., GAAP reserves net of any DSI or VOBA assets). The premium deficiency test is also performed using a discount rate based on the average crediting rate. A premium deficiency exists when the net reserve plus the present value of expected future gross premiums are determined to be insufficient to cover expected future benefits and non-level expenses.
The business written or assumed by us includes participating life insurance contracts, under which the policyholder is entitled to share in the earnings of such contracts via receipt of dividends. The dividend scale for participating policies is reviewed annually and may be adjusted to reflect recent experience and future expectations.
MRBs
MRBs are contracts or contract features that provide protection to the policyholder from other-than-nominal capital market risk and expose us to other-than-nominal capital market risk upon the occurrence of a specific event or circumstance, such as death, annuitization or periodic withdrawal. MRBs do not include the death benefit component of a life insurance contract (i.e., the difference between the account balance and the death benefit amount). All long-duration insurance contracts and certain investment contracts are subject to MRB evaluation. An MRB can be in either an asset or a liability position. Our MRB assets and MRB liabilities are reported at fair value separately on the Consolidated Balance Sheets.
We issue variable and fixed annuity contracts that may include various types of guaranteed living benefit (“GLB”) and guaranteed death benefit (“GDB”) riders that we have classified as MRBs. For contracts that contain multiple features that qualify as MRBs, the MRBs are valued on a combined basis using an integrated model. We have entered into reinsurance agreements to cede certain GLB and GDB riders where the reinsurance agreements themselves are accounted for as MRBs or contain MRBs. We therefore record ceded MRB assets and ceded MRB liabilities associated with these reinsurance agreements. Ceded MRB liabilities are included in other assets and ceded MRB assets are included in other liabilities on the Consolidated Balance Sheets.
MRBs are valued based on a stochastic projection of risk-neutral scenarios that incorporate a spread reflecting our non-performance risk. Ceded MRBs are valued based on a stochastic projection of risk-neutral scenarios that incorporate a spread reflecting our counterparties’ non-performance risk. The scenario assumptions, at each valuation date, are those we view to be appropriate for a hypothetical market participant and include assumptions for capital markets, policyholder behavior (e.g., policy lapse, rider utilization, etc.) mortality, risk margin and administrative expenses. These assumptions are based on a combination of historical data and actuarial judgments. During the third quarter of each year, we conduct our comprehensive review of the actuarial assumptions and projection models used in estimating these MRBs and update these assumptions on a prospective basis as needed. We may also update these assumptions in other quarters as we become aware of information that is indicative of the need for such an update. The assumptions for our own non-performance risk and our counterparties’ non-performance risk for MRBs and ceded MRBs, respectively, are determined at each valuation date and reflect our and our counterparties’ risks of not fulfilling the obligations of the underlying liability. The spread for the non-performance risk is added to the discount rates used in determining the fair value from the net cash flows. For information on fair value inputs, see Note 14.
Policyholder Account Balances
Policyholder account balances include the contract value that has accrued to the benefit of the policyholder as of the balance sheet date. The liability for policyholder account balances includes UL and VUL and investment-type annuity products where account balances are equal to deposits plus interest credited less withdrawals, surrender charges, policyholder assessments, as well as amounts representing the fair value of embedded derivative instruments associated with our IUL and indexed annuity products. During the third quarter of each year, we conduct our comprehensive review of the assumptions and projection models used in estimating these embedded derivatives and update assumptions as needed. We may also update these assumptions in other quarters as we become aware of information that is indicative of the need for such an update.
Short-Term and Long-Term Debt
Short-term debt has contractual or expected maturities of one year or less. Long-term debt has contractual or expected maturities greater than one year.
Payables for Collateral on Investments
When we enter into collateralized financing transactions on our investments, a liability is recorded equal to the cash or non-cash collateral received. This liability is included within payables for collateral on investments on the Consolidated Balance Sheets. Income and expenses associated with these transactions are recorded as investment income and investment expenses within net investment income on the Consolidated Statements of Comprehensive Income (Loss). Changes in payables for collateral on investments are reflected within cash flows from investing activities on the Consolidated Statements of Cash Flows.
Contingencies and Commitments
A loss contingency is an existing condition, situation or set of circumstances involving uncertainty as to possible loss that will ultimately be resolved when one or more future events occur or fail to occur. Contingencies arising from environmental remediation costs, regulatory judgments, claims, assessments, guarantees, litigation, recourse reserves, fines, penalties and other sources are recorded when deemed probable and reasonably estimable, based on our best estimate.
Fee Income
Fee income for investment and interest-sensitive life insurance contracts consists of asset-based fees, percent of premium charges, contract administration charges and surrender charges that are assessed against policyholder account balances. Investment products consist primarily of individual and group variable and fixed annuities. Interest-sensitive life insurance products include UL, VUL, linked-benefit UL and VUL and other interest-sensitive life insurance policies. These products include life insurance sold to individuals, corporate-owned life insurance and bank-owned life insurance.
The timing of revenue recognition as it relates to fees assessed on investment contracts is determined based on the nature of such fees. Asset-based fees and contract administration charges are assessed on a daily or monthly basis and recognized as revenue as performance obligations are met, over the period underlying customer assets are owned or advisory services are provided. Percent of premium charges are assessed at the time of premium payment and recognized as revenue when assessed and earned. Certain amounts assessed that represent compensation for services to be provided in future periods are reported as unearned revenue and recognized in income over the periods benefited. Surrender charges are recognized upon surrender of a contract by the policyholder in accordance with contractual terms. For investment and interest-sensitive life insurance contracts, the amounts collected from policyholders are considered deposits and are not included in revenue.
Wholesaling-related 12b-1 fees received from separate account fund sponsors as compensation for servicing the underlying mutual funds are recorded as revenues based on a contractual percentage of the market value of mutual fund assets over the period shares are owned by customers. Net investment advisory fees related to asset management of certain separate account funds are recorded as revenues based on a contractual percentage of the customer’s managed assets over the period advisory services are provided.
Insurance Premiums
Insurance premiums consist primarily of group insurance products, traditional life insurance and payout annuities with life contingencies. These insurance premiums are recognized as revenue when due.
Net Investment Income
We earn investment income on the underlying general account investments supporting our fixed products less related expenses. Dividends and interest income, recorded in net investment income, are recognized when earned. Amortization of premiums and accretion of discounts on investments in debt securities are reflected in net investment income over the contractual terms of the investments in a manner that produces a constant effective yield.
For CLOs and MBS, included in the trading and fixed maturity AFS securities portfolios, we recognize income using a constant effective yield based on anticipated prepayments and the estimated economic life of the securities. When actual prepayments differ significantly from originally anticipated prepayments, the retrospective effective yield is recalculated to reflect actual payments to date and a catch up adjustment is recorded in the current period. In addition, the new effective yield, which reflects anticipated future payments, is used prospectively. Any adjustments resulting from changes in effective yield are reflected in net investment income on the Consolidated Statements of Comprehensive Income (Loss).
Realized Gain (Loss)
Realized gain (loss) includes realized gains and losses from the sale of investments, write-downs for impairments of investments and changes in the allowance for credit losses for financial assets, changes in fair value of mortgage loans on real estate accounted for under the fair value option, changes in fair value of equity securities, certain derivative and embedded derivative gains and losses, gains and losses on the sale of subsidiaries and businesses and net gains and losses on reinsurance-related embedded derivatives and trading securities. Realized gains and losses on the sale of investments are determined using the specific identification method. Realized gain (loss) is reported net of allocations of investment gains and losses to certain policyholders, certain funds withheld on reinsurance arrangements and certain modified coinsurance arrangements for which we have a contractual obligation.
MRB Gain (Loss)
MRB gain (loss) includes the change in fair value of MRB and ceded MRB assets and liabilities. Changes in the fair value of MRB assets and liabilities are recognized in net income (loss), except for the portion attributable to the change in non-performance risk that is recognized in OCI. Changes in the fair value of ceded MRB assets and liabilities, including the changes in our counterparties’ non-performance risks, are recognized in net income (loss).
Other Revenues
Other revenues consist primarily of fees attributable to broker-dealer services recorded as performance obligations are met, either at the time of sale or over time based on a contractual percentage of customer account balances, and proceeds from reinsurance recaptures. The broker-dealer services primarily relate to our retail sales network and consist of commission revenue for the sale of non-affiliated securities recorded on a trade date basis and advisory fee income. Advisory fee income is asset-based revenues recorded as earned based on a contractual percentage of customer account balances. Other revenues earned by our Group Protection segment consist of fees from administrative services performed, which are recognized as performance obligations are met over the terms of the underlying agreements.
Interest Credited
We credit interest to our policyholder account balances based on the contractual terms supporting our products.
Benefits
Benefits for UL and other interest-sensitive life insurance products include benefit claims incurred during the period in excess of contract account balances. Benefits also include the change in reserves for life insurance products with secondary guarantee benefits, annuity products with guaranteed death and living benefits and certain annuities with life contingencies. For traditional life, group life and disability income products, benefits are recognized when incurred in a manner consistent with the related premium recognition policies.
Policyholder Liability Remeasurement Gain (Loss)
Policyholder liability remeasurement gain (loss) recognized in net income (loss) includes remeasurement gains and losses resulting from updates in cash flow assumptions and actual variance from expected experience used in the net premium ratio or benefit ratio calculation for future policy benefits associated with traditional life insurance and limited payment life-contingent annuity products, liabilities for future claims associated with our group products, and additional liabilities for other insurance benefits on certain guaranteed benefits associated with our UL products.
Policyholder liability remeasurement gain (loss) recognized in OCI includes any changes resulting from the discount rate remeasurement of future policy benefits associated with traditional life insurance and limited payment life-contingent annuity products and liabilities for future claims associated with our group products as of each reporting period.
Spark Program Expense
Spark program expense consists primarily of costs related to our Spark Initiative.
Pension and Other Postretirement Benefit Plans
Pursuant to the accounting rules for our obligations to employees and agents under our various pension and other postretirement benefit plans, we are required to make a number of assumptions to estimate related liabilities and expenses. The mortality assumption is based on actual and anticipated plan experience, determined using acceptable actuarial methods.
We use assumptions for the weighted-average discount rate and expected return on plan assets to estimate pension expense. The discount rate assumptions are determined using an analysis of current market information and the projected benefit flows associated with these plans. The expected long-term rate of return on plan assets is based on historical and projected future rates of return on the funds invested in the plan. The calculation of our accumulated postretirement benefit obligation also uses an assumption of weighted-average annual rate of increase in the per capita cost of covered benefits, which reflects a health care cost trend rate.
Stock-Based Compensation
In general, we expense the fair value of stock awards included in our incentive compensation plans. As of the date our stock awards are approved, the fair value of stock options is determined using a Black-Scholes options valuation methodology, and the fair value of other stock awards is based upon the market value of the stock. The fair value of the awards is expensed over the performance or service period, which generally corresponds to the vesting period, and is recognized as an increase to common stock in stockholders’ equity. We apply an estimated forfeiture rate to our accrual of compensation cost. We classify certain stock awards as liabilities. For these awards, the settlement value is classified as a liability on the Consolidated Balance Sheets, and the liability is marked-to-market through net income at the end of each reporting period. Stock-based compensation expense is reflected in commissions and other expenses on the Consolidated Statements of Comprehensive Income (Loss).
Interest and Debt Expense
Interest expense on our short-term and long-term debt is recognized as due and any associated premiums, discounts and debt issuance costs are amortized (accreted) over the term of the related borrowing utilizing the effective interest method. In addition, gains or losses related to certain derivative instruments associated with debt are recognized in interest and debt expense during the period of the change.
Income Taxes
We file a U.S. consolidated income tax return that includes all of our eligible subsidiaries. Ineligible subsidiaries file separate individual corporate tax returns. Subsidiaries operating outside of the U.S. are taxed, and income tax expense is recorded, based on applicable foreign statutes. Deferred income taxes are recognized, based on enacted rates, when assets and liabilities have different values for financial statement and tax reporting purposes. A valuation allowance is recorded to the extent required. Considerable judgment and the use of estimates are required in determining whether a valuation allowance is necessary and, if so, the amount of such valuation allowance. In evaluating the need for a valuation allowance, we consider many factors, including: the nature and character of the deferred tax assets and liabilities; taxable income in prior carryback years; future reversals of temporary differences; the length of time carryovers can be utilized; and any tax planning strategies we would employ to avoid a tax benefit from expiring unused.
Foreign Currency Translation
The balance sheet accounts and income statement items of foreign subsidiaries, reported in functional currencies other than the U.S. dollar are translated at the current and average exchange rates for the year, respectively. Resulting translation adjustments and other translation adjustments for foreign currency transactions that affect cash flows are reported in AOCI, a component of stockholders’ equity.
Earnings Per Share
Basic earnings per share (“EPS”) is computed by dividing earnings available to common shareholders by the average common shares outstanding. Diluted EPS is computed assuming the conversion or exercise of non-vested stock, stock options and performance share units outstanding during the year.
For any period where a net loss is experienced, shares used in the diluted EPS calculation represent basic shares, as the use of diluted shares would result in a lower loss per share.
2. New Accounting Standards
The following table provides a description of our adoption of new Accounting Standards Updates (“ASUs”) issued by the FASB and the impact of the adoption on the consolidated financial statements. ASUs not listed below were assessed and determined to be either not applicable or insignificant in presentation or amount.
|
|
|
|
Standard |
Description |
Effective Date |
Effect on Financial Statements or Other Significant Matters |
ASU 2020-04, Reference Rate Reform (Topic 848) and related amendments |
The amendments in this update provide optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions impacted by reference rate reform. If certain criteria are met, an entity will not be required to remeasure or reassess contracts impacted by reference rate reform. Additionally, changes to the critical terms of a hedging relationship affected by reference rate reform will not require entities to de-designate the relationship if certain requirements are met. The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2024, with certain exceptions. The amendments are effective for contract modifications made between March 12, 2020, and December 31, 2024. |
March 12, 2020 through December 31, 2024 |
This standard may be elected and applied prospectively. We have elected practical expedients under this guidance to maintain hedge accounting for certain derivatives. This ASU has not had a material impact to our consolidated financial condition and results of operations to date. |
ASU 2018-12, Targeted Improvements to the Accounting for Long-Duration Contracts and related amendments |
See Note 3 for information about ASU 2018-12. |
January 1, 2023 |
We adopted this ASU effective January 1, 2023, with a transition date of January 1, 2021, using a modified retrospective approach, except for MRBs for which we applied a full retrospective transition approach. See Note 3 for transition disclosures related to the adoption of this ASU. |
3. Adoption of ASU 2018-12
On January 1, 2023, we adopted FASB ASU 2018-12, Targeted Improvements to the Accounting for Long-Duration Contracts and related amendments (“ASU 2018-12”) with a transition date of January 1, 2021. ASU 2018-12 updated accounting and reporting requirements for long-duration contracts and certain investment contracts issued by insurance entities. We adopted ASU 2018-12 under the modified retrospective approach, except for MRBs, which applied the full retrospective approach. Our consolidated financial statements are presented under the new guidance for reporting periods beginning January 1, 2021.
Under ASU 2018-12, we include actual historical cash flows along with best estimate future cash flows to derive the net premium ratio when calculating the LFPB associated with our traditional and limited-payment long-duration contracts. We review and update, if necessary, assumptions used to measure future cash flows included in the net premium ratio at least annually. Historical cash flows included in the net premium ratio are updated for actual experience quarterly and as assumptions are updated. Changes in the measurement of our LFPB result from updates to cash flow assumptions and actual experience, which impacts are reported within policyholder remeasurement gain (loss) on our Consolidated Statements of Comprehensive Income (Loss). We use an upper-medium grade (low credit risk) fixed-income instrument yield (single-A) discount rate when calculating the LFPB. This discount rate is updated quarterly at each reporting date with the impact recognized in OCI. ASU 2018-12 also eliminated loss recognition testing, premium deficiency testing and the provision for adverse deviation for LFPB.
ASU 2018-12 introduced the category of MRBs, which are contracts or contract features that provide protection to the policyholder from other-than-nominal capital market risk and expose us to other-than-nominal capital market risk upon the occurrence of a specific event or circumstance, such as death, annuitization or periodic withdrawal. MRBs are required to be measured at fair value, with periodic changes in fair value reported within MRB gain (loss) on our Consolidated Statements of Comprehensive Income (Loss), except for periodic changes to instrument-specific credit risk related to direct policies, which are recognized in OCI. Changes in the fair value of ceded MRB assets and liabilities are also reported within MRB gain (loss) on our Consolidated Statements of Comprehensive Income (Loss).
ASU 2018-12 simplified the amortization model for DAC and DAC-like intangible balances, including VOBA, DSI and DFEL. Historically these balances were amortized in proportion to premium or over expected gross profits. They are now amortized on a constant-level basis over the expected term of the contract. Loss recognition testing and impairment testing are no longer applicable for DAC.
ASU 2018-12 requires disaggregated rollforwards of the beginning of year to the end of the reporting period balances. We also disclose information about inputs, judgments, assumptions, methods, changes during the period and the effect of these changes on the measurement of applicable balances. In determining the appropriate level of aggregation, we considered our reportable segments, nature and risk characteristics of our products and level of aggregation we used in disclosures presented outside the financial statements.
The following table presents the cumulative effect adjustments (in millions), after-tax and shown as increase (decrease), to the components of stockholders’ equity due to the adoption of ASU 2018-12 as of January 1, 2021, by primary accounting topic:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|||
|
Retained |
|
|
|
Stockholders’ |
|
|||
|
Earnings |
|
AOCI |
|
Equity |
|
|||
Shadow impacts: |
|
|
|
|
|
|
|
|
|
DAC, VOBA, DSI and DFEL |
$ |
- |
|
$ |
2,271 |
|
$ |
2,271 |
|
Additional liabilities for other |
|
|
|
|
|
|
|
|
|
insurance benefits |
|
- |
|
|
1,197 |
|
|
1,197 |
|
LFPB and other (1) |
|
(187 |
) |
|
(1,715 |
) |
|
(1,902 |
) |
MRBs (2) |
|
(6,086 |
) |
|
2,874 |
|
|
(3,212 |
) |
Total |
$ |
(6,273 |
) |
$ |
4,627 |
|
$ |
(1,646 |
) |
(1)Includes impacts to reserves and ceded reserves reported within future contract benefits and reinsurance recoverables, respectively on the Consolidated Balance Sheets, excluding shadow impacts on additional liabilities for other insurance benefits.
(2)Includes impacts related to MRB assets and MRB liabilities reported on the Consolidated Balance Sheets, and ceded MRBs reported within other assets on the Consolidated Balance Sheets.
The following table summarizes the effect of the adoption of ASU 2018-12 as of January 1, 2021, (in millions) on the Consolidated Balance Sheets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|||
|
Retained |
|
|
|
Stockholders’ |
|
|||
|
Earnings |
|
AOCI |
|
Equity |
|
|||
DAC, VOBA and DSI |
$ |
- |
|
$ |
6,079 |
|
$ |
6,079 |
|
Reinsurance recoverables |
|
607 |
|
|
2,431 |
|
|
3,038 |
|
Other assets (1) |
|
242 |
|
|
- |
|
|
242 |
|
Future contract benefits |
|
(844 |
) |
|
(3,088 |
) |
|
(3,932 |
) |
MRBs, net |
|
(7,956 |
) |
|
3,656 |
|
|
(4,300 |
) |
DFEL |
|
- |
|
|
(3,190 |
) |
|
(3,190 |
) |
Other liabilities (2) |
|
1,678 |
|
|
(1,261 |
) |
|
417 |
|
Total |
$ |
(6,273 |
) |
$ |
4,627 |
|
$ |
(1,646 |
) |
(1)Consists primarily of ceded MRB adjustments.
(2)Consists of state and federal tax adjustments.
The following table summarizes the changes in DAC, VOBA and DSI, pre-tax, (in millions) due to the adoption of ASU 2018-12 and reconciles this balance to the Consolidated Balance Sheets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impact from |
|
|
|
|||
|
Balance |
|
Removal of |
|
Balance |
|
|||
|
Pre-Adoption |
|
Shadow |
|
Post-Adoption |
|
|||
|
December 31, |
|
Balances |
|
January 1, |
|
|||
|
2020 |
|
from AOCI |
|
2021 |
|
|||
DAC |
|
|
|
|
|
|
|
|
|
Variable Annuities |
$ |
3,518 |
|
$ |
52 |
|
$ |
3,570 |
|
Fixed Annuities |
|
264 |
|
|
215 |
|
|
479 |
|
Traditional Life |
|
1,082 |
|
|
- |
|
|
1,082 |
|
UL and Other |
|
394 |
|
|
5,031 |
|
|
5,425 |
|
Group Protection |
|
187 |
|
|
- |
|
|
187 |
|
Retirement Plan Services |
|
120 |
|
|
112 |
|
|
232 |
|
Total DAC |
|
5,565 |
|
|
5,410 |
|
|
10,975 |
|
|
|
|
|
|
|
|
|
|
|
VOBA |
|
|
|
|
|
|
|
|
|
Fixed Annuities |
|
- |
|
|
23 |
|
|
23 |
|
Traditional Life |
|
67 |
|
|
- |
|
|
67 |
|
UL and Other |
|
180 |
|
|
630 |
|
|
810 |
|
Total VOBA |
|
247 |
|
|
653 |
|
|
900 |
|
|
|
|
|
|
|
|
|
|
|
DSI (1) |
|
|
|
|
|
|
|
|
|
Variable Annuities |
|
148 |
|
|
2 |
|
|
150 |
|
Fixed Annuities |
|
17 |
|
|
13 |
|
|
30 |
|
UL and Other |
|
35 |
|
|
- |
|
|
35 |
|
Retirement Plan Services |
|
13 |
|
|
1 |
|
|
14 |
|
Total DSI |
|
213 |
|
|
16 |
|
|
229 |
|
Total DAC, VOBA and DSI |
$ |
6,025 |
|
$ |
6,079 |
|
$ |
12,104 |
|
(1)Pre-adoption DSI balance was previously reported in other assets on the Consolidated Balance Sheets.
The following table summarizes the changes in DFEL, pre-tax, (in millions) due to the adoption of ASU 2018-12 and reconciles this balance to the Consolidated Balance Sheets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impact from |
|
|
|
|
|
|
Balance |
|
Removal of |
|
Balance |
|
|||
|
Pre-Adoption |
|
Shadow |
|
Post-Adoption |
|
|||
|
December 31, |
|
Balances |
|
January 1, |
|
|||
|
2020 |
|
from AOCI |
|
2021 |
|
|||
DFEL (1) |
|
|
|
|
|
|
|
|
|
Variable Annuities |
$ |
288 |
|
$ |
5 |
|
$ |
293 |
|
UL and Other |
|
113 |
|
|
3,185 |
|
|
3,298 |
|
Total DFEL |
$ |
401 |
|
$ |
3,190 |
|
$ |
3,591 |
|
(1)Pre-adoption DFEL balance was previously reported in other contract holder funds on the Consolidated Balance Sheets.
The following table summarizes the changes in future contract benefits, pre-tax, (in millions) due to the adoption of ASU 2018-12 and reconciles this balance to the Consolidated Balance Sheets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impact from |
|
Single-A |
|
|
|
|
|
|
|
||
|
Balance |
|
Removal of |
|
Discount |
|
Cumulative |
|
Balance |
|
|||||
|
Pre-Adoption |
|
Shadow |
|
Rate |
|
Effect to |
|
Post-Adoption |
|
|||||
|
December 31, |
|
Balances |
|
Measurement |
|
Retained |
|
January 1, |
|
|||||
|
2020 (1) |
|
from AOCI |
|
in AOCI |
|
Earnings |
|
2021 |
|
|||||
LFPB |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payout Annuities |
$ |
2,314 |
|
$ |
(105 |
) |
$ |
415 |
|
$ |
44 |
|
$ |
2,668 |
|
Traditional Life |
|
3,483 |
|
|
- |
|
|
943 |
|
|
- |
|
|
4,426 |
|
Liability for Future Claims |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Group Protection |
|
5,422 |
|
|
- |
|
|
517 |
|
|
- |
|
|
5,939 |
|
Additional Liabilities for Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance Benefits |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UL and Other |
|
13,649 |
|
|
(1,515 |
) |
|
- |
|
|
174 |
|
|
12,308 |
|
Other Operations (2) |
|
10,463 |
|
|
(80 |
) |
|
2,913 |
|
|
626 |
|
|
13,922 |
|
Other (3) |
|
3,565 |
|
|
- |
|
|
- |
|
|
- |
|
|
3,565 |
|
Total future contract benefits |
$ |
38,896 |
|
$ |
(1,700 |
) |
$ |
4,788 |
|
$ |
844 |
|
$ |
42,828 |
|
(1)Balance pre-adoption excludes features that meet the definition of an MRB upon transition, including features that were previously accounted for as an additional liability. Also, balance pre-adoption reflects certain reclassifications of non-life contingent account balances from future contract benefits to policyholder account balances within the Consolidated Balance Sheets.
(2)Represents future contract benefits reported in Other Operations primarily attributable to the indemnity reinsurance agreements with Protective ($6.3 billion and $7.4 billion as of December 31, 2020, and January 1, 2021, respectively) and Swiss Re ($2.0 billion and $3.5 billion as of December 31, 2020, and January 1, 2021, respectively). Includes LFPB and additional liabilities balances.
(3)Represents other miscellaneous reserves outside the scope of ASU 2018-12.
The following table summarizes the changes in reinsurance recoverables, pre-tax, (in millions) due to the adoption of ASU 2018-12 and reconciles this balance to the Consolidated Balance Sheets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Single-A |
|
|
|
|
|
|
|
|
|
Balance |
|
Discount |
|
Cumulative |
|
Balance |
|
||||
|
Pre-Adoption |
|
Rate |
|
Effect to |
|
Post-Adoption |
|
||||
|
December 31, |
|
Measurement |
|
Retained |
|
January 1, |
|
||||
|
2020 (1) |
|
in AOCI |
|
Earnings |
|
2021 |
|
||||
Reinsured LFPB |
|
|
|
|
|
|
|
|
|
|
|
|
Payout Annuities |
$ |
2 |
|
$ |
- |
|
$ |
- |
|
$ |
2 |
|
Traditional Life |
|
755 |
|
|
151 |
|
|
- |
|
|
906 |
|
Reinsured Liability for Future |
|
|
|
|
|
|
|
|
|
|
|
|
Claims |
|
|
|
|
|
|
|
|
|
|
|
|
Group Protection |
|
148 |
|
|
14 |
|
|
- |
|
|
162 |
|
Reinsured Additional Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
for Other Insurance Benefits |
|
|
|
|
|
|
|
|
|
|
|
|
UL and Other |
|
335 |
|
|
- |
|
|
(3 |
) |
|
332 |
|
Reinsured Other Operations (2) |
|
14,320 |
|
|
2,266 |
|
|
610 |
|
|
17,196 |
|
Reinsured Other (3) |
|
790 |
|
|
- |
|
|
- |
|
|
790 |
|
Total reinsurance recoverables |
$ |
16,350 |
|
$ |
2,431 |
|
$ |
607 |
|
$ |
19,388 |
|
(1)Balance pre-adoption excludes features that meet the definition of a ceded MRB upon transition, including features that were previously accounted for as reinsured additional liabilities.
(2)Represents reinsurance recoverables reported in Other Operations primarily attributable to the indemnity reinsurance agreements with Protective ($12.0 billion and $13.2 billion as of December 31, 2020, and January 1, 2021, respectively) and Swiss Re ($1.3 billion and $2.6 billion as of December 31, 2020, and January 1, 2021, respectively). Includes reinsured LFPB and reinsured additional liabilities balances.
(3)Represents other miscellaneous reinsurance recoverables outside the scope of ASU 2018-12.
The following table summarizes the changes in the net liability position of MRBs, pre-tax, (in millions) due to the adoption of ASU 2018-12 and reconciles this balance to the Consolidated Balance Sheets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Balance |
|
Cumulative |
|
Cumulative |
|
Balance |
|
||||
|
Pre-Adoption |
|
Effect of |
|
Effect to |
|
Post-Adoption |
|
||||
|
December 31, |
|
Credit Risk |
|
Retained |
|
January 1, |
|
||||
|
2020 (1) |
|
to AOCI |
|
Earnings |
|
2021 |
|
||||
MRBs, Net |
|
|
|
|
|
|
|
|
|
|
|
|
Variable Annuities |
$ |
831 |
|
$ |
(3,592 |
) |
$ |
7,968 |
|
$ |
5,207 |
|
Fixed Annuities |
|
192 |
|
|
(52 |
) |
|
(22 |
) |
|
118 |
|
Retirement Plan Services |
|
11 |
|
|
(12 |
) |
|
10 |
|
|
9 |
|
Total MRBs, net |
$ |
1,034 |
|
$ |
(3,656 |
) |
$ |
7,956 |
|
$ |
5,334 |
|
(1)Balance pre-adoption includes all features that meet the definition of an MRB upon transition, including features that were previously accounted for as additional liabilities or embedded derivatives.
The following table summarizes the changes in the net asset position of ceded MRBs, pre-tax, (in millions) due to the adoption of ASU 2018-12, reported in other assets on the Consolidated Balance Sheets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Balance |
|
Cumulative |
|
Balance |
|
|||
|
Pre-Adoption |
|
Effect to |
|
Post-Adoption |
|
|||
|
December 31, |
|
Retained |
|
January 1, |
|
|||
|
2020 (1) |
|
Earnings |
|
2021 |
|
|||
Ceded MRBs, Net |
|
|
|
|
|
|
|
|
|
Variable Annuities |
$ |
215 |
|
$ |
121 |
|
$ |
336 |
|
Total ceded MRBs, net |
$ |
215 |
|
$ |
121 |
|
$ |
336 |
|
(1)Balance pre-adoption includes all features that meet the definition of a ceded MRB upon transition, including features that were previously accounted for as reinsured additional liabilities or embedded derivatives.
The following summarizes the effect of the adoption of ASU 2018-12 (in millions) on certain financial statement line items within the previously reported Consolidated Balance Sheets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2022 |
|
|||||||
|
|
|
Adoption |
|
|
|
|
||
|
As |
|
of New |
|
|
|
|
||
|
Previously |
|
Accounting |
|
As |
|
|||
|
Reported (1) |
|
Standard |
|
Adjusted |
|
|||
Deferred acquisition costs, value of business acquired and |
|
|
|
|
|
|
|
|
|
deferred sales inducements (2) |
$ |
13,803 |
|
$ |
(1,568 |
) |
$ |
12,235 |
|
Reinsurance recoverables, net of allowance for credit losses |
|
19,882 |
|
|
(439 |
) |
|
19,443 |
|
Market risk benefit assets |
|
- |
|
|
2,807 |
|
|
2,807 |
|
Other assets (2) |
|
20,493 |
|
|
(1,691 |
) |
|
18,802 |
|
Total assets |
|
335,108 |
|
|
(891 |
) |
|
334,217 |
|
Future contract benefits (2) |
|
41,756 |
|
|
(2,930 |
) |
|
38,826 |
|
Market risk benefit liabilities |
|
- |
|
|
2,078 |
|
|
2,078 |
|
Deferred front-end loads (2) |
|
5,669 |
|
|
(617 |
) |
|
5,052 |
|
Other liabilities (2) |
|
11,976 |
|
|
45 |
|
|
12,021 |
|
Total liabilities |
|
330,539 |
|
|
(1,424 |
) |
|
329,115 |
|
Retained earnings |
|
6,707 |
|
|
(783 |
) |
|
5,924 |
|
Accumulated other comprehensive income (loss) |
|
(7,668 |
) |
|
1,316 |
|
|
(6,352 |
) |
Total stockholders’ equity |
|
4,569 |
|
|
533 |
|
|
5,102 |
|
(1)The amounts as previously reported were derived from Note 1 in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K.
(2)Certain amounts have been reclassified to conform to the presentation adopted in the current period.
The following summarizes the effect of the adoption of ASU 2018-12 (in millions) on certain financial statement line items within the previously reported Consolidated Statements of Comprehensive Income (Loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended September 30, 2022 |
||||||||
|
|
|
Adoption |
|
|
|
|
||
|
As |
|
of New |
|
|
|
|
||
|
Previously |
|
Accounting |
|
As |
|
|||
|
Reported (1) |
|
Standard |
|
Adjusted |
|
|||
Fee income |
$ |
1,527 |
|
$ |
(146 |
) |
$ |
1,381 |
|
Realized gain (loss) |
|
212 |
|
|
37 |
|
|
249 |
|
Total revenues |
|
4,781 |
|
|
(109 |
) |
|
4,672 |
|
Benefits |
|
5,103 |
|
|
(2,954 |
) |
|
2,149 |
|
Interest credited |
|
722 |
|
|
4 |
|
|
726 |
|
Market risk benefit (gain) loss |
|
- |
|
|
(798 |
) |
|
(798 |
) |
Policyholder liability remeasurement (gain) loss |
|
- |
|
|
2,692 |
|
|
2,692 |
|
Commissions and other expenses |
|
1,355 |
|
|
(75 |
) |
|
1,280 |
|
Total expenses |
|
7,929 |
|
|
(1,131 |
) |
|
6,798 |
|
Income (loss) before taxes |
|
(3,148 |
) |
|
1,022 |
|
|
(2,126 |
) |
Federal income tax expense (benefit) |
|
(565 |
) |
|
215 |
|
|
(350 |
) |
Net income (loss) |
|
(2,583 |
) |
|
807 |
|
|
(1,776 |
) |
Unrealized investment gain (loss) |
|
(4,287 |
) |
|
(768 |
) |
|
(5,055 |
) |
Market risk benefit non-performance risk gain (loss) |
|
- |
|
|
(150 |
) |
|
(150 |
) |
Policyholder liability discount rate remeasurement gain (loss) |
|
- |
|
|
549 |
|
|
549 |
|
Total other comprehensive income (loss), net of tax |
|
(4,291 |
) |
|
(369 |
) |
|
(4,660 |
) |
Comprehensive income (loss) |
|
(6,874 |
) |
|
438 |
|
|
(6,436 |
) |
Net income (loss) per common share: |
|
|
|
|
|
|
|
|
|
Basic |
|
(15.22 |
) |
|
4.76 |
|
|
(10.46 |
) |
Diluted |
|
(15.23 |
) |
|
4.76 |
|
|
(10.47 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, 2022 |
||||||||
|
|
|
Adoption |
|
|
|
|
||
|
As |
|
of New |
|
|
|
|
||
|
Previously |
|
Accounting |
|
As |
|
|||
|
Reported (1) |
|
Standard |
|
Adjusted |
|
|||
Fee income |
$ |
4,601 |
|
$ |
(352 |
) |
$ |
4,249 |
|
Realized gain (loss) |
|
752 |
|
|
779 |
|
|
1,531 |
|
Total revenues |
|
14,542 |
|
|
427 |
|
|
14,969 |
|
Benefits |
|
10,561 |
|
|
(4,302 |
) |
|
6,259 |
|
Interest credited |
|
2,125 |
|
|
8 |
|
|
2,133 |
|
Market risk benefit (gain) loss |
|
- |
|
|
(1,679 |
) |
|
(1,679 |
) |
Policyholder liability remeasurement (gain) loss |
|
- |
|
|
2,818 |
|
|
2,818 |
|
Commissions and other expenses |
|
3,714 |
|
|
27 |
|
|
3,741 |
|
Total expenses |
|
17,358 |
|
|
(3,129 |
) |
|
14,229 |
|
Income (loss) before taxes |
|
(2,816 |
) |
|
3,556 |
|
|
740 |
|
Federal income tax expense (benefit) |
|
(552 |
) |
|
747 |
|
|
195 |
|
Net income (loss) |
|
(2,264 |
) |
|
2,809 |
|
|
545 |
|
Unrealized investment gain (loss) |
|
(15,058 |
) |
|
(4,149 |
) |
|
(19,207 |
) |
Market risk benefit non-performance risk gain (loss) |
|
- |
|
|
224 |
|
|
224 |
|
Policyholder liability discount rate remeasurement gain (loss) |
|
- |
|
|
2,070 |
|
|
2,070 |
|
Total other comprehensive income (loss), net of tax |
|
(15,069 |
) |
|
(1,855 |
) |
|
(16,924 |
) |
Comprehensive income (loss) |
|
(17,333 |
) |
|
954 |
|
|
(16,379 |
) |
Net income (loss) per common share: |
|
|
|
|
|
|
|
|
|
Basic |
|
(13.18 |
) |
|
16.36 |
|
|
3.18 |
|
Diluted |
|
(13.23 |
) |
|
16.33 |
|
|
3.10 |
|
(1)The amounts as previously reported were derived from Note 23 in our 2022 Form 10-K/A.
The following summarizes the effect of the adoption of ASU 2018-12 (in millions) on certain financial statement line items within the previously reported Consolidated Statements of Stockholders’ Equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended September 30, 2022 |
||||||||
|
|
|
Adoption |
|
|
|
|
||
|
As |
|
of New |
|
|
|
|
||
|
Previously |
|
Accounting |
|
As |
|
|||
|
Reported (1) |
|
Standard |
|
Adjusted |
|
|||
Retained earnings balance as of beginning-of-period |
$ |
9,445 |
|
$ |
(2,380 |
) |
$ |
7,065 |
|
Net income (loss) |
|
(2,583 |
) |
|
807 |
|
|
(1,776 |
) |
Retained earnings balance as of end-of-period |
|
6,762 |
|
|
(1,573 |
) |
|
5,189 |
|
Accumulated other comprehensive income (loss) balance |
|
|
|
|
|
|
|
|
|
as of beginning-of-period |
|
(4,337 |
) |
|
2,057 |
|
|
(2,280 |
) |
Other comprehensive income (loss), net of tax |
|
(4,291 |
) |
|
(369 |
) |
|
(4,660 |
) |
Accumulated other comprehensive income (loss) balance |
|
|
|
|
|
|
|
|
|
as of end-of-period |
|
(8,628 |
) |
|
1,688 |
|
|
(6,940 |
) |
Total stockholders’ equity as of end-of-period |
|
2,668 |
|
|
115 |
|
|
2,783 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, 2022 |
||||||||
|
|
|
Adoption |
|
|
|
|
||
|
As |
|
of New |
|
|
|
|
||
|
Previously |
|
Accounting |
|
As |
|
|||
|
Reported (1) |
|
Standard |
|
Adjusted |
|
|||
Retained earnings balance as of beginning-of-year |
$ |
9,578 |
|
$ |
(4,382 |
) |
$ |
5,196 |
|
Net income (loss) |
|
(2,264 |
) |
|
2,809 |
|
|
545 |
|
Retained earnings balance as of end-of-period |
|
6,762 |
|
|
(1,573 |
) |
|
5,189 |
|
Accumulated other comprehensive income (loss) balance |
|
|
|
|
|
|
|
|
|
as of beginning-of-year |
|
6,441 |
|
|
3,543 |
|
|
9,984 |
|
Other comprehensive income (loss), net of tax |
|
(15,069 |
) |
|
(1,855 |
) |
|
(16,924 |
) |
Accumulated other comprehensive income (loss) balance |
|
|
|
|
|
|
|
|
|
as of end-of-period |
|
(8,628 |
) |
|
1,688 |
|
|
(6,940 |
) |
Total stockholders’ equity as of end-of-period |
|
2,668 |
|
|
115 |
|
|
2,783 |
|
(1)The amounts as previously reported were derived from Note 23 in our 2022 Form 10-K/A.
The following summarizes the effect of the adoption of ASU 2018-12 (in millions) on certain financial statement line items within the previously reported Consolidated Statements of Cash Flows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, 2022 |
||||||||
|
|
|
Adoption |
|
|
|
|
||
|
As |
|
of New |
|
|
|
|
||
|
Previously |
|
Accounting |
|
As |
|
|||
|
Reported (1) |
|
Standard |
|
Adjusted |
|
|||
Net income (loss) |
$ |
(2,264 |
) |
$ |
2,809 |
|
$ |
545 |
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) |
|
|
|
|
|
|
|
|
|
operating activities: |
|
|
|
|
|
|
|
|
|
Realized (gain) loss |
|
(752 |
) |
|
(779 |
) |
|
(1,531 |
) |
Market risk benefit (gain) loss |
|
- |
|
|
(1,679 |
) |
|
(1,679 |
) |
Change in: |
|
|
|
|
|
|
|
|
|
Deferred acquisition costs, value of business acquired, deferred sales |
|
|
|
|
|
|
|
|
|
inducements and deferred front-end loads |
|
74 |
|
|
291 |
|
|
365 |
|
Insurance liabilities and reinsurance-related balances (2) |
|
5,872 |
|
|
(1,409 |
) |
|
4,463 |
|
Accrued expenses |
|
(402 |
) |
|
(5 |
) |
|
(407 |
) |
Federal income tax accruals |
|
(498 |
) |
|
747 |
|
|
249 |
|
Other (2) |
|
299 |
|
|
25 |
|
|
324 |
|
(1)The amounts as previously reported were derived from Note 23 in our 2022 Form 10-K/A.
(2)Certain amounts have been reclassified to conform to the presentation adopted in the current period.
4. Investments
Fixed Maturity AFS Securities
The amortized cost, gross unrealized gains and losses, allowance for credit losses and fair value of fixed maturity AFS securities (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
Allowance |
|
|
|
|
|
|
Amortized |
|
Gross Unrealized |
|
for Credit |
|
Fair |
|
|||||||
|
Cost |
|
Gains |
|
Losses |
|
Losses |
|
Value |
|
|||||
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
88,326 |
|
$ |
447 |
|
$ |
12,763 |
|
$ |
9 |
|
$ |
76,001 |
|
U.S. government bonds |
|
418 |
|
|
3 |
|
|
48 |
|
|
- |
|
|
373 |
|
State and municipal bonds |
|
5,247 |
|
|
67 |
|
|
544 |
|
|
- |
|
|
4,770 |
|
Foreign government bonds |
|
326 |
|
|
9 |
|
|
62 |
|
|
- |
|
|
273 |
|
RMBS |
|
2,192 |
|
|
18 |
|
|
276 |
|
|
6 |
|
|
1,928 |
|
CMBS |
|
1,963 |
|
|
- |
|
|
262 |
|
|
- |
|
|
1,701 |
|
ABS |
|
13,201 |
|
|
37 |
|
|
840 |
|
|
5 |
|
|
12,393 |
|
Hybrid and redeemable preferred securities |
|
361 |
|
|
25 |
|
|
20 |
|
|
1 |
|
|
365 |
|
Total fixed maturity AFS securities |
$ |
112,034 |
|
$ |
606 |
|
$ |
14,815 |
|
$ |
21 |
|
$ |
97,804 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2022 |
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
Allowance |
|
|
|
|
|
|
Amortized |
|
Gross Unrealized |
|
for Credit |
|
Fair |
|
|||||||
|
Cost |
|
Gains |
|
Losses |
|
Losses |
|
Value |
|
|||||
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
89,249 |
|
$ |
787 |
|
$ |
11,004 |
|
$ |
9 |
|
$ |
79,023 |
|
U.S. government bonds |
|
405 |
|
|
5 |
|
|
31 |
|
|
- |
|
|
379 |
|
State and municipal bonds |
|
5,410 |
|
|
172 |
|
|
512 |
|
|
- |
|
|
5,070 |
|
Foreign government bonds |
|
348 |
|
|
17 |
|
|
47 |
|
|
- |
|
|
318 |
|
RMBS |
|
2,216 |
|
|
22 |
|
|
222 |
|
|
7 |
|
|
2,009 |
|
CMBS |
|
1,917 |
|
|
3 |
|
|
246 |
|
|
- |
|
|
1,674 |
|
ABS |
|
11,797 |
|
|
38 |
|
|
926 |
|
|
5 |
|
|
10,904 |
|
Hybrid and redeemable preferred securities |
|
365 |
|
|
25 |
|
|
30 |
|
|
1 |
|
|
359 |
|
Total fixed maturity AFS securities |
$ |
111,707 |
|
$ |
1,069 |
|
$ |
13,018 |
|
$ |
22 |
|
$ |
99,736 |
|
The amortized cost and fair value of fixed maturity AFS securities by contractual maturities (in millions) as of September 30, 2023, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortized |
|
Fair |
|
||
|
Cost |
|
Value |
|
||
Due in one year or less |
$ |
3,961 |
|
$ |
3,917 |
|
Due after one year through five years |
|
18,847 |
|
|
17,848 |
|
Due after five years through ten years |
|
16,862 |
|
|
14,929 |
|
Due after ten years |
|
55,008 |
|
|
45,088 |
|
Subtotal |
|
94,678 |
|
|
81,782 |
|
Structured securities (RMBS, CMBS, ABS) |
|
17,356 |
|
|
16,022 |
|
Total fixed maturity AFS securities |
$ |
112,034 |
|
$ |
97,804 |
|
Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations.
The fair value and gross unrealized losses of fixed maturity AFS securities (dollars in millions) for which an allowance for credit losses has not been recorded, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
|||||||||||||||||
|
Less Than or Equal |
|
Greater Than |
|
|
|
|
|
|
|
|
||||||||
|
to Twelve Months |
|
Twelve Months |
|
Total |
|
|||||||||||||
|
|
|
Gross |
|
|
Gross |
|
|
|
Gross |
|||||||||
|
Fair |
Unrealized |
Fair |
Unrealized |
Fair |
|
Unrealized |
||||||||||||
|
Value |
|
Losses |
|
Value |
|
Losses |
|
Value |
|
|
Losses (1) |
|
||||||
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
19,817 |
|
$ |
1,528 |
|
$ |
48,011 |
|
$ |
11,235 |
|
$ |
67,828 |
|
|
$ |
12,763 |
|
U.S. government bonds |
|
70 |
|
|
5 |
|
|
222 |
|
|
43 |
|
|
292 |
|
|
|
48 |
|
State and municipal bonds |
|
1,357 |
|
|
42 |
|
|
1,655 |
|
|
502 |
|
|
3,012 |
|
|
|
544 |
|
Foreign government bonds |
|
75 |
|
|
6 |
|
|
120 |
|
|
56 |
|
|
195 |
|
|
|
62 |
|
RMBS |
|
613 |
|
|
46 |
|
|
1,119 |
|
|
230 |
|
|
1,732 |
|
|
|
276 |
|
CMBS |
|
608 |
|
|
21 |
|
|
1,077 |
|
|
241 |
|
|
1,685 |
|
|
|
262 |
|
ABS |
|
2,376 |
|
|
67 |
|
|
7,742 |
|
|
773 |
|
|
10,118 |
|
|
|
840 |
|
Hybrid and redeemable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
preferred securities |
|
60 |
|
|
3 |
|
|
116 |
|
|
17 |
|
|
176 |
|
|
|
20 |
|
Total fixed maturity AFS securities |
$ |
24,976 |
|
$ |
1,718 |
|
$ |
60,062 |
|
$ |
13,097 |
|
$ |
85,038 |
|
|
$ |
14,815 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total number of fixed maturity AFS securities in an unrealized loss position |
|
|
|
8,590 |
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2022 |
|
|||||||||||||||||
|
Less Than or Equal |
|
Greater Than |
|
|
|
|
|
|
|
|
||||||||
|
to Twelve Months |
|
Twelve Months |
|
Total |
|
|||||||||||||
|
|
|
Gross |
|
|
|
Gross |
|
|
|
|
|
Gross |
|
|||||
|
Fair |
Unrealized |
Fair |
Unrealized |
Fair |
|
Unrealized |
||||||||||||
|
Value |
|
Losses |
|
Value |
|
Losses |
|
Value |
|
|
Losses (1) |
|
||||||
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
59,929 |
|
$ |
9,049 |
|
$ |
7,094 |
|
$ |
1,955 |
|
$ |
67,023 |
|
|
$ |
11,004 |
|
U.S. government bonds |
|
261 |
|
|
25 |
|
|
27 |
|
|
6 |
|
|
288 |
|
|
|
31 |
|
State and municipal bonds |
|
1,958 |
|
|
440 |
|
|
237 |
|
|
72 |
|
|
2,195 |
|
|
|
512 |
|
Foreign government bonds |
|
130 |
|
|
19 |
|
|
58 |
|
|
28 |
|
|
188 |
|
|
|
47 |
|
RMBS |
|
1,490 |
|
|
179 |
|
|
193 |
|
|
43 |
|
|
1,683 |
|
|
|
222 |
|
CMBS |
|
1,224 |
|
|
156 |
|
|
320 |
|
|
90 |
|
|
1,544 |
|
|
|
246 |
|
ABS |
|
6,715 |
|
|
552 |
|
|
3,326 |
|
|
374 |
|
|
10,041 |
|
|
|
926 |
|
Hybrid and redeemable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
preferred securities |
|
63 |
|
|
5 |
|
|
97 |
|
|
25 |
|
|
160 |
|
|
|
30 |
|
Total fixed maturity AFS securities |
$ |
71,770 |
|
$ |
10,425 |
|
$ |
11,352 |
|
$ |
2,593 |
|
$ |
83,122 |
|
|
$ |
13,018 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total number of fixed maturity AFS securities in an unrealized loss position |
|
|
|
8,175 |
|
||||||||||||||
(1)As of September 30, 2023, and December 31, 2022, we recognized $12 million and $6 million of gross unrealized losses, respectively, in OCI for fixed maturity AFS securities for which an allowance for credit losses has been recorded.
The fair value, gross unrealized losses (in millions) and number of fixed maturity AFS securities where the fair value had declined and remained below amortized cost by greater than 20% were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
||||||||
|
|
|
|
Gross |
|
|
Number |
|
||
|
Fair |
|
Unrealized |
|
|
of |
|
|||
|
Value |
|
Losses |
|
Securities (1) |
|||||
Less than six months |
$ |
10,439 |
|
$ |
3,443 |
|
|
|
1,362 |
|
Six months or greater, but less than nine months |
|
802 |
|
|
439 |
|
|
|
176 |
|
Nine months or greater, but less than twelve months |
|
183 |
|
|
85 |
|
|
|
25 |
|
Twelve months or greater |
|
5,386 |
|
|
4,036 |
|
|
|
1,057 |
|
Total |
$ |
16,810 |
|
$ |
8,003 |
|
|
|
2,620 |
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2022 |
|
||||||||
|
|
|
Gross |
|
|
Number |
|
|||
|
Fair |
|
Unrealized |
|
|
of |
|
|||
|
Value |
|
Losses |
|
Securities (1) |
|||||
Less than six months |
$ |
11,351 |
|
$ |
3,659 |
|
|
|
1,500 |
|
Six months or greater, but less than nine months |
|
4,411 |
|
|
2,226 |
|
|
|
650 |
|
Nine months or greater, but less than twelve months |
|
447 |
|
|
302 |
|
|
|
74 |
|
Twelve months or greater |
|
2 |
|
|
1 |
|
|
|
15 |
|
Total |
$ |
16,211 |
|
$ |
6,188 |
|
|
|
2,239 |
|
(1)We may reflect a security in more than one aging category based on various purchase dates.
Our gross unrealized losses on fixed maturity AFS securities increased by $1.8 billion for the nine months ended September 30, 2023. Other than with respect to those certain fixed maturity AFS securities intended to be sold as part of the previously announced Fortitude Reinsurance Company Ltd. (“Fortitude Re”) reinsurance transaction (as discussed further below), we do not believe the unrealized loss position as of September 30, 2023, required an impairment recognized in earnings as: (i) we did not intend to sell these fixed maturity AFS securities; (ii) it is not more likely than not that we will be required to sell the fixed maturity AFS securities before recovery of their amortized cost basis; and (iii) the difference in the fair value compared to the amortized cost was due to factors other than credit loss. Based upon this evaluation as of September 30, 2023, management believes we have the ability to generate adequate amounts of cash from our normal operations (e.g., insurance premiums, fee income and investment income) to meet cash requirements with a prudent margin of safety without requiring the sale of our impaired securities. For additional information related to the intent to sell impairments, see “Impairments on Fixed Maturity AFS Securities” below.
As of September 30, 2023, the unrealized losses associated with our corporate bond, U.S. government bond, state and municipal bond and foreign government bond securities were attributable primarily to rising interest rates and widening credit spreads since purchase. We performed a detailed analysis of the financial performance of the underlying issuers and determined that we expected to recover the entire amortized cost of each impaired security.
Credit ratings express opinions about the credit quality of a security. Securities rated investment grade (those rated BBB- or higher by S&P Global Ratings (“S&P”) or Baa3 or higher by Moody’s Investors Service (“Moody’s”)) are generally considered by the rating agencies and market participants to be low credit risk. As of September 30, 2023, and December 31, 2022, 96% of the fair value of our corporate bond portfolio was rated investment grade. As of September 30, 2023, and December 31, 2022, the portion of our corporate bond portfolio rated below investment grade had an amortized cost of $3.4 billion and $3.7 billion, respectively, and a fair value of $3.2 billion and $3.5 billion, respectively. Based upon the analysis discussed above, we believe that as of September 30, 2023, and December 31, 2022, we would have recovered the amortized cost of each corporate bond.
As of September 30, 2023, the unrealized losses associated with our MBS and ABS were attributable primarily to rising interest rates and widening credit spreads since purchase. We assessed for credit impairment using a cash flow model that incorporates key assumptions including default rates, severities and prepayment rates. We estimated losses for a security by forecasting the underlying loans in each transaction. The forecasted loan performance was used to project cash flows to the various tranches in the structure, as applicable. Our forecasted cash flows also considered, as applicable, independent industry analyst reports and forecasts and other independent market data. Based upon our assessment of the expected credit losses of the security given the performance of the underlying collateral compared to our subordination or other credit enhancement, we expected to recover the entire amortized cost of each impaired security.
As of September 30, 2023, the unrealized losses associated with our hybrid and redeemable preferred securities were attributable primarily to wider credit spreads caused by illiquidity in the market and subordination within the capital structure, as well as credit risk of underlying issuers. For our hybrid and redeemable preferred securities, we evaluated the financial performance of the underlying issuers based upon credit performance and investment ratings and determined that we expected to recover the entire amortized cost of each impaired security.
Credit Loss Impairment on Fixed Maturity AFS Securities
We regularly review our fixed maturity AFS securities for declines in fair value that we determine to be impairment-related, including those attributable to credit risk factors that may require an allowance for credit losses. Changes in the allowance for credit losses on fixed maturity AFS securities (in millions), aggregated by investment category, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
||||||||||
|
Months Ended |
|
||||||||||
|
September 30, 2023 |
|
||||||||||
|
Corporate |
|
|
|
|
|
|
|
|
|
|
|
|
Bonds |
|
RMBS |
|
Other |
|
Total |
|
||||
Balance as of beginning-of-period |
$ |
13 |
|
$ |
6 |
|
$ |
6 |
|
$ |
25 |
|
Additions from purchases of PCD debt securities (1) |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
Additions for securities for which credit losses were not |
|
|
|
|
|
|
|
|
|
|
|
|
previously recognized |
|
1 |
|
|
- |
|
|
- |
|
|
1 |
|
Additions (reductions) for securities for which credit losses |
|
|
|
|
|
|
|
|
|
|
|
|
were previously recognized |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
Reductions for securities charged-off |
|
(5 |
) |
|
- |
|
|
- |
|
|
(5 |
) |
Balance as of end-of-period (2) |
$ |
9 |
|
$ |
6 |
|
$ |
6 |
|
$ |
21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine |
|
||||||||||
|
Months Ended |
|
||||||||||
|
September 30, 2023 |
|
||||||||||
|
Corporate |
|
|
|
|
|
|
|
|
|
|
|
|
Bonds |
|
RMBS |
|
Other |
|
Total |
|
||||
Balance as of beginning-of-year |
$ |
9 |
|
$ |
7 |
|
$ |
6 |
|
$ |
22 |
|
Additions from purchases of PCD debt securities (1) |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
Additions for securities for which credit losses were not |
|
|
|
|
|
|
|
|
|
|
|
|
previously recognized |
|
21 |
|
|
- |
|
|
- |
|
|
21 |
|
Additions (reductions) for securities for which credit losses |
|
|
|
|
|
|
|
|
|
|
|
|
were previously recognized |
|
(2 |
) |
|
(1 |
) |
|
- |
|
|
(3 |
) |
Reductions for securities disposed |
|
(1 |
) |
|
- |
|
|
- |
|
|
(1 |
) |
Reductions for securities charged-off |
|
(18 |
) |
|
- |
|
|
- |
|
|
(18 |
) |
Balance as of end-of-period (2) |
$ |
9 |
|
$ |
6 |
|
$ |
6 |
|
$ |
21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
||||||||||
|
Months Ended |
|
||||||||||
|
September 30, 2022 |
|
||||||||||
|
Corporate |
|
|
|
|
|
|
|
|
|
|
|
|
Bonds |
|
RMBS |
|
Other |
|
Total |
|
||||
Balance as of beginning-of-period |
$ |
7 |
|
$ |
3 |
|
$ |
2 |
|
$ |
12 |
|
Additions from purchases of PCD debt securities (1) |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
Additions for securities for which credit losses were not |
|
|
|
|
|
|
|
|
|
|
|
|
previously recognized |
|
- |
|
|
2 |
|
|
1 |
|
|
3 |
|
Additions (reductions) for securities for which credit losses |
|
|
|
|
|
|
|
|
|
|
|
|
were previously recognized |
|
- |
|
|
- |
|
|
3 |
|
|
3 |
|
Balance as of end-of-period (2) |
$ |
7 |
|
$ |
5 |
|
$ |
6 |
|
$ |
18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine |
|
||||||||||
|
Months Ended |
|
||||||||||
|
September 30, 2022 |
|
||||||||||
|
Corporate |
|
|
|
|
|
|
|
|
|
|
|
|
Bonds |
|
RMBS |
|
Other |
|
Total |
|
||||
Balance as of beginning-of-year |
$ |
17 |
|
$ |
1 |
|
$ |
1 |
|
$ |
19 |
|
Additions from purchases of PCD debt securities (1) |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
Additions for securities for which credit losses were not |
|
|
|
|
|
|
|
|
|
|
|
|
previously recognized |
|
2 |
|
|
2 |
|
|
1 |
|
|
5 |
|
Additions (reductions) for securities for which credit losses |
|
|
|
|
|
|
|
|
|
|
|
|
were previously recognized |
|
1 |
|
|
2 |
|
|
4 |
|
|
7 |
|
Reductions for securities disposed |
|
(1 |
) |
|
- |
|
|
- |
|
|
(1 |
) |
Reductions for securities charged-off |
|
(12 |
) |
|
- |
|
|
- |
|
|
(12 |
) |
Balance as of end-of-period (2) |
$ |
7 |
|
$ |
5 |
|
$ |
6 |
|
$ |
18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)Represents purchased credit-deteriorated (“PCD”) fixed maturity AFS securities.
(2)As of September 30, 2023 and 2022, accrued investment income on fixed maturity AFS securities totaled $1.2 billion and $1.1 billion, respectively, and was excluded from the estimate of credit losses.
Mortgage Loans on Real Estate
The following provides the current and past due composition of our mortgage loans on real estate (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
As of December 31, 2022 |
|
||||||||||||||
|
Commercial |
|
Residential |
|
Total |
|
Commercial |
|
Residential |
|
Total |
|
||||||
Current |
$ |
17,221 |
|
$ |
1,555 |
|
$ |
18,776 |
|
$ |
17,003 |
|
$ |
1,315 |
|
$ |
18,318 |
|
30 to 59 days past due |
|
- |
|
|
24 |
|
|
24 |
|
|
19 |
|
|
23 |
|
|
42 |
|
60 to 89 days past due |
|
- |
|
|
13 |
|
|
13 |
|
|
- |
|
|
6 |
|
|
6 |
|
90 or more days past due |
|
- |
|
|
44 |
|
|
44 |
|
|
- |
|
|
33 |
|
|
33 |
|
Allowance for credit losses |
|
(89 |
) |
|
(24 |
) |
|
(113 |
) |
|
(84 |
) |
|
(15 |
) |
|
(99 |
) |
Unamortized premium (discount) |
|
(7 |
) |
|
40 |
|
|
33 |
|
|
(8 |
) |
|
36 |
|
|
28 |
|
Mark-to-market gains (losses) (1) |
|
(27 |
) |
|
1 |
|
|
(26 |
) |
|
(27 |
) |
|
- |
|
|
(27 |
) |
Total carrying value |
$ |
17,098 |
|
$ |
1,653 |
|
$ |
18,751 |
|
$ |
16,903 |
|
$ |
1,398 |
|
$ |
18,301 |
|
(1)Represents the mark-to-market on certain mortgage loans on real estate for which we have elected the fair value option. See Note 14 for additional information.
Our commercial mortgage loan portfolio had the largest concentrations in California, which accounted for 28% and 27% of commercial mortgage loans on real estate as of September 30, 2023, and December 31, 2022, respectively, and Texas, which accounted for 9% of commercial mortgage loans on real estate as of September 30, 2023, and December 31, 2022.
As of September 30, 2023, our residential mortgage loan portfolio had the largest concentrations in California and New York, which accounted for 14% and 13% of residential mortgage loans on real estate, respectively. As of December 31, 2022, our residential mortgage loan portfolio had the largest concentrations in California and New Jersey, which accounted for 17% and 12% of residential mortgage loans on real estate, respectively.
As of September 30, 2023, and December 31, 2022, we had 89 and 73 residential mortgage loans, respectively, that were either delinquent or in foreclosure. As of September 30, 2023, and December 31, 2022, we had 66 and 49 residential mortgage loans in foreclosure, respectively, with an aggregate carrying value of $30 million and $21 million, respectively.
We adopted ASU 2022-02, Troubled Debt Restructurings and Vintage Disclosures as of January 1, 2023, and accordingly no longer identify certain debt modifications as troubled debt restructurings. Losses from loan modifications for the three and nine months ended September 30, 2023, were less than $1 million and reported in realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).
As of September 30, 2023, and December 31, 2022, there were three and two specifically identified impaired commercial mortgage loans, respectively, with an aggregate carrying value of $3 million and less than $1 million, respectively.
As of September 30, 2023, and December 31, 2022, there were 67 and 37 specifically identified impaired residential mortgage loans, respectively, with an aggregate carrying value of $34 million and $16 million, respectively.
Additional information related to impaired mortgage loans on real estate (in millions) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Average aggregate carrying value for impaired mortgage loans on real estate |
$ |
34 |
|
$ |
13 |
|
$ |
25 |
|
$ |
16 |
|
Interest income recognized on impaired mortgage loans on real estate |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
Interest income collected on impaired mortgage loans on real estate |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
The amortized cost of mortgage loans on real estate on nonaccrual status (in millions) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
As of December 31, 2022 |
|
||||||||
|
Nonaccrual |
|
|
|
|
Nonaccrual |
|
|
|
|
||
|
with no |
|
|
|
|
with no |
|
|
|
|
||
|
Allowance |
|
|
|
|
Allowance |
|
|
|
|
||
|
for Credit |
|
|
|
|
for Credit |
|
|
|
|
||
|
Losses |
|
Nonaccrual |
|
Losses |
|
Nonaccrual |
|
||||
Commercial mortgage loans on real estate |
$ |
- |
|
$ |
- |
|
$ |
- |
|
$ |
- |
|
Residential mortgage loans on real estate |
|
- |
|
|
47 |
|
|
- |
|
|
34 |
|
Total |
$ |
- |
|
$ |
47 |
|
$ |
- |
|
$ |
34 |
|
We use loan-to-value and debt-service coverage ratios as credit quality indicators for our commercial mortgage loans on real estate. The amortized cost of commercial mortgage loans on real estate (dollars in millions) by year of origination and credit quality indicator was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
||||||||||||||||
|
|
|
|
Debt- |
|
|
|
|
Debt- |
|
|
|
|
Debt- |
|
|
|
|
|
|
|
|
Service |
|
|
|
|
Service |
|
|
|
|
Service |
|
|
|
|
|
Less |
|
Coverage |
|
65% |
|
Coverage |
|
Greater |
|
Coverage |
|
|
|
||||
|
than 65% |
|
Ratio |
|
to 75% |
|
Ratio |
|
than 75% |
|
Ratio |
|
Total |
|
||||
Origination Year |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
$ |
936 |
|
1.87 |
|
$ |
48 |
|
1.42 |
|
$ |
- |
|
- |
|
$ |
984 |
|
2022 |
|
1,766 |
|
2.06 |
|
|
88 |
|
2.06 |
|
|
1 |
|
1.13 |
|
|
1,855 |
|
2021 |
|
2,340 |
|
3.36 |
|
|
64 |
|
1.57 |
|
|
- |
|
- |
|
|
2,404 |
|
2020 |
|
1,231 |
|
3.20 |
|
|
11 |
|
1.50 |
|
|
- |
|
- |
|
|
1,242 |
|
2019 |
|
2,485 |
|
2.45 |
|
|
82 |
|
1.48 |
|
|
10 |
|
2.33 |
|
|
2,577 |
|
2018 and prior |
|
7,999 |
|
2.42 |
|
|
152 |
|
1.59 |
|
|
1 |
|
1.67 |
|
|
8,152 |
|
Total |
$ |
16,757 |
|
|
|
$ |
445 |
|
|
|
$ |
12 |
|
|
|
$ |
17,214 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2022 |
|
||||||||||||||||
|
|
|
|
Debt- |
|
|
|
|
Debt- |
|
|
|
|
Debt- |
|
|
|
|
|
|
|
|
Service |
|
|
|
|
Service |
|
|
|
|
Service |
|
|
|
|
|
Less |
|
Coverage |
|
65% |
|
Coverage |
|
Greater |
|
Coverage |
|
|
|
||||
|
than 65% |
|
Ratio |
|
to 75% |
|
Ratio |
|
than 75% |
|
Ratio |
|
Total |
|
||||
Origination Year |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2022 |
$ |
1,769 |
|
2.06 |
|
$ |
105 |
|
1.50 |
|
$ |
2 |
|
1.45 |
|
$ |
1,876 |
|
2021 |
|
2,354 |
|
3.05 |
|
|
72 |
|
1.53 |
|
|
- |
|
- |
|
|
2,426 |
|
2020 |
|
1,289 |
|
3.00 |
|
|
17 |
|
1.58 |
|
|
- |
|
- |
|
|
1,306 |
|
2019 |
|
2,685 |
|
2.18 |
|
|
81 |
|
1.50 |
|
|
29 |
|
1.58 |
|
|
2,795 |
|
2018 |
|
2,225 |
|
2.17 |
|
|
71 |
|
1.62 |
|
|
- |
|
- |
|
|
2,296 |
|
2017 and prior |
|
6,184 |
|
2.44 |
|
|
131 |
|
1.75 |
|
|
- |
|
- |
|
|
6,315 |
|
Total |
$ |
16,506 |
|
|
|
$ |
477 |
|
|
|
$ |
31 |
|
|
|
$ |
17,014 |
|
We use loan performance status as the primary credit quality indicator for our residential mortgage loans on real estate. The amortized cost of residential mortgage loans on real estate (in millions) by year of origination and credit quality indicator was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
|||||||||
|
Performing |
|
Nonperforming |
|
Total |
|
|||||
Origination Year |
|
|
|
|
|
|
|
|
|
|
|
2023 |
$ |
359 |
|
|
$ |
- |
|
|
$ |
359 |
|
2022 |
|
552 |
|
|
|
17 |
|
|
|
569 |
|
2021 |
|
477 |
|
|
|
14 |
|
|
|
491 |
|
2020 |
|
83 |
|
|
|
1 |
|
|
|
84 |
|
2019 |
|
103 |
|
|
|
12 |
|
|
|
115 |
|
2018 and prior |
|
55 |
|
|
|
3 |
|
|
|
58 |
|
Total |
$ |
1,629 |
|
|
$ |
47 |
|
|
$ |
1,676 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2022 |
|
|||||||||
|
Performing |
|
Nonperforming |
|
Total |
|
|||||
Origination Year |
|
|
|
|
|
|
|
|
|
|
|
2022 |
$ |
578 |
|
|
$ |
5 |
|
|
$ |
583 |
|
2021 |
|
527 |
|
|
|
6 |
|
|
|
533 |
|
2020 |
|
90 |
|
|
|
3 |
|
|
|
93 |
|
2019 |
|
119 |
|
|
|
18 |
|
|
|
137 |
|
2018 |
|
65 |
|
|
|
2 |
|
|
|
67 |
|
2017 and prior |
|
- |
|
|
|
- |
|
|
|
- |
|
Total |
$ |
1,379 |
|
|
$ |
34 |
|
|
$ |
1,413 |
|
Credit Losses on Mortgage Loans on Real Estate
In connection with our recognition of an allowance for credit losses for mortgage loans on real estate, we perform a quantitative analysis using a probability of default/loss given default/exposure at default approach to estimate expected credit losses in our mortgage loan portfolio as well as unfunded commitments related to commercial mortgage loans, exclusive of certain mortgage loans held at fair value.
Changes in the allowance for credit losses on mortgage loans on real estate (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
|||||||
|
Months Ended |
|
|||||||
|
September 30, 2023 |
|
|||||||
|
Commercial |
|
Residential |
|
Total |
|
|||
Balance as of beginning-of-period |
$ |
82 |
|
$ |
23 |
|
$ |
105 |
|
Additions (reductions) from provision for credit loss expense (1) |
|
7 |
|
|
1 |
|
|
8 |
|
Additions from purchases of PCD mortgage loans on real estate |
|
- |
|
|
- |
|
|
- |
|
Balance as of end-of-period (2) |
$ |
89 |
|
$ |
24 |
|
$ |
113 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine |
|
|||||||
|
Months Ended |
|
|||||||
|
September 30, 2023 |
|
|||||||
|
Commercial |
|
Residential |
|
Total |
|
|||
Balance as of beginning-of-year |
$ |
84 |
|
$ |
15 |
|
$ |
99 |
|
Additions (reductions) from provision for credit loss expense (1) |
|
5 |
|
|
9 |
|
|
14 |
|
Additions from purchases of PCD mortgage loans on real estate |
|
- |
|
|
- |
|
|
- |
|
Balance as of end-of-period (2) |
$ |
89 |
|
$ |
24 |
|
$ |
113 |
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
|||||||
|
Months Ended |
|
|||||||
|
September 30, 2022 |
|
|||||||
|
Commercial |
|
Residential |
|
Total |
|
|||
Balance as of beginning-of-period |
$ |
72 |
|
$ |
9 |
|
$ |
81 |
|
Additions (reductions) from provision for credit loss expense (1) |
|
8 |
|
|
2 |
|
|
10 |
|
Additions from purchases of PCD mortgage loans on real estate |
|
- |
|
|
- |
|
|
- |
|
Balance as of end-of-period (2) |
$ |
80 |
|
$ |
11 |
|
$ |
91 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine |
|
|||||||
|
Months Ended |
|
|||||||
|
September 30, 2022 |
|
|||||||
|
Commercial |
|
Residential |
|
Total |
|
|||
Balance as of beginning-of-year |
$ |
79 |
|
$ |
17 |
|
$ |
96 |
|
Additions (reductions) from provision for credit loss expense (1) |
|
1 |
|
|
(6 |
) |
|
(5 |
) |
Additions from purchases of PCD mortgage loans on real estate |
|
- |
|
|
- |
|
|
- |
|
Balance as of end-of-period (2) |
$ |
80 |
|
$ |
11 |
|
$ |
91 |
|
(1)We recognized $(1) million and $1 million of credit loss benefit (expense) related to unfunded commitments for mortgage loans on real estate for the three months ended September 30, 2023 and 2022, respectively. We recognized $(2) million and $(1) million of credit loss benefit (expense) related to unfunded commitments for mortgage loans on real estate for the nine months ended September 30, 2023 and 2022, respectively.
(2)Accrued investment income on mortgage loans on real estate totaled $54 million and $50 million as of September 30, 2023 and 2022, respectively, and was excluded from the estimate of credit losses.
Alternative Investments
As of September 30, 2023, and December 31, 2022, alternative investments included investments in 348 and 337 different partnerships, respectively, and represented approximately 2% of total investments.
Impairments on Fixed Maturity AFS Securities
Details underlying intent to sell impairments and credit loss benefit (expense) incurred that were recognized in net income (loss) and included in realized gain (loss) on fixed maturity AFS securities (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Intent to Sell Impairments (1) |
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
(422 |
) |
$ |
- |
|
$ |
(941 |
) |
$ |
- |
|
State and municipal bonds |
|
(28 |
) |
|
- |
|
|
(48 |
) |
|
- |
|
RMBS |
|
(9 |
) |
|
- |
|
|
(28 |
) |
|
- |
|
CMBS |
|
(5 |
) |
|
- |
|
|
(36 |
) |
|
- |
|
ABS |
|
(2 |
) |
|
- |
|
|
(37 |
) |
|
- |
|
Hybrid and redeemable preferred securities |
|
(1 |
) |
|
- |
|
|
(1 |
) |
|
- |
|
Total intent to sell impairments |
$ |
(467 |
) |
$ |
- |
|
$ |
(1,091 |
) |
$ |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit Loss Benefit (Expense) |
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
(1 |
) |
$ |
- |
|
$ |
(18 |
) |
$ |
(2 |
) |
RMBS |
|
- |
|
|
(2 |
) |
|
1 |
|
|
(4 |
) |
ABS |
|
- |
|
|
(3 |
) |
|
- |
|
|
(5 |
) |
Total credit loss benefit (expense) |
$ |
(1 |
) |
$ |
(5 |
) |
$ |
(17 |
) |
$ |
(11 |
) |
(1)Represents impairment of certain fixed maturity AFS securities in an unrealized loss position, resulting from the Company’s intent to sell these securities as part of the previously announced Fortitude Re reinsurance transaction. Within the investment portfolio anticipated to be sold in the transaction, there are additional fixed maturity AFS securities in an unrealized gain position of approximately $208 million pre-tax as of September 30, 2023. Pursuant to the applicable accounting guidance, the Company impaired the securities in a loss position down to fair market value upon entry into the agreement in the second quarter and recognized additional impairment on certain of these securities during the third quarter due to higher interest rates. The Company will recognize a gain for any securities in an unrealized gain position at the time when the transaction closes. See Note 8 for additional information.
Payables for Collateral on Investments
The carrying value of the payables for collateral on investments included on the Consolidated Balance Sheets and the fair value of the related investments or collateral (in millions) consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
As of December 31, 2022 |
|
||||||||
|
Carrying |
|
Fair |
|
Carrying |
|
Fair |
|
||||
|
Value |
|
Value |
|
Value |
|
Value |
|
||||
Collateral payable for derivative investments (1) |
$ |
4,836 |
|
$ |
4,836 |
|
$ |
3,284 |
|
$ |
3,284 |
|
Securities pledged under securities lending agreements (2) |
|
290 |
|
|
280 |
|
|
298 |
|
|
287 |
|
Investments pledged for FHLBI (3) |
|
2,920 |
|
|
3,860 |
|
|
3,130 |
|
|
3,925 |
|
Total payables for collateral on investments |
$ |
8,046 |
|
$ |
8,976 |
|
$ |
6,712 |
|
$ |
7,496 |
|
(1)We obtain collateral based upon contractual provisions with our counterparties. These agreements take into consideration the counterparties’ credit rating as compared to ours, the fair value of the derivative investments and specified thresholds that if exceeded result in the receipt of cash that is typically invested in cash and invested cash. This also includes interest payable on collateral. See Note 6 for additional information.
(2)Our pledged securities under securities lending agreements are included in fixed maturity AFS securities on the Consolidated Balance Sheets. We generally obtain collateral in an amount equal to 102% and 105% of the fair value of the domestic and foreign securities, respectively. We value collateral daily and obtain additional collateral when deemed appropriate. The cash received in our securities lending program is typically invested in cash and invested cash or fixed maturity AFS securities.
(3)Our pledged investments for FHLB of Indianapolis (“FHLBI”) are included in fixed maturity AFS securities and mortgage loans on real estate on the Consolidated Balance Sheets. The collateral requirements are generally 105% to 115% of the fair value for fixed maturity AFS securities and 155% to 175% of the fair value for mortgage loans on real estate. The cash received in these transactions is primarily invested in cash and invested cash or fixed maturity AFS securities.
We have repurchase agreements through which we can obtain liquidity by pledging securities. The collateral requirements are generally 80% to 95% of the fair value of the securities, and our agreements with third parties contain contractual provisions to allow for additional collateral to be obtained when necessary. The cash received in our repurchase program is typically invested in fixed maturity AFS securities. As of September 30, 2023, and December 31, 2022, we were not participating in any open repurchase agreements.
Increase (decrease) in payables for collateral on investments (in millions) consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine |
|
||||
|
Months Ended |
|
||||
|
September 30, |
|
||||
|
2023 |
|
2022 |
|
||
Collateral payable for derivative investments |
$ |
1,552 |
|
$ |
(2,140 |
) |
Securities pledged under securities lending agreements |
|
(8 |
) |
|
59 |
|
Investments pledged for FHLBI |
|
(210 |
) |
|
- |
|
Total increase (decrease) in payables for collateral on investments |
$ |
1,334 |
|
$ |
(2,081 |
) |
We have elected not to offset our securities lending transactions in the consolidated financial statements. The remaining contractual maturities of securities lending transactions accounted for as secured borrowings (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
|||||||||||||
|
Overnight and Continuous |
|
Up to 30 Days |
|
30 - 90 |
|
Greater Than 90 Days |
|
Total |
|
|||||
Securities Lending |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
281 |
|
$ |
- |
|
$ |
- |
|
$ |
- |
|
$ |
281 |
|
Foreign government bonds |
|
1 |
|
|
- |
|
|
- |
|
|
- |
|
|
1 |
|
Equity securities |
|
8 |
|
|
- |
|
|
- |
|
|
- |
|
|
8 |
|
Total gross secured borrowings |
$ |
290 |
|
$ |
- |
|
$ |
- |
|
$ |
- |
|
$ |
290 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2022 |
|
|||||||||||||
|
Overnight and Continuous |
|
Up to 30 Days |
|
30 - 90 |
|
Greater Than 90 Days |
|
Total |
|
|||||
Securities Lending |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
288 |
|
$ |
- |
|
$ |
- |
|
$ |
- |
|
$ |
288 |
|
Foreign government bonds |
|
2 |
|
|
- |
|
|
- |
|
|
- |
|
|
2 |
|
Equity securities |
|
8 |
|
|
- |
|
|
- |
|
|
- |
|
|
8 |
|
Total gross secured borrowings |
$ |
298 |
|
$ |
- |
|
$ |
- |
|
$ |
- |
|
$ |
298 |
|
We accept collateral in the form of securities in connection with repurchase agreements. In instances where we are permitted to sell or re-pledge the securities received, we report the fair value of the collateral received and a related obligation to return the collateral in the consolidated financial statements. In addition, we receive securities in connection with securities borrowing agreements that we are permitted to sell or re-pledge. As of September 30, 2023, the fair value of this collateral received that we are permitted to sell or re-pledge was $25 million, and we had not re-pledged any of this collateral to cover our collateral requirements.
We also accept collateral from derivative counterparties in the form of securities that we are permitted to sell or re-pledge. As of September 30, 2023, the fair value of this collateral received that we are permitted to sell or re-pledge was $1.0 billion, and we had re-pledged $335 million of this collateral to cover our collateral requirements.
We have also pledged fixed maturity AFS securities to derivative counterparties with a fair value of $87 million as of September 30, 2023.
Investment Commitments
As of September 30, 2023, our investment commitments were $2.3 billion, which included $1.9 billion of LPs, $257 million of mortgage loans on real estate and $223 million of private placement securities.
Concentrations of Financial Instruments
As of September 30, 2023, and December 31, 2022, our most significant investments in one issuer were our investments in securities issued by the Federal National Mortgage Association with a fair value of $748 million and $745 million, respectively, or 1% of total investments, and our investments in securities issued by the Federal Home Loan Mortgage Corporation with a fair value of $640 million and $720 million, respectively, or 1% of total investments. These concentrations include fixed maturity AFS, trading and equity securities.
As of September 30, 2023, and December 31, 2022, our most significant investments in one industry were our investments in securities in the financial services industry with a fair value of $15.5 billion and $16.6 billion, respectively, or 12% and 13%, respectively, of total investments, and our investments in securities in the consumer non-cyclical industry with a fair value of $14.9 billion and $15.1 billion, respectively, or 11% of total investments. These concentrations include fixed maturity AFS, trading and equity securities.
5. Variable Interest Entities
Consolidated VIEs
Asset information (dollars in millions) for the consolidated VIEs included on our Consolidated Balance Sheets was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
|
As of December 31, 2022 |
|
||||||||||||||||
|
|
Number |
|
|
|
|
|
|
|
|
|
Number |
|
|
|
|
|
|
|
|
||
|
|
of |
|
|
Notional |
|
Carrying |
|
|
of |
|
|
Notional |
|
Carrying |
|
||||||
|
Instruments |
|
Amounts |
|
Value |
|
Instruments |
|
Amounts |
|
Value |
|
||||||||||
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total return swap |
|
|
1 |
|
|
$ |
543 |
|
$ |
- |
|
|
|
1 |
|
|
$ |
568 |
|
$ |
- |
|
There were no gains or losses for consolidated VIEs recognized on our Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2023 and 2022.
Unconsolidated VIEs
Structured Securities
Through our investment activities, we make passive investments in structured securities issued by VIEs for which we are not the manager. These structured securities include our ABS, RMBS and CMBS. We have not provided financial or other support with respect to these VIEs other than our original investment. We have determined that we are not the primary beneficiary of these VIEs due to the relative size of our investment in comparison to the principal amount of the structured securities issued by the VIEs and the level of credit subordination that reduces our obligation to absorb losses or right to receive benefits. Our maximum exposure to loss on these structured securities is limited to the amortized cost for these investments. We recognize our variable interest in these VIEs at fair value on our Consolidated Balance Sheets. For information about these structured securities, see Note 4.
Limited Partnerships and Limited Liability Companies
We invest in certain LPs and limited liability companies (“LLCs”) that we have concluded are VIEs. Our exposure to loss is limited to the capital we invest in the LPs and LLCs. We do not hold any substantive kick-out or participation rights in the LPs and LLCs, and we do not receive any performance fees or decision maker fees from the LPs and LLCs. Based on our analysis of the LPs and LLCs, we are not the primary beneficiary of the VIEs as we do not have the power to direct the most significant activities of the LPs and LLCs. The carrying amounts of our investments in the LPs and LLCs are recognized in other investments on our Consolidated Balance Sheets and were $3.3 billion and $3.1 billion as of September 30, 2023, and December 31, 2022, respectively.
6. Derivative Instruments
We maintain an overall risk management strategy that incorporates the use of derivative instruments to minimize significant unplanned fluctuations in earnings that are caused by interest rate risk, foreign currency exchange risk, equity market risk, basis risk, commodity risk and credit risk. We assess these risks by continually identifying and monitoring changes in our exposures that may adversely affect expected future cash flows and by evaluating hedging opportunities.
Derivative activities are monitored by various management committees. The committees are responsible for overseeing the implementation of various hedging strategies that are developed through the analysis of financial simulation models and other internal and industry sources. The resulting hedging strategies are incorporated into our overall risk management strategies.
See Note 14 for additional disclosures related to the fair value of our derivative instruments.
Interest Rate Contracts
We use derivative instruments as part of our interest rate risk management strategy. These instruments are economic hedges unless otherwise noted and include:
Forward-Starting Interest Rate Swaps
We use forward-starting interest rate swaps to hedge the interest rate exposure within our life and annuity products.
Interest Rate Cap Corridors
We use interest rate cap corridors to provide a level of protection from the effect of rising interest rates for certain annuity contracts and life insurance products. Interest rate cap corridors involve purchasing an interest rate cap at a specific cap rate and selling an interest rate cap with a higher cap rate. For each corridor, the amount of quarterly payments, if any, is determined by the rate at which the underlying index rate resets above the original capped rate. The corridor limits the benefit the purchaser can receive as the related interest rate index rises above the higher capped rate. There is no additional liability to us other than the purchase price associated with the interest rate cap corridor.
Interest Rate Futures
We use interest rate futures contracts to hedge the liability exposure on certain options in variable annuity products. These futures contracts require payment between our counterparty and us on a daily basis for changes in the futures index price.
Interest Rate Swap Agreements
We use interest rate swap agreements to hedge the liability exposure on certain options in variable annuity products.
We also use interest rate swap agreements designated and qualifying as cash flow hedges to hedge the interest rate risk of floating-rate bond coupon payments by replicating a fixed-rate bond.
Finally, we use interest rate swap agreements designated and qualifying as fair value hedges to hedge against changes in the fair value of certain fixed-rate long-term debt and fixed maturity securities due to interest rate risks.
Treasury and Reverse Treasury Locks
We use treasury locks designated and qualifying as cash flow hedges to hedge the interest rate exposure related to our issuance of fixed-rate securities or the anticipated future cash flows of floating-rate fixed maturity securities due to changes in interest rates. In addition, we use reverse treasury locks designated and qualifying as cash flow hedges to hedge the interest rate exposure related to the anticipated purchase of fixed-rate securities or the anticipated future cash flows of floating-rate fixed maturity securities due to changes in interest rates. These derivatives are primarily structured to hedge interest rate risk inherent in the assumptions used to price certain liabilities.
Foreign Currency Contracts
We use derivative instruments as part of our foreign currency risk management strategy. These instruments are economic hedges unless otherwise noted and include:
Currency Futures
We use currency futures to hedge foreign exchange risk associated with certain options in variable annuity products. Currency futures exchange one currency for another at a specified date in the future at a specified exchange rate.
Foreign Currency Swaps
We use foreign currency swaps to hedge foreign exchange risk of investments in fixed maturity securities denominated in foreign currencies. A foreign currency swap is a contractual agreement to exchange one currency for another at specified dates in the future at a specified exchange rate.
We also use foreign currency swaps designated and qualifying as cash flow hedges to hedge foreign exchange risk of investments in fixed maturity securities denominated in foreign currencies.
Foreign Currency Forwards
We use foreign currency forwards to hedge foreign exchange risk of investments in fixed maturity securities denominated in foreign currencies. A foreign currency forward is a contractual agreement to exchange one currency for another at specified dates in the future at a specified current exchange rate.
Equity Market Contracts
We use derivative instruments as part of our equity market risk management strategy that are economic hedges and include:
Call Options Based on the S&P 500® Index and Other Indices
We use call options to hedge the liability exposure on certain options in variable annuity, indexed variable annuity (RILA), fixed indexed annuity, IUL and VUL products.
Our indexed annuity and IUL contracts permit the holder to elect an interest rate return or an equity market component, where interest credited to the contracts is linked to the performance of the S&P 500 Index or other indices. Policyholders may elect to rebalance index options at renewal dates. At the end of each indexed term, which can be up to six years, we have the opportunity to re-price the indexed component by establishing participation rates, caps, spreads and specified rates, subject to contractual guarantees. We use call options that are highly correlated to the portfolio allocation decisions of our policyholders, such that we are economically hedged with respect to equity returns for the current reset period.
Consumer Price Index Swaps
We use consumer price index swaps to hedge the liability exposure on certain options in fixed annuity products. Consumer price index swaps are contracts entered into at no cost and whose payoff is the difference between the consumer price index inflation rate and the fixed-rate determined as of inception.
Equity Futures
We use equity futures contracts to hedge the liability exposure on certain options in variable annuity products. These futures contracts require payment between our counterparty and us on a daily basis for changes in the futures index price.
Put Options
We use put options to hedge the liability exposure on certain options in variable annuity, indexed variable annuity (RILA) and VUL products. Put options are contracts that require buyers to pay at a specified future date the amount, if any, by which a specified equity index is less than the strike rate stated in the agreement, applied to a notional amount.
Total Return Swaps
We use total return swaps to hedge the liability exposure on certain options in variable annuity, indexed variable annuity (RILA) and VUL products.
In addition, we use total return swaps to hedge a portion of the liability related to our deferred compensation plans. We receive the total return on a portfolio of indexes and pay a floating-rate of interest.
Commodity Contracts
We use commodity contracts to economically hedge certain investments that are closely tied to the changes in commodity values. The commodity contract is an over-the-counter contract that combines a purchase put/sold call to lock in a commodity price within a predetermined range in exchange for a net premium.
Credit Contracts
We use derivative instruments as part of our credit risk management strategy that are economic hedges and include:
Credit Default Swaps – Buying Protection
We use credit default swaps (“CDSs”) to hedge the liability exposure on certain options in variable annuity products.
We buy CDSs to hedge against a drop in bond prices due to credit concerns of certain bond issuers. A CDS allows us to put the bond back to the counterparty at par upon a default event by the bond issuer. A default event is defined as bankruptcy, failure to pay, obligation acceleration or restructuring.
CDSs – Selling Protection
We use CDSs to hedge the liability exposure on certain options in variable annuity products.
We sell CDSs to offer credit protection to policyholders and investors. The CDSs hedge the policyholders and investors against a drop in bond prices due to credit concerns of certain bond issuers. A CDS allows the investor to put the bond back to us at par upon a default event by the bond issuer. A default event is defined as bankruptcy, failure to pay, obligation acceleration or restructuring.
Embedded Derivatives
We have embedded derivatives that include:
Indexed Annuity and IUL Contracts Embedded Derivatives
Our indexed annuity and IUL contracts permit the holder to elect an interest rate return or an equity market component, where interest credited to the contracts is linked to the performance of the S&P 500® Index or other indices. Policyholders may elect to rebalance index options at renewal dates. At the end of each indexed term, which can be up to six years, we have the opportunity to re-price the indexed component by establishing participation rates, caps, spreads and specified rates, subject to contractual guarantees. We use options that are highly correlated to the portfolio allocation decisions of our policyholders, such that we are economically hedged with respect to equity returns for the current reset period.
Reinsurance-Related Embedded Derivatives
We have certain modified coinsurance and coinsurance with funds withheld reinsurance agreements with embedded derivatives related to the withheld assets of the related funds. These derivatives are considered total return swaps with contractual returns that are attributable to various assets and liabilities associated with these reinsurance agreements.
We have derivative instruments with off-balance-sheet risks whose notional or contract amounts exceed the related credit exposure. Outstanding derivative instruments with off-balance-sheet risks (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
As of December 31, 2022 |
|
||||||||||||||
|
Notional |
|
Fair Value |
|
Notional |
|
Fair Value |
|
||||||||||
|
Amounts |
|
Asset |
|
Liability |
|
Amounts |
|
Asset |
|
Liability |
|
||||||
Qualifying Hedges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flow hedges: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts (1) |
$ |
1,876 |
|
$ |
318 |
|
$ |
146 |
|
$ |
2,590 |
|
$ |
123 |
|
$ |
232 |
|
Foreign currency contracts (1) |
|
4,578 |
|
|
550 |
|
|
33 |
|
|
4,383 |
|
|
643 |
|
|
18 |
|
Total cash flow hedges |
|
6,454 |
|
|
868 |
|
|
179 |
|
|
6,973 |
|
|
766 |
|
|
250 |
|
Fair value hedges: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts (1) |
|
1,115 |
|
|
17 |
|
|
15 |
|
|
1,155 |
|
|
2 |
|
|
44 |
|
Non-Qualifying Hedges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts (1) |
|
89,067 |
|
|
1,003 |
|
|
1,398 |
|
|
105,977 |
|
|
709 |
|
|
935 |
|
Foreign currency contracts (1) |
|
353 |
|
|
24 |
|
|
1 |
|
|
395 |
|
|
27 |
|
|
2 |
|
Equity market contracts (1) |
|
285,840 |
|
|
8,194 |
|
|
3,366 |
|
|
142,946 |
|
|
5,135 |
|
|
2,035 |
|
Commodity contracts (1) |
|
27 |
|
|
9 |
|
|
11 |
|
|
13 |
|
|
14 |
|
|
3 |
|
Credit contracts (1) |
|
307 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
Embedded derivatives: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reinsurance-related (2) |
|
- |
|
|
393 |
|
|
- |
|
|
- |
|
|
416 |
|
|
- |
|
Indexed annuity and IUL contracts (2) (3) |
|
- |
|
|
586 |
|
|
7,174 |
|
|
- |
|
|
525 |
|
|
4,783 |
|
Total derivative instruments |
$ |
383,163 |
|
$ |
11,094 |
|
$ |
12,144 |
|
$ |
257,459 |
|
$ |
7,594 |
|
$ |
8,052 |
|
(1)These asset and liability balances are presented on a gross basis. Amounts are reported in derivative investments and other liabilities on the Consolidated Balance Sheets after the evaluation for right of offset subject to master netting agreements.
(2)Reported in other assets and other liabilities on the Consolidated Balance Sheets.
(3)Reported in policyholder account balances on the Consolidated Balance Sheets.
The maturity of the notional amounts of derivative instruments (in millions) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remaining Life as of September 30, 2023 |
|
||||||||||||||||
|
Less Than |
|
1 - 5 |
|
6 - 10 |
|
11 - 30 |
|
Over 30 |
|
|
|
||||||
|
1 Year |
|
Years |
|
Years |
|
Years |
|
Years |
|
Total |
|
||||||
Interest rate contracts (1) |
$ |
27,214 |
|
$ |
16,713 |
|
$ |
22,487 |
|
$ |
21,431 |
|
$ |
4,213 |
|
$ |
92,058 |
|
Foreign currency contracts (2) |
|
252 |
|
|
953 |
|
|
1,592 |
|
|
2,092 |
|
|
42 |
|
|
4,931 |
|
Equity market contracts |
|
194,309 |
|
|
74,262 |
|
|
7,014 |
|
|
9 |
|
|
10,246 |
|
|
285,840 |
|
Commodity contracts |
|
27 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
27 |
|
Credit contracts |
|
- |
|
|
- |
|
|
307 |
|
|
- |
|
|
- |
|
|
307 |
|
Total derivative instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
with notional amounts |
$ |
221,802 |
|
$ |
91,928 |
|
$ |
31,400 |
|
$ |
23,532 |
|
$ |
14,501 |
|
$ |
383,163 |
|
(1)As of September 30, 2023, the latest maturity date for which we were hedging our exposure to the variability in future cash flows for these instruments was April 20, 2067.
(2)As of September 30, 2023, the latest maturity date for which we were hedging our exposure to the variability in future cash flows for these instruments was June 16, 2061.
The following amounts (in millions) were recorded on the Consolidated Balance Sheets related to cumulative basis adjustments for fair value hedges:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative Fair Value |
|
|
|||||
|
|
|
|
|
|
|
|
|
Hedging Adjustment |
|
|
|||||
|
|
|
|
|
|
|
|
|
Included in the |
|
|
|||||
|
Amortized Cost of the |
|
|
Amortized Cost of the |
|
|
||||||||||
|
Hedged |
|
|
Hedged |
|
|
||||||||||
|
Assets / (Liabilities) |
|
|
Assets / (Liabilities) |
|
|
||||||||||
|
As of |
|
|
As of |
|
|
As of |
|
|
As of |
|
|
||||
|
September 30, |
|
December 31, |
|
September 30, |
|
December 31, |
|
||||||||
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
|
||||
Line Item in the Consolidated Balance Sheets in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
which the Hedged Item is Included |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities, at fair value |
$ |
498 |
|
|
$ |
587 |
|
|
$ |
- |
|
|
$ |
44 |
|
|
Long-term debt (1) |
|
(656 |
) |
|
|
(698 |
) |
|
|
219 |
|
|
|
177 |
|
|
(1)Includes $(330) million and $(341) million of unamortized adjustments from discontinued hedges as of September 30, 2023, and December 31, 2022, respectively.
The change in our unrealized gain (loss) on derivative instruments within AOCI (in millions) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine |
|
||||
|
Months Ended |
|
||||
|
September 30, |
|
||||
|
2023 |
|
2022 |
|
||
Unrealized Gain (Loss) on Derivative Instruments |
|
|
|
|
|
|
Balance as of beginning-of-year |
$ |
388 |
|
$ |
(85 |
) |
Other comprehensive income (loss): |
|
|
|
|
|
|
Unrealized holding gains (losses) arising during the period: |
|
|
|
|
|
|
Cash flow hedges: |
|
|
|
|
|
|
Interest rate contracts |
|
323 |
|
|
123 |
|
Foreign currency contracts |
|
(92 |
) |
|
178 |
|
Change in foreign currency exchange rate adjustment |
|
30 |
|
|
623 |
|
Income tax benefit (expense) |
|
(55 |
) |
|
(194 |
) |
Less: |
|
|
|
|
|
|
Reclassification adjustment for gains (losses) |
|
|
|
|
|
|
included in net income (loss): |
|
|
|
|
|
|
Cash flow hedges: |
|
|
|
|
|
|
Interest rate contracts (1) |
|
- |
|
|
1 |
|
Interest rate contracts (2) |
|
22 |
|
|
(11 |
) |
Foreign currency contracts (1) |
|
42 |
|
|
48 |
|
Foreign currency contracts (3) |
|
4 |
|
|
29 |
|
Income tax benefit (expense) |
|
(14 |
) |
|
(14 |
) |
Balance as of end-of-period |
$ |
540 |
|
$ |
592 |
|
(1)The OCI offset is reported within net investment income on the Consolidated Statements of Comprehensive Income (Loss).
(2)The OCI offset is reported within interest and debt expense on the Consolidated Statements of Comprehensive Income (Loss).
(3)The OCI offset is reported within realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).
The effects of qualifying and non-qualifying hedges (in millions) on the Consolidated Statements of Comprehensive Income (Loss) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain (Loss) Recognized in Income |
|
||||||||||||||||
|
For the Three Months Ended September 30, |
|
||||||||||||||||
|
2023 |
|
2022 |
|
||||||||||||||
|
Realized |
|
Net |
|
Interest |
|
Realized |
|
Net |
|
Interest |
|
||||||
|
Gain |
|
Investment |
|
and Debt |
|
Gain |
|
Investment |
|
and Debt |
|
||||||
|
(Loss) |
|
Income |
|
Expense |
|
(Loss) |
|
Income |
|
Expense |
|
||||||
Total Line Items in which the |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effects of Fair Value or Cash |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Flow Hedges are Recorded |
$ |
(453 |
) |
$ |
1,494 |
|
$ |
84 |
|
$ |
249 |
|
$ |
1,295 |
|
$ |
71 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Qualifying Hedges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain or (loss) on fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
hedging relationships: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hedged items |
|
- |
|
|
(41 |
) |
|
46 |
|
|
- |
|
|
(42 |
) |
|
36 |
|
Derivatives designated as |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
hedging instruments |
|
- |
|
|
41 |
|
|
(46 |
) |
|
- |
|
|
42 |
|
|
(36 |
) |
Gain or (loss) on cash flow |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
hedging relationships: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of gain or (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
reclassified from AOCI |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
into income |
|
- |
|
|
- |
|
|
8 |
|
|
- |
|
|
- |
|
|
(1 |
) |
Foreign currency contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of gain or (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
reclassified from AOCI |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
into income |
|
2 |
|
|
14 |
|
|
- |
|
|
25 |
|
|
19 |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Qualifying Hedges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts |
|
(604 |
) |
|
- |
|
|
- |
|
|
(552 |
) |
|
- |
|
|
- |
|
Foreign currency contracts |
|
- |
|
|
- |
|
|
- |
|
|
4 |
|
|
- |
|
|
- |
|
Equity market contracts |
|
163 |
|
|
- |
|
|
- |
|
|
(188 |
) |
|
- |
|
|
- |
|
Commodity contracts |
|
(1 |
) |
|
- |
|
|
- |
|
|
(6 |
) |
|
- |
|
|
- |
|
Credit contracts |
|
- |
|
|
- |
|
|
- |
|
|
(2 |
) |
|
- |
|
|
- |
|
Embedded derivatives: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reinsurance-related |
|
24 |
|
|
- |
|
|
- |
|
|
174 |
|
|
- |
|
|
- |
|
Indexed annuity and IUL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
contracts |
|
572 |
|
|
- |
|
|
- |
|
|
347 |
|
|
- |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain (Loss) Recognized in Income |
|
||||||||||||||||
|
For the Nine Months Ended September 30, |
|
||||||||||||||||
|
2023 |
|
2022 |
|
||||||||||||||
|
Realized |
|
Net |
|
Interest |
|
Realized |
|
Net |
|
Interest |
|
||||||
|
Gain |
|
Investment |
|
and Debt |
|
Gain |
|
Investment |
|
and Debt |
|
||||||
|
(Loss) |
|
Income |
|
Expense |
|
(Loss) |
|
Income |
|
Expense |
|
||||||
Total Line Items in which the |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effects of Fair Value or Cash |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Flow Hedges are Recorded |
$ |
(3,066 |
) |
$ |
4,468 |
|
$ |
250 |
|
$ |
1,531 |
|
$ |
4,105 |
|
$ |
205 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Qualifying Hedges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain or (loss) on fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
hedging relationships: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hedged items |
|
- |
|
|
(44 |
) |
|
41 |
|
|
- |
|
|
(164 |
) |
|
154 |
|
Derivatives designated as |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
hedging instruments |
|
- |
|
|
44 |
|
|
(41 |
) |
|
- |
|
|
164 |
|
|
(154 |
) |
Gain or (loss) on cash flow |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
hedging relationships: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of gain or (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
reclassified from AOCI |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
into income |
|
- |
|
|
- |
|
|
22 |
|
|
- |
|
|
1 |
|
|
(11 |
) |
Foreign currency contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of gain or (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
reclassified from AOCI |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
into income |
|
4 |
|
|
42 |
|
|
- |
|
|
29 |
|
|
48 |
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Qualifying Hedges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts |
|
(593 |
) |
|
- |
|
|
- |
|
|
(1,998 |
) |
|
- |
|
|
- |
|
Foreign currency contracts |
|
(2 |
) |
|
- |
|
|
- |
|
|
6 |
|
|
- |
|
|
- |
|
Equity market contracts |
|
913 |
|
|
- |
|
|
- |
|
|
(2,100 |
) |
|
- |
|
|
- |
|
Commodity contracts |
|
10 |
|
|
- |
|
|
- |
|
|
4 |
|
|
- |
|
|
- |
|
Credit contracts |
|
(2 |
) |
|
- |
|
|
- |
|
|
(2 |
) |
|
- |
|
|
- |
|
Embedded derivatives: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reinsurance-related |
|
(23 |
) |
|
- |
|
|
- |
|
|
685 |
|
|
- |
|
|
- |
|
Indexed annuity and IUL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
contracts |
|
(1,706 |
) |
|
- |
|
|
- |
|
|
3,030 |
|
|
- |
|
|
- |
|
As of September 30, 2023, $93 million of the deferred net gains (losses) on derivative instruments in AOCI were expected to be reclassified to earnings during the next 12 months. This reclassification would be due primarily to interest rate variances related to our interest rate swap agreements.
For the nine months ended September 30, 2023 and 2022, there were no material reclassifications to earnings due to hedged firm commitments no longer deemed probable or due to hedged forecasted transactions that had not occurred by the end of the originally specified time period.
As of September 30, 2023 and December 31, 2022, we did not have any exposure related to CDSs for which we are the seller.
Credit Risk
We are exposed to credit losses in the event of non-performance by our counterparties on various derivative contracts and reflect assumptions regarding the credit or non-performance risk. The non-performance risk is based upon assumptions for each counterparty’s credit spread over the estimated weighted average life of the counterparty exposure, less collateral held. As of September 30, 2023, the non-performance risk adjustment was zero. The credit risk associated with such agreements is minimized by entering into agreements with financial institutions with long-standing, superior performance records. Additionally, we maintain a policy of requiring derivative contracts to be governed by an International Swaps and Derivatives Association (“ISDA”) Master Agreement. We are required to maintain minimum ratings as a matter of routine practice in negotiating ISDA agreements. Under some ISDA agreements, our insurance subsidiaries have agreed to maintain certain financial strength or claims-paying ratings. A downgrade below these levels could result in termination of derivative contracts, at which time any amounts payable by us would be dependent on the market value of the underlying derivative contracts. In certain transactions, we and the counterparty have entered into a credit support annex requiring either party to post collateral when net exposures exceed pre-determined thresholds. These thresholds vary by counterparty and credit rating. The amount of such exposure is essentially the net replacement cost or market value less collateral held for such agreements with each counterparty if the net market value is in our favor. We did not have any exposure as of September 30, 2023, or December 31, 2022.
The amounts recognized (in millions) by S&P credit rating of counterparty, for which we had the right to reclaim cash collateral or were obligated to return cash collateral, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
As of December 31, 2022 |
|
||||||||
|
|
Collateral |
|
Collateral |
|
Collateral |
|
Collateral |
|
||||
|
|
Posted by |
|
Posted by |
|
Posted by |
|
Posted by |
|
||||
S&P |
|
Counter- |
|
LNC |
|
Counter- |
|
LNC |
|
||||
Credit |
|
Party |
|
(Held by |
|
Party |
|
(Held by |
|
||||
Rating of |
|
(Held by |
|
Counter- |
|
(Held by |
|
Counter- |
|
||||
Counterparty |
|
LNC) |
|
Party) |
|
LNC) |
|
Party) |
|
||||
AA- |
|
$ |
1,061 |
|
$ |
(42 |
) |
$ |
383 |
|
$ |
(6 |
) |
A+ |
|
|
3,528 |
|
|
(390 |
) |
|
1,718 |
|
|
(166 |
) |
A |
|
|
168 |
|
|
(49 |
) |
|
1,172 |
|
|
- |
|
A- |
|
|
58 |
|
|
- |
|
|
- |
|
|
- |
|
|
|
$ |
4,815 |
|
$ |
(481 |
) |
$ |
3,273 |
|
$ |
(172 |
) |
Balance Sheet Offsetting
Information related to the effects of offsetting on the Consolidated Balance Sheets (in millions) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
|||||||||
|
|
|
|
|
|
Embedded |
|
|
|
|
||
|
|
Derivative |
|
|
Derivative |
|
|
|
|
|||
|
|
Instruments |
|
|
Instruments |
|
Total |
|
||||
Financial Assets |
|
|
|
|
|
|
|
|
|
|
|
|
Gross amount of recognized assets |
|
$ |
8,905 |
|
|
$ |
979 |
|
|
$ |
9,884 |
|
Gross amounts offset |
|
|
(3,115 |
) |
|
|
- |
|
|
|
(3,115 |
) |
Net amount of assets |
|
|
5,790 |
|
|
|
979 |
|
|
|
6,769 |
|
Gross amounts not offset: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash collateral |
|
|
(4,815 |
) |
|
|
- |
|
|
|
(4,815 |
) |
Non-cash collateral (1) |
|
|
(975 |
) |
|
|
- |
|
|
|
(975 |
) |
Net amount |
|
$ |
- |
|
|
$ |
979 |
|
|
$ |
979 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
Gross amount of recognized liabilities |
|
$ |
1,887 |
|
|
$ |
7,174 |
|
|
$ |
9,061 |
|
Gross amounts offset |
|
|
(1,242 |
) |
|
|
- |
|
|
|
(1,242 |
) |
Net amount of liabilities |
|
|
645 |
|
|
|
7,174 |
|
|
|
7,819 |
|
Gross amounts not offset: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash collateral |
|
|
(481 |
) |
|
|
- |
|
|
|
(481 |
) |
Non-cash collateral (2) |
|
|
(164 |
) |
|
|
- |
|
|
|
(164 |
) |
Net amount |
|
$ |
- |
|
|
$ |
7,174 |
|
|
$ |
7,174 |
|
(1)Excludes excess non-cash collateral received of $803 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.
(2)Excludes excess non-cash collateral pledged of $343 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2022 |
|
|||||||||
|
|
|
|
|
|
Embedded |
|
|
|
|
||
|
|
Derivative |
|
|
Derivative |
|
|
|
|
|||
|
|
Instruments |
|
|
Instruments |
|
Total |
|
||||
Financial Assets |
|
|
|
|
|
|
|
|
|
|
|
|
Gross amount of recognized assets |
|
$ |
6,604 |
|
|
$ |
941 |
|
|
$ |
7,545 |
|
Gross amounts offset |
|
|
(3,010 |
) |
|
|
- |
|
|
|
(3,010 |
) |
Net amount of assets |
|
|
3,594 |
|
|
|
941 |
|
|
|
4,535 |
|
Gross amounts not offset: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash collateral |
|
|
(3,273 |
) |
|
|
- |
|
|
|
(3,273 |
) |
Non-cash collateral (1) |
|
|
(321 |
) |
|
|
- |
|
|
|
(321 |
) |
Net amount |
|
$ |
- |
|
|
$ |
941 |
|
|
$ |
941 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
Gross amount of recognized liabilities |
|
$ |
260 |
|
|
$ |
4,783 |
|
|
$ |
5,043 |
|
Gross amounts offset |
|
|
(50 |
) |
|
|
- |
|
|
|
(50 |
) |
Net amount of liabilities |
|
|
210 |
|
|
|
4,783 |
|
|
|
4,993 |
|
Gross amounts not offset: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash collateral |
|
|
(172 |
) |
|
|
- |
|
|
|
(172 |
) |
Non-cash collateral (2) |
|
|
(38 |
) |
|
|
- |
|
|
|
(38 |
) |
Net amount |
|
$ |
- |
|
|
$ |
4,783 |
|
|
$ |
4,783 |
|
(1)Excludes excess non-cash collateral received of $1.1 billion, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.
(2)Excludes excess non-cash collateral pledged of $8 million, as the collateral offset is limited to the net estimated fair value of derivatives after application of netting arrangements.
7. DAC, VOBA, DSI and DFEL
The following table reconciles DAC, VOBA and DSI (in millions) to the Consolidated Balance Sheets:
|
|
|
|
|
|
|
|
|
As of |
|
As of |
|
|
||
|
September 30, |
|
December 31, |
|
|
||
|
2023 |
|
2022 |
|
|
||
DAC, VOBA and DSI |
|
|
|
|
|
|
|
Variable Annuities |
$ |
3,871 |
|
$ |
3,879 |
|
|
Fixed Annuities |
|
454 |
|
|
479 |
|
|
Traditional Life |
|
1,417 |
|
|
1,383 |
|
|
UL and Other |
|
6,192 |
|
|
6,100 |
|
|
Group Protection |
|
147 |
|
|
141 |
|
|
Retirement Plan Services |
|
260 |
|
|
253 |
|
|
Total DAC, VOBA and DSI |
$ |
12,341 |
|
$ |
12,235 |
|
|
The following table reconciles DFEL (in millions) to the Consolidated Balance Sheets:
|
|
|
|
|
|
|
|
|
As of |
|
As of |
|
|
||
|
September 30, |
|
December 31, |
|
|
||
|
2023 |
|
2022 |
|
|
||
DFEL |
|
|
|
|
|
|
|
Variable Annuities |
$ |
280 |
|
$ |
286 |
|
|
UL and Other |
|
5,373 |
|
|
4,766 |
|
|
Total DFEL |
$ |
5,653 |
|
$ |
5,052 |
|
|
The following tables summarize the changes in DAC (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, 2023 |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retirement |
|
|||
|
Variable |
|
Fixed |
|
Traditional |
|
UL and |
|
Group |
|
Plan |
|
||||||
|
Annuities |
|
Annuities |
|
Life |
|
Other |
|
Protection |
|
Services |
|
||||||
Balance as of beginning-of-year |
$ |
3,751 |
|
$ |
439 |
|
$ |
1,333 |
|
$ |
5,605 |
|
$ |
141 |
|
$ |
236 |
|
Deferrals |
|
269 |
|
|
31 |
|
|
148 |
|
|
346 |
|
|
79 |
|
|
16 |
|
Amortization |
|
(272 |
) |
|
(51 |
) |
|
(108 |
) |
|
(221 |
) |
|
(73 |
) |
|
(14 |
) |
Balance as of end-of-period |
$ |
3,748 |
|
$ |
419 |
|
$ |
1,373 |
|
$ |
5,730 |
|
$ |
147 |
|
$ |
238 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2022 |
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retirement |
|
|||
|
Variable |
|
Fixed |
|
Traditional |
|
UL and |
|
Group |
|
Plan |
|
||||||
|
Annuities |
|
Annuities |
|
Life |
|
Other |
|
Protection |
|
Services |
|
||||||
Balance as of beginning-of-year |
$ |
3,717 |
|
$ |
448 |
|
$ |
1,195 |
|
$ |
5,360 |
|
$ |
140 |
|
$ |
235 |
|
Deferrals |
|
391 |
|
|
60 |
|
|
266 |
|
|
539 |
|
|
98 |
|
|
20 |
|
Amortization |
|
(357 |
) |
|
(69 |
) |
|
(128 |
) |
|
(294 |
) |
|
(97 |
) |
|
(19 |
) |
Balance as of end-of-year |
$ |
3,751 |
|
$ |
439 |
|
$ |
1,333 |
|
$ |
5,605 |
|
$ |
141 |
|
$ |
236 |
|
DAC amortization expense of $247 million and $739 million was recorded in commissions and other expenses on the Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2023, respectively, and $241 million and $721 million for the corresponding periods in 2022.
The following tables summarize the changes in VOBA (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
For the Nine Months Ended |
|
|
|||||||
|
September 30, 2023 |
|
|
|||||||
|
Fixed |
|
Traditional |
|
UL and |
|
|
|||
|
Annuities |
|
Life |
|
Other |
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
Balance as of beginning-of-year |
$ |
17 |
|
$ |
50 |
|
$ |
465 |
|
|
Deferrals |
|
- |
|
|
- |
|
|
1 |
|
|
Amortization |
|
(2 |
) |
|
(6 |
) |
|
(33 |
) |
|
Balance as of end-of-period |
$ |
15 |
|
$ |
44 |
|
$ |
433 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended |
|
|
|||||||
|
December 31, 2022 |
|
|
|||||||
|
Fixed |
|
Traditional |
|
UL and |
|
|
|||
|
Annuities |
|
Life |
|
Other |
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
Balance as of beginning-of-year |
$ |
20 |
|
$ |
59 |
|
$ |
511 |
|
|
Deferrals |
|
- |
|
|
- |
|
|
2 |
|
|
Amortization |
|
(3 |
) |
|
(9 |
) |
|
(48 |
) |
|
Balance as of end-of-year |
$ |
17 |
|
$ |
50 |
|
$ |
465 |
|
|
VOBA amortization expense of $13 million and $41 million was recorded in commissions and other expenses on the Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2023, respectively, and $15 million and $45 million for the corresponding periods in 2022. No additions or write-offs were recorded for each respective year.
The following tables summarize the changes in DSI (in millions):10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, 2023 |
|
||||||||||
|
|
|
|
|
|
|
Retirement |
|
||||
|
Variable |
|
Fixed |
|
UL and |
|
Plan |
|
||||
|
Annuities |
|
Annuities |
|
Other |
|
Services |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of beginning-of-year |
$ |
128 |
|
$ |
23 |
|
$ |
30 |
|
$ |
17 |
|
Deferrals |
|
4 |
|
|
- |
|
|
1 |
|
|
5 |
|
Amortization |
|
(9 |
) |
|
(3 |
) |
|
(2) |
|
|
- |
|
Balance as of end-of-period |
$ |
123 |
|
$ |
20 |
|
$ |
29 |
|
$ |
22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31, 2022 |
|
||||||||||
|
|
|
|
|
|
|
Retirement |
|
||||
|
Variable |
|
Fixed |
|
UL and |
|
Plan |
|
||||
|
Annuities |
|
Annuities |
|
Other |
|
Services |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of beginning-of-year |
$ |
139 |
|
$ |
27 |
|
$ |
31 |
|
$ |
14 |
|
Deferrals |
|
1 |
|
|
- |
|
|
1 |
|
|
4 |
|
Amortization |
|
(12 |
) |
|
(4 |
) |
|
(2 |
) |
|
(1 |
) |
Balance as of end-of-year |
$ |
128 |
|
$ |
23 |
|
$ |
30 |
|
$ |
17 |
|
DSI amortization expense of $5 million and $14 million was recorded in interest credited on the Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2023, respectively, and $5 million and $15 million for the corresponding periods in 2022.
The following tables summarize the changes in DFEL (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine |
|
|
|
|
|
|
|
||||
|
Months Ended |
|
For the Year Ended |
|
||||||||
|
September 30, 2023 |
|
December 31, 2022 |
|
||||||||
|
Variable |
|
UL and |
|
Variable |
|
UL and |
|
||||
|
Annuities |
|
Other |
|
Annuities |
|
Other |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of beginning-of-year |
$ |
286 |
|
$ |
4,766 |
|
$ |
291 |
|
$ |
3,934 |
|
Deferrals |
|
14 |
|
|
800 |
|
|
23 |
|
|
1,061 |
|
Amortization |
|
(20 |
) |
|
(193 |
) |
|
(28 |
) |
|
(229 |
) |
Balance as of end-of-period |
$ |
280 |
|
$ |
5,373 |
|
$ |
286 |
|
$ |
4,766 |
|
DFEL amortization of $74 million and $213 million was recorded in fee income on the Consolidated Statements of Comprehensive Income (Loss) for the three and nine months ended September 30, 2023, respectively, and $63 million and $191 million for the corresponding periods in 2022.
8. Reinsurance
On May 2, 2023, we entered into a reinsurance agreement with Fortitude Re. Pursuant to the agreement, we will cede approximately $28 billion of in-force UL with secondary guarantees (“ULSG”), MoneyGuard® and fixed annuity statutory reserves to Fortitude Re.
The transaction is structured as a coinsurance treaty between us and Fortitude Re for the ULSG and fixed annuities blocks, and as coinsurance with funds withheld for the MoneyGuard block, with counterparty protections including a comfort trust established by Fortitude Re subject to investment guidelines to meet our risk management objectives. Fortitude Re is an authorized Bermuda reinsurer with reciprocal jurisdiction reinsurer status in Indiana. Under the terms of the reinsurance agreement, we will retain account administration and recordkeeping of the policies including claims management.
This transaction is subject to customary closing conditions, including regulatory approvals. The transaction is expected to reduce balance sheet risk, strengthen our capital position and improve free cash flow.
Credit Losses on Reinsurance-Related Assets
In connection with our recognition of an allowance for credit losses for reinsurance-related assets, we perform a quantitative analysis using a probability of loss approach to estimate expected credit losses for reinsurance recoverables, inclusive of similar assets recognized using the deposit method of accounting. Our allowance for credit losses was $115 million and $317 million as of September 30, 2023 and December 31, 2022, respectively. The decrease was primarily attributable to the release of the allowance for credit losses related to a third-party reinsurer, Scottish Re (U.S.) Inc. (“Scottish Re”), where liquidation proceedings commenced during the third quarter of 2023. As of September 30, 2023, reinsurance coverage terminated and all business ceded to Scottish Re was therefore recaptured. See Note 18 for additional information.
9. Goodwill
The changes in the carrying amount of goodwill (in millions) by reportable segment were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended |
|||||||||
|
|
|
|
|
|
|
|
|
|
September 30, 2023 |
|||||||||
|
Gross |
Accumulated |
|
Net |
|
|
|
|
|
|
|||||||||
|
Goodwill |
Impairment |
|
Goodwill |
|
|
|
|
|
|
Net |
||||||||
|
as of |
as of |
|
as of |
|
|
|
|
|
Goodwill |
|||||||||
|
Beginning- |
Beginning- |
|
Beginning- |
|
|
|
|
|
as of End- |
|||||||||
|
|
of-Year |
|
|
of-Year |
|
|
of-Year |
|
|
Impairment |
|
|
of-Period |
|||||
Annuities |
|
$ |
1,040 |
|
|
$ |
(600 |
) |
|
$ |
440 |
|
|
$ |
- |
|
|
$ |
440 |
Life Insurance |
|
|
2,188 |
|
|
|
(2,188 |
) |
|
|
- |
|
|
|
- |
|
|
|
- |
Group Protection |
|
|
684 |
|
|
|
- |
|
|
|
684 |
|
|
|
- |
|
|
|
684 |
Retirement Plan Services |
|
|
20 |
|
|
|
- |
|
|
|
20 |
|
|
|
- |
|
|
|
20 |
Total goodwill |
|
$ |
3,932 |
|
|
$ |
(2,788 |
) |
|
$ |
1,144 |
|
|
$ |
- |
|
|
$ |
1,144 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended |
|||||||||
|
|
|
|
|
|
|
|
|
|
September 30, 2022 |
|||||||||
|
|
Gross |
Accumulated |
|
Net |
|
|
|
|
|
|
||||||||
|
|
Goodwill |
Impairment |
|
Goodwill |
|
|
|
|
|
|
Net |
|||||||
|
|
as of |
as of |
|
as of |
|
|
|
|
|
Goodwill |
||||||||
|
|
Beginning- |
Beginning- |
|
Beginning- |
|
|
|
|
|
as of End- |
||||||||
|
|
of-Year |
|
|
of-Year |
|
|
of-Year |
|
|
Impairment |
|
|
of-Period |
|||||
Annuities |
|
$ |
1,040 |
|
|
$ |
(600 |
) |
|
$ |
440 |
|
|
$ |
- |
|
|
$ |
440 |
Life Insurance |
|
|
2,188 |
|
|
|
(1,554 |
) |
|
|
634 |
|
|
|
(634) |
|
|
|
- |
Group Protection |
|
|
684 |
|
|
|
- |
|
|
|
684 |
|
|
|
- |
|
|
|
684 |
Retirement Plan Services |
|
|
20 |
|
|
|
- |
|
|
|
20 |
|
|
|
- |
|
|
|
20 |
Total goodwill |
|
$ |
3,932 |
|
|
$ |
(2,154 |
) |
|
$ |
1,778 |
|
|
$ |
(634) |
|
|
$ |
1,144 |
The fair values of our reporting units (Level 3 fair value estimates) are comprised of the value of in-force (i.e., existing) business and the value of new business. Specifically, new business is representative of cash flows and profitability associated with policies or contracts we expect to issue in the future, reflecting our forecasts of future sales volume and product mix over a 10-year period. To determine the values of in-force and new business, we use a discounted cash flows technique that applies a discount rate reflecting the market expected, weighted-average rate of return adjusted for the risk factors associated with operations to the projected future cash flows for each reporting unit.
As a result of the capital market environment during the third quarter of 2022, including (i) declining equity markets and (ii) the impact of rising interest rates on our discount rate assumption, we accelerated our quantitative goodwill impairment test for our Life Insurance reporting unit as we concluded that there were indicators of impairment. Based on this quantitative test, which included updating our best estimate assumptions therein, we incurred an impairment during the third quarter of 2022 of the Life Insurance reporting unit goodwill of $634 million, which represented a write-off of the entire balance of goodwill for the reporting unit.
We concluded that, for the third quarter of 2022, there were not indicators of impairment for our remaining reporting units (Annuities, Group Protection and Retirement Plan Services).
As of October 1, 2022, we performed our annual quantitative goodwill impairment test for our other reporting units, and, as of such date, the fair value was in excess of the carrying value for each of the Annuities, Group Protection and Retirement Plan Services reporting units.
During the fourth quarter of 2023, we will perform our annual quantitative goodwill impairment test as of October 1, 2023, on all of our reporting units.
10. MRBs
The following table reconciles MRBs (in millions) to MRB assets and MRB liabilities on the Consolidated Balance Sheets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
As of December 31, 2022 |
|
||||||||||||||
|
|
|
|
|
|
|
Net |
|
|
|
|
|
|
|
Net |
|
||
|
|
|
|
|
|
|
(Assets) |
|
|
|
|
|
|
|
(Assets) |
|
||
|
Assets |
|
Liabilities |
|
Liabilities |
|
Assets |
|
Liabilities |
|
Liabilities |
|
||||||
Variable Annuities |
$ |
3,966 |
|
$ |
1,293 |
|
$ |
(2,673 |
) |
$ |
2,666 |
|
$ |
2,004 |
|
$ |
(662 |
) |
Fixed Annuities |
|
105 |
|
|
88 |
|
|
(17 |
) |
|
117 |
|
|
72 |
|
|
(45 |
) |
Retirement Plan Services |
|
37 |
|
|
4 |
|
|
(33 |
) |
|
24 |
|
|
2 |
|
|
(22 |
) |
Total MRBs |
$ |
4,108 |
|
$ |
1,385 |
|
$ |
(2,723 |
) |
$ |
2,807 |
|
$ |
2,078 |
|
$ |
(729 |
) |
The following table summarizes the balances of and changes in net MRB (assets) liabilities (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of or For the Nine Months Ended |
|
As of or For the Year Ended |
|
||||||||||||||
|
September 30, 2023 |
|
December 31, 2022 |
|
||||||||||||||
|
|
|
|
|
Retirement |
|
|
|
|
|
Retirement |
|
||||||
|
Variable |
|
Fixed |
|
Plan |
|
Variable |
|
Fixed |
|
Plan |
|
||||||
|
Annuities |
|
Annuities |
|
Services |
|
Annuities |
|
Annuities |
|
Services |
|
||||||
Balance as of beginning-of-year |
$ |
(662 |
) |
$ |
(45 |
) |
$ |
(22 |
) |
$ |
2,398 |
|
$ |
114 |
|
$ |
(1 |
) |
Less: Effect of cumulative changes in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
non-performance risk |
|
(2,173 |
) |
|
(40 |
) |
|
(2 |
) |
|
(2,425 |
) |
|
(44 |
) |
|
(13 |
) |
Balance as of beginning-of-year, before the effect |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
of changes in non-performance risk |
|
1,511 |
|
|
(5 |
) |
|
(20 |
) |
|
4,823 |
|
|
158 |
|
|
12 |
|
Issuances |
|
3 |
|
|
- |
|
|
- |
|
|
12 |
|
|
- |
|
|
(3 |
) |
Attributed fees collected |
|
1,127 |
|
|
23 |
|
|
4 |
|
|
1,571 |
|
|
32 |
|
|
6 |
|
Benefit payments |
|
(49 |
) |
|
- |
|
|
- |
|
|
(63 |
) |
|
- |
|
|
- |
|
Effect of changes in interest rates |
|
(2,347 |
) |
|
(66 |
) |
|
(7 |
) |
|
(9,346 |
) |
|
(232 |
) |
|
(55 |
) |
Effect of changes in equity markets |
|
(1,430 |
) |
|
(5 |
) |
|
(6 |
) |
|
4,293 |
|
|
12 |
|
|
18 |
|
Effect of changes in equity index volatility |
|
(358 |
) |
|
6 |
|
|
(3 |
) |
|
(225 |
) |
|
14 |
|
|
(1 |
) |
In-force updates and other changes in MRBs (1) |
|
182 |
|
|
4 |
|
|
- |
|
|
661 |
|
|
10 |
|
|
3 |
|
Effect of assumption review: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of changes in future expected |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
policyholder behavior |
|
(33 |
) |
|
70 |
|
|
- |
|
|
(158 |
) |
|
1 |
|
|
- |
|
Effect of changes in other future expected |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
assumptions (2) |
|
(66 |
) |
|
15 |
|
|
(2 |
) |
|
(57 |
) |
|
- |
|
|
- |
|
Balance as of end-of-period, before the effect of |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
changes in non-performance risk |
|
(1,460 |
) |
|
42 |
|
|
(34 |
) |
|
1,511 |
|
|
(5 |
) |
|
(20 |
) |
Effect of cumulative changes in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
non-performance risk |
|
(1,213 |
) |
|
(59 |
) |
|
1 |
|
|
(2,173 |
) |
|
(40 |
) |
|
(2 |
) |
Balance as of end-of-period |
|
(2,673 |
) |
|
(17 |
) |
|
(33 |
) |
|
(662 |
) |
|
(45 |
) |
|
(22 |
) |
Less: ceded MRB assets (liabilities) |
|
(303 |
) |
|
- |
|
|
- |
|
|
(193 |
) |
|
- |
|
|
- |
|
Balance as of end-of-period, net of reinsurance |
$ |
(2,370 |
) |
$ |
(17 |
) |
$ |
(33 |
) |
$ |
(469 |
) |
$ |
(45 |
) |
$ |
(22 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average age of policyholders (years) |
|
72 |
|
|
68 |
|
|
63 |
|
|
71 |
|
|
68 |
|
|
63 |
|
Net amount at risk (3) |
|
6,235 |
|
|
188 |
|
|
9 |
|
|
7,974 |
|
|
171 |
|
|
15 |
|
(1)Consists primarily of changes in MRB assets and liabilities related to differences between separate account fund performance and modeled indices and other changes such as actual to expected policyholder behavior.
(2)Consists primarily of the update of fund mapping, volatility and other capital market assumptions.
(3)Net amount at risk (“NAR”) is the current guaranteed minimum benefit in excess of the current account balance as of the balance sheet date. For GLBs, the guaranteed minimum benefit is calculated based on the present value of GLB payments. Our variable annuity products may offer more than one type of guaranteed benefit rider to a policyholder. In instances where more than one guaranteed benefit feature exists in a contract, the guaranteed benefit rider that provides the highest NAR is used in the calculation.
Effect of Assumption Review
For the nine months ended September 30, 2023, Variable Annuities had a favorable impact to net income (loss) attributable to the annual assumption review from updates to volatility and policyholder GLB utilization behavior assumptions, partially offset by unfavorable impacts from updates to mortality and policyholder lapse behavior assumptions. For the nine months ended September 30, 2023, Fixed Annuities had an unfavorable impact to net income (loss) attributable to the annual assumption review from updates to mortality and policyholder GLB utilization and lapse behavior assumptions. Retirement Plan Services did not have any significant assumption updates.
For the year ended December 31, 2022, Variable Annuities had a favorable impact to net income (loss) attributable to the annual assumption review from updates to policyholder benefit utilization behavior and fund mapping and volatility assumptions. Fixed Annuities and Retirement Plan Services did not have any significant assumption updates.
See “MRBs” in Note 1 and Note 14 for details related to our fair value judgments, assumptions, inputs and valuation methodology.
11. Separate Accounts
The following table presents the fair value of separate account assets (in millions) reported on the Consolidated Balance Sheets by major investment category:
|
|
|
|
|
|
|
|
|
As of |
|
As of |
|
|
||
|
September 30, |
|
December 31, |
|
|
||
|
2023 |
|
2022 |
|
|
||
Mutual funds and collective investment trusts |
$ |
145,178 |
|
$ |
142,892 |
|
|
Exchange-traded funds |
|
269 |
|
|
258 |
|
|
Fixed maturity AFS securities |
|
161 |
|
|
169 |
|
|
Cash and invested cash |
|
70 |
|
|
98 |
|
|
Other investments |
|
132 |
|
|
119 |
|
|
Total separate account assets |
$ |
145,810 |
|
$ |
143,536 |
|
|
The following table reconciles separate account liabilities (in millions) to the Consolidated Balance Sheets:
|
|
|
|
|
|
|
|
|
As of |
|
As of |
|
|
||
|
September 30, |
|
December 31, |
|
|
||
|
2023 |
|
2022 |
|
|
||
Variable Annuities |
$ |
105,192 |
|
$ |
105,573 |
|
|
UL and Other |
|
22,642 |
|
|
20,920 |
|
|
Retirement Plan Services |
|
17,928 |
|
|
16,996 |
|
|
Other Operations (1) |
|
48 |
|
|
47 |
|
|
Total separate account liabilities |
$ |
145,810 |
|
$ |
143,536 |
|
|
(1)Represents separate account liabilities reported in Other Operations primarily attributable to the indemnity reinsurance agreements with Protective ($42 million as of September 30, 2023, and December 31, 2022) that are excluded from the following tables.
The following table summarizes the balances of and changes in separate account liabilities (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of or For the Nine Months Ended |
|
As of or For the Year Ended |
|
||||||||||||||
|
September 30, 2023 |
|
December 31, 2022 |
|
||||||||||||||
|
|
|
|
|
Retirement |
|
|
|
|
|
Retirement |
|
||||||
|
Variable |
|
UL and |
|
Plan |
|
Variable |
|
UL and |
|
Plan |
|
||||||
|
Annuities |
|
Other |
|
Services |
|
Annuities |
|
Other |
|
Services |
|
||||||
Balance as of beginning-of-year |
$ |
105,573 |
|
$ |
20,920 |
|
$ |
16,996 |
|
$ |
136,665 |
|
$ |
24,785 |
|
$ |
21,068 |
|
Gross deposits |
|
2,137 |
|
|
1,178 |
|
|
1,576 |
|
|
3,371 |
|
|
1,900 |
|
|
2,378 |
|
Withdrawals |
|
(7,402 |
) |
|
(227 |
) |
|
(1,795 |
) |
|
(9,238 |
) |
|
(454 |
) |
|
(2,378 |
) |
Policyholder assessments |
|
(1,883 |
) |
|
(714 |
) |
|
(121 |
) |
|
(2,603 |
) |
|
(938 |
) |
|
(164 |
) |
Change in market performance |
|
6,320 |
|
|
1,573 |
|
|
1,316 |
|
|
(23,194 |
) |
|
(4,371 |
) |
|
(3,710 |
) |
Net transfers from (to) general account |
|
447 |
|
|
(88 |
) |
|
(44 |
) |
|
572 |
|
|
(2 |
) |
|
(198 |
) |
Balance as of end-of-period |
$ |
105,192 |
|
$ |
22,642 |
|
$ |
17,928 |
|
$ |
105,573 |
|
$ |
20,920 |
|
$ |
16,996 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash surrender value |
$ |
103,729 |
|
$ |
20,324 |
|
$ |
17,914 |
|
$ |
103,987 |
|
$ |
18,666 |
|
$ |
16,982 |
|
12. Policyholder Account Balances
The following table reconciles policyholder account balances (in millions) to the Consolidated Balance Sheets:
|
|
|
|
|
|
|
|
As of |
|
As of |
|
||
|
September 30, |
|
December 31, |
|
||
|
2023 |
|
2022 |
|
||
Variable Annuities |
$ |
26,772 |
|
$ |
22,184 |
|
Fixed Annuities |
|
23,681 |
|
|
23,365 |
|
UL and Other |
|
37,217 |
|
|
37,694 |
|
Retirement Plan Services |
|
24,099 |
|
|
25,138 |
|
Other (1) |
|
5,441 |
|
|
6,054 |
|
Total policyholder account balances |
$ |
117,210 |
|
$ |
114,435 |
|
(1)Represents policyholder account balances reported primarily in Other Operations attributable to the indemnity reinsurance agreements with Protective ($5.1 billion and $5.7 billion as of September 30, 2023, and December 31, 2022, respectively) that are excluded from the following tables.
The following table summarizes the balances and changes in policyholder account balances (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of or For the Nine Months Ended September 30, 2023 |
|
||||||||||
|
|
|
|
|
|
|
Retirement |
|
||||
|
Variable |
|
Fixed |
|
UL and |
|
Plan |
|
||||
|
Annuities |
|
Annuities |
|
Other |
|
Services |
|
||||
Balance as of beginning-of-year |
$ |
22,184 |
|
$ |
23,365 |
|
$ |
37,694 |
|
$ |
25,138 |
|
Gross deposits |
|
3,626 |
|
|
2,698 |
|
|
2,749 |
|
|
2,026 |
|
Withdrawals |
|
(508 |
) |
|
(2,863 |
) |
|
(1,095 |
) |
|
(3,262 |
) |
Policyholder assessments |
|
(1 |
) |
|
(41 |
) |
|
(3,373 |
) |
|
(10 |
) |
Net transfers from (to) separate account |
|
(311 |
) |
|
- |
|
|
90 |
|
|
(297 |
) |
Interest credited |
|
391 |
|
|
470 |
|
|
1,114 |
|
|
504 |
|
Change in fair value of embedded derivative instruments |
|
1,391 |
|
|
52 |
|
|
38 |
|
|
- |
|
Balance as of end-of-period |
$ |
26,772 |
|
$ |
23,681 |
|
$ |
37,217 |
|
$ |
24,099 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average crediting rate |
|
2.1% |
|
|
2.6% |
|
|
4.0% |
|
|
2.7% |
|
Net amount at risk (1)(2) |
$ |
6,235 |
|
$ |
188 |
|
$ |
303,628 |
|
$ |
9 |
|
Cash surrender value |
|
25,629 |
|
|
22,779 |
|
|
33,741 |
|
|
24,094 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of or For the Year Ended December 31, 2022 |
|
||||||||||
|
|
|
|
|
|
|
Retirement |
|
||||
|
Variable |
|
Fixed |
|
UL and |
|
Plan |
|
||||
|
Annuities |
|
Annuities |
|
Other |
|
Services |
|
||||
Balance as of beginning-of-year |
$ |
19,148 |
|
$ |
22,552 |
|
$ |
38,200 |
|
$ |
23,579 |
|
Gross deposits |
|
5,178 |
|
|
3,284 |
|
|
3,921 |
|
|
4,012 |
|
Withdrawals |
|
(417 |
) |
|
(2,514 |
) |
|
(1,244 |
) |
|
(3,579 |
) |
Policyholder assessments |
|
(2 |
) |
|
(51 |
) |
|
(4,496 |
) |
|
(13 |
) |
Net transfers from (to) separate account |
|
(492 |
) |
|
- |
|
|
2 |
|
|
510 |
|
Interest credited |
|
287 |
|
|
532 |
|
|
1,494 |
|
|
629 |
|
Change in fair value of embedded derivative instruments |
|
(1,518 |
) |
|
(438 |
) |
|
(183 |
) |
|
- |
|
Balance as of end-of-year |
$ |
22,184 |
|
$ |
23,365 |
|
$ |
37,694 |
|
$ |
25,138 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average crediting rate |
|
1.4% |
|
|
2.4% |
|
|
3.9% |
|
|
2.6% |
|
Net amount at risk (1)(2) |
$ |
7,974 |
|
$ |
171 |
|
$ |
304,348 |
|
$ |
15 |
|
Cash surrender value |
|
21,147 |
|
|
22,529 |
|
|
34,210 |
|
|
25,133 |
|
(1)NAR is the current guaranteed minimum benefit in excess of the current account balance as of the balance sheet date. For GLBs, the guaranteed minimum benefit is calculated based on the present value of GLB payments. Our variable annuity products may offer more than one type of guaranteed benefit rider to a policyholder. In instances where more than one guaranteed benefit rider exists in a contract, the guaranteed benefit rider that provides the highest NAR is used in the calculation.
(2)Calculation is based on total account balances and includes both policyholder account balances and separate account balances.
The following table presents policyholder account balances (in millions) by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between the interest being credited to policyholders and the respective guaranteed contract minimums:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
Greater |
|
|
|
||||||
|
|
|
1-50 |
|
51-100 |
|
101-150 |
|
Than 150 |
|
|
|
||||||
|
At |
|
Basis |
|
Basis |
|
Basis |
|
Basis |
|
|
|
||||||
Range of Guaranteed |
Guaranteed |
|
Points |
|
Points |
|
Points |
|
Points |
|
|
|
||||||
Minimum Crediting Rate |
Minimum |
|
Above |
|
Above |
|
Above |
|
Above |
|
Total |
|
||||||
Variable Annuities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Up to 1.00% |
$ |
- |
|
$ |
- |
|
$ |
- |
|
$ |
- |
|
$ |
- |
|
$ |
- |
|
1.01% - 2.00% |
|
5 |
|
|
- |
|
|
- |
|
|
- |
|
|
8 |
|
|
13 |
|
2.01% - 3.00% |
|
602 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
602 |
|
3.01% - 4.00% |
|
1,429 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
1,429 |
|
4.01% and above |
|
10 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
10 |
|
Other (1) |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
24,718 |
|
Total |
$ |
2,046 |
|
$ |
- |
|
$ |
- |
|
$ |
- |
|
$ |
8 |
|
$ |
26,772 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed Annuities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Up to 1.00% |
$ |
744 |
|
$ |
427 |
|
$ |
515 |
|
$ |
518 |
|
$ |
2,427 |
|
$ |
4,631 |
|
1.01% - 2.00% |
|
481 |
|
|
106 |
|
|
212 |
|
|
456 |
|
|
1,264 |
|
|
2,519 |
|
2.01% - 3.00% |
|
1,881 |
|
|
32 |
|
|
6 |
|
|
- |
|
|
3 |
|
|
1,922 |
|
3.01% - 4.00% |
|
955 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
955 |
|
4.01% and above |
|
182 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
182 |
|
Other (1) |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
13,472 |
|
Total |
$ |
4,243 |
|
$ |
565 |
|
$ |
733 |
|
$ |
974 |
|
$ |
3,694 |
|
$ |
23,681 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UL and Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Up to 1.00% |
$ |
284 |
|
$ |
- |
|
$ |
192 |
|
$ |
34 |
|
$ |
362 |
|
$ |
872 |
|
1.01% - 2.00% |
|
553 |
|
|
- |
|
|
- |
|
|
- |
|
|
3,181 |
|
|
3,734 |
|
2.01% - 3.00% |
|
6,998 |
|
|
11 |
|
|
147 |
|
|
- |
|
|
- |
|
|
7,156 |
|
3.01% - 4.00% |
|
15,780 |
|
|
- |
|
|
1 |
|
|
- |
|
|
- |
|
|
15,781 |
|
4.01% and above |
|
3,783 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
3,783 |
|
Other (1) |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
5,891 |
|
Total |
$ |
27,398 |
|
$ |
11 |
|
$ |
340 |
|
$ |
34 |
|
$ |
3,543 |
|
$ |
37,217 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retirement Plan Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Up to 1.00% |
$ |
407 |
|
$ |
596 |
|
$ |
762 |
|
$ |
4,882 |
|
$ |
2,837 |
|
$ |
9,484 |
|
1.01% - 2.00% |
|
610 |
|
|
2,405 |
|
|
1,474 |
|
|
668 |
|
|
- |
|
|
5,157 |
|
2.01% - 3.00% |
|
2,594 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
2,594 |
|
3.01% - 4.00% |
|
5,223 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
5,223 |
|
4.01% and above |
|
1,641 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
1,641 |
|
Total |
$ |
10,475 |
|
$ |
3,001 |
|
$ |
2,236 |
|
$ |
5,550 |
|
$ |
2,837 |
|
$ |
24,099 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2022 |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
Greater |
|
|
|
||||||
|
|
|
1-50 |
|
51-100 |
|
101-150 |
|
Than 150 |
|
|
|
||||||
|
At |
|
Basis |
|
Basis |
|
Basis |
|
Basis |
|
|
|
||||||
Range of Guaranteed |
Guaranteed |
|
Points |
|
Points |
|
Points |
|
Points |
|
|
|
||||||
Minimum Crediting Rate |
Minimum |
|
Above |
|
Above |
|
Above |
|
Above |
|
Total |
|
||||||
Variable Annuities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Up to 1.00% |
$ |
- |
|
$ |
- |
|
$ |
- |
|
$ |
- |
|
$ |
- |
|
$ |
- |
|
1.01% - 2.00% |
|
4 |
|
|
- |
|
|
- |
|
|
8 |
|
|
- |
|
|
12 |
|
2.01% - 3.00% |
|
658 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
658 |
|
3.01% - 4.00% |
|
1,545 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
1,545 |
|
4.01% and above |
|
11 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
11 |
|
Other (1) |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
19,958 |
|
Total |
$ |
2,218 |
|
$ |
- |
|
$ |
- |
|
$ |
8 |
|
$ |
- |
|
$ |
22,184 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed Annuities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Up to 1.00% |
$ |
891 |
|
$ |
497 |
|
$ |
589 |
|
$ |
563 |
|
$ |
1,329 |
|
$ |
3,869 |
|
1.01% - 2.00% |
|
544 |
|
|
144 |
|
|
179 |
|
|
492 |
|
|
1,057 |
|
|
2,416 |
|
2.01% - 3.00% |
|
1,973 |
|
|
5 |
|
|
1 |
|
|
- |
|
|
- |
|
|
1,979 |
|
3.01% - 4.00% |
|
1,353 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
1,353 |
|
4.01% and above |
|
193 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
193 |
|
Other (1) |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
13,555 |
|
Total |
$ |
4,954 |
|
$ |
646 |
|
$ |
769 |
|
$ |
1,055 |
|
$ |
2,386 |
|
$ |
23,365 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UL and Other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Up to 1.00% |
$ |
318 |
|
$ |
- |
|
$ |
194 |
|
$ |
29 |
|
$ |
292 |
|
$ |
833 |
|
1.01% - 2.00% |
|
558 |
|
|
- |
|
|
- |
|
|
- |
|
|
3,282 |
|
|
3,840 |
|
2.01% - 3.00% |
|
7,218 |
|
|
156 |
|
|
- |
|
|
- |
|
|
- |
|
|
7,374 |
|
3.01% - 4.00% |
|
16,282 |
|
|
- |
|
|
1 |
|
|
- |
|
|
- |
|
|
16,283 |
|
4.01% and above |
|
3,824 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
3,824 |
|
Other (1) |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
5,540 |
|
Total |
$ |
28,200 |
|
$ |
156 |
|
$ |
195 |
|
$ |
29 |
|
$ |
3,574 |
|
$ |
37,694 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retirement Plan Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Up to 1.00% |
$ |
961 |
|
$ |
1,001 |
|
$ |
4,304 |
|
$ |
1,703 |
|
$ |
1,908 |
|
$ |
9,877 |
|
1.01% - 2.00% |
|
1,774 |
|
|
2,197 |
|
|
982 |
|
|
462 |
|
|
- |
|
|
5,415 |
|
2.01% - 3.00% |
|
2,711 |
|
|
1 |
|
|
- |
|
|
- |
|
|
- |
|
|
2,712 |
|
3.01% - 4.00% |
|
5,622 |
|
|
1 |
|
|
- |
|
|
- |
|
|
- |
|
|
5,623 |
|
4.01% and above |
|
1,511 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
1,511 |
|
Total |
$ |
12,579 |
|
$ |
3,200 |
|
$ |
5,286 |
|
$ |
2,165 |
|
$ |
1,908 |
|
$ |
25,138 |
|
(1)Consists of indexed account balances that include the fair value of embedded derivative instruments, payout annuity account balances, short-term dollar cost averaging annuities business and policy loans.
13. Future Contract Benefits
The following table reconciles future contract benefits (in millions) to the Consolidated Balance Sheets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of |
|
As of |
|
||
|
September 30, |
|
December 31, |
|
||
|
2023 |
|
2022 |
|
||
Payout Annuities (1) |
$ |
1,943 |
|
$ |
2,004 |
|
Traditional Life (1) |
|
3,538 |
|
|
3,509 |
|
Group Protection (2) |
|
5,373 |
|
|
5,462 |
|
UL and Other (3) |
|
15,965 |
|
|
14,818 |
|
Other Operations (4) |
|
9,277 |
|
|
9,782 |
|
Other (5) |
|
3,266 |
|
|
3,251 |
|
Total future contract benefits |
$ |
39,362 |
|
$ |
38,826 |
|
(1)See “LFPB” below for further information.
(2)See “Liability for Future Claims” below for further information.
(3)See “Additional Liabilities for Other Insurance Benefits” below for further information.
(4)Represents future contract benefits reported in Other Operations primarily attributable to the indemnity reinsurance agreements with Protective ($5.3 billion and $5.4 billion as of September 30, 2023, and December 31, 2022, respectively) and Swiss Re ($2.1 billion and $2.3 billion as of September 30, 2023, and December 31, 2022, respectively) that are excluded from the following tables.
(5)Represents other miscellaneous reserves outside the scope of ASU 2018-12 that are excluded from the following tables.
LFPB
The following table summarizes the balances of and changes in the present values of expected net premiums and LFPB (in millions, except years):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of or For the |
|
As of or For the |
|
||||||||
|
Nine Months Ended |
|
Year Ended |
|
||||||||
|
September 30, 2023 |
|
December 31, 2022 |
|
||||||||
|
Payout |
|
Traditional |
|
Payout |
|
Traditional |
|
||||
|
Annuities |
|
Life |
|
Annuities |
|
Life |
|
||||
Present Value of Expected Net Premiums |
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of beginning-of-year |
$ |
- |
|
$ |
6,063 |
|
$ |
- |
|
$ |
6,858 |
|
Less: Effect of cumulative changes in discount |
|
|
|
|
|
|
|
|
|
|
|
|
rate assumptions |
|
- |
|
|
(582 |
) |
|
- |
|
|
883 |
|
Beginning balance at original discount rate |
|
- |
|
|
6,645 |
|
|
- |
|
|
5,975 |
|
Effect of changes in cash flow assumptions |
|
- |
|
|
(12 |
) |
|
- |
|
|
(484 |
) |
Effect of actual variances from expected |
|
|
|
|
|
|
|
|
|
|
|
|
experience |
|
- |
|
|
(280 |
) |
|
- |
|
|
50 |
|
Adjusted balance as of beginning-of-year |
|
- |
|
|
6,353 |
|
|
- |
|
|
5,541 |
|
Issuances |
|
- |
|
|
460 |
|
|
- |
|
|
1,656 |
|
Interest accrual |
|
- |
|
|
182 |
|
|
- |
|
|
222 |
|
Net premiums collected |
|
- |
|
|
(604 |
) |
|
- |
|
|
(765 |
) |
Flooring impact of LFPB |
|
- |
|
|
(3 |
) |
|
- |
|
|
(9 |
) |
Ending balance at original discount rate |
|
- |
|
|
6,388 |
|
|
- |
|
|
6,645 |
|
Effect of cumulative changes in discount |
|
|
|
|
|
|
|
|
|
|
|
|
rate assumptions |
|
- |
|
|
(527 |
) |
|
- |
|
|
(582 |
) |
Balance as of end-of-period |
$ |
- |
|
$ |
5,861 |
|
$ |
- |
|
$ |
6,063 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Present Value of Expected LFPB |
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of beginning-of-year |
$ |
2,004 |
|
$ |
9,572 |
|
$ |
2,512 |
|
$ |
11,008 |
|
Less: Effect of cumulative changes in discount |
|
|
|
|
|
|
|
|
|
|
|
|
rate assumptions |
|
(263 |
) |
|
(785 |
) |
|
266 |
|
|
1,561 |
|
Beginning balance at original discount rate (1) |
|
2,267 |
|
|
10,357 |
|
|
2,246 |
|
|
9,447 |
|
Effect of changes in cash flow assumptions |
|
17 |
|
|
(29 |
) |
|
- |
|
|
(415 |
) |
Effect of actual variances from expected |
|
|
|
|
|
|
|
|
|
|
|
|
experience |
|
(1 |
) |
|
(309 |
) |
|
3 |
|
|
69 |
|
Adjusted balance as of beginning-of-year |
|
2,283 |
|
|
10,019 |
|
|
2,249 |
|
|
9,101 |
|
Issuances |
|
83 |
|
|
461 |
|
|
122 |
|
|
1,655 |
|
Interest accrual |
|
64 |
|
|
288 |
|
|
84 |
|
|
356 |
|
Benefit payments |
|
(143 |
) |
|
(537 |
) |
|
(188 |
) |
|
(755 |
) |
Ending balance at original discount rate (1) |
|
2,287 |
|
|
10,231 |
|
|
2,267 |
|
|
10,357 |
|
Effect of cumulative changes in discount |
|
|
|
|
|
|
|
|
|
|
|
|
rate assumptions |
|
(344 |
) |
|
(832 |
) |
|
(263 |
) |
|
(785 |
) |
Balance as of end-of-period |
$ |
1,943 |
|
$ |
9,399 |
|
$ |
2,004 |
|
$ |
9,572 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net balance as of end-of-period |
$ |
1,943 |
|
$ |
3,538 |
|
$ |
2,004 |
|
$ |
3,509 |
|
Less: reinsurance recoverables |
|
3 |
|
|
450 |
|
|
3 |
|
|
532 |
|
Net balance as of end-of-period, net of reinsurance |
$ |
1,940 |
|
$ |
3,088 |
|
$ |
2,001 |
|
$ |
2,977 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average duration of future policyholder |
|
|
|
|
|
|
|
|
|
|
|
|
benefit liability (years) |
|
9 |
|
|
9 |
|
|
9 |
|
|
10 |
|
(1)Includes DPL within Payout Annuities of $38 million, $38 million and $22 million as of September 30, 2023, December 31, 2022 and December 31, 2021, respectively.
For the nine months ended September 30, 2023, Payout Annuities had an unfavorable cash flow assumption impact to net income (loss) attributable to the annual assumption review from updates to mortality assumptions, and Traditional Life had a favorable cash flow assumption impact from updates to mortality assumptions, partially offset by an unfavorable impact from updates to policyholder lapse behavior assumptions.
For the nine months ended September 30, 2023, Payout Annuities and Traditional Life did not have any significantly different actual experience compared to expected.
For the year ended December 31, 2022, Payout Annuities did not have any significant assumption updates. Traditional Life had an unfavorable cash flow assumption impact to net income (loss) attributable to the annual assumption review from updates to mortality and lapse assumptions resulting in lower projected premiums and benefits, and a corresponding increase in reserves. For the year ended December 31, 2022, Payout Annuities and Traditional Life did not have any significantly different actual experience compared to expected.
The following table summarizes the discounted and undiscounted expected future gross premiums and expected future benefit payments (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
As of December 31, 2022 |
|
||||||||
|
Undiscounted |
|
Discounted |
|
Undiscounted |
|
Discounted |
|
||||
Payout Annuities |
|
|
|
|
|
|
|
|
|
|
|
|
Expected future gross premiums |
$ |
- |
|
$ |
- |
|
$ |
- |
|
$ |
- |
|
Expected future benefit payments |
|
3,553 |
|
|
1,943 |
|
|
3,472 |
|
|
2,004 |
|
Traditional Life |
|
|
|
|
|
|
|
|
|
|
|
|
Expected future gross premiums |
|
14,070 |
|
|
9,294 |
|
|
13,945 |
|
|
9,475 |
|
Expected future benefit payments |
|
13,891 |
|
|
9,399 |
|
|
13,640 |
|
|
9,572 |
|
The following table summarizes the gross premiums and interest accretion (in millions) recognized in insurance premiums and benefits, respectively, on the Consolidated Statements of Comprehensive Income (Loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Payout Annuities |
|
|
|
|
|
|
|
|
|
|
|
|
Gross premiums |
$ |
16 |
|
$ |
49 |
|
$ |
88 |
|
$ |
92 |
|
Interest accretion |
|
21 |
|
|
21 |
|
|
64 |
|
|
63 |
|
Traditional Life |
|
|
|
|
|
|
|
|
|
|
|
|
Gross premiums |
|
310 |
|
|
303 |
|
|
937 |
|
|
897 |
|
Interest accretion |
|
35 |
|
|
34 |
|
|
106 |
|
|
100 |
|
The following table summarizes the weighted-average interest rates:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine |
|
|
|
||
|
Months |
|
For the Year |
|
||
|
Ended |
|
Ended |
|
||
|
September 30, |
|
December 31, |
|
||
|
2023 |
|
2022 |
|
||
Payout Annuities |
|
|
|
|
|
|
Interest accretion rate |
|
3.9% |
|
|
3.9% |
|
Current discount rate |
|
5.8% |
|
|
5.3% |
|
Traditional Life |
|
|
|
|
|
|
Interest accretion rate |
|
5.0% |
|
|
5.1% |
|
Current discount rate |
|
5.6% |
|
|
5.1% |
|
Liability for Future Claims
The following table summarizes the balances of and changes in liability for future claims (in millions, except years):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Group Protection |
|
|
|
|
|
|
|
||||
|
As of or For |
|
|
|
|
|
|
|
|
|
|
|
|
the Nine |
|
As of or For |
|
|
|
|
|
|
|
||
|
Months |
|
the Year |
|
|
|
|
|
|
|
||
|
Ended |
|
Ended |
|
|
|
|
|
|
|
||
|
September 30, |
|
December 31, |
|
|
|
|
|
|
|
||
|
2023 |
|
2022 |
|
|
|
|
|
|
|
||
Balance as of beginning-of-year |
$ |
5,462 |
|
$ |
5,936 |
|
|
|
|
|
|
|
Less: Effect of cumulative changes in discount |
|
|
|
|
|
|
|
|
|
|
|
|
rate assumptions |
|
(597 |
) |
|
262 |
|
|
|
|
|
|
|
Beginning balance at original discount rate |
|
6,059 |
|
|
5,674 |
|
|
|
|
|
|
|
Effect of changes in cash flow assumptions |
|
(27 |
) |
|
15 |
|
|
|
|
|
|
|
Effect of actual variances from expected |
|
|
|
|
|
|
|
|
|
|
|
|
experience |
|
(233 |
) |
|
(117 |
) |
|
|
|
|
|
|
Adjusted beginning-of-year balance |
|
5,799 |
|
|
5,572 |
|
|
|
|
|
|
|
New incidence |
|
1,267 |
|
|
1,777 |
|
|
|
|
|
|
|
Interest |
|
122 |
|
|
141 |
|
|
|
|
|
|
|
Benefit payments |
|
(1,095 |
) |
|
(1,431 |
) |
|
|
|
|
|
|
Ending balance at original discount rate |
|
6,093 |
|
|
6,059 |
|
|
|
|
|
|
|
Effect of cumulative changes in discount |
|
|
|
|
|
|
|
|
|
|
|
|
rate assumptions |
|
(720 |
) |
|
(597 |
) |
|
|
|
|
|
|
Balance as of end-of-period |
|
5,373 |
|
|
5,462 |
|
|
|
|
|
|
|
Less: reinsurance recoverables |
|
117 |
|
|
127 |
|
|
|
|
|
|
|
Balance as of end-of-period, net of reinsurance |
$ |
5,256 |
|
$ |
5,335 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average duration of liability for future |
|
|
|
|
|
|
|
|
|
|
|
|
claims (years) |
|
5 |
|
|
4 |
|
|
|
|
|
|
|
For the nine months ended September 30, 2023, we had a favorable cash flow assumption impact to net income (loss) attributable to the annual assumption review from updates to long-term disability and life waiver claim termination rate assumptions, partially offset by unfavorable impacts from updates to long-term disability social security offset assumptions. For the nine months ended September 30, 2023, we experienced more favorable reported incidence and claim terminations than assumed.
For the year ended December 31, 2022, we had an unfavorable cash flow assumption impact to net income (loss) attributable to the annual assumption review from updates to the long-term disability incidence and severity assumptions, partially offset by favorable impacts from updates to the life waiver termination rate assumptions. For the year ended December 31, 2022, we experienced more favorable claim terminations than assumed.
The following table summarizes the discounted and undiscounted expected future benefit payments (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
As of December 31, 2022 |
|
||||||||
|
Undiscounted |
|
Discounted |
|
Undiscounted |
|
Discounted |
|
||||
Group Protection |
|
|
|
|
|
|
|
|
|
|
|
|
Expected future benefit payments |
$ |
7,148 |
|
$ |
6,093 |
|
$ |
7,063 |
|
$ |
6,059 |
|
The following table summarizes the gross premiums and interest accretion (in millions) recognized in insurance premiums and benefits, respectively, on the Consolidated Statements of Comprehensive Income (Loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Group Protection |
|
|
|
|
|
|
|
|
|
|
|
|
Gross premiums |
$ |
874 |
|
$ |
852 |
|
$ |
2,645 |
|
$ |
2,523 |
|
Interest accretion |
|
39 |
|
|
33 |
|
|
122 |
|
|
111 |
|
The following table summarizes the weighted-average interest rates:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine |
|
|
|
|
|
|
|
|
|
||
|
Months |
|
For the Year |
|
|
|
|
|
|
|||
|
Ended |
|
Ended |
|
|
|
|
|
||||
|
September 30, |
|
December 31, |
|
|
|
|
|
||||
|
2023 |
|
2022 |
|
|
|
|
|
||||
Group Protection |
|
|
|
|
|
|
|
|
|
|
||
Interest accretion rate |
|
3.0% |
|
|
2.8% |
|
|
|
|
|
|
|
Current discount rate |
|
5.7% |
|
|
5.1% |
|
|
|
|
|
|
|
Additional Liabilities for Other Insurance Benefits
The following table summarizes the balances of and changes in additional liabilities for other insurance benefits (in millions, except years):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UL and Other |
|
||||
|
As of or For |
|
|
|
|
|
|
the Nine |
|
As of or For |
|
||
|
Months |
|
the Year |
|
||
|
Ended |
|
Ended |
|
||
|
September 30, |
|
December 31, |
|
||
|
2023 |
|
2022 |
|
||
Balance as of beginning-of-year |
$ |
14,818 |
|
$ |
12,556 |
|
Less: Effect of cumulative changes in shadow |
|
|
|
|
|
|
balance in AOCI |
|
(905 |
) |
|
1,113 |
|
Balance as of beginning-of-year, excluding |
|
|
|
|
|
|
shadow balance in AOCI |
|
15,723 |
|
|
11,443 |
|
Effect of changes in cash flow assumptions |
|
173 |
|
|
3,108 |
|
Effect of actual variances from expected |
|
|
|
|
|
|
experience |
|
(28 |
) |
|
195 |
|
Adjusted beginning-of-year balance |
|
15,868 |
|
|
14,746 |
|
Issuances |
|
- |
|
|
7 |
|
Interest accrual |
|
573 |
|
|
626 |
|
Net assessments collected |
|
895 |
|
|
972 |
|
Benefit payments |
|
(473 |
) |
|
(628 |
) |
Balance as of end-of-period, excluding |
|
|
|
|
|
|
shadow balance in AOCI |
|
16,863 |
|
|
15,723 |
|
Effect of cumulative changes in shadow |
|
|
|
|
|
|
balance in AOCI |
|
(897 |
) |
|
(905 |
) |
Balance as of end-of-period |
|
15,965 |
|
|
14,818 |
|
Less: reinsurance recoverables |
|
654 |
|
|
856 |
|
Balance as of end-of-period, net of reinsurance |
$ |
15,311 |
|
$ |
13,962 |
|
|
|
|
|
|
|
|
Weighted-average duration of additional liabilities |
|
|
|
|
|
|
for other insurance benefits (years) |
|
17 |
|
|
17 |
|
For the nine months ended September 30, 2023, we had an unfavorable cash flow assumption impact to net income (loss) attributable to the annual assumption review from updates to policyholder lapse behavior assumptions, partially offset by a favorable impact from updates to interest rate assumptions. For the nine months ended September 30, 2023, we did not have any significantly different actual experience compared to expected.
For the year ended December 31, 2022, we had an unfavorable cash flow assumption impact to net income (loss) attributable to the annual assumption review primarily from updates to policyholder lapse behavior assumptions related to UL products with secondary guarantees in the amount of $1.9 billion, net of reinsurance, after-tax, and to a lesser extent mortality and morbidity assumptions. We had unfavorable actual mortality experience compared to expected due to ongoing effects of the COVID-19 pandemic.
The following table summarizes the gross assessments and interest accretion (in millions) recognized in insurance premiums and benefits, respectively, on the Consolidated Statements of Comprehensive Income (Loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
UL and Other |
|
|
|
|
|
|
|
|
|
|
|
|
Gross assessments |
$ |
337 |
|
$ |
690 |
|
$ |
1,794 |
|
$ |
2,097 |
|
Interest accretion |
|
197 |
|
|
175 |
|
|
573 |
|
|
446 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table summarizes the weighted-average interest rates:
|
|
|
|
|
|
|
|
For the Nine |
|
|
|
|
|
|
Months |
|
For the Year |
|
||
|
Ended |
|
Ended |
|
||
|
September 30, |
|
December 31, |
|
||
|
2023 |
|
2022 |
|
||
UL and Other |
|
|
|
|
|
|
Interest accretion rate |
|
5.1% |
|
|
5.0% |
|
14. Fair Value of Financial Instruments
The carrying values and estimated fair values of our financial instruments (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
As of December 31, 2022 |
|
||||||||
|
Carrying |
|
Fair |
|
Carrying |
|
Fair |
|
||||
|
Value |
|
Value |
|
Value |
|
Value |
|
||||
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities |
$ |
97,804 |
|
$ |
97,804 |
|
$ |
99,736 |
|
$ |
99,736 |
|
Trading securities |
|
2,788 |
|
|
2,788 |
|
|
3,498 |
|
|
3,498 |
|
Equity securities |
|
383 |
|
|
383 |
|
|
427 |
|
|
427 |
|
Mortgage loans on real estate |
|
18,751 |
|
|
16,626 |
|
|
18,301 |
|
|
16,553 |
|
Derivative investments |
|
5,789 |
|
|
5,789 |
|
|
3,594 |
|
|
3,594 |
|
Other investments |
|
4,550 |
|
|
4,550 |
|
|
3,739 |
|
|
3,739 |
|
Cash and invested cash |
|
2,529 |
|
|
2,529 |
|
|
3,343 |
|
|
3,343 |
|
MRB assets |
|
4,108 |
|
|
4,108 |
|
|
2,807 |
|
|
2,807 |
|
Other assets: |
|
|
|
|
|
|
|
|
|
|
|
|
Ceded MRBs |
|
2 |
|
|
2 |
|
|
12 |
|
|
12 |
|
Reinsurance-related embedded derivatives |
|
393 |
|
|
393 |
|
|
416 |
|
|
416 |
|
Indexed annuity ceded embedded derivatives |
|
586 |
|
|
586 |
|
|
525 |
|
|
525 |
|
Separate account assets |
|
145,810 |
|
|
145,810 |
|
|
143,536 |
|
|
143,536 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder account balances: |
|
|
|
|
|
|
|
|
|
|
|
|
Account balances of certain investment contracts |
|
(43,094 |
) |
|
(30,890 |
) |
|
(43,578 |
) |
|
(34,274 |
) |
Indexed annuity and IUL contracts embedded derivatives |
|
(7,174 |
) |
|
(7,174 |
) |
|
(4,783 |
) |
|
(4,783 |
) |
MRB liabilities |
|
(1,385 |
) |
|
(1,385 |
) |
|
(2,078 |
) |
|
(2,078 |
) |
Short-term debt |
|
- |
|
|
- |
|
|
(500 |
) |
|
(496 |
) |
Long-term debt |
|
(5,905 |
) |
|
(4,829 |
) |
|
(5,955 |
) |
|
(5,005 |
) |
Other liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Ceded MRBs |
|
(305 |
) |
|
(305 |
) |
|
(205 |
) |
|
(205 |
) |
Derivative liabilities |
|
(644 |
) |
|
(644 |
) |
|
(210 |
) |
|
(210 |
) |
Remaining guaranteed interest and similar contracts |
|
(433 |
) |
|
(433 |
) |
|
(574 |
) |
|
(574 |
) |
Valuation Methodologies and Associated Inputs for Financial Instruments Not Carried at Fair Value
The following discussion outlines the methodologies and assumptions used to determine the fair value of our financial instruments not carried at fair value on the Consolidated Balance Sheets. Considerable judgment is required to develop these assumptions used to measure fair value. Accordingly, the estimates shown are not necessarily indicative of the amounts that would be realized in a one-time, current market exchange of all of our financial instruments.
Mortgage Loans on Real Estate
The fair value of mortgage loans on real estate, excluding mortgage loans accounted for using the fair value option, is established using a discounted cash flow method based on credit rating, maturity and future income. The ratings for mortgages in good standing are based on property type, location, market conditions, occupancy, debt-service coverage, loan-to-value, quality of tenancy, borrower and payment record. The fair value for impaired mortgage loans is based on the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s market price or the fair value of the collateral if the loan is collateral dependent. The inputs used to measure the fair value of our mortgage loans on real estate, excluding mortgage loans accounted for using the fair value option, are classified as Level 2 within the fair value hierarchy.
Other Investments
The carrying value of our assets classified as other investments, excluding short-term investments, approximates fair value. Other investments includes primarily LPs and other privately held investments that are accounted for using the equity method of accounting and the carrying value is based on our proportional share of the net assets of the LPs. Other investments also includes FHLB stock carried at cost and periodically evaluated for impairment based on ultimate recovery of par value. The inputs used to measure the fair value of our LPs, other privately held investments and FHLB stock are classified as Level 3 within the fair value hierarchy. The remaining assets in other investments include cash collateral receivables and securities that are not LPs or other privately held investments. The inputs used to measure the fair value of these assets are classified as Level 2 within the fair value hierarchy.
Separate Account Assets
Separate account assets are primarily carried at fair value. A portion of our separate account assets includes LPs, which are accounted for using the equity method of accounting. The carrying value is based on our proportional share of the net assets of the LPs and approximates fair value. The inputs used to measure the fair value of the separate account asset LPs are classified as Level 3 within the fair value hierarchy.
Policyholder Account Balances
Policyholder account balances include account balances of certain investment contracts. The fair value of the account balances of certain investment contracts is based on their approximate surrender value as of the balance sheet date. The inputs used to measure the fair value of these policyholder account balances are classified as Level 3 within the fair value hierarchy.
Other Liabilities
Other liabilities include remaining guaranteed interest and similar contracts. The fair value for the remaining guaranteed interest and similar contracts is estimated using discounted cash flow calculations as of the balance sheet date. These calculations are based on interest rates currently offered on similar contracts with maturities that are consistent with those remaining for the contracts being valued. As of September 30, 2023, and December 31, 2022, the remaining guaranteed interest and similar contracts carrying value approximated fair value. The inputs used to measure the fair value of these other liabilities are classified as Level 3 within the fair value hierarchy.
Short-Term and Long-Term Debt
The fair value of short-term and long-term debt is based on quoted market prices. The inputs used to measure the fair value of our short-term and long-term debt are classified as Level 2 within the fair value hierarchy.
Fair Value Option
Mortgage loans on real estate, net of allowance for credit losses, as reported on the Consolidated Balance Sheets, includes mortgage loans on real estate for which the fair value option was elected. The fair value option allows us to elect fair value as an alternative measurement for mortgage loans not otherwise reported at fair value. We have made these elections for certain mortgage loans associated with modified coinsurance agreements to help mitigate the inconsistency in earnings that would otherwise result from the use of embedded derivatives included with these loans. Changes in fair value are reflected in realized gain (loss) on the Consolidated Statement of Comprehensive Income (Loss). Changes in fair value due to instrument-specific credit risk are estimated using changes in credit spreads and quality ratings for the period reported. Mortgage loans on real estate for which the fair value option was elected are valued using third-party pricing services. We have procedures in place to review the valuations each quarter to ensure they are reasonable, including utilizing a separate third party to reperform the valuation for a selection of mortgage loans on an annual basis. Due to lack of observable inputs, mortgage loans electing the fair value option are classified as Level 3 within the fair value hierarchy.
The fair value and aggregate contractual principal for mortgage loans on real estate where the fair value option was elected (in millions) were as follows:
|
|
|
|
|
|
|
|
|
As of |
|
As of |
|
|
||
|
September 30, |
|
December 31, |
|
|
||
|
2023 |
|
2022 |
|
|
||
Fair value |
$ |
315 |
|
$ |
487 |
|
|
Aggregate contractual principal |
|
341 |
|
|
514 |
|
|
As of September 30, 2023, and December 31, 2022, no loans for which the fair value option was elected were in non-accrual status, and none were more than 90 days past due and still accruing interest.
Financial Instruments Carried at Fair Value
We did not have any assets or liabilities measured at fair value on a nonrecurring basis as of September 30, 2023, or December 31, 2022.
The following summarizes our financial instruments carried at fair value (in millions) on a recurring basis by the fair value hierarchy levels:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
|||||||||||||
|
|
Quoted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prices |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Markets for |
Significant |
Significant |
|
|
|
|
|||||||||
|
|
Identical |
|
Observable |
Unobservable |
|
Total |
|
||||||||
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
Fair |
|
||||
|
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Value |
|
||||
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
|
$ |
- |
|
|
$ |
73,591 |
|
|
$ |
2,410 |
|
|
$ |
76,001 |
|
U.S. government bonds |
|
|
333 |
|
|
|
40 |
|
|
|
- |
|
|
|
373 |
|
State and municipal bonds |
|
|
- |
|
|
|
4,737 |
|
|
|
33 |
|
|
|
4,770 |
|
Foreign government bonds |
|
|
- |
|
|
|
273 |
|
|
|
- |
|
|
|
273 |
|
RMBS |
|
|
- |
|
|
|
1,916 |
|
|
|
12 |
|
|
|
1,928 |
|
CMBS |
|
|
- |
|
|
|
1,701 |
|
|
|
- |
|
|
|
1,701 |
|
ABS |
|
|
- |
|
|
|
11,056 |
|
|
|
1,337 |
|
|
|
12,393 |
|
Hybrid and redeemable preferred securities |
|
|
46 |
|
|
|
271 |
|
|
|
48 |
|
|
|
365 |
|
Trading securities |
|
|
- |
|
|
|
2,438 |
|
|
|
350 |
|
|
|
2,788 |
|
Equity securities |
|
|
1 |
|
|
|
245 |
|
|
|
137 |
|
|
|
383 |
|
Mortgage loans on real estate |
|
|
- |
|
|
|
- |
|
|
|
315 |
|
|
|
315 |
|
Derivative investments (1) |
|
|
- |
|
|
|
9,238 |
|
|
|
877 |
|
|
|
10,115 |
|
Other investments – short-term investments |
|
|
- |
|
|
|
170 |
|
|
|
- |
|
|
|
170 |
|
Cash and invested cash |
|
|
- |
|
|
|
2,529 |
|
|
|
- |
|
|
|
2,529 |
|
MRB assets |
|
|
- |
|
|
|
- |
|
|
|
4,108 |
|
|
|
4,108 |
|
Other assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ceded MRBs |
|
|
- |
|
|
|
- |
|
|
|
2 |
|
|
|
2 |
|
Reinsurance-related embedded derivatives |
|
|
- |
|
|
|
393 |
|
|
|
- |
|
|
|
393 |
|
Indexed annuity ceded embedded derivatives |
|
|
- |
|
|
|
- |
|
|
|
586 |
|
|
|
586 |
|
Separate account assets |
|
|
430 |
|
|
|
145,380 |
|
|
|
- |
|
|
|
145,810 |
|
Total assets |
|
$ |
810 |
|
|
$ |
253,978 |
|
|
$ |
10,215 |
|
|
$ |
265,003 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder account balances – indexed annuity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and IUL contracts embedded derivatives |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
(7,174 |
) |
|
$ |
(7,174 |
) |
MRB liabilities |
|
|
- |
|
|
|
- |
|
|
|
(1,385 |
) |
|
|
(1,385 |
) |
Other liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ceded MRBs |
|
|
- |
|
|
|
- |
|
|
|
(305 |
) |
|
|
(305 |
) |
Derivative liabilities (1) |
|
|
- |
|
|
|
(4,106 |
) |
|
|
(864 |
) |
|
|
(4,970 |
) |
Total liabilities |
|
$ |
- |
|
|
$ |
(4,106 |
) |
|
$ |
(9,728 |
) |
|
$ |
(13,834 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2022 |
|
|||||||||||||
|
|
Quoted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prices |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Markets for |
Significant |
Significant |
|
|
|
|
|||||||||
|
|
Identical |
|
Observable |
Unobservable |
|
Total |
|
||||||||
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
Fair |
|
||||
|
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Value |
|
||||
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
|
$ |
- |
|
|
$ |
76,728 |
|
|
$ |
2,295 |
|
|
$ |
79,023 |
|
U.S. government bonds |
|
|
359 |
|
|
|
20 |
|
|
|
- |
|
|
|
379 |
|
State and municipal bonds |
|
|
- |
|
|
|
5,035 |
|
|
|
35 |
|
|
|
5,070 |
|
Foreign government bonds |
|
|
- |
|
|
|
318 |
|
|
|
- |
|
|
|
318 |
|
RMBS |
|
|
- |
|
|
|
2,008 |
|
|
|
1 |
|
|
|
2,009 |
|
CMBS |
|
|
- |
|
|
|
1,674 |
|
|
|
- |
|
|
|
1,674 |
|
ABS |
|
|
- |
|
|
|
9,787 |
|
|
|
1,117 |
|
|
|
10,904 |
|
Hybrid and redeemable preferred securities |
|
|
41 |
|
|
|
269 |
|
|
|
49 |
|
|
|
359 |
|
Trading securities |
|
|
- |
|
|
|
2,917 |
|
|
|
581 |
|
|
|
3,498 |
|
Equity securities |
|
|
- |
|
|
|
274 |
|
|
|
153 |
|
|
|
427 |
|
Mortgage loans on real estate |
|
|
- |
|
|
|
- |
|
|
|
487 |
|
|
|
487 |
|
Derivative investments (1) |
|
|
- |
|
|
|
6,048 |
|
|
|
605 |
|
|
|
6,653 |
|
Other investments – short-term investments |
|
|
- |
|
|
|
75 |
|
|
|
- |
|
|
|
75 |
|
Cash and invested cash |
|
|
- |
|
|
|
3,343 |
|
|
|
- |
|
|
|
3,343 |
|
MRB assets |
|
|
- |
|
|
|
- |
|
|
|
2,807 |
|
|
|
2,807 |
|
Other assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ceded MRBs |
|
|
- |
|
|
|
- |
|
|
|
12 |
|
|
|
12 |
|
Reinsurance-related embedded derivatives |
|
|
- |
|
|
|
416 |
|
|
|
- |
|
|
|
416 |
|
Indexed annuity ceded embedded derivatives |
|
|
- |
|
|
|
- |
|
|
|
525 |
|
|
|
525 |
|
Separate account assets |
|
|
412 |
|
|
|
143,124 |
|
|
|
- |
|
|
|
143,536 |
|
Total assets |
|
$ |
812 |
|
|
$ |
252,036 |
|
|
$ |
8,667 |
|
|
$ |
261,515 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder account balances – indexed annuity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and IUL contracts embedded derivatives |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
(4,783 |
) |
|
$ |
(4,783 |
) |
MRB liabilities |
|
|
- |
|
|
|
- |
|
|
|
(2,078 |
) |
|
|
(2,078 |
) |
Other liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ceded MRBs |
|
|
- |
|
|
|
- |
|
|
|
(205 |
) |
|
|
(205 |
) |
Derivative liabilities (1) |
|
|
- |
|
|
|
(2,666 |
) |
|
|
(603 |
) |
|
|
(3,269 |
) |
Total liabilities |
|
$ |
- |
|
|
$ |
(2,666 |
) |
|
$ |
(7,669 |
) |
|
$ |
(10,335 |
) |
(1)Derivative investment assets and liabilities are presented within the fair value hierarchy on a gross basis by derivative type and not on a master netting basis by counterparty.
The following summarizes changes to our financial instruments carried at fair value (in millions) and classified within Level 3 of the fair value hierarchy. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. The summary schedule excludes changes to MRB assets and MRB liabilities as these balances are rolled forward in Note 10.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended September 30, 2023 |
|
||||||||||||||||
|
|
|
|
|
|
|
Gains |
Issuances, |
Transfers |
|
|
|
|
|||||
|
|
|
|
Items |
|
(Losses) |
|
Sales, |
|
Into or |
|
|
|
|
||||
|
|
|
|
Included |
|
in |
Maturities, |
Out |
|
|
|
|
||||||
|
Beginning |
|
in |
|
OCI |
Settlements, |
of |
|
Ending |
|
||||||||
|
Fair |
|
Net |
|
and |
|
Calls, |
|
Level 3, |
|
Fair |
|
||||||
|
Value |
|
Income |
|
Other (1) |
|
Net |
|
Net |
|
Value |
|
||||||
Investments: (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
2,366 |
|
$ |
(4 |
) |
$ |
(14 |
) |
$ |
105 |
|
$ |
(43 |
) |
$ |
2,410 |
|
State and municipal bonds |
|
36 |
|
|
(4 |
) |
|
1 |
|
|
- |
|
|
- |
|
|
33 |
|
RMBS |
|
6 |
|
|
- |
|
|
(1 |
) |
|
- |
|
|
7 |
|
|
12 |
|
ABS |
|
1,208 |
|
|
- |
|
|
(5 |
) |
|
247 |
|
|
(113 |
) |
|
1,337 |
|
Hybrid and redeemable preferred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
securities |
|
60 |
|
|
- |
|
|
1 |
|
|
- |
|
|
(13 |
) |
|
48 |
|
Trading securities |
|
351 |
|
|
(3 |
) |
|
- |
|
|
(4 |
) |
|
6 |
|
|
350 |
|
Equity securities |
|
125 |
|
|
12 |
|
|
- |
|
|
- |
|
|
- |
|
|
137 |
|
Mortgage loans on real estate |
|
404 |
|
|
2 |
|
|
(3 |
) |
|
(88 |
) |
|
- |
|
|
315 |
|
Derivative investments |
|
31 |
|
|
(26 |
) |
|
- |
|
|
8 |
|
|
- |
|
|
13 |
|
Other assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ceded MRBs (3) |
|
2 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
2 |
|
Indexed annuity ceded embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives (4) |
|
603 |
|
|
(49 |
) |
|
- |
|
|
32 |
|
|
- |
|
|
586 |
|
Policyholder account balances – indexed |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
annuity and IUL contracts embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives (4) |
|
(7,600 |
) |
|
621 |
|
|
- |
|
|
(195 |
) |
|
- |
|
|
(7,174 |
) |
Other liabilities – ceded MRBs (3) |
|
(293 |
) |
|
(12 |
) |
|
- |
|
|
- |
|
|
- |
|
|
(305 |
) |
Total, net |
$ |
(2,701 |
) |
$ |
537 |
|
$ |
(21 |
) |
$ |
105 |
|
$ |
(156 |
) |
$ |
(2,236 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended September 30, 2022 |
|
||||||||||||||||
|
|
|
|
|
|
|
Gains |
Issuances, |
Transfers |
|
|
|
|
|||||
|
|
|
|
Items |
|
(Losses) |
|
Sales, |
|
Into or |
|
|
|
|
||||
|
|
|
|
Included |
|
in |
Maturities, |
Out |
|
|
|
|
||||||
|
Beginning |
|
in |
|
OCI |
Settlements, |
of |
|
Ending |
|
||||||||
|
Fair |
|
Net |
|
and |
|
Calls, |
|
Level 3, |
|
Fair |
|
||||||
|
Value |
|
Income |
|
Other (1) |
|
Net |
|
Net |
|
Value |
|
||||||
Investments: (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
5,476 |
|
$ |
1 |
|
$ |
(513 |
) |
$ |
65 |
|
$ |
(16 |
) |
$ |
5,013 |
|
Foreign government bonds |
|
37 |
|
|
- |
|
|
(3 |
) |
|
- |
|
|
- |
|
|
34 |
|
RMBS |
|
1 |
|
|
- |
|
|
- |
|
|
9 |
|
|
- |
|
|
10 |
|
ABS |
|
1,153 |
|
|
- |
|
|
(38 |
) |
|
123 |
|
|
(147 |
) |
|
1,091 |
|
Hybrid and redeemable preferred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
securities |
|
104 |
|
|
(2 |
) |
|
(37 |
) |
|
(6 |
) |
|
- |
|
|
59 |
|
Trading securities |
|
620 |
|
|
(24 |
) |
|
- |
|
|
3 |
|
|
3 |
|
|
602 |
|
Equity securities |
|
145 |
|
|
24 |
|
|
- |
|
|
(1 |
) |
|
- |
|
|
168 |
|
Mortgage loans on real estate |
|
528 |
|
|
(1 |
) |
|
(4 |
) |
|
(28 |
) |
|
- |
|
|
495 |
|
Derivative investments |
|
3 |
|
|
3 |
|
|
- |
|
|
- |
|
|
(1 |
) |
|
5 |
|
Other assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ceded MRBs (3) |
|
23 |
|
|
(3 |
) |
|
- |
|
|
- |
|
|
- |
|
|
20 |
|
Indexed annuity ceded embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives (4) |
|
440 |
|
|
(47 |
) |
|
- |
|
|
63 |
|
|
- |
|
|
456 |
|
Policyholder account balances – indexed |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
annuity and IUL contracts embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives (4) |
|
(3,366 |
) |
|
394 |
|
|
- |
|
|
(222 |
) |
|
- |
|
|
(3,194 |
) |
Other liabilities – ceded MRBs (3) |
|
(115 |
) |
|
(54 |
) |
|
- |
|
|
- |
|
|
- |
|
|
(169 |
) |
Total, net |
$ |
5,049 |
|
$ |
291 |
|
$ |
(595 |
) |
$ |
6 |
|
$ |
(161 |
) |
$ |
4,590 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, 2023 |
|
||||||||||||||||
|
|
|
|
|
|
|
Gains |
Issuances, |
Transfers |
|
|
|
|
|||||
|
|
|
|
Items |
|
(Losses) |
Sales, |
Into or |
|
|
|
|
||||||
|
|
|
|
Included |
|
in |
Maturities, |
Out |
|
|
|
|
||||||
|
Beginning |
|
in |
|
OCI |
Settlements, |
of |
|
Ending |
|
||||||||
|
Fair |
|
Net |
|
and |
|
Calls, |
|
Level 3, |
|
Fair |
|
||||||
|
Value |
|
Income |
|
Other (1) |
|
Net |
|
Net |
|
Value |
|
||||||
Investments: (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
2,295 |
|
$ |
1 |
|
$ |
(13 |
) |
$ |
130 |
|
$ |
(3 |
) |
$ |
2,410 |
|
State and municipal bonds |
|
35 |
|
|
(4 |
) |
|
3 |
|
|
(1 |
) |
|
- |
|
|
33 |
|
RMBS |
|
1 |
|
|
- |
|
|
(1 |
) |
|
5 |
|
|
7 |
|
|
12 |
|
CMBS |
|
- |
|
|
- |
|
|
- |
|
|
(4 |
) |
|
4 |
|
|
- |
|
ABS |
|
1,117 |
|
|
- |
|
|
(3 |
) |
|
567 |
|
|
(344 |
) |
|
1,337 |
|
Hybrid and redeemable preferred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
securities |
|
49 |
|
|
- |
|
|
(2 |
) |
|
(2 |
) |
|
3 |
|
|
48 |
|
Trading securities |
|
581 |
|
|
(1 |
) |
|
- |
|
|
(236 |
) |
|
6 |
|
|
350 |
|
Equity securities |
|
153 |
|
|
(17 |
) |
|
- |
|
|
1 |
|
|
- |
|
|
137 |
|
Mortgage loans on real estate |
|
487 |
|
|
- |
|
|
2 |
|
|
(174 |
) |
|
- |
|
|
315 |
|
Derivative investments |
|
2 |
|
|
(28 |
) |
|
- |
|
|
8 |
|
|
31 |
|
|
13 |
|
Other assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ceded MRBs (3) |
|
12 |
|
|
(10 |
) |
|
- |
|
|
- |
|
|
- |
|
|
2 |
|
Indexed annuity ceded embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives (4) |
|
525 |
|
|
(37 |
) |
|
- |
|
|
98 |
|
|
- |
|
|
586 |
|
Policyholder account balances – indexed |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
annuity and IUL contracts embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives (4) |
|
(4,783 |
) |
|
(1,669 |
) |
|
- |
|
|
(722 |
) |
|
- |
|
|
(7,174 |
) |
Other liabilities – ceded MRBs (3) |
|
(205 |
) |
|
(100 |
) |
|
- |
|
|
- |
|
|
- |
|
|
(305 |
) |
Total, net |
$ |
269 |
|
$ |
(1,865 |
) |
$ |
(14 |
) |
$ |
(330 |
) |
$ |
(296 |
) |
$ |
(2,236 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, 2022 |
|
||||||||||||||||
|
|
|
|
|
|
|
Gains |
Issuances, |
Transfers |
|
|
|
|
|||||
|
|
|
|
Items |
|
(Losses) |
Sales, |
Into or |
|
|
|
|
||||||
|
|
|
|
Included |
|
in |
Maturities, |
Out |
|
|
|
|
||||||
|
Beginning |
|
in |
|
OCI |
Settlements, |
of |
|
Ending |
|
||||||||
|
Fair |
|
Net |
|
and |
|
Calls, |
|
Level 3, |
|
Fair |
|
||||||
|
Value |
|
Income |
|
Other (1) |
|
Net |
|
Net |
|
Value |
|
||||||
Investments: (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
5,720 |
|
$ |
2 |
|
$ |
(1,523 |
) |
$ |
716 |
|
$ |
98 |
|
$ |
5,013 |
|
Foreign government bonds |
|
41 |
|
|
- |
|
|
(7 |
) |
|
- |
|
|
- |
|
|
34 |
|
RMBS |
|
4 |
|
|
- |
|
|
- |
|
|
21 |
|
|
(15 |
) |
|
10 |
|
CMBS |
|
- |
|
|
- |
|
|
- |
|
|
17 |
|
|
(17 |
) |
|
- |
|
ABS |
|
870 |
|
|
- |
|
|
(98 |
) |
|
576 |
|
|
(257 |
) |
|
1,091 |
|
Hybrid and redeemable preferred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
securities |
|
93 |
|
|
(2 |
) |
|
(26 |
) |
|
(6 |
) |
|
- |
|
|
59 |
|
Trading securities |
|
828 |
|
|
(82 |
) |
|
- |
|
|
(143 |
) |
|
(1 |
) |
|
602 |
|
Equity securities |
|
95 |
|
|
56 |
|
|
- |
|
|
17 |
|
|
- |
|
|
168 |
|
Mortgage loans on real estate |
|
739 |
|
|
(16 |
) |
|
(10 |
) |
|
(218 |
) |
|
- |
|
|
495 |
|
Derivative investments |
|
21 |
|
|
5 |
|
|
(6 |
) |
|
- |
|
|
(15 |
) |
|
5 |
|
Other assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ceded MRBs (3) |
|
95 |
|
|
(75 |
) |
|
- |
|
|
- |
|
|
- |
|
|
20 |
|
Indexed annuity ceded embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives (4) |
|
528 |
|
|
(214 |
) |
|
- |
|
|
142 |
|
|
- |
|
|
456 |
|
Policyholder account balances – indexed |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
annuity and IUL contracts embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives (4) |
|
(6,131 |
) |
|
3,244 |
|
|
- |
|
|
(307 |
) |
|
- |
|
|
(3,194 |
) |
Other liabilities – ceded MRBs (3) |
|
(17 |
) |
|
(152 |
) |
|
- |
|
|
- |
|
|
- |
|
|
(169 |
) |
Total, net |
$ |
2,886 |
|
$ |
2,766 |
|
$ |
(1,670 |
) |
$ |
815 |
|
$ |
(207 |
) |
$ |
4,590 |
|
(1)The changes in fair value of the interest rate swaps are offset by an adjustment to derivative investments (see Note 6).
(2)Amortization and accretion of premiums and discounts are included in net investment income on the Consolidated Statements of Comprehensive Income (Loss). Gains (losses) from sales, maturities, settlements and calls and credit loss expense are included in realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).
(3)Gains (losses) from the changes in fair value are included in market risk benefit gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).
(4)Gains (losses) from the changes in fair value are included in realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).
The following provides the components of the items included in issuances, sales, maturities, settlements and calls, net, (in millions) as reported above:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended September 30, 2023 |
|
||||||||||||||||
|
Issuances |
|
Sales |
|
Maturities |
Settlements |
Calls |
|
Total |
|
||||||||
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
178 |
|
$ |
(28 |
) |
$ |
- |
|
$ |
(45 |
) |
$ |
- |
|
$ |
105 |
|
ABS |
|
279 |
|
|
- |
|
|
- |
|
|
(32 |
) |
|
- |
|
|
247 |
|
Trading securities |
|
- |
|
|
- |
|
|
- |
|
|
(4 |
) |
|
- |
|
|
(4 |
) |
Mortgage loans on real estate |
|
1 |
|
|
- |
|
|
- |
|
|
(89 |
) |
|
- |
|
|
(88 |
) |
Derivative investments |
|
9 |
|
|
- |
|
|
(1 |
) |
|
- |
|
|
- |
|
|
8 |
|
Other assets – indexed annuity ceded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
embedded derivatives |
|
28 |
|
|
- |
|
|
- |
|
|
4 |
|
|
- |
|
|
32 |
|
Policyholder account balances – indexed |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
annuity and IUL contracts embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives |
|
(231 |
) |
|
- |
|
|
- |
|
|
36 |
|
|
- |
|
|
(195 |
) |
Total, net |
$ |
264 |
|
$ |
(28 |
) |
$ |
(1 |
) |
$ |
(130 |
) |
$ |
- |
|
$ |
105 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended September 30, 2022 |
|
||||||||||||||||
|
Issuances |
|
Sales |
|
Maturities |
Settlements |
Calls |
|
Total |
|
||||||||
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
173 |
|
$ |
(4 |
) |
$ |
(50 |
) |
$ |
(52 |
) |
$ |
(2 |
) |
$ |
65 |
|
RMBS |
|
9 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
9 |
|
ABS |
|
213 |
|
|
- |
|
|
- |
|
|
(90 |
) |
|
- |
|
|
123 |
|
Hybrid and redeemable preferred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
securities |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
(6 |
) |
|
(6 |
) |
Trading securities |
|
11 |
|
|
- |
|
|
- |
|
|
(8 |
) |
|
- |
|
|
3 |
|
Equity securities |
|
- |
|
|
(1 |
) |
|
- |
|
|
- |
|
|
- |
|
|
(1 |
) |
Mortgage loans on real estate |
|
2 |
|
|
- |
|
|
- |
|
|
(30 |
) |
|
- |
|
|
(28 |
) |
Other assets – indexed annuity ceded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
embedded derivatives |
|
37 |
|
|
- |
|
|
- |
|
|
26 |
|
|
- |
|
|
63 |
|
Policyholder account balances – indexed |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
annuity and IUL contracts embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives |
|
(181 |
) |
|
- |
|
|
- |
|
|
(41 |
) |
|
- |
|
|
(222 |
) |
Total, net |
$ |
264 |
|
$ |
(5 |
) |
$ |
(50 |
) |
$ |
(195 |
) |
$ |
(8 |
) |
$ |
6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, 2023 |
|
||||||||||||||||
|
Issuances |
|
Sales |
|
Maturities |
Settlements |
Calls |
|
Total |
|
||||||||
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
587 |
|
$ |
(65 |
) |
$ |
(34 |
) |
$ |
(347 |
) |
$ |
(11 |
) |
$ |
130 |
|
State and municipal bonds |
|
- |
|
|
(1 |
) |
|
- |
|
|
- |
|
|
- |
|
|
(1 |
) |
RMBS |
|
5 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
5 |
|
CMBS |
|
- |
|
|
- |
|
|
- |
|
|
(4 |
) |
|
- |
|
|
(4 |
) |
ABS |
|
736 |
|
|
(2 |
) |
|
- |
|
|
(167 |
) |
|
- |
|
|
567 |
|
Hybrid and redeemable preferred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
securities |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
(2 |
) |
|
(2 |
) |
Trading securities |
|
- |
|
|
(155 |
) |
|
- |
|
|
(81 |
) |
|
- |
|
|
(236 |
) |
Equity securities |
|
1 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
1 |
|
Mortgage loans on real estate |
|
5 |
|
|
- |
|
|
- |
|
|
(179 |
) |
|
- |
|
|
(174 |
) |
Derivative investments |
|
9 |
|
|
- |
|
|
(1 |
) |
|
- |
|
|
- |
|
|
8 |
|
Other assets – indexed annuity ceded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
embedded derivatives |
|
112 |
|
|
- |
|
|
- |
|
|
(14 |
) |
|
- |
|
|
98 |
|
Policyholder account balances – indexed |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
annuity and IUL contracts embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives |
|
(846 |
) |
|
- |
|
|
- |
|
|
124 |
|
|
- |
|
|
(722 |
) |
Total, net |
$ |
609 |
|
$ |
(223 |
) |
$ |
(35 |
) |
$ |
(668 |
) |
$ |
(13 |
) |
$ |
(330 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, 2022 |
|
||||||||||||||||
|
Issuances |
|
Sales |
|
Maturities |
Settlements |
Calls |
|
Total |
|
||||||||
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
1,026 |
|
$ |
(4 |
) |
$ |
(75 |
) |
$ |
(181 |
) |
$ |
(50 |
) |
$ |
716 |
|
RMBS |
|
21 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
21 |
|
CMBS |
|
17 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
17 |
|
ABS |
|
768 |
|
|
- |
|
|
- |
|
|
(185 |
) |
|
(7 |
) |
|
576 |
|
Hybrid and redeemable preferred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
securities |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
(6 |
) |
|
(6 |
) |
Trading securities |
|
282 |
|
|
(220 |
) |
|
- |
|
|
(205 |
) |
|
- |
|
|
(143 |
) |
Equity securities |
|
26 |
|
|
(9 |
) |
|
- |
|
|
- |
|
|
- |
|
|
17 |
|
Mortgage loans on real estate |
|
14 |
|
|
- |
|
|
- |
|
|
(232 |
) |
|
- |
|
|
(218 |
) |
Other assets – indexed annuity ceded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
embedded derivatives |
|
76 |
|
|
- |
|
|
- |
|
|
66 |
|
|
- |
|
|
142 |
|
Policyholder account balances – indexed |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
annuity and IUL contracts embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives |
|
(410 |
) |
|
- |
|
|
- |
|
|
103 |
|
|
- |
|
|
(307 |
) |
Total, net |
$ |
1,820 |
|
$ |
(233 |
) |
$ |
(75 |
) |
$ |
(634 |
) |
$ |
(63 |
) |
$ |
815 |
|
The following summarizes changes in unrealized gains (losses) included in net income related to financial instruments carried at fair value classified within Level 3 that we still held (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
|
||||||||
|
Months Ended |
|
Months Ended |
|
|
||||||||
|
September 30, |
|
September 30, |
|
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
|
||||
Trading securities (1) |
$ |
(3 |
) |
$ |
(23 |
) |
$ |
(2 |
) |
$ |
(81 |
) |
|
Equity securities (1) |
|
12 |
|
|
23 |
|
|
(17 |
) |
|
57 |
|
|
Mortgage loans on real estate (1) |
|
2 |
|
|
(1 |
) |
|
(1 |
) |
|
(16 |
) |
|
Derivative investments (1) |
|
(25 |
) |
|
2 |
|
|
(27 |
) |
|
5 |
|
|
MRBs (2) |
|
1,415 |
|
|
780 |
|
|
2,783 |
|
|
1,639 |
|
|
Embedded derivatives – indexed annuity |
|
|
|
|
|
|
|
|
|
|
|
|
|
and IUL contracts (1) |
|
(4 |
) |
|
(55 |
) |
|
(223 |
) |
|
4 |
|
|
Total, net |
$ |
1,397 |
|
$ |
726 |
|
$ |
2,513 |
|
$ |
1,608 |
|
|
(1)Included in realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).
(2)Included in market risk benefit gain (loss) on the Consolidated Statements of Comprehensive Income (Loss).
The following summarizes changes in unrealized gains (losses) included in OCI, net of tax, related to financial instruments carried at fair value classified within Level 3 that we still held (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
|
||||||||
|
Months Ended |
|
Months Ended |
|
|
||||||||
|
September 30, |
|
September 30, |
|
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
|
||||
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
(19 |
) |
$ |
(519 |
) |
$ |
(21 |
) |
$ |
(1,532 |
) |
|
State and municipal bonds |
|
2 |
|
|
- |
|
|
3 |
|
|
- |
|
|
Foreign government bonds |
|
- |
|
|
(2 |
) |
|
- |
|
|
(7 |
) |
|
RMBS |
|
(1 |
) |
|
- |
|
|
(1 |
) |
|
- |
|
|
ABS |
|
(5 |
) |
|
(39 |
) |
|
(4 |
) |
|
(101 |
) |
|
Hybrid and redeemable preferred |
|
|
|
|
|
|
|
|
|
|
|
|
|
securities |
|
- |
|
|
(38 |
) |
|
(2 |
) |
|
(26 |
) |
|
Mortgage loans on real estate |
|
(3 |
) |
|
(4 |
) |
|
1 |
|
|
(10 |
) |
|
Total, net |
$ |
(26 |
) |
$ |
(602 |
) |
$ |
(24 |
) |
$ |
(1,676 |
) |
|
The following provides the components of the transfers into and out of Level 3 (in millions) as reported above:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Three |
|
||||||||||||||
|
Months Ended |
|
Months Ended |
|
||||||||||||||
|
September 30, 2023 |
|
September 30, 2022 |
|
||||||||||||||
|
Transfers |
|
Transfers |
|
|
|
|
Transfers |
|
Transfers |
|
|
|
|
||||
|
Into |
|
Out of |
|
|
|
|
Into |
|
Out of |
|
|
|
|
||||
|
Level 3 |
|
Level 3 |
|
Total |
|
Level 3 |
|
Level 3 |
|
Total |
|
||||||
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
36 |
|
$ |
(79 |
) |
$ |
(43 |
) |
$ |
37 |
|
$ |
(53 |
) |
$ |
(16 |
) |
RMBS |
|
12 |
|
|
(5 |
) |
|
7 |
|
|
- |
|
|
- |
|
|
- |
|
ABS |
|
- |
|
|
(113 |
) |
|
(113 |
) |
|
15 |
|
|
(162 |
) |
|
(147 |
) |
Hybrid and redeemable preferred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
securities |
|
- |
|
|
(13 |
) |
|
(13 |
) |
|
- |
|
|
- |
|
|
- |
|
Trading securities |
|
6 |
|
|
- |
|
|
6 |
|
|
4 |
|
|
(1 |
) |
|
3 |
|
Derivative investments |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
(1 |
) |
|
(1 |
) |
Total, net |
$ |
54 |
|
$ |
(210 |
) |
$ |
(156 |
) |
$ |
56 |
|
$ |
(217 |
) |
$ |
(161 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
For the Nine |
|
For the Nine |
|
||||||||||||||
|
Months Ended |
|
Months Ended |
|
||||||||||||||
|
September 30, 2023 |
|
September 30, 2022 |
|
||||||||||||||
|
Transfers |
|
Transfers |
|
|
|
|
Transfers |
|
Transfers |
|
|
|
|
||||
|
Into |
|
Out of |
|
|
|
|
Into |
|
Out of |
|
|
|
|
||||
|
Level 3 |
|
Level 3 |
|
Total |
|
Level 3 |
|
Level 3 |
|
Total |
|
||||||
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
195 |
|
$ |
(198 |
) |
$ |
(3 |
) |
$ |
265 |
|
$ |
(167 |
) |
$ |
98 |
|
RMBS |
|
12 |
|
|
(5 |
) |
|
7 |
|
|
- |
|
|
(15 |
) |
|
(15 |
) |
CMBS |
|
4 |
|
|
- |
|
|
4 |
|
|
- |
|
|
(17 |
) |
|
(17 |
) |
ABS |
|
2 |
|
|
(346 |
) |
|
(344 |
) |
|
16 |
|
|
(273 |
) |
|
(257 |
) |
Hybrid and redeemable preferred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
securities |
|
16 |
|
|
(13 |
) |
|
3 |
|
|
- |
|
|
- |
|
|
- |
|
Trading securities |
|
6 |
|
|
- |
|
|
6 |
|
|
4 |
|
|
(5 |
) |
|
(1 |
) |
Derivative investments |
|
31 |
|
|
- |
|
|
31 |
|
|
- |
|
|
(15 |
) |
|
(15 |
) |
Total, net |
$ |
266 |
|
$ |
(562 |
) |
$ |
(296 |
) |
$ |
285 |
|
$ |
(492 |
) |
$ |
(207 |
) |
Transfers into and out of Level 3 are generally the result of observable market information on financial instruments no longer being available or becoming available to our pricing vendors. For the three and nine months ended September 30, 2023 and 2022, transfers in and out of Level 3 were attributable primarily to the financial instruments’ observable market information no longer being available or becoming available. The following summarizes the fair value (in millions), valuation techniques and significant unobservable inputs of the Level 3 fair value measurements as of September 30, 2023:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average |
||
|
Fair |
|
Valuation |
|
Significant |
|
Assumption or |
|
Input |
||||||||||
|
Value |
|
Technique |
|
Unobservable Inputs |
|
Input Ranges |
|
Range (1) |
||||||||||
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS and |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
trading securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
189 |
|
Discounted cash flow |
|
Liquidity/duration adjustment (2) |
|
(0.1) |
% |
|
- |
3.7 |
% |
|
2.0 |
% |
|
||
State and municipal |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bonds |
|
33 |
|
Discounted cash flow |
|
Liquidity/duration adjustment (2) |
|
0.8 |
% |
|
- |
1.9 |
% |
|
1.8 |
% |
|
||
ABS |
|
13 |
|
Discounted cash flow |
|
Liquidity/duration adjustment (2) |
|
1.7 |
% |
|
- |
1.7 |
% |
|
1.7 |
% |
|
||
Hybrid and redeemable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
preferred securities |
|
7 |
|
Discounted cash flow |
|
Liquidity/duration adjustment (2) |
|
1.3 |
% |
|
- |
1.5 |
% |
|
1.4 |
% |
|
||
Equity securities |
|
4 |
|
Discounted cash flow |
|
Liquidity/duration adjustment (2) |
|
4.5 |
% |
|
- |
4.5 |
% |
|
4.5 |
% |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MRB assets |
|
4,108 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Other assets – ceded MRBs |
|
2 |
|
Discounted cash flow |
|
Lapse (3) |
|
1 |
% |
|
- |
30 |
% |
|
(10) |
|
|
||
|
|
|
|
|
|
|
Utilization of GLB withdrawals (4) |
85 |
% |
|
- |
100 |
% |
|
94 |
% |
|
||
|
|
|
|
|
|
|
Claims utilization factor (5) |
|
60 |
% |
|
- |
100 |
% |
|
(10) |
|
|
|
|
|
|
|
|
|
|
Premiums utilization factor (5) |
|
80 |
% |
|
- |
115 |
% |
|
(10) |
|
|
|
|
|
|
|
|
|
|
Non-performance risk (6) |
|
0.74 |
% |
|
- |
2.56 |
% |
|
2.15 |
% |
|
|
|
|
|
|
|
|
|
Mortality (7) |
|
|
|
|
|
(9) |
|
|
(10) |
|
|
|
|
|
|
|
|
|
|
Volatility (8) |
|
1 |
% |
|
- |
29 |
% |
|
13.65 |
% |
|
|
Other assets – indexed |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
annuity ceded embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives |
|
586 |
|
Discounted cash flow |
|
Lapse (3) |
|
0 |
% |
|
- |
9 |
% |
|
(10) |
|
|
||
|
|
|
|
|
|
|
Mortality (7) |
|
|
|
|
|
(9) |
|
|
(10) |
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder account |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
balances – indexed annuity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
contracts embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives |
$ |
(7,163 |
) |
Discounted cash flow |
|
Lapse (3) |
|
0 |
% |
|
- |
9 |
% |
|
(10) |
|
|
||
|
|
|
|
|
|
|
Mortality (7) |
|
|
|
|
|
(9) |
|
|
(10) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MRB liabilities |
|
(1,385 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other liabilities – ceded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MRBs |
|
(305 |
) |
Discounted cash flow |
|
Lapse (3) |
|
1 |
% |
|
- |
30 |
% |
|
(10) |
|
|
||
|
|
|
|
|
|
|
Utilization of GLB withdrawals (4) |
85 |
% |
|
- |
100 |
% |
|
94 |
% |
|
||
|
|
|
|
|
|
|
Claims utilization factor (5) |
|
60 |
% |
|
- |
100 |
% |
|
(10) |
|
|
|
|
|
|
|
|
|
|
Premiums utilization factor (5) |
|
80 |
% |
|
- |
115 |
% |
|
(10) |
|
|
|
|
|
|
|
|
|
|
Non-performance risk (6) |
|
0.74 |
% |
|
- |
2.56 |
% |
|
2.15 |
% |
|
|
|
|
|
|
|
|
|
Mortality (7) |
|
|
|
|
|
(9) |
|
|
(10) |
|
|
|
|
|
|
|
|
|
|
Volatility (8) |
|
1 |
% |
|
- |
29 |
% |
|
13.65 |
% |
|
|
The following summarizes the fair value (in millions), valuation techniques and significant unobservable inputs of the Level 3 fair value measurements as of December 31, 2022:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average |
||
|
Fair |
|
Valuation |
|
Significant |
|
Assumption or |
|
Input |
||||||||||
|
Value |
|
Technique |
|
Unobservable Inputs |
|
Input Ranges |
|
Range (1) |
||||||||||
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS and |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
trading securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
$ |
204 |
|
Discounted cash flow |
|
Liquidity/duration adjustment (2) |
|
(0.2) |
% |
|
- |
4.2 |
% |
|
2.1 |
% |
|
||
State and municipal |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bonds |
|
35 |
|
Discounted cash flow |
|
Liquidity/duration adjustment (2) |
|
1.2 |
% |
|
- |
2.4 |
% |
|
2.3 |
% |
|
||
ABS |
|
15 |
|
Discounted cash flow |
|
Liquidity/duration adjustment (2) |
|
1.4 |
% |
|
- |
1.4 |
% |
|
1.4 |
% |
|
||
Hybrid and redeemable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
preferred securities |
|
3 |
|
Discounted cash flow |
|
Liquidity/duration adjustment (2) |
|
1.5 |
% |
|
- |
1.5 |
% |
|
1.5 |
% |
|
||
Equity securities |
|
4 |
|
Discounted cash flow |
|
Liquidity/duration adjustment (2) |
|
4.5 |
% |
|
- |
4.5 |
% |
|
4.5 |
% |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MRB assets |
|
2,807 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Other assets – ceded MRBs |
|
12 |
|
Discounted cash flow |
|
Lapse (3) |
|
1 |
% |
|
- |
30 |
% |
|
(10) |
|
|
||
|
|
|
|
|
|
|
Utilization of GLB withdrawals (4) |
85 |
% |
|
- |
100 |
% |
|
94 |
% |
|
||
|
|
|
|
|
|
|
Claims utilization factor (5) |
|
60 |
% |
|
- |
100 |
% |
|
(10) |
|
|
|
|
|
|
|
|
|
|
Premiums utilization factor (5) |
|
80 |
% |
|
- |
115 |
% |
|
(10) |
|
|
|
|
|
|
|
|
|
|
Non-performance risk (6) |
|
0.35 |
% |
|
- |
2.41 |
% |
|
1.73 |
% |
|
|
|
|
|
|
|
|
|
Mortality (7) |
|
|
|
|
|
(9) |
|
|
(10) |
|
|
|
|
|
|
|
|
|
|
Volatility (8) |
|
1 |
% |
|
- |
28 |
% |
|
14.47 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other assets – indexed |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
annuity ceded embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives |
|
525 |
|
Discounted cash flow |
|
Lapse (3) |
|
0 |
% |
|
- |
9 |
% |
|
(10) |
|
|
||
|
|
|
|
|
|
|
Mortality (7) |
|
|
|
|
|
(9) |
|
|
(10) |
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder account |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
balances – indexed annuity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
contracts embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives |
$ |
(4,845 |
) |
Discounted cash flow |
|
Lapse (3) |
|
0 |
% |
|
- |
9 |
% |
|
(10) |
|
|
||
|
|
|
|
|
|
|
Mortality (7) |
|
|
|
|
|
(9) |
|
|
(10) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MRB liabilities |
|
(2,078 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other liabilities – ceded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MRBs |
|
(205 |
) |
Discounted cash flow |
|
Lapse (3) |
|
1 |
% |
|
- |
30 |
% |
|
(10) |
|
|
||
|
|
|
|
|
|
|
Utilization of GLB withdrawals (4) |
85 |
% |
|
- |
100 |
% |
|
94 |
% |
|
||
|
|
|
|
|
|
|
Claims utilization factor (5) |
|
60 |
% |
|
- |
100 |
% |
|
(10) |
|
|
|
|
|
|
|
|
|
|
Premiums utilization factor (5) |
|
80 |
% |
|
- |
115 |
% |
|
(10) |
|
|
|
|
|
|
|
|
|
|
Non-performance risk (6) |
|
0.35 |
% |
|
- |
2.41 |
% |
|
1.73 |
% |
|
|
|
|
|
|
|
|
|
Mortality (7) |
|
|
|
|
|
(9) |
|
|
(10) |
|
|
|
|
|
|
|
|
|
|
Volatility (8) |
|
1 |
% |
|
- |
28 |
% |
|
14.47 |
% |
|
|
(1)Unobservable inputs were weighted by the relative fair value of the instruments, unless otherwise noted.
(2)The liquidity/duration adjustment input represents an estimated market participant composite of adjustments attributable to liquidity premiums, expected durations, structures and credit quality that would be applied to the market observable information of an investment.
(3)The lapse input represents the estimated probability of a contract surrendering during a year, and thereby forgoing any future benefits. The range for indexed annuity contracts represents the lapses during the surrender charge period.
(4)The utilization of GLB withdrawals input represents the estimated percentage of policyholders that utilize the GLB withdrawal riders.
(5)The utilization factors are applied to the present value of claims or premiums, as appropriate, in the MRB calculation to estimate the impact of inefficient GLB withdrawal behavior, including taking less than or more than the maximum GLB withdrawal.
(6)The non-performance risk input represents the estimated additional credit spread that market participants would apply to the market observable discount rate when pricing a contract. The non-performance risk input was weighted by the absolute value of the sensitivity of the reserve to the non-performance risk assumption.
(7)The mortality input represents the estimated probability of when an individual belonging to a particular group, categorized according to age or some other factor such as gender, will die.
(8)The volatility input represents overall volatilities assumed for the underlying variable annuity funds, which include a mixture of equity and fixed-income assets. Volatility assumptions vary by fund due to the benchmarking of different indices. The volatility input was weighted by the relative account value assigned to each index.
(9)The mortality is based on a combination of company and industry experience, adjusted for improvement factors.
(10)A weighted average input range is not a meaningful measurement for lapse, utilization factors or mortality.
From the table above, we have excluded Level 3 fair value measurements obtained from independent, third-party pricing sources. We do not develop the significant inputs used to measure the fair value of these assets and liabilities, and the information regarding the significant inputs is not readily available to us. Independent broker-quoted fair values are non-binding quotes developed by market makers or broker-dealers obtained from third-party sources recognized as market participants. The fair value of a broker-quoted asset or liability is based solely on the receipt of an updated quote from a single market maker or a broker-dealer recognized as a market participant as we do not adjust broker quotes when used as the fair value measurement for an asset or liability. Significant increases or decreases in any of the quotes received from a third-party broker-dealer may result in a significantly higher or lower fair value measurement.
Changes in any of the significant inputs presented in the table above would have resulted in a significant change in the fair value measurement of the asset or liability as follows:
Investments – An increase in the liquidity/duration adjustment input would have resulted in a decrease in the fair value measurement.
Indexed annuity contracts embedded derivatives – For direct embedded derivatives, an increase in the lapse or mortality inputs would have resulted in a decrease in the fair value measurement.
MRBs – Assuming our MRBs are in a liability position: an increase in our lapse, non-performance risk or mortality inputs would have resulted in a decrease in the fair value measurement except for policies with GDB riders only, an increase in mortality inputs would have resulted in an increase in the fair value measurement.
For each category discussed above, the unobservable inputs are not inter-related; therefore, a directional change in one input would not have affected the other inputs. As part of our ongoing valuation process, we assess the reasonableness of our valuation techniques or models and make adjustments as necessary.
15. Contingencies and Commitments
Contingencies
Reinsurance Disputes
Certain reinsurers have sought rate increases on certain yearly renewable term agreements. We are disputing the requested rate increases under these agreements. We may initiate legal proceedings, as necessary, under these agreements in order to protect our contractual rights. Additionally, reinsurers have initiated, and may in the future initiate, legal proceedings against us. While this may impact the Life Insurance segment, we believe it is unlikely the outcome of these disputes would have a material impact on the consolidated financial statements.
Regulatory and Litigation Matters
Regulatory bodies, such as state insurance departments, the SEC, Financial Industry Regulatory Authority and other regulatory bodies regularly make inquiries and conduct examinations or investigations concerning our compliance with, among other things, insurance laws, securities laws, laws governing the activities of broker-dealers, registered investment advisers and unclaimed property laws.
LNC is involved in various pending or threatened legal or regulatory proceedings, including purported class actions, arising from the conduct of business both in the ordinary course and otherwise. In some of the matters, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages or other relief. Jurisdictions may permit claimants not to specify the monetary damages sought or may permit claimants to state only that the amount sought is sufficient to invoke the jurisdiction of the trial court. In addition, jurisdictions may permit plaintiffs to allege monetary damages in amounts well exceeding verdicts obtained in the jurisdiction for similar matters. This variability in pleadings, together with the actual experiences of LNC in litigating or resolving through settlement numerous claims over an extended period of time, demonstrates to management that the monetary relief which may be specified in a lawsuit or claim bears little relevance to its merits or disposition value.
Due to the unpredictable nature of litigation, the outcome of a litigation matter and the amount or range of potential loss at particular points in time is normally difficult to ascertain. Uncertainties can include how fact finders will evaluate documentary evidence and the credibility and effectiveness of witness testimony, and how trial and appellate courts will apply the law in the context of the pleadings or evidence presented, whether by motion practice, or at trial or on appeal. Disposition valuations are also subject to the uncertainty of how opposing parties and their counsel will themselves view the relevant evidence and applicable law.
We establish liabilities for litigation and regulatory loss contingencies when information related to the loss contingencies shows both that it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. It is possible that some matters could require us to pay damages or make other expenditures or establish accruals in amounts that could not be estimated as of September 30, 2023.
For some matters, the Company is able to estimate a reasonably possible range of loss. For such matters in which a loss is probable, an accrual has been made. For such matters where a loss is believed to be reasonably possible, but not probable, no accrual has been made. Accordingly, the estimate contained in this paragraph reflects two types of matters. For some matters included within this estimate, an accrual has been made, but there is a reasonable possibility that an exposure exists in excess of the amount accrued. In these cases, the estimate reflects the reasonably possible range of loss in excess of the accrued amount. For other matters included within this estimation, no accrual has been made because a loss, while potentially estimable, is believed to be reasonably possible but not probable. In these cases, the estimate reflects the reasonably possible loss or range of loss. As of September 30, 2023, we estimate the aggregate range of reasonably possible losses, including amounts in excess of amounts accrued for these matters as of such date, to be up to approximately $190 million, after-tax. Any estimate is not an indication of expected loss, if any, or of the Company’s maximum possible loss exposure on such matters.
For other matters, we are not currently able to estimate the reasonably possible loss or range of loss. We are often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts and the progress of settlement negotiations. On a quarterly and annual basis, we review relevant information with respect to litigation contingencies and update our accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews.
Among other matters, we are presently engaged in litigation, including relating to cost of insurance rates (“Cost of Insurance and Other Litigation”), as described below. No accrual has been made for some of these matters. Although a loss is believed to be reasonably possible for these matters, for some of these matters, we are not able to estimate a reasonably possible amount or range of potential liability. An adverse outcome in one or more of these matters may have a material impact on the consolidated financial statements, but, based on information currently known, management does not believe those cases are likely to have such an impact.
Cost of Insurance and Other Litigation
Cost of Insurance Litigation
Glover v. Connecticut General Life Insurance Company and The Lincoln National Life Insurance Company, filed in the U.S. District Court for the District of Connecticut, No. 3:16-cv-00827, is a putative class action that was served on The Lincoln National Life Insurance Company (“LNL”) on June 8, 2016. Plaintiff is the owner of a universal life insurance policy who alleges that LNL charged more for non-guaranteed cost of insurance than permitted by the policy. Plaintiff seeks to represent all universal life and variable universal life policyholders who owned policies containing non-guaranteed cost of insurance provisions that are similar to those of plaintiff’s policy and seeks damages on behalf of all such policyholders. On January 11, 2019, the court dismissed plaintiff’s complaint in its entirety. In response, plaintiff filed a motion for leave to amend the complaint, which, on September 25, 2023, the court granted in part and denied in part. Plaintiff filed an amended complaint on October 10, 2023. We are vigorously defending this matter.
EFG Bank AG, Cayman Branch, et al. v. The Lincoln National Life Insurance Company, pending in the U.S. District Court for the Eastern District of Pennsylvania, No. 2:17-cv-02592, is a civil action filed on February 1, 2017. Plaintiffs own universal life insurance policies originally issued by Jefferson-Pilot (now LNL). Among other things, plaintiffs allege that LNL breached the terms of policyholders’ contracts when it increased non-guaranteed cost of insurance rates beginning in 2016. We are vigorously defending this matter.
In re: Lincoln National COI Litigation, pending in the U.S. District Court for the Eastern District of Pennsylvania, Case No. 2:16-cv-06605-GJP, is a consolidated litigation matter related to multiple putative class action cases that were consolidated by an order dated March 20, 2017. Plaintiffs purport to own certain universal life insurance policies originally issued by Jefferson-Pilot (now LNL). Among other things, plaintiffs allege that LNL and LNC breached the terms of policyholders’ contracts by increasing non-guaranteed cost of insurance rates beginning in 2016. Plaintiffs sought to represent classes of policyowners and sought damages on their behalf. On August 9, 2022, the court denied plaintiffs’ motion for class certification. The parties participated in a mediation on December 13, 2022, and subsequently reached a settlement. On January 26, 2023, the parties informed the presiding judge of a class settlement in this action, subject to final documentation and court approval. On March 24, 2023, plaintiffs filed a motion for preliminary approval of the class settlement, which was granted by the court on June 14, 2023. The provisional settlement, which was subject to both preliminary and final approval of the court, consisted of $117.75 million in pre-tax cash (in the aggregate for both this litigation and the In re: Lincoln National 2017 COI Rate Litigation matter discussed immediately below) and a five-year cost of insurance rate freeze, among other terms. After certain policyholders timely opted out or otherwise excluded themselves from the settlement class with respect to certain policies, the pre-tax cash settlement fund was reduced to $109.96 million.
The court granted final approval of the settlement on October 5, 2023. Certain of the policyholders who did not participate in the settlement are plaintiffs in the Brighton Trustees, LLC, et al. v. The Lincoln National Life Insurance Company discussed further below. The remaining policyholders who did not participate in the settlement may bring individual actions in the future to the extent they have not already done so.
In re: Lincoln National 2017 COI Rate Litigation, pending in the U.S. District Court for the Eastern District of Pennsylvania, Case No. 2:17-cv-04150, is a consolidated litigation matter related to multiple putative class action cases that were consolidated by an order dated March 28, 2018. Plaintiffs purport to own certain universal life insurance policies originally issued by Jefferson-Pilot (now LNL). Among other things, plaintiffs allege that LNL and LNC breached the terms of policyholders’ contracts by increasing non-guaranteed cost of insurance rates beginning in 2017. Plaintiffs sought to represent classes of policyholders and sought damages on their behalf. On August 9, 2022, the court denied plaintiffs’ motion for class certification. The parties participated in a mediation on December 13, 2022, and subsequently reached a settlement. On January 26, 2023, the parties informed the presiding judge of a class settlement in this action, subject to final documentation and court approval. On March 24, 2023, plaintiffs filed a motion for preliminary approval of the class settlement, which was granted by the court on June 14, 2023. The provisional settlement, which was subject to both preliminary and final approval of the court, consists of $117.75 million in pre-tax cash (in the aggregate for both this litigation and the In re: Lincoln National COI Litigation matter discussed immediately above) and a five-year cost of insurance rate freeze, among other terms. After certain policyholders timely opted out or otherwise excluded themselves from the settlement class with respect to certain policies, the pre-tax cash settlement fund was reduced to $109.96 million. The court granted final approval of the settlement on October 5, 2023. Certain of the policyholders who did not participate in the settlement are plaintiffs in the Brighton Trustees, LLC, et al. v. The Lincoln National Life Insurance Company discussed further below. The remaining policyholders who did not participate in the settlement may bring individual actions in the future to the extent they have not already done so.
Iwanski v. First Penn-Pacific Life Insurance Company (“FPP”), No. 2:18-cv-01573 filed in the U.S. District Court for the Eastern District of Pennsylvania is a putative class action that was filed on April 13, 2018. Plaintiff alleges that defendant FPP breached the terms of his life insurance policy by deducting non-guaranteed cost of insurance charges in excess of what is permitted by the policies. Plaintiff seeks to represent all owners of universal life insurance policies issued by FPP containing non-guaranteed cost of insurance provisions that are similar to those of Plaintiff’s policy and seeks damages on their behalf. Breach of contract is the only cause of action asserted. We are vigorously defending this matter.
TVPX ARS INC., as Securities Intermediary for Consolidated Wealth Management, LTD. v. The Lincoln National Life Insurance Company, filed in the U.S. District Court for the Eastern District of Pennsylvania, No. 2:18-cv-02989, is a putative class action that was filed on July 17, 2018. Plaintiff alleges that LNL charged more for non-guaranteed cost of insurance than permitted by the policy. Plaintiff seeks to represent all universal life and variable universal life policyholders who own policies issued by LNL or its predecessors containing non-guaranteed cost of insurance provisions that are similar to those of Plaintiff’s policy and seeks damages on behalf of all such policyholders. We are vigorously defending this matter.
LSH Co. and Wells Fargo Bank, National Association, as securities intermediary for LSH Co. v. Lincoln National Corporation and The Lincoln National Life Insurance Company, pending in the U.S. District Court for the Eastern District of Pennsylvania, No. 2:18-cv-05529, is a civil action filed on December 21, 2018. Plaintiffs own universal life insurance policies originally issued by Jefferson-Pilot (now LNL). Among other things, plaintiffs allege that LNL and LNC breached the terms of policyholders’ contracts when LNL increased non-guaranteed cost of insurance rates in 2016 and 2017. We are vigorously defending this matter.
Vida Longevity Fund, LP v. Lincoln Life & Annuity Company of New York, pending in the U.S. District Court for the Southern District of New York, No. 1:19-cv-06004, is a putative class action that was filed on June 27, 2019. Plaintiff alleges that Lincoln Life & Annuity Company of New York (“LLANY”) charged more for non-guaranteed cost of insurance than was permitted by the policies. On March 31, 2022, the court issued an order granting plaintiff’s motion for class certification and certified a class of all current or former owners of six universal life insurance products issued by LLANY that were assessed a cost of insurance charge any time on or after June 27, 2013. Plaintiff seeks damages on behalf of the class. On April 19, 2023, LLANY filed a motion for summary judgment, which remains pending. We are vigorously defending this matter.
Angus v. The Lincoln National Life Insurance Company, pending in the U.S. District Court for the Eastern District of Pennsylvania, No. 2:22-cv-01878, is a putative class action filed on May 13, 2022. Plaintiff alleges that defendant LNL breached the terms of her life insurance policy by deducting non-guaranteed cost of insurance charges in excess of what is permitted by the policies. Plaintiff seeks to represent all owners of universal life insurance policies issued or insured by LNL or its predecessors containing non-guaranteed cost of insurance provisions that are similar to those of plaintiff’s policy and seeks damages on their behalf. Breach of contract is the only cause of action asserted. On August 26, 2022, LNL filed a motion to dismiss. We are vigorously defending this matter.
Brighton Trustees, LLC, et al. v. The Lincoln National Life Insurance Company, pending in the U.S. District Court for the Eastern District of Pennsylvania, Case No. 2:23-cv-02251, is a civil action filed on April 20, 2023. On June 12, 2023, the U.S. District Court for the Northern District of Indiana granted a motion filed by LNL to transfer the case to the U.S. District Court for the Eastern District of Pennsylvania. Plaintiffs purport to own universal life insurance policies originally issued by Jefferson-Pilot (now LNL). Among other things, plaintiffs allege that LNL breached the terms of policyholders’ contracts and converted property when it increased non-guaranteed cost of insurance rates beginning in 2016. We are vigorously defending this matter.
Other Litigation
Andrew Nitkewicz v. Lincoln Life & Annuity Company of New York, pending in the U.S. District Court for the Southern District of New York, No. 1:20-cv-06805, is a putative class action that was filed on August 24, 2020. Plaintiff Andrew Nitkewicz, as trustee of the Joan C. Lupe Trust, seeks to represent all current and former owners of universal life (including variable universal life) policies who own or owned policies issued by LLANY and its predecessors in interest that were in force at any time on or after June 27, 2013, and for which planned annual, semi-annual, or quarterly premiums were paid for any period beyond the end of the policy month of the insured’s death. Plaintiff alleges LLANY failed to refund unearned premium in violation of New York Insurance Law Section 3203(a)(2) in connection with the payment of death benefit claims for certain insurance policies. Plaintiff seeks compensatory damages and pre-judgment interest on behalf of the various classes and sub-class. On July 2, 2021, the court granted, with prejudice, LLANY’s November 2020 motion to dismiss this matter. Plaintiff filed a notice of appeal on July 28, 2021, and on September 26, 2022, the U.S. Court of Appeals for the Second Circuit reserved its decision and certified a question to the New York Court of Appeals. On October 20, 2022, the New York Court of Appeals accepted the question. On October 19, 2023, the New York Court of Appeals answered the question in LLANY’s favor and transmitted the decision to the U.S. Court of Appeals for the Second Circuit.
Henry Morgan et al. v. Lincoln National Corporation d/b/a Lincoln Financial Group, et al, filed in the District Court of the 14th Judicial District of Dallas County, Texas, No. DC-23-02492, is a putative class action that was filed on February 22, 2023. Plaintiffs Henry Morgan, Susan Smith, Charles Smith, Laura Seale, Terri Cogburn, Laura Baesel, Kathleen Walton, Terry Warner, and Toni Hale (“Plaintiffs”) allege on behalf of a putative class that Lincoln National Corporation d/b/a Lincoln Financial Group, LNL and LLANY (together, “Lincoln”), FMR, LLC, and Fidelity Product Services, LLC (“Fidelity”) created and marketed misleading and deceptive insurance products with attributes of investment products. The putative class comprises all individuals and entities who purchased Lincoln OptiBlend products that allocated account monies to the 1-Year Fidelity AIM Dividend Participation Account, between January 1, 2020, to December 31, 2022. Plaintiffs assert the following claims individually and on behalf of the class, (1) violations of the Texas Deceptive Trade Practices Act against Lincoln; (2) common-law fraud against Lincoln; (3) negligent misrepresentation against Lincoln and Fidelity; and (4) aiding and abetting fraud against Fidelity. Plaintiffs allege they suffered damages from “a missed investment return of approximately 5-6%” and mitigation damages. They seek actual, consequential and punitive damages, as well as pre-judgment and post-judgment interest, attorney’s fees, and litigation costs. On March 31, 2023, the Lincoln defendants filed a notice of removal removing the action from the 14th Judicial District of Dallas County, Texas, to the United States District Court for the Northern District of Texas, Dallas Division. On May 8, 2023, the Lincoln defendants and the Fidelity defendants filed motions to dismiss, which remain pending. We are vigorously defending this matter.
16. Shares and Stockholders’ Equity
Preferred Shares
Preferred stock authorized, issued and outstanding (number of shares) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
As of December 31, 2022 |
|
||||||||
|
Shares Authorized |
|
Shares Issued |
|
Shares Outstanding |
|
Shares Authorized |
|
Shares Issued |
|
Shares Outstanding |
|
9.250% Fixed Rate Reset Non-Cumulative |
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock, Series C |
20,000 |
|
20,000 |
|
20,000 |
|
20,000 |
|
20,000 |
|
20,000 |
|
9.000% Non-Cumulative Preferred Stock, Series D |
20,000 |
|
20,000 |
|
20,000 |
|
20,000 |
|
20,000 |
|
20,000 |
|
Not designated |
9,960,000 |
|
- |
|
- |
|
9,960,000 |
|
- |
|
- |
|
Total preferred shares |
10,000,000 |
|
40,000 |
|
40,000 |
|
10,000,000 |
|
40,000 |
|
40,000 |
|
The per share and aggregate dividends declared for preferred stock by series (in millions except per share data) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended September 30, |
|
||||||||||
|
2023 |
|
2022 |
|
||||||||
|
|
Dividend |
|
|
Aggregate |
|
|
Dividend |
|
|
Aggregate |
|
Series |
|
Per Share |
|
|
Dividend |
|
|
Per Share |
|
|
Dividend |
|
Series C |
$ |
1,156.25 |
|
$ |
23 |
|
$ |
- |
|
$ |
- |
|
Series D |
|
562.50 |
|
|
11 |
|
|
- |
|
|
- |
|
Total |
$ |
1,718.75 |
|
$ |
34 |
|
$ |
- |
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, |
|
||||||||||
|
2023 |
|
2022 |
|
||||||||
|
|
Dividend |
|
|
Aggregate |
|
|
Dividend |
|
|
Aggregate |
|
Series |
|
Per Share |
|
|
Dividend |
|
|
Per Share |
|
|
Dividend |
|
Series C |
$ |
1,792.19 |
|
$ |
36 |
|
$ |
- |
|
$ |
- |
|
Series D |
|
1,743.75 |
|
|
35 |
|
|
- |
|
|
- |
|
Total |
$ |
3,535.94 |
|
$ |
71 |
|
$ |
- |
|
$ |
- |
|
Common Shares
The changes in our common stock (number of shares) were as follows:
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||
|
Months Ended |
|
Months Ended |
|
||||
|
September 30, |
|
September 30, |
|
||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
Common Stock |
|
|
|
|
|
|
|
|
Balance as of beginning-of-period |
169,630,880 |
|
170,224,116 |
|
169,220,511 |
|
177,193,515 |
|
Stock compensation/issued for benefit plans |
27,391 |
|
10,052 |
|
437,760 |
|
686,473 |
|
Retirement/cancellation of shares |
- |
|
(1,019,675 |
) |
- |
|
(8,665,495 |
|
Balance as of end-of-period |
169,658,271 |
|
169,214,493 |
|
169,658,271 |
|
169,214,493 |
|
|
|
|
|
|
|
|
|
|
Common Stock as of End-of-Period |
|
|
|
|
|
|
|
|
Basic basis |
169,658,271 |
|
169,214,493 |
|
169,658,271 |
|
169,214,493 |
|
Diluted basis |
171,033,121 |
|
170,658,861 |
|
171,033,121 |
|
170,658,861 |
|
Our common stock is without par value.
Average Common Shares
A reconciliation of the denominator (number of shares) in the calculations of basic and diluted earnings (loss) per common share was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||
|
Months Ended |
|
Months Ended |
|
||||
|
September 30, |
|
September 30, |
|
||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
Weighted-average shares, as used in basic calculation |
169,645,881 |
|
169,706,526 |
|
169,529,509 |
|
171,647,108 |
|
Shares to cover non-vested stock |
620,088 |
|
779,215 |
|
504,949 |
|
1,011,546 |
|
Average stock options outstanding during the period |
42,457 |
|
380,706 |
|
24,862 |
|
1,236,484 |
|
Assumed acquisition of shares with assumed |
|
|
|
|
|
|
|
|
proceeds and benefits from exercising stock |
|
|
|
|
|
|
|
|
options (at average market price for the period) |
(37,461 |
) |
(280,067 |
) |
(21,377 |
) |
(978,538 |
|
Shares repurchasable from measured but |
|
|
|
|
|
|
|
|
unrecognized stock option expense |
(2,045 |
) |
- |
|
(682 |
) |
(28,008 |
|
Average deferred compensation shares |
621,582 |
|
508,980 |
|
588,183 |
|
507,487 |
|
Weighted-average shares, as used in diluted calculation (1) |
170,890,502 |
|
171,095,360 |
|
170,625,444 |
|
173,396,079 |
|
(1)Due to reporting a net loss for the three months ended September 30, 2022, basic shares were used in the diluted earnings per share (“EPS”) calculation for those periods as the use of diluted shares would have resulted in a lower loss per share.
In the event the average market price of LNC common stock exceeds the issue price of stock options and the options have a dilutive effect to our EPS, such options will be shown in the table above.
The income used in the calculation of our diluted EPS is our net income (loss), reduced by preferred stock dividends. This amount is presented on our Consolidated Statements of Income (Loss).
We have participants in our deferred compensation plans who selected LNC stock as the measure for the investment return attributable to all or a portion of their deferral amounts. This obligation is settled in either cash or LNC stock pursuant to the applicable plan document.
We exclude deferred units of LNC stock that are antidilutive from our diluted EPS calculation. The mark-to-market adjustment of these deferred units excluded from our diluted EPS calculation was less than $1 million and $1 million for the three months ended September 30, 2023 and 2022, respectively, and $2 million and $8 million for the nine months ended September 30, 2023 and 2022, respectively.
AOCI
The following summarizes the components and changes in AOCI (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine |
|
||||
|
Months Ended |
|
||||
|
September 30, |
|
||||
|
2023 |
|
2022 |
|
||
Unrealized Gain (Loss) on Fixed Maturity AFS Securities and Certain Other |
|
|
|
|
|
|
Investments |
|
|
|
|
|
|
Balance as of beginning-of-year |
$ |
(8,916 |
) |
$ |
9,616 |
|
Unrealized holding gains (losses) arising during the period |
|
(3,405 |
) |
|
(27,065 |
) |
Change in foreign currency exchange rate adjustment |
|
(21 |
) |
|
(620 |
) |
Change in future contract benefits and policyholder account balances |
|
27 |
|
|
2,395 |
|
Income tax benefit (expense) |
|
707 |
|
|
5,399 |
|
Less: |
|
|
|
|
|
|
Reclassification adjustment for gains (losses) included in net income (loss) |
|
(1,145 |
) |
|
(9 |
) |
Income tax benefit (expense) |
|
240 |
|
|
2 |
|
Balance as of end-of-period |
$ |
(10,703 |
) |
$ |
(10,268 |
) |
Unrealized Gain (Loss) on Derivative Instruments |
|
|
|
|
|
|
Balance as of beginning-of-year |
$ |
388 |
|
$ |
(85 |
) |
Unrealized holding gains (losses) arising during the period |
|
231 |
|
|
301 |
|
Change in foreign currency exchange rate adjustment |
|
30 |
|
|
623 |
|
Income tax benefit (expense) |
|
(55 |
) |
|
(194 |
) |
Less: |
|
|
|
|
|
|
Reclassification adjustment for gains (losses) included in net income (loss) |
|
68 |
|
|
67 |
|
Income tax benefit (expense) |
|
(14 |
) |
|
(14 |
) |
Balance as of end-of-period |
$ |
540 |
|
$ |
592 |
|
Market Risk Benefit Non-Performance Risk Gain (Loss) |
|
|
|
|
|
|
Balance as of beginning-of-year |
$ |
1,741 |
|
$ |
1,951 |
|
Adjustment arising during the period |
|
(944 |
) |
|
285 |
|
Income tax benefit (expense) |
|
202 |
|
|
(61 |
) |
Balance as of end-of-period |
$ |
999 |
|
$ |
2,175 |
|
Policyholder Liability Discount Rate Remeasurement Gain (Loss) |
|
|
|
|
|
|
Balance as of beginning-of-year |
$ |
747 |
|
$ |
(1,265 |
) |
Adjustment arising during the period |
|
347 |
|
|
2,631 |
|
Income tax benefit (expense) |
|
(73 |
) |
|
(561 |
) |
Balance as of end-of-period |
$ |
1,021 |
|
$ |
805 |
|
Foreign Currency Translation Adjustment |
|
|
|
|
|
|
Balance as of beginning-of-year |
$ |
(34 |
) |
$ |
(14 |
) |
Foreign currency translation adjustment arising during the period |
|
1 |
|
|
(32 |
) |
Income tax benefit (expense) |
|
- |
|
|
(1 |
) |
Balance as of end-of-period |
$ |
(33 |
) |
$ |
(47 |
) |
Funded Status of Employee Benefit Plans |
|
|
|
|
|
|
Balance as of beginning-of-year |
$ |
(278 |
) |
$ |
(219 |
) |
Adjustment arising during the period |
|
(26 |
) |
|
22 |
|
Balance as of end-of-period |
$ |
(304 |
) |
$ |
(197 |
) |
The following summarizes the reclassifications out of AOCI (in millions) and the associated line item on the Consolidated Statements of Comprehensive Income (Loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Nine |
|
|
|||||
|
Months Ended |
|
|
|||||
|
September 30, |
|
|
|||||
|
2023 |
|
|
2022 |
|
|
||
Unrealized Gain (Loss) on Fixed Maturity AFS |
|
|
|
|
|
|
|
|
Securities and Certain Other Investments |
|
|
|
|
|
|
|
|
Reclassification |
$ |
(1,175 |
) |
|
$ |
(9 |
) |
Realized gain (loss) |
Associated change in future contract benefits |
|
30 |
|
|
|
- |
|
Benefits |
Reclassification before income tax benefit (expense) |
|
(1,145 |
) |
|
|
(9 |
) |
Income (loss) before taxes |
Income tax benefit (expense) |
|
247 |
|
|
|
2 |
|
Federal income tax expense (benefit) |
Reclassification, net of income tax |
$ |
(898 |
) |
|
$ |
(7 |
) |
Net income (loss) |
|
|
|
|
|
|
|
|
|
Unrealized Gain (Loss) on Derivative Instruments |
|
|
|
|
|
|
|
|
Interest rate contracts |
$ |
- |
|
|
$ |
1 |
|
Net investment income |
Interest rate contracts |
|
22 |
|
|
|
(11 |
) |
Interest and debt expense |
Foreign currency contracts |
|
42 |
|
|
|
48 |
|
Net investment income |
Foreign currency contracts |
|
4 |
|
|
|
29 |
|
Realized gain (loss) |
Reclassifications before income tax benefit (expense) |
|
68 |
|
|
|
67 |
|
Income (loss) before taxes |
Income tax benefit (expense) |
|
(14 |
) |
|
|
(14 |
) |
Federal income tax expense (benefit) |
Reclassifications, net of income tax |
$ |
54 |
|
|
$ |
53 |
|
Net income (loss) |
17. Segment Information
We provide products and services and report results through our Annuities, Life Insurance, Group Protection and Retirement Plan Services segments. We also have Other Operations, which includes the financial data for operations that are not directly related to the business segments. Our reporting segments reflect the manner by which our chief operating decision makers view and manage the business. A discussion of these segments and Other Operations is found in Note 21 in our 2022 Form 10-K/A, as updated by Note 20 in the May 2023 Form 8-K.
Segment operating revenues and income (loss) from operations are internal measures used by our management and Board of Directors to evaluate and assess the results of our segments. Income (loss) from operations is GAAP net income excluding the after-tax effects of the following items, as applicable:
Items related to annuity product features, which include changes in MRBs, including gains and losses and benefit payments, changes in the fair value of the derivative instruments we hold to hedge GLB and GDB riders, net of fee income allocated to support the cost of hedging them, and changes in the fair value of the embedded derivative liabilities of our indexed annuity contracts and the associated index options we hold to hedge them, including collateral expense associated with the hedge program (collectively, “net annuity product features”);
Items related to life insurance product features, which include changes in the fair value of derivatives we hold as part of VUL hedging, changes in reserves resulting from benefit ratio unlocking associated with the impact of capital markets, and changes in the fair value of the embedded derivative liabilities of our IUL contracts and the associated index options we hold to hedge them (collectively, “net life insurance product features”);
Credit loss-related adjustments on fixed maturity AFS securities, mortgage loans on real estate and reinsurance-related assets (“credit loss-related adjustments”);
Changes in the fair value of equity securities, certain derivatives, certain other investments and realized gains (losses) on sales, disposals and impairments of financial assets (collectively, “investment gains (losses)”);
Changes in the fair value of reinsurance-related embedded derivatives, trading securities and mortgage loans on real estate electing the fair value option (“changes in the fair value of reinsurance-related embedded derivatives, trading securities and certain mortgage loans”);
Income (loss) from the initial adoption of new accounting standards, regulations and policy changes;
Income (loss) from reserve changes, net of related amortization, on business sold through reinsurance;
Transaction and integration costs related to mergers and acquisitions including the acquisition or divestiture, through reinsurance or other means, of businesses or blocks of business;
Gains (losses) on modification or early extinguishment of debt;
Losses from the impairment of intangible assets and gains (losses) on other non-financial assets; and
Income (loss) from discontinued operations.
Operating revenues represent GAAP revenues excluding the pre-tax effects of the following items, as applicable:
Changes in the fair value of the derivative instruments we hold to hedge GLB and GDB riders, net of fee income allocated to support the cost of hedging them, and changes in the fair value of the embedded derivative liabilities of our indexed annuity and IUL contracts and the associated index options we hold to hedge them (collectively, “revenue adjustments from annuity and life insurance product features”);
Credit loss-related adjustments;
Investment gains (losses);
Changes in the fair value of reinsurance-related embedded derivatives, trading securities and certain mortgage loans;
Revenue adjustments from the initial adoption of new accounting standards; and
Amortization of deferred gains arising from reserve changes on business sold through reinsurance.
The tables below reconcile our segment measures of performance to the GAAP measures presented in the Consolidated Statements of Comprehensive Income (Loss) (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
|
For the Nine |
|
||||||||
|
Months Ended |
|
|
Months Ended |
|
||||||||
|
September 30, |
|
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
|
2023 |
|
2022 |
|
||||
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating revenues: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Annuities |
$ |
1,197 |
|
$ |
1,113 |
|
|
$ |
3,528 |
|
$ |
3,356 |
|
Life Insurance |
|
1,723 |
|
|
1,623 |
|
|
|
5,241 |
|
|
5,059 |
|
Group Protection |
|
1,388 |
|
|
1,333 |
|
|
|
4,176 |
|
|
3,958 |
|
Retirement Plan Services |
|
327 |
|
|
316 |
|
|
|
988 |
|
|
949 |
|
Other Operations |
|
38 |
|
|
36 |
|
|
|
127 |
|
|
111 |
|
Revenue adjustments from annuity and life insurance product features |
|
(14 |
) |
|
386 |
|
|
|
(1,908 |
) |
|
1,697 |
|
Credit loss-related adjustments |
|
(27 |
) |
|
(133 |
) |
|
|
(53 |
) |
|
(122 |
) |
Investment gains (losses) (1) |
|
(400 |
) |
|
13 |
|
|
|
(1,126 |
) |
|
6 |
|
Changes in the fair value of reinsurance-related embedded derivatives, |
|
|
|
|
|
|
|
|
|
|
|
|
|
trading securities and certain mortgage loans |
|
(29 |
) |
|
(15 |
) |
|
|
(27 |
) |
|
(46 |
) |
Total revenues |
$ |
4,203 |
|
$ |
4,672 |
|
|
$ |
10,946 |
|
$ |
14,969 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
|
For the Nine |
|
||||||||
|
Months Ended |
|
|
Months Ended |
|
||||||||
|
September 30, |
|
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
|
2023 |
|
2022 |
|
||||
Net Income (Loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Annuities |
$ |
248 |
|
$ |
275 |
|
|
$ |
794 |
|
$ |
886 |
|
Life Insurance |
|
(173 |
) |
|
(2,171 |
) |
|
|
(153 |
) |
|
(2,085 |
) |
Group Protection |
|
68 |
|
|
12 |
|
|
|
247 |
|
|
15 |
|
Retirement Plan Services |
|
43 |
|
|
47 |
|
|
|
133 |
|
|
159 |
|
Other Operations |
|
(113 |
) |
|
(112 |
) |
|
|
(306 |
) |
|
(276 |
) |
Net annuity product features, after-tax |
|
1,045 |
|
|
893 |
|
|
|
850 |
|
|
2,591 |
|
Net life insurance product features, after-tax |
|
85 |
|
|
20 |
|
|
|
(133 |
) |
|
16 |
|
Credit loss-related adjustments, after-tax |
|
(21 |
) |
|
(104 |
) |
|
|
(41 |
) |
|
(96 |
) |
Investment gains (losses), after-tax (1) |
|
(306 |
) |
|
10 |
|
|
|
(880 |
) |
|
5 |
|
Changes in the fair value of reinsurance-related embedded derivatives, |
|
|
|
|
|
|
|
|
|
|
|
|
|
trading securities and certain mortgage loans, after-tax |
|
(23 |
) |
|
(12 |
) |
|
|
(21 |
) |
|
(36 |
) |
Impairment of intangibles |
|
- |
|
|
(634 |
) |
|
|
- |
|
|
(634 |
) |
Transaction and integration costs related to mergers, |
|
|
|
|
|
|
|
|
|
|
|
|
|
acquisitions and divestitures, after-tax (2) |
|
- |
|
|
- |
|
|
|
(7 |
) |
|
- |
|
Net income (loss) |
$ |
853 |
|
$ |
(1,776 |
) |
|
$ |
483 |
|
$ |
545 |
|
(1)Includes a $467 million pre-tax ($369 million after-tax) and $1.1 billion pre-tax ($862 million after-tax) impairment of fixed maturity AFS securities in an unrealized loss position for the three and nine months ended September 30, 2023, respectively, resulting from the Company’s intent to sell these securities as part of the previously announced Fortitude Re reinsurance transaction. Within the investment portfolio anticipated to be sold in the transaction, there are additional fixed maturity AFS securities in an unrealized gain position of approximately $164 million after-tax as of September 30, 2023. Pursuant to the applicable accounting guidance, the Company impaired the securities in a loss position down to fair market value upon entry into the agreement in the second quarter and recognized additional impairment of certain of these securities during the third quarter due to higher interest rates. The Company will recognize a gain for any securities in an unrealized gain position at the time when the transaction closes. For more information, see Notes 4 and 8.
(2)Includes costs pertaining to the Fortitude Re reinsurance transaction. For more information, see Note 8.
Other segment information (in millions) was as follows:
|
|
|
|
|
|
|
As of |
|
As of |
||
|
September 30, |
|
December 31, |
||
|
2023 |
|
2022 |
||
Assets |
|
|
|
|
|
Annuities |
$ |
171,598 |
|
$ |
167,377 |
Life Insurance |
|
94,237 |
|
|
94,536 |
Group Protection |
|
9,389 |
|
|
9,780 |
Retirement Plan Services |
|
41,558 |
|
|
41,900 |
Other Operations |
|
21,629 |
|
|
20,624 |
Total assets |
$ |
338,411 |
|
$ |
334,217 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18. Realized Gain (Loss)
Realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss) includes realized gains and losses from the sale of investments, write-downs for impairments of investments and changes in the allowance for credit losses for financial assets, changes in fair value for mortgage loans on real estate accounted for under the fair value option, changes in fair value of equity securities, VUL derivative and embedded derivative gains and losses, gains and losses on the sale of subsidiaries and businesses and net gains and losses on reinsurance-related embedded derivatives and trading securities. Realized gains and losses on the sale of investments are determined using the specific identification method. Realized gain (loss) is also net of allocations of investment gains and losses to certain policyholders, certain funds withheld on reinsurance arrangements and certain modified coinsurance arrangements for which we have a contractual obligation. Details underlying realized gain (loss) (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
Gross gains |
$ |
1 |
|
$ |
11 |
|
$ |
35 |
|
$ |
15 |
|
Gross losses |
|
(3 |
) |
|
(15 |
) |
|
(119 |
) |
|
(24 |
) |
Credit loss benefit (expense) (1) |
|
(1 |
) |
|
(5 |
) |
|
(17 |
) |
|
(11 |
) |
Intent to sell impairments (2) |
|
(467 |
) |
|
- |
|
|
(1,091 |
) |
|
- |
|
Realized gain (loss) on equity securities (3) |
|
8 |
|
|
16 |
|
|
(20 |
) |
|
(3 |
) |
Credit loss benefit (expense) on mortgage loans on real estate |
|
(9 |
) |
|
(9 |
) |
|
(16 |
) |
|
4 |
|
Credit loss benefit (expense) on reinsurance-related assets (4) |
|
(16 |
) |
|
(118 |
) |
|
(20 |
) |
|
(115 |
) |
Realized gain (loss) on the mark-to-market on certain instruments (5)(6) |
|
128 |
|
|
40 |
|
|
(147 |
) |
|
31 |
|
Indexed product derivative results (7) |
|
4 |
|
|
(25 |
) |
|
(199 |
) |
|
113 |
|
Derivative results (8) |
|
(81 |
) |
|
382 |
|
|
(1,454 |
) |
|
1,554 |
|
Other realized gain (loss) |
|
(17 |
) |
|
(28 |
) |
|
(18 |
) |
|
(33 |
) |
Total realized gain (loss) |
$ |
(453 |
) |
$ |
249 |
|
$ |
(3,066 |
) |
$ |
1,531 |
|
(1)Includes changes in the allowance for credit losses as well as direct write-downs to amortized cost as a result of negative credit events.
(2)Includes impairments of certain fixed maturity AFS securities in an unrealized loss position, resulting from the Company’s intent to sell these securities as part of the Fortitude Re reinsurance transaction. Within the investment portfolio anticipated to be sold in the transaction, there are additional fixed maturity AFS securities in an unrealized gain position of approximately $208 million pre-tax as of September 30, 2023. Pursuant to the applicable accounting guidance, the Company impaired the securities in a loss position down to fair market value upon entry into the agreement in the second quarter and recognized additional impairment on certain of these securities during the third quarter due to higher interest rates. The Company will recognize a gain for any securities in an unrealized gain position at the time when the transaction closes. See Notes 4 and 8 for additional information.
(3)Includes mark-to-market adjustments on equity securities still held of $9 million and $16 million for the three months ended September 30, 2023 and 2022, respectively, and $(22) million and $2 million for the nine months ended September 30, 2023 and 2022, respectively.
(4)Includes the release of reinsurance recoverables and the corresponding allowance for credit losses related to a third-party reinsurer, Scottish Re, where liquidation proceedings commenced during the third quarter of 2023. As of September 30, 2023, reinsurance coverage terminated and all business ceded to Scottish Re was therefore recaptured.
(5)Represents changes in the fair values of derivatives we hold as part of VUL hedging, reinsurance-related embedded derivatives and trading securities.
(6)Includes gains and losses from fair value changes on mortgage loans on real estate accounted for under the fair value option of $2 million and $(1) million for the three months ended September 30, 2023 and 2022, respectively, and $1 million and $(18) million for the nine months ended September 30, 2023 and 2022, respectively.
(7)Represents the change in fair value of the index options that we hold and the change in the fair value of the embedded derivative liabilities of our indexed annuity and IUL contracts, and the associated index options to hedge policyholder index allocations applicable to future reset periods for our indexed annuity products.
(8)Includes the change in the fair value of the derivative instruments we own to support capital needs associated with our GLB and GDB riders net of fee income allocated to support the cost of purchasing the hedging instruments.
19. Federal Income Taxes
The effective tax rate is the ratio of tax expense (benefit) over pre-tax income (loss). The effective tax rate was 18% and (4)% for the three and nine months ended September 30, 2023, respectively, compared to 16% and 26%, respectively, for the corresponding periods in 2022. The effective tax rate on pre-tax income is typically lower than the prevailing corporate federal income tax rate of 21% due to benefits from preferential tax items including the separate accounts dividends-received deduction and tax credits.
For the three months ended September 30, 2023, the effective tax rate differed from the prevailing corporate federal income tax rate due primarily to the effects of preferential tax items. For the nine months ended September 30, 2023, the effective tax rate differed from the prevailing corporate federal income tax rate due primarily to the effects of preferential tax items exceeding the tax expense at 21% on pre-tax income.
For the three months ended September 30, 2022, the effective tax rate differed from the prevailing corporate federal income tax rate due primarily to a tax benefit at 21% from pre-tax losses in addition to the effects of preferential tax items. For the nine months ended September 30, 2022, the effective tax rate differed from the prevailing corporate federal income tax rate due primarily to the effects of preferential tax items.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Index to Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
|
Page |
90 |
|
91 |
|
91 |
|
92 |
|
100 |
|
102 |
|
106 |
|
111 |
|
116 |
|
121 |
|
123 |
|
135 |
The following Management’s Discussion and Analysis (“MD&A”) is intended to help the reader understand the financial condition as of September 30, 2023, compared with December 31, 2022, and the results of operations for the three and nine months ended September 30, 2023, compared with the corresponding periods in 2022 of Lincoln National Corporation and its consolidated subsidiaries. Unless otherwise stated or the context otherwise requires, “LNC,” “Company,” “we,” “our” or “us” refers to Lincoln National Corporation and its consolidated subsidiaries.
The MD&A is provided as a supplement to, and should be read in conjunction with, the consolidated financial statements and the accompanying notes to the consolidated financial statements (“Notes”) presented in “Part I – Item 1. Financial Statements”; our Annual Report on Form 10-K/A for the year ended December 31, 2022 (“2022 Form 10-K/A”), as updated by our Current Report on Form 8-K filed with the Securities and Exchange Commission (“SEC”) on May 22, 2023 (the “May 2023 Form 8-K”); and other reports filed with the SEC. For more detailed information on the risks and uncertainties associated with the Company’s business activities, see the risks described in “Part I – Item 1A. Risk Factors” in our 2022 Form 10-K/A.
On January 1, 2023, we adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2018-12, Targeted Improvements to the Accounting for Long-Duration Contracts and related amendments (“ASU 2018-12”) with a transition date of January 1, 2021. ASU 2018-12 updated accounting and reporting requirements for long-duration contracts and certain investment contracts issued by insurance entities. We adopted ASU 2018-12 under the modified retrospective approach, except for market risk benefits (“MRBs”) for which we applied the full retrospective approach. For more information, see Note 3.
FORWARD-LOOKING STATEMENTS – CAUTIONARY LANGUAGE
Certain statements made in this report and in other written or oral statements made by us or on our behalf are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (“PSLRA”). A forward-looking statement is a statement that is not a historical fact and, without limitation, includes any statement that may predict, forecast, indicate or imply future results, performance or achievements. Forward-looking statements may contain words like: “anticipate,” “believe,” “estimate,” “expect,” “project,” “shall,” “will” and other words or phrases with similar meaning in connection with a discussion of future operating or financial performance. In particular, these include statements relating to future actions, trends in our businesses, prospective services or products, future performance or financial results and the outcome of contingencies, such as legal proceedings. We claim the protection afforded by the safe harbor for forward-looking statements provided by the PSLRA.
Forward-looking statements are subject to risks and uncertainties. Actual results could differ materially from those expressed in or implied by such forward-looking statements due to a variety of factors, including:
Weak general economic and business conditions that may affect demand for our products, account balances, investment results, guaranteed benefit liabilities, premium levels and claims experience;
Adverse global capital and credit market conditions that may affect our ability to raise capital, if necessary, and may cause us to realize impairments on investments and certain intangible assets, including goodwill and the valuation allowance against deferred tax assets, which may reduce future earnings and/or affect our financial condition and ability to raise additional capital or refinance existing debt as it matures;
The inability of our subsidiaries to pay dividends to the holding company in sufficient amounts, which could harm the holding company’s ability to meet its obligations;
Legislative, regulatory or tax changes, both domestic and foreign, that affect: the cost of, or demand for, our subsidiaries’ products; the required amount of reserves and/or surplus; our ability to conduct business and our captive reinsurance arrangements as well as restrictions on the payment of revenue sharing and 12b-1 distribution fees;
The impact of U.S. federal tax reform legislation on our business, earnings and capital;
The impact of regulations adopted by the SEC, the Department of Labor or other federal or state regulators or self-regulatory organizations relating to the standard of care owed by investment advisers and/or broker-dealers that could affect our distribution model;
The impact of new and emerging privacy regulations that may lead to increased compliance costs and reputation risk;
Increasing scrutiny and evolving expectations and regulations regarding environmental, social and governance (“ESG”) matters that may adversely affect our reputation and our investment portfolio;
Actions taken by reinsurers to raise rates on in-force business;
Declines in or sustained low interest rates causing a reduction in investment income, the interest margins of our businesses and demand for our products;
Rapidly increasing interest rates causing policyholders to surrender life insurance and annuity policies, thereby causing realized investment losses;
The impact of the implementation of the provisions of the European Market Infrastructure Regulation relating to the regulation of derivatives transactions;
The initiation of legal or regulatory proceedings against us, and the outcome of any legal or regulatory proceedings, such as: adverse actions related to present or past business practices common in businesses in which we compete; adverse decisions in significant actions including, but not limited to, actions brought by federal and state authorities and class action cases; new decisions that result in changes in law; and unexpected trial court rulings; A decline or continued volatility in the equity markets causing a reduction in the sales of our subsidiaries’ products; a reduction of asset-based fees that our subsidiaries charge on various investment and insurance products; and an increase in liabilities related to guaranteed benefit riders, which are accounted for as MRBs, of our subsidiaries’ variable annuity products;
Ineffectiveness of our risk management policies and procedures, including our various hedging strategies;
A deviation in actual experience regarding future policyholder behavior, mortality, morbidity, interest rates or equity market returns from the assumptions used in pricing our subsidiaries’ products and in establishing related insurance reserves, which may reduce future earnings;
Changes in accounting principles that may affect our consolidated financial statements;
Lowering of one or more of our debt ratings issued by nationally recognized statistical rating organizations and the adverse effect such action may have on our ability to raise capital and on our liquidity and financial condition;
Lowering of one or more of the insurer financial strength ratings of our insurance subsidiaries and the adverse effect such action may have on the premium writings, policy retention, profitability of our insurance subsidiaries and liquidity;
Significant credit, accounting, fraud, corporate governance or other issues that may adversely affect the value of certain financial assets, as well as counterparties to which we are exposed to credit risk, requiring that we realize losses on financial assets;
Interruption in telecommunication, information technology or other operational systems or failure to safeguard the confidentiality or privacy of sensitive data on such systems, including from cyberattacks or other breaches of our data security systems;
The effect of acquisitions and divestitures, restructurings, product withdrawals and other unusual items;
The inability to realize or sustain the benefits we expect from, greater than expected investments in, and the potential impact of efforts related to, our strategic initiatives, including the Spark Initiative;
The adequacy and collectability of reinsurance that we have obtained;
Pandemics, acts of terrorism, war or other man-made and natural catastrophes that may adversely impact liabilities for policyholder claims, affect our businesses and increase the cost and availability of reinsurance;
Competitive conditions, including pricing pressures, new product offerings and the emergence of new competitors, that may affect the level of premiums and fees that our subsidiaries can charge for their products;
The unknown effect on our subsidiaries’ businesses resulting from evolving market preferences and the changing demographics of our client base; and
The unanticipated loss of key management, financial planners or wholesalers.
The risks and uncertainties included here are not exhaustive. Our 2022 Form 10-K/A as well as other reports that we file with the SEC include additional factors that could affect our businesses and financial performance. Moreover, we operate in a rapidly changing and competitive environment. New risk factors emerge from time to time, and it is not possible for management to predict all such risk factors.
Further, it is not possible to assess the effect of all risk factors on our businesses or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results. In addition, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances that occur after the date of this report.
INTRODUCTION
Executive Summary
We are a holding company that operates multiple insurance and retirement businesses through subsidiary companies. We sell a wide range of wealth accumulation, wealth protection, group protection and retirement income products and solutions through our four business segments:
Annuities;
Life Insurance;
Group Protection; and
Retirement Plan Services
We also have Other Operations, which includes the financial data for operations that are not directly related to the business segments. See “Part I – Item 1. Business” in our 2022 Form 10-K/A for a discussion of our business segments and products.
In this report, in addition to providing consolidated revenues and net income (loss), we also provide segment operating revenues and income (loss) from operations because we believe they are meaningful measures of revenues and the profitability of our operating segments. Operating revenues and income (loss) from operations are the financial performance measures we use to evaluate and assess the results of our segments. Accordingly, we define and report operating revenues and income (loss) from operations by segment in Note 17. Our management believes that operating revenues and income (loss) from operations explain the results of our ongoing businesses in a manner that allows for a better understanding of the underlying trends in our current businesses. Certain items are excluded from operating revenue and income (loss) from operations because they are unpredictable and not necessarily indicative of current operating fundamentals or future performance of the business segments, and, in many instances, decisions regarding these items do not necessarily relate to the operations of the individual segments.
In addition, we believe that our definitions of operating revenues and income (loss) from operations will provide investors with a more valuable measure of our performance because it better reveals trends in our businesses.
We provide information about our segments’ and Other Operations’ operating revenue and expense line items, key drivers of changes and historical details underlying the line items below. For factors that could cause actual results to differ materially from those set forth, see “Forward-Looking Statements – Cautionary Language” above and “Part I – Item 1A. Risk Factors” in our 2022 Form 10-K/A.
On May 2, 2023, we entered into a reinsurance agreement with Fortitude Reinsurance Company Ltd. (“Fortitude Re”) expected to reduce balance sheet risk, strengthen our capital position and improve free cash flow. For more information, see Note 8.
Industry trends, significant operational matters and outlook are described in “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary” of our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K.
Critical Accounting Policies and Estimates
We have identified the accounting policies below as critical to the understanding of our results of operations and our financial condition. In applying these critical accounting policies in preparing our financial statements, management must use critical assumptions, estimates and judgments concerning future results or other developments, including the likelihood, timing or amount of one or more future events. Actual results may differ from these estimates under different assumptions or conditions. On an ongoing basis, we evaluate our assumptions, estimates and judgments based upon historical experience and various other information that we believe to be reasonable under the circumstances. For a detailed discussion of other significant accounting policies, see Note 1. The following information updates the “Critical Accounting Policies and Estimates” provided in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K, and therefore, should be read in conjunction with that disclosure.
DAC, VOBA, DSI and DFEL
Deferrals
Qualifying deferrable acquisition expenses are recorded as an asset on the Consolidated Balance Sheets as deferred acquisition costs (“DAC”) for products we sold during a period or value of business acquired (“VOBA”) for books of business we acquired during a period. DAC and VOBA when amortized increase commissions and other expenses on the Consolidated Statements of Comprehensive Income (Loss). In addition, we defer costs associated with deferred sales inducements (“DSI”) and revenues associated with deferred front-end loads (“DFEL”). DSI is an asset on the Consolidated Balance Sheets, and when amortized, increases interest credited on the Consolidated Statements of Comprehensive Income (Loss). DFEL is a liability on the Consolidated Balance Sheets, and when amortized, increases fee income on the Consolidated Statements of Comprehensive Income (Loss).
We incur certain costs that can be capitalized in the acquisition of insurance contracts. Only those costs incurred that result directly from and are essential to the successful acquisition of new or renewal insurance contracts may be capitalized as deferrable acquisition costs in the period they are incurred. This determination of deferability must be made on a contract-level basis. Some examples of acquisition costs that are subject to deferral include the following:
Employee, agent or broker commissions;
Wholesaler production bonuses;
Renewal commissions and bonuses to agents or brokers;
Medical and inspection fees;
Premium-related taxes and assessments; and
A portion of the salaries and benefits of certain employees involved in the underwriting, contract issuance and processing, medical and inspection and sales force contract selling functions.
All other acquisition-related costs, including costs incurred by the insurer for soliciting potential customers, market research, training, administration, management of distribution and underwriting functions, unsuccessful acquisition or renewal efforts and product development, are considered non-deferrable acquisition costs and must be expensed in the period incurred.
In addition, the following indirect costs are considered non-deferrable acquisition costs and must be charged to expense in the period incurred:
Administrative costs;
Rent;
Depreciation;
Occupancy costs;
Equipment costs (including data processing equipment dedicated to acquiring insurance contracts);
Trail commissions; and
Other general overhead.
Amortization
The amortization of DAC, VOBA, DSI and DFEL, associated with our long-duration insurance contracts and certain investment contracts, is based on assumptions consistent with those used in the development of the underlying contract reserves adjusted for emerging experience and expected trends. The amortization basis results in a constant level amortization pattern for the expected term of the related contracts by each reportable segment. When identifying the amortization basis we consider actuarial assumptions that are inputs to the models for establishing the expected term, including but not limited to, mortality, morbidity, lapse and surrenders. During the third quarter of each year, we conduct our comprehensive review of these actuarial assumptions and update these actuarial assumptions as needed. We may update these actuarial assumptions in other quarters as we become aware of information that warrants updating outside of our annual comprehensive review. Any updates are applied prospectively.
For a discussion of the amortization basis and periods over which we amortize our DAC, VOBA, DSI and DFEL, see “DAC, VOBA, DSI and DFEL” in Note 1.
Investments
Investment Valuation
The following summarizes investments on the Consolidated Balance Sheets carried at fair value by pricing source and fair value hierarchy level (in millions) as of September 30, 2023:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prices |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Markets for |
Significant |
Significant |
|
|
|
|
|||||||||
|
|
Identical |
|
Observable |
Unobservable |
|
|
|
|
|||||||
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
Total |
|
||||
|
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Fair Value |
|
||||
Priced by third-party pricing services |
|
$ |
380 |
|
|
$ |
85,260 |
|
|
$ |
139 |
|
|
$ |
85,779 |
|
Priced by independent broker quotations |
|
|
- |
|
|
|
- |
|
|
|
4,270 |
|
|
|
4,270 |
|
Priced by matrices |
|
|
- |
|
|
|
16,310 |
|
|
|
- |
|
|
|
16,310 |
|
Priced by other methods (1) |
|
|
- |
|
|
|
- |
|
|
|
246 |
|
|
|
246 |
|
Total |
|
$ |
380 |
|
|
$ |
101,570 |
|
|
$ |
4,655 |
|
|
$ |
106,605 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent of total |
|
|
0% |
|
|
|
95% |
|
|
|
5% |
|
|
|
100% |
|
(1)Represents primarily securities for which pricing models were used to compute fair value.
For more information about the valuation of our financial instruments carried at fair value, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Critical Accounting Policies and Estimates – Investments – Investment Valuation” in our 2022 Form 10-K/A as updated by the May 2023 Form 8-K and Note 14 herein.
Derivatives
Derivatives are primarily used for hedging purposes. We hedge certain portions of our exposure to interest rate risk, foreign currency exchange risk, equity market risk, basis risk, commodity risk and credit risk by entering into derivative transactions. We also purchase and issue financial instruments that contain embedded derivative instruments. See “Policyholder Account Balances” below for information on embedded derivatives. Assessing the effectiveness of hedging and evaluating the carrying values of the related derivatives often involve a variety of assumptions and estimates.
We carry our derivative instruments at fair value, which we determine through valuation techniques or models that use market data inputs or independent broker quotations. The fair values fluctuate from period to period due to the volatility of the valuation inputs, including but not limited to swap interest rates, interest and equity volatility and equity index levels, foreign currency forward and spot rates, credit spreads and correlations, some of which are significantly affected by economic conditions.
The effect to revenue is reported in realized gain (loss) and such amount along with the associated federal income taxes is excluded from income (loss) from operations of our segments.
For more information on derivatives, see Notes 1 and 6. For more information on market exposures associated with our derivatives, including sensitivities, see “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K.
Future Contract Benefits
Future contract benefits represent liability reserves that we have established and carry based on estimates of how much we will need to pay for future benefits and claims.
Liability for Future Policy Benefits
Liability for future policy benefits (“LFPB”) represents the reserve amounts associated with non-participating traditional life insurance contracts and limited payment life-contingent annuity contracts that are calculated to meet the various policy and contract obligations as they mature. Establishing adequate reserves for our obligations to policyholders requires assumptions to be made that are intended to represent an estimation of experience for the period that policy benefits are payable. If actual experience is better than or equal to the assumptions, then reserves should be adequate to provide for future benefits and expenses. If experience is worse than the assumptions, additional reserves may be required. Significant assumptions include mortality rates, morbidity and policyholder behavior (e.g., persistency) and withdrawals. During the third quarter of each year, we conduct our comprehensive review of the actuarial assumptions to best estimate future premium and benefit cash flows (“cash flow assumptions”) and projection models used in estimating these liabilities and update these assumptions as needed (excluding the claims settlement expense assumption that is locked-in at inception) in the calculation of the net premium ratio. We may also update these assumptions in other quarters as we become aware of information that is indicative of the need for such an update. See “Annual Assumption Review” below for more information. In measuring our LFPB, we establish cohorts, which are groupings of long-duration contracts. On a quarterly basis, we retrospectively update the net premium ratio at the cohort level for actual experience. For all contract cohorts issued after January 1, 2021, interest is accrued on LFPB at the single-A interest rate on the contract cohort inception date. For contract cohorts issued prior to January 1, 2021, interest remains accruing at the original discount rate in effect on the contract cohort inception date due to the modified retrospective transition method. We also remeasure the LFPB using the single-A interest rate as of the end of each reporting period.
Liability for Future Claims
Future contract benefits include reserves for long-term life and disability claims associated with our Group Protection segment. These reserves use actuarial assumptions primarily based on claim termination rates, offsets for other insurance including social security and long-term disability incidence and severity assumptions. Such cash flow assumptions are subject to the comprehensive review process discussed above. We remeasure the liability for future claims using a single-A interest rate as of the end of each reporting period. See “Annual Assumption Review” below for more information.
Universal Life Insurance Products with Secondary Guarantees
We issue UL-type contracts where we provide a secondary guarantee to the policyholder. The policy can remain in force, even if the base policy account balance is zero, as long as contractual secondary guarantee requirements have been met. These guaranteed benefits require an additional liability that is calculated based on the application of a benefit ratio (calculated as the present value of total expected benefit payments over the life of the contract from inception divided by the present value of total expected assessments over the life of the contract). These secondary guarantees are reported within future contract benefits on the Consolidated Balance Sheets. The level and direction of the change in reserves will vary over time based on the emergence of the benefit ratio and the level of assessments associated with the contracts. Cash flow assumptions incorporated in a benefit ratio in measuring these additional liabilities for other insurance benefits include mortality rates, morbidity, policyholder behavior (e.g., persistency) and withdrawals based principally on generally accepted actuarial methods and assumptions. During the third quarter of each year, we conduct our comprehensive review of the cash flow assumptions and projection models used in estimating these liabilities and update these assumptions in the calculation of the benefit ratio. We may also update these assumptions in other quarters as we become aware of information that is indicative of the need for such an update. See “Annual Assumption Review” below for more information.
For additional information on future contract benefits, see Note 13.
Market Risk Benefits
MRBs are contracts or contract features that provide protection to the policyholder from other-than-nominal capital market risk and expose us to other-than-nominal capital market risk upon the occurrence of a specific event or circumstance, such as death, annuitization or period withdrawal. An MRB can be in either an asset or a liability position. Our MRB assets and MRB liabilities are reported at fair value separately on the Consolidated Balance Sheet.
We issue variable and fixed annuity contracts that may include various types of guaranteed living benefit (“GLB”) and guaranteed death benefit (“GDB”) riders that we have accounted for as MRBs. For contracts that contain multiple riders that qualify as MRBs, the MRBs are valued on a combined basis using an integrated model. We have entered into reinsurance agreements to cede certain GLB and GDB riders where the reinsurance agreements themselves are accounted for as MRBs or contain MRBs. We therefore record ceded MRB assets and ceded MRB liabilities associated with these reinsurance agreements. We report ceded MRBs associated with these reinsurance agreements in other assets or other liabilities on the Consolidated Balance Sheets.
Net amount at risk (“NAR”) represents the amount of GLB or GDB in excess of a policyholder’s account balance at the balance sheet date. Underperforming markets increase our exposure to potential benefits with the GLB and GDB riders. A contract with a GDB rider is “in the money” if the policyholder’s account balance falls below the GDB. As of September 30, 2023 and 2022, 27% and 33%, respectively, of all in-force contracts with a GDB rider were “in the money.” A contract with a GLB rider is “in the money” if the policyholder’s account balance falls below the present value of GLB payments, assuming no full surrenders. As of September 30, 2023 and 2022, 33% and 72%, respectively, of all in-force contracts with a GLB rider were “in the money.” However, the only way the policyholder can realize the excess of the present value of benefits over the account balance of the contract is through a series of withdrawals or income payments that do not exceed a maximum amount. If, after the series of withdrawals or income payments, the account balance is exhausted, the policyholder will continue to receive a series of annuity payments. The account balance can also fluctuate with market returns on a daily basis resulting in increases or decreases in the excess of the present value of benefits over account balance.
Many policyholders have both a GLB or GDB present on the same policy. The total NAR represents the greater of GLB NAR and GDB NAR for each policy as only one benefit can be exercised in practice. Details underlying the NAR, net of reinsurance, (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Annuities |
|
Retirement Plan Services |
|
|
||||||||
|
As of September 30, |
|
As of September 30, |
|
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GLB NAR |
$ |
2,929 |
|
$ |
4,803 |
|
$ |
2 |
|
$ |
5 |
|
|
GDB NAR |
|
3,696 |
|
|
6,729 |
|
|
7 |
|
|
23 |
|
|
Total NAR |
|
6,256 |
|
|
10,618 |
|
|
9 |
|
|
27 |
|
|
Change in the fair value of MRB assets and liabilities is reported in market risk benefit gain (loss) in the Consolidated Statements of Comprehensive Income (Loss), except for the portion attributable to the change in non-performance risk, which is recognized in OCI. Change in the fair value of ceded MRB assets and liabilities, including the changes in our counterparties’ non-performance risks, is reported in market risk benefit gain (loss) in the Consolidated Statements of Comprehensive Income (Loss).
MRBs are valued based on a stochastic projection of risk-neutral scenarios that incorporate a spread reflecting our non-performance risk. Ceded MRBs are valued based on a stochastic projection of risk-neutral scenarios that incorporate a spread reflecting our counterparties’ non-performance risk. The scenario assumptions, at each valuation date, are those we view to be appropriate for a hypothetical market participant and include assumptions for capital markets, lapse, benefit utilization, mortality, risk margin and administrative expenses. These assumptions are based on a combination of historical data and actuarial judgments. The assumption for our own non-performance risk and our counterparties’ non-performance risk for MRBs and ceded MRBs, respectively, are determined at each valuation date and reflect our risk and our counterparties’ risks of not fulfilling the obligations of the underlying liability. The spread for the non-performance risk is added to the discount rates used in determining the fair value from the net cash flows. We believe these assumptions are consistent with those that would be used by a market participant; however, as the related markets develop, we will continue to reassess our assumptions. During the third quarter of each year, we conduct our comprehensive review of the assumptions used in calculating the fair value of these MRBs and update these assumptions on a prospective basis as needed. We may also update these assumptions in other quarters as we become aware of information that is indicative of the need for such an update. For information on fair value inputs, see Note 14. See “Annual Assumption Review” below for more information.
For illustrative purposes, the following presents hypothetical effects to MRBs attributable to changes to key assumptions / inputs, assuming all other factors remain constant:
|
|
|
|
|
|
|
|
|
|
|
|
|
Hypothetical |
|
Hypothetical |
|
|
|
|
Actual |
|
Effect |
|
Effect |
|
|
Assumption / Input |
|
Experience |
|
to MRB Liability |
|
to Net Income |
|
Description of Assumption / Input |
Equity market return |
|
Increase / (Decrease) |
|
(Decrease) / Increase |
|
Increase / (Decrease) |
|
Equity market return input represents impact based on movements in equity markets. |
|
|
|
|
|
|
|
|
|
Interest rate |
|
Higher / Lower |
|
(Decrease) / Increase |
|
Increase / (Decrease) |
|
Interest rate input represents impact based on movements in interest rates and impact to fixed-income assets. |
|
|
|
|
|
|
|
|
|
Volatility |
|
Increase / (Decrease) |
|
Increase / (Decrease) |
|
(Decrease) / Increase |
|
Volatility assumption represents overall volatilities assumed for the underlying variable annuity funds, which include a mixture of equity and fixed-income assets. Volatility assumptions vary by fund due to the benchmarking of difference indices. |
|
|
|
|
|
|
|
|
|
Mortality |
|
Increase / (Decrease) |
|
(Decrease) / Increase |
|
Increase / (Decrease) |
|
Mortality represents the estimated probability of when an individual belonging to a particular group, categorized according to age or some other factor such as gender, will die. |
|
|
|
|
|
|
|
|
|
Mortality contracts with only GDB rider |
|
Increase / (Decrease) |
|
Increase / (Decrease) |
|
(Decrease) / Increase |
|
Mortality represents the estimated probability of when an individual belonging to a particular group, categorized according to age or some other factor such as gender, will die. |
|
|
|
|
|
|
|
|
|
Lapse |
|
Higher / Lower |
|
(Decrease) / Increase |
|
Increase / (Decrease) |
|
Lapse assumption represents the estimated probability of a contract surrendering during a year, thereby forgoing any future benefits. |
|
|
|
|
|
|
|
|
|
Benefit utilization |
|
Higher / Lower |
|
Increase / (Decrease) |
|
(Decrease) / Increase |
|
Benefit utilization assumption of guaranteed withdrawals represents the estimated percentage of policyholders that utilize the guaranteed withdrawal feature. |
We use derivative instruments to hedge our exposure to selected risk caused by changes in equity markets and interest rates associated with GLB and GDB riders that are available in our variable annuity products and accounted for as MRBs. Effective January 1, 2023, we revised our hedge program that continues to focus on generating sufficient assets to fund future claims with a goal of maximizing distributable earnings and explicitly protecting capital. We utilize options and total return swaps on U.S.-based equity indices, and futures on U.S.-based and international equity indices, as well as interest rate futures, interest rate swaps and currency futures. For additional information on our derivatives, see Note 6.
As part of our hedge program, equity market and interest rate conditions are monitored on a daily basis. We rebalance our hedge positions based upon changes in these factors as needed. While we actively manage our hedge positions, these positions may not completely offset changes in the fair value of our GLB and GDB riders caused by movements in these factors due to, among other things, differences in timing between when a market exposure changes and corresponding changes to the hedge positions, extreme swings in the equity markets, interest rates and market-implied volatilities, realized market volatility, policyholder behavior, divergence between the performance of the underlying funds and the hedging indices, divergence between the actual and expected performance of the hedge instruments or our ability to purchase hedging instruments at prices consistent with our desired risk and return trade-off.
The following table presents our after-tax estimates of the potential instantaneous effect to net income (loss) that could result from sudden changes that may occur in equity markets and interest rates (in millions) and excludes the net cost of operating the hedge program. The amounts represent the difference between the change in GLB and GDB riders and the change in the fair value of the underlying hedge instruments. These estimates are based upon the balance as of September 30, 2023, net of reinsurance, and the related hedge instruments in place as of that date.
The effects presented in the table below are not representative of the aggregate impacts that could result if a combination of such changes to equity market returns and interest rates occurred.
|
|
|
|
|
|
|
|
|
In Force Sensitivities |
|
|||
Equity Market Return |
|
-10% |
|
|
+10% |
|
Hypothetical effect to net income |
$ |
(525 |
) |
$ |
500 |
|
|
|
|
|
|
|
|
Interest Rates |
|
-25 bps |
|
|
+25 bps |
|
Hypothetical effect to net income |
|
(425 |
) |
|
400 |
|
The actual effects of the results illustrated in the table above could vary significantly depending on a variety of factors, many of which are out of our control, and consideration should be given to the following:
The analysis is only valid as of September 30, 2023, due to changing market conditions, policyholder activity, hedge positions and other factors;
The analysis assumes instantaneous shifts in the capital market factors and no ability to rebalance hedge positions prior to the market changes;
The analysis assumes constant exchange rates and implied dividend yields;
Assumptions regarding shifts in the market factors, such as assuming parallel shifts in interest rates, may be overly simplistic and not indicative of actual market behavior in stress scenarios;
It is very unlikely that one capital market sector (e.g., equity markets) will sustain such a large instantaneous movement without affecting other capital market sectors; and
The analysis assumes that there is no tracking or basis risk between the funds and/or indices affecting the GLB and GDB riders and the instruments utilized to hedge these exposures.
For additional information on MRBs, see Note 10.
Policyholder Account Balances
Policyholder account balances include the contract value that has accrued to the benefit of the policyholder as of the balance sheet date. This liability includes UL and VUL and investment-type annuity products where account balances are equal to deposits plus interest credited less withdrawals, surrender charges, asset-based fees and policyholder administration charges (collectively known as “policyholder assessments”), as well as amounts representing the fair value of embedded derivative instruments associated with our IUL and indexed annuity products. During the third quarter of each year, we conduct our comprehensive review of the assumptions and projection models underlying our reserves and embedded derivatives and update assumptions as needed. We may also update these assumptions in other quarters as we become aware of information that is indicative of the need for such an update. See “Annual Assumption Review” below for more information.
Our indexed annuity and IUL contracts permit the holder to elect a fixed interest rate return or a return where interest credited to the contracts is linked to the performance of the S&P 500® Index or other indices. The value of the variable portion of the policyholder’s account balance varies with the performance of the underlying variable funds chosen by the policyholder. Policyholders may elect to rebalance among the various accounts within the product at renewal dates. At the end of each indexed term, which can be up to six years, we have the opportunity to re-price the indexed component by establishing different participation rates, caps, spreads or specified rates, subject to contractual guarantees. We purchase and sell index options that are highly correlated to the portfolio allocation decisions of our policyholders, such that we are economically hedged with respect to equity returns for the current reset period. The mark-to-market of the options held generally offsets the change in value of the embedded derivative within the contract, both of which are recorded as a component of realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss). The Derivatives and Hedging and the Fair Value Measurements and Disclosures Topics of the FASB ASC require that we calculate fair values of index options we may purchase or sell in the future to hedge policyholder index allocations in future reset periods. These fair values represent an estimate of the cost of the options we will purchase or sell in the future, discounted back to the date of the balance sheet, using current market indicators of volatility and interest rates. Changes in the fair values of these liabilities are included as a component of realized gain (loss) on the Consolidated Statements of Comprehensive Income (Loss). For more information on indexed product net derivative results, see Note 17.
For additional information on the liability for policyholder account balances, see Note 12.
Annual Assumption Review
During the third quarter of each year, we conduct our comprehensive review of the assumptions and projection models used in estimating DAC, VOBA, DSI, DFEL, MRBs, reserves and embedded derivatives. For more information on our comprehensive review, see Note 1.
Details underlying the effect to net income (loss) from our annual assumption review (in millions) were as follows:
|
|
|
|
|
|
|
|
|
For the Three |
|
|
||||
|
Months Ended |
|
|
||||
|
September 30, |
|
|
||||
|
2023 |
|
2022 |
|
|
||
Income (loss) from operations: |
|
|
|
|
|
|
|
Annuities |
$ |
(12 |
) |
$ |
1 |
|
|
Life Insurance |
|
(156 |
) |
|
(2,107 |
) |
|
Group Protection |
|
24 |
|
|
(12 |
) |
|
Retirement Plan Services |
|
- |
|
|
- |
|
|
Excluded from income (loss) from operations |
|
(36 |
) |
|
74 |
|
|
Net income (loss) |
$ |
(180 |
) |
$ |
(2,044 |
) |
|
The impacts of our annual assumption review were driven primarily by the following:
2023
For Annuities, the unfavorable impact was driven by updates to mortality assumptions.
For Life Insurance, the unfavorable impact was driven by updates to policyholder lapse behavior and mortality assumptions, partially offset by the favorable impact of a 50 basis points increase in our long-term new money investment yield assumption.
For Group Protection, the favorable impact was driven by updates to long-term disability and life waiver claim termination rate assumptions, partially offset by the unfavorable impact due to updates to long-term disability social security offset assumptions.
For excluded from income (loss) from operations, the unfavorable impact, related to net annuity product features, was driven by updates to mortality and policyholder lapse behavior assumptions and other items, partially offset by a favorable impact from updates to volatility and policyholder GLB utilization behavior assumptions.
2022
For Life Insurance, the unfavorable impact was driven by updates to the policyholder lapse behavior assumptions related to UL products with secondary guarantees in the amount of $1.9 billion, after-tax, as well as updates to mortality and morbidity assumptions and other items.
For Group Protection, the unfavorable impact was driven by updates to long-term disability incidence and severity assumptions, partially offset by the favorable impact of updates to life waiver termination assumptions.
For excluded from income (loss) from operations, the favorable impact, related to net annuity product features, was driven by updates to policyholder benefit utilization behavior and fund mapping and volatility assumptions, partially offset by an unfavorable impact from updates to policyholder lapse behavior assumptions related to UL products with secondary guarantees that impacted ceded reserves.
Goodwill
Goodwill is not amortized, but is reviewed for impairment annually as of October 1 and more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value.
The fair values of our reporting units are comprised of the value of in-force (i.e., existing) business and the value of new business. Specifically, new business is representative of cash flows and profitability associated with policies or contracts we expect to issue in the future, reflecting our forecasts of future sales volume and product mix over a 10-year period. To determine the values of in-force and new business, we use a discounted cash flows technique that applies a discount rate reflecting the market expected, weighted-average rate of return adjusted for the risk factors associated with operations to the projected future cash flows for each reporting unit.
We apply significant judgment when determining the estimated fair value of our reporting units. Factors that can influence the value of goodwill include capital markets, competitive landscape, regulatory environment, consumer confidence and any items that can directly or indirectly affect new business future cash flows. Factors that could affect production levels and profitability of new business include mix of new business, pricing changes, customer acceptance of our products and distribution strength. Spread compression and related effects to profitability caused by lower interest rates affect the valuation of in-force business more significantly than the valuation of new business, as new business pricing assumptions reflect the current and anticipated future interest rate environment. Estimates of fair value are inherently uncertain and represent only management’s reasonable expectation regarding future developments.
In the third quarter of 2022, as a result of the capital market environment, including (i) declining equity markets and (ii) the impact of rising interest rates on our discount rate assumption, we accelerated our quantitative goodwill impairment test for our Life Insurance reporting unit as we concluded that there were indicators of impairment. Based on this quantitative test, which included updating our best estimate assumptions therein, we incurred an impairment during the third quarter of 2022 of the Life Insurance reporting unit goodwill of $634 million, which represented the write-off of the entire balance of goodwill for the reporting unit.
We concluded that, for the third quarter of 2022, there were not indicators of impairment for our remaining reporting units (Annuities, Group Protection and Retirement Plan Services). As of October 1, 2022, we performed our annual quantitative goodwill impairment test for our other reporting units, and, as of such date, the fair value was in excess of the carrying value for each of the Annuities, Group Protection and Retirement Plan Services reporting units.
During the fourth quarter of 2023, we will perform our annual quantitative goodwill impairment test as of October 1, 2023, on all of our reporting units.
For more information on goodwill, see Notes 1 and 9 herein and “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Critical Accounting Policies and Estimates – Goodwill and Other Intangible Assets” and Note 9 in our 2022 Form 10-K/A.
Income Taxes
Management uses certain assumptions and estimates in determining the income taxes payable or refundable for the current year, the deferred income tax assets and liabilities for items recognized differently in its financial statements from amounts shown on its income tax returns and the federal income tax expense. Determining these amounts requires analysis and interpretation of current tax laws and regulations. Management exercises judgment in evaluating the amount and timing of recognition of the resulting income tax assets and liabilities. These judgments and estimates are re-evaluated on a continual basis as regulatory and business factors change. Legislative changes to the Internal Revenue Code of 1986, as amended, modifications or new regulations, administrative rulings, or court decisions could increase or decrease our effective tax rate.
The application of GAAP requires us to evaluate the recoverability of our deferred tax assets and establish a valuation allowance, if necessary, to reduce our deferred tax asset to an amount that is more likely than not to be realizable. Judgment and the use of estimates are required in determining whether a valuation allowance is necessary, and if so, the amount of such valuation allowance. In evaluating the need for a valuation allowance, we consider many factors, including: the nature and character of the deferred tax assets and liabilities; taxable income in prior carryback years; future reversals of existing temporary differences; the length of time carryovers can be utilized; and any future prudent and feasible tax planning strategies.
As of September 30, 2023, we had an approximate $2.1 billion deferred tax asset related to net unrealized losses on fixed maturity available-for-sale (“AFS”) securities. In the assessment of the future realizability of this deferred tax asset, management concluded that its tax planning strategy to hold these securities to recovery was prudent and feasible as these unrealized losses were caused by factors other than credit loss, and we have the intent and ability to hold these securities to recovery and collect all of the contractual cash flows. As of September 30, 2023, we had an approximate $840 million deferred tax asset related to the portfolio of investments anticipated to be sold in the Fortitude Re reinsurance transaction. See “Results of Consolidated Operations – Additional Information” below and Notes 4 and 8 for additional information. In the assessment of the future realizability of this deferred tax asset, management considered future tax planning strategies, including sales of certain appreciated fixed maturity securities, sales of certain investments in limited partnerships, sales of certain corporate assets and other investment management strategies. Such tax planning strategies are viewed by management as prudent and feasible, and one or a combination of these strategies may be implemented if necessary to realize the deferred tax asset.
We may experience an increased likelihood of recording a valuation allowance in the future based on the following factors:
Adverse global capital and credit market conditions that may impact the value of appreciated securities and the sale of certain corporate assets; and
Legislative, regulatory or tax changes that may impact the sale of certain corporate assets.
Additionally, as of September 30, 2023, we had a $257 million deferred tax asset related to net operating loss carryforwards and a $132 million deferred tax asset related to credit carryforwards that can be used to offset taxable income in future periods and reduce our income taxes payable in those future periods. The net operating loss carryforwards do not expire and can be carried forward indefinitely. The credit carryforwards expire in 10 and 20 years for foreign tax credits and general business credits, respectively.
Although realization is not assured, management believes it is more likely than not that the deferred tax assets, will be realized.
For risks related to establishing a valuation allowance against our deferred tax assets, see “Part I–Item1A. Risk Factors – Assumptions and Estimates – We may be required to recognize an impairment of our goodwill or to establish a valuation allowance against our deferred tax assets” in our 2022 Form 10-K/A.
For additional information on income taxes, see Note 19.
RESULTS OF CONSOLIDATED OPERATIONS
Details underlying the consolidated results (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Net Income (Loss) |
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from operations: |
|
|
|
|
|
|
|
|
|
|
|
|
Annuities |
$ |
248 |
|
$ |
275 |
|
$ |
794 |
|
$ |
886 |
|
Life Insurance |
|
(173 |
) |
|
(2,171 |
) |
|
(153 |
) |
|
(2,085 |
) |
Group Protection |
|
68 |
|
|
12 |
|
|
247 |
|
|
15 |
|
Retirement Plan Services |
|
43 |
|
|
47 |
|
|
133 |
|
|
159 |
|
Other Operations |
|
(113 |
) |
|
(112 |
) |
|
(306 |
) |
|
(276 |
) |
Net annuity product features, after-tax |
|
1,045 |
|
|
893 |
|
|
850 |
|
|
2,591 |
|
Net life insurance product features, after-tax |
|
85 |
|
|
20 |
|
|
(133 |
) |
|
16 |
|
Credit loss-related adjustments, after-tax |
|
(21 |
) |
|
(104 |
) |
|
(41 |
) |
|
(96 |
) |
Investment gains (losses), after-tax |
|
(306 |
) |
|
10 |
|
|
(880 |
) |
|
5 |
|
Changes in the fair value of reinsurance-related |
|
|
|
|
|
|
|
|
|
|
|
|
embedded derivatives, trading securities and |
|
|
|
|
|
|
|
|
|
|
|
|
certain mortgage loans, after-tax |
|
(23 |
) |
|
(12 |
) |
|
(21 |
) |
|
(36 |
) |
Impairment of intangibles |
|
- |
|
|
(634 |
) |
|
- |
|
|
(634 |
) |
Transaction and integration costs related to mergers, |
|
|
|
|
|
|
|
|
|
|
|
|
acquisitions and divestitures, after-tax |
|
- |
|
|
- |
|
|
(7 |
) |
|
- |
|
Net income (loss) |
$ |
853 |
|
$ |
(1,776 |
) |
$ |
483 |
|
$ |
545 |
|
Comparison of the Three Months Ended September 30, 2023 to 2022
Net income increased due primarily to the following:
Less unfavorable impact from our annual assumption review.
Goodwill impairment in 2022 in our Life Insurance segment.
Higher gain in net annuity product features driven by favorable MRB-related impacts attributable to the impact of capital markets.
Investment income on alternative investments in 2023 compared to negative performance on alternative investments in 2022.
Lower total loss ratio in our Group Protection segment.
The increase in net income was partially offset by investment losses in 2023 compared to investment gains in 2022 driven primarily by a $369 million after-tax impairment on fixed maturity AFS securities in an unrealized loss position, resulting from our intent to sell these securities as part of the Fortitude Re reinsurance transaction.
Comparison of the Nine Months Ended September 30, 2023 to 2022
Net income decreased due primarily to the following:
Lower gain in net annuity product features driven by unfavorable changes in the fair value of GLB and GDB hedge instruments in 2023 compared to favorable changes in 2022 attributable to the impact of capital markets, partially offset by higher gains in MRB-related impacts due to the impact of capital markets.
Investment losses in 2023 compared to investment gains in 2022 driven by an $862 million after-tax impairment on fixed maturity AFS securities in an unrealized loss position, resulting from our intent to sell these securities as part of the Fortitude Re reinsurance transaction.
Loss in net life insurance product features in 2023 compared to gain in 2022 driven by mark-to-market losses on hedges associated with VUL products.
Higher compensation-related expenses and other costs pertaining to business operations.
The decrease in net income was partially offset by the following:
Less unfavorable impact from our annual assumption review.
Goodwill impairment in 2022 in our Life Insurance segment.
Lower total loss ratio in our Group Protection segment.
Additional Information
Within the investment portfolio anticipated to be sold in the Fortitude Re reinsurance transaction discussed above, there are additional fixed maturity AFS securities in an unrealized gain position of approximately $164 million after-tax as of September 30, 2023. Pursuant to the applicable accounting guidance, the Company impaired the securities in a loss position down to fair market value upon entry into the agreement in the second quarter and recognized additional impairment of certain of these securities during the third quarter due to market fluctuations. The Company will recognize a gain for any securities in an unrealized gain position at the time when the transaction closes. For more information on the Fortitude Re reinsurance transaction, see Notes 4 and 8.
For a discussion of the goodwill impairment, see “Introduction – Critical Accounting Policies and Estimates – Goodwill” above.
RESULTS OF ANNUITIES
Income (Loss) from Operations
Details underlying the results for Annuities (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Operating Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
Insurance premiums (1) |
$ |
24 |
|
$ |
57 |
|
$ |
116 |
|
$ |
112 |
|
Fee income |
|
557 |
|
|
574 |
|
|
1,644 |
|
|
1,791 |
|
Net investment income |
|
451 |
|
|
348 |
|
|
1,309 |
|
|
1,075 |
|
Amortization of deferred gain on |
|
|
|
|
|
|
|
|
|
|
|
|
business sold through reinsurance |
|
11 |
|
|
6 |
|
|
22 |
|
|
19 |
|
Other revenues (2) |
|
154 |
|
|
128 |
|
|
437 |
|
|
359 |
|
Total operating revenues |
|
1,197 |
|
|
1,113 |
|
|
3,528 |
|
|
3,356 |
|
Operating Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
Benefits (1) |
|
45 |
|
|
79 |
|
|
177 |
|
|
179 |
|
Interest credited |
|
330 |
|
|
224 |
|
|
914 |
|
|
646 |
|
Policyholder liability remeasurement |
|
|
|
|
|
|
|
|
|
|
|
|
(gain) loss |
|
19 |
|
|
1 |
|
|
17 |
|
|
3 |
|
Commissions and other expenses |
|
521 |
|
|
496 |
|
|
1,528 |
|
|
1,501 |
|
Total operating expenses |
|
915 |
|
|
800 |
|
|
2,636 |
|
|
2,329 |
|
Income (loss) from operations before taxes |
|
282 |
|
|
313 |
|
|
892 |
|
|
1,027 |
|
Federal income tax expense (benefit) |
|
34 |
|
|
38 |
|
|
98 |
|
|
141 |
|
Income (loss) from operations |
$ |
248 |
|
$ |
275 |
|
$ |
794 |
|
$ |
886 |
|
(1)Insurance premiums include primarily our income annuities that have a corresponding offset in benefits. Benefits include primarily changes in income annuity reserves driven by insurance premiums.
(2)Consists primarily of revenues attributable to broker-dealer services, which are subject to market volatility and the net settlement related to certain reinsurance transactions, which has a corresponding offset in net investment income and interest credited.
Comparison of the Three Months Ended September 30, 2023 to 2022
Income from operations for this segment decreased due primarily to the following:
Higher commissions and other expenses driven by higher compensation-related expenses and other costs pertaining to business operations.
Higher policyholder liability remeasurement loss driven by the impact from our annual assumption review.
Lower fee income driven by higher fees allocated to support the cost of hedging GLB and GDB riders.
Comparison of the Nine Months Ended September 30, 2023 to 2022
Income from operations for this segment decreased due primarily to the following:
Lower fee income driven by lower average daily variable account balances.
Lower net investment income, net of interest credited, driven by lower prepayment and bond make-whole premiums.
Higher commissions and other expenses driven by higher compensation-related expenses and other costs pertaining to business operations.
Higher policyholder liability remeasurement loss driven by the impact from our annual assumption review.
The decrease in income from operations was partially offset by lower federal income tax expense due to a more favorable tax return true-up driven by the separate account dividends-received deduction.
See “Critical Accounting Policies and Estimates – Annual Assumption Review” above for information on the impacts from our annual assumption review.
Additional Information
We expect an ongoing increase in income from operations in future quarters of approximately $5 million per quarter upon the closing of the reinsurance transaction announced in the second quarter of 2023. See Note 8 for more information on the transaction, which is expected to advance the Company’s enterprise strategic objectives by reducing balance sheet risk, strengthening our capital position and improving free cash flow.
New deposits are an important component of net flows and key to our efforts to grow our business. Although deposits do not significantly affect current period income from operations, they can significantly impact future income from operations.
The other component of net flows relates to the retention of new business and account balances. An important measure of retention is the reduction in account balances caused by full surrenders, deaths and other contract benefits. These outflows as a percentage of average gross account balances were 9% for the three and nine months ended September 30, 2023, and 7% for the corresponding periods in 2022. Our outflow rate increase in 2023 is due primarily to an increase in full surrenders as a result of the increased interest rate environment.
Our fixed annuities and indexed variable annuities, also referred to as registered index-linked annuities, have discretionary fixed and indexed crediting rates that reset on an annual or periodic basis and may be subject to surrender charges. Our ability to retain these annuities will be subject to current competitive conditions at the time crediting rates for these products reset. We expect to manage the effects of spreads on near-term income from operations through portfolio management and, to a lesser extent, crediting rate actions, which assumes no significant changes in net flows or other changes that may cause interest rate spreads to differ from our expectations. For information on interest rate spreads and interest rate risk, see “Part I – Item 1A. Risk Factors – Market Conditions – Changes in interest rates and sustained low interest rates may cause interest rate spreads to decrease, impacting our profitability, and make it more challenging to meet certain statutory requirements” and “Part I – Item 1A. Risk Factors – Market Conditions – Increases in interest rates may negatively affect our profitability, capital position and the value of our investment portfolio and may also result in increased contract withdrawals” in our 2022 Form 10-K/A; and “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk” in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K and “Item 3. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk” below. For information on the interest rate environment, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary” in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K.
Fee Income
Details underlying fee income (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Fee Income |
|
|
|
|
|
|
|
|
|
|
|
|
Mortality, expense and other assessments (1) |
$ |
543 |
|
$ |
566 |
|
$ |
1,607 |
|
$ |
1,769 |
|
Surrender charges |
|
12 |
|
|
6 |
|
|
32 |
|
|
18 |
|
DFEL: |
|
|
|
|
|
|
|
|
|
|
|
|
Deferrals |
|
(5 |
) |
|
(5 |
) |
|
(15 |
) |
|
(17 |
) |
Amortization |
|
7 |
|
|
7 |
|
|
20 |
|
|
21 |
|
Total fee income |
$ |
557 |
|
$ |
574 |
|
$ |
1,644 |
|
$ |
1,791 |
|
(1)Presented net of GLB and GDB hedge allowance.
We charge policyholders mortality and expense assessments on variable annuity accounts to cover insurance and administrative expenses. These assessments are a function of the rates priced into the product and the average daily variable account balances. Average daily variable account balances are driven by net flows and variable fund returns. Charges on GLB riders are assessed based on a contractual rate that is applied either to the account balance or the guaranteed amount. We allocate a portion of these fees to support the cost of hedging GLB and GDB riders. For more information, see Note 17. We may collect surrender charges when our fixed and variable annuity policyholders surrender their contracts during the surrender charge period to protect us from premature withdrawals.
Net Investment Income and Interest Credited
Details underlying net investment income and interest credited (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Net Investment Income |
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities, mortgage loans on |
|
|
|
|
|
|
|
|
|
|
|
|
real estate and other, net of investment expenses |
$ |
416 |
|
$ |
321 |
|
$ |
1,206 |
|
$ |
948 |
|
Commercial mortgage loan prepayment and bond |
|
|
|
|
|
|
|
|
|
|
|
|
make-whole premiums (1) |
|
- |
|
|
1 |
|
|
1 |
|
|
30 |
|
Surplus investments (2) |
|
34 |
|
|
26 |
|
|
99 |
|
|
97 |
|
Net investment income pertaining to broker-dealer services |
|
1 |
|
|
- |
|
|
3 |
|
|
- |
|
Total net investment income |
$ |
451 |
|
$ |
348 |
|
$ |
1,309 |
|
$ |
1,075 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Credited |
|
|
|
|
|
|
|
|
|
|
|
|
Amount provided to policyholders |
$ |
328 |
|
$ |
220 |
|
$ |
906 |
|
$ |
635 |
|
DSI deferrals |
|
(2 |
) |
|
- |
|
|
(3 |
) |
|
(1 |
) |
Interest credited before DSI amortization |
|
326 |
|
|
220 |
|
|
903 |
|
|
634 |
|
DSI amortization |
|
4 |
|
|
4 |
|
|
11 |
|
|
12 |
|
Total interest credited |
$ |
330 |
|
$ |
224 |
|
$ |
914 |
|
$ |
646 |
|
(1)See “Consolidated Investments – Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.
(2)Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities. See “Consolidated Investments – Alternative Investments” below for more information on alternative investments.
A portion of our investment income earned is credited to the policyholders of our deferred fixed annuity products, including the fixed portion of variable annuity contracts. We expect to earn a spread between what we earn on the underlying general account investments supporting the fixed annuity product line, including the fixed portion of variable annuity contracts, and what we credit to our fixed annuity policyholders’ accounts, including the fixed portion of variable annuity contracts. Changes in commercial mortgage loan prepayments and bond make-whole premiums, investment income on alternative investments and surplus investment income can vary significantly from period to period due to a number of factors and, therefore, may contribute to investment income results that are not indicative of the underlying trends.
Account Balances
Details underlying account balances (dollars in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of or For the Three |
|
As of or For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Variable Annuity Account Balance Information (1) |
|
|
|
|
|
|
|
|
|
|
|
|
Variable annuity deposits |
$ |
769 |
|
$ |
727 |
|
$ |
2,137 |
|
$ |
2,728 |
|
Variable annuity net flows |
|
(1,718 |
) |
|
(1,459 |
) |
|
(5,265 |
) |
|
(4,318 |
) |
Variable annuity account balances |
|
105,193 |
|
|
101,906 |
|
|
105,193 |
|
|
101,906 |
|
Average daily variable annuity account balances |
|
109,765 |
|
|
110,275 |
|
|
108,840 |
|
|
117,893 |
|
Average daily S&P 500® Index (2) |
|
4,456 |
|
|
3,983 |
|
|
4,222 |
|
|
4,185 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed Annuity Account Balance Information (3) |
|
|
|
|
|
|
|
|
|
|
|
|
Fixed annuity deposits |
$ |
1,968 |
|
$ |
2,505 |
|
$ |
6,324 |
|
$ |
5,907 |
|
Fixed annuity net flows |
|
845 |
|
|
1,781 |
|
|
2,953 |
|
|
3,829 |
|
Fixed annuity account balances (4) |
|
41,458 |
|
|
34,681 |
|
|
41,458 |
|
|
34,681 |
|
Average fixed annuity account balances (4) |
|
41,547 |
|
|
34,583 |
|
|
39,773 |
|
|
34,115 |
|
(1)Excludes the fixed portion of variable annuities.
(2)We generally use the S&P 500® Index as a benchmark for the performance of our variable account balances. The account balances of our variable annuity contracts are invested by our policyholders in a variety of investment options including, but not limited to, domestic and international equity securities and fixed income, which do not necessarily align with S&P 500 Index performance.
(3)Includes the fixed portion of variable annuities.
(4)Net of reinsurance.
Commissions and Other Expenses
Details underlying commissions and other expenses (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Commissions and Other Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
Commissions: |
|
|
|
|
|
|
|
|
|
|
|
|
Deferrable |
$ |
86 |
|
$ |
103 |
|
$ |
259 |
|
$ |
302 |
|
Non-deferrable |
|
152 |
|
|
151 |
|
|
460 |
|
|
475 |
|
General and administrative expenses |
|
124 |
|
|
107 |
|
|
353 |
|
|
306 |
|
Expenses associated with reserve financing |
|
|
|
|
|
|
|
|
|
|
|
|
and LOC expenses |
|
3 |
|
|
1 |
|
|
9 |
|
|
3 |
|
Taxes, licenses and fees |
|
14 |
|
|
9 |
|
|
31 |
|
|
29 |
|
Total expenses incurred, excluding broker-dealer |
|
379 |
|
|
371 |
|
|
1,112 |
|
|
1,115 |
|
DAC deferrals |
|
(102 |
) |
|
(117 |
) |
|
(300 |
) |
|
(346 |
) |
Total pre-broker-dealer expenses incurred, |
|
|
|
|
|
|
|
|
|
|
|
|
excluding amortization |
|
277 |
|
|
254 |
|
|
812 |
|
|
769 |
|
DAC and VOBA amortization: |
|
|
|
|
|
|
|
|
|
|
|
|
Amortization |
|
111 |
|
|
109 |
|
|
326 |
|
|
323 |
|
Impact from annual assumption review |
|
(2 |
) |
|
(1 |
) |
|
(2 |
) |
|
(1 |
) |
Broker-dealer expenses incurred |
|
135 |
|
|
134 |
|
|
392 |
|
|
410 |
|
Total commissions and other expenses |
$ |
521 |
|
$ |
496 |
|
$ |
1,528 |
|
$ |
1,501 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DAC Deferrals |
|
|
|
|
|
|
|
|
|
|
|
|
As a percentage of sales/deposits |
|
3.7% |
|
|
3.6% |
|
|
3.5% |
|
|
4.0% |
|
Commissions and other costs that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable and are amortized on a constant level basis over the expected term of the related contracts using the groupings and actuarial assumptions consistent with those used for calculating the related policyholder liability balances. Certain types of commissions, such as trail commissions that are based on account balances, are expensed as incurred rather than deferred and amortized.
Broker-dealer expenses that vary with and are related to sales are expensed as incurred and not deferred and amortized. Fluctuations in these expenses correspond with fluctuations in other revenues. For more information, see “Critical Accounting Policies and Estimates – DAC, VOBA, DSI and DFEL” above.
RESULTS OF LIFE INSURANCE
Income (Loss) from Operations
Details underlying the results for Life Insurance (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Operating Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
Insurance premiums (1) |
$ |
289 |
|
$ |
289 |
|
$ |
867 |
|
$ |
849 |
|
Fee income |
|
739 |
|
|
745 |
|
|
2,269 |
|
|
2,260 |
|
Net investment income |
|
689 |
|
|
585 |
|
|
2,083 |
|
|
1,937 |
|
Operating realized gain (loss) |
|
(2 |
) |
|
(2 |
) |
|
(5 |
) |
|
(5 |
) |
Amortization of deferred gain on |
|
|
|
|
|
|
|
|
|
|
|
|
business sold through reinsurance |
|
4 |
|
|
4 |
|
|
12 |
|
|
13 |
|
Other revenues |
|
4 |
|
|
2 |
|
|
15 |
|
|
5 |
|
Total operating revenues |
|
1,723 |
|
|
1,623 |
|
|
5,241 |
|
|
5,059 |
|
Operating Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
Benefits |
|
1,129 |
|
|
1,041 |
|
|
3,354 |
|
|
2,992 |
|
Interest credited |
|
325 |
|
|
329 |
|
|
978 |
|
|
984 |
|
Policyholder liability remeasurement |
|
|
|
|
|
|
|
|
|
|
|
|
(gain) loss |
|
183 |
|
|
2,708 |
|
|
183 |
|
|
2,855 |
|
Commissions and other expenses |
|
315 |
|
|
303 |
|
|
943 |
|
|
890 |
|
Total operating expenses |
|
1,952 |
|
|
4,381 |
|
|
5,458 |
|
|
7,721 |
|
Income (loss) from operations before taxes |
|
(229 |
) |
|
(2,758 |
) |
|
(217 |
) |
|
(2,662 |
) |
Federal income tax expense (benefit) |
|
(56 |
) |
|
(587 |
) |
|
(64 |
) |
|
(577 |
) |
Income (loss) from operations |
$ |
(173 |
) |
$ |
(2,171 |
) |
$ |
(153 |
) |
$ |
(2,085 |
) |
(1)Includes term insurance premiums, which have a corresponding partial offset in benefits for changes in reserves.
Comparison of the Three and Nine Months Ended September 30, 2023 to 2022
Loss from operations for this segment decreased due primarily to lower policyholder liability remeasurement (gain) loss driven by less unfavorable impacts from the annual assumption review, partially offset by higher benefits due to growth in reserves.
The decrease in loss from operations was partially offset by higher commissions and other expenses due to higher compensation-related expenses and other costs pertaining to business operations.
Additionally, for the three months ended September 30, 2023, the decrease in loss from operations was driven by higher net investment income, net of interest credited, driven by investment income on alternative investments compared to negative performance on alternative investments in the third quarter of 2022 and growth in investments, partially offset by lower prepayment and bond make-whole premiums.
Additionally, for the nine months ended September 30, 2023, the decrease in loss from operations was driven by higher net investment income, net of interest credited, driven by higher investment income on alternative investments and growth in investments, and higher insurance premiums due to growth in business in force, partially offset by lower prepayment and bond make-whole premiums.
See “Critical Accounting Policies and Estimates – Annual Assumption Review” above for information on the impacts from our annual assumption review.
Additional Information
We expect an ongoing reduction in income from operations in future quarters of approximately $25 million to $30 million per quarter upon the closing of the reinsurance transaction announced in the second quarter of 2023. See Note 8 for more information on the transaction, which is expected to advance the Company’s enterprise strategic objectives by reducing balance sheet risk, strengthening our capital position and improving free cash flow.
For information on interest rate spreads and interest rate risk, see “Part I – Item 1A. Risk Factors – Market Conditions – Changes in interest rates and sustained low interest rates may cause interest rate spreads to decrease, impacting our profitability, and make it more challenging to meet certain statutory requirements” and “Part I – Item 1A. Risk Factors – Market Conditions – Increases in interest rates may negatively affect our profitability, capital position and the value of our investment portfolio and may also result in increased contract withdrawals” in our 2022 Form 10-K/A; and “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk” in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K and “Item 3. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk” below. For information on the interest rate environment, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary” in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K.
Insurance Premiums
Insurance premiums relate to traditional products and are a function of the rates priced into the product and insurance in force. Insurance in force, in turn, is driven by sales, persistency and mortality claims.
Fee Income
Details underlying fee income, sales, net flows, account balances and in-force face amount (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Fee Income |
|
|
|
|
|
|
|
|
|
|
|
|
Cost of insurance assessments |
$ |
558 |
|
$ |
565 |
|
$ |
1,734 |
|
$ |
1,711 |
|
Expense assessments |
|
379 |
|
|
384 |
|
|
1,119 |
|
|
1,137 |
|
Surrender charges |
|
7 |
|
|
8 |
|
|
22 |
|
|
23 |
|
DFEL: |
|
|
|
|
|
|
|
|
|
|
|
|
Deferrals |
|
(272 |
) |
|
(268 |
) |
|
(799 |
) |
|
(782 |
) |
Amortization |
|
67 |
|
|
60 |
|
|
193 |
|
|
175 |
|
Impact from annual assumption review |
|
- |
|
|
(4 |
) |
|
- |
|
|
(4 |
) |
Total fee income |
$ |
739 |
|
$ |
745 |
|
$ |
2,269 |
|
$ |
2,260 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Sales by Product |
|
|
|
|
|
|
|
|
|
|
|
|
IUL/UL |
$ |
23 |
|
$ |
40 |
|
$ |
85 |
|
$ |
93 |
|
MoneyGuard® |
|
27 |
|
|
22 |
|
|
71 |
|
|
69 |
|
VUL |
|
29 |
|
|
36 |
|
|
93 |
|
|
114 |
|
Term |
|
23 |
|
|
47 |
|
|
79 |
|
|
138 |
|
Executive Benefits |
|
42 |
|
|
26 |
|
|
69 |
|
|
104 |
|
Total sales |
$ |
144 |
|
$ |
171 |
|
$ |
397 |
|
$ |
518 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Flows |
|
|
|
|
|
|
|
|
|
|
|
|
Deposits |
$ |
1,272 |
|
$ |
1,406 |
|
$ |
3,927 |
|
$ |
4,216 |
|
Withdrawals and deaths |
|
(451 |
) |
|
(404 |
) |
|
(1,322 |
) |
|
(1,242 |
) |
Net flows |
$ |
821 |
|
$ |
1,002 |
|
$ |
2,605 |
|
$ |
2,974 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder Assessments |
$ |
1,362 |
|
$ |
1,359 |
|
$ |
4,087 |
|
$ |
4,051 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, |
|
|
|
|
|
|
|
||||
|
2023 |
|
2022 |
|
|
|
|
|
|
|
||
Account Balances (1) |
|
|
|
|
|
|
|
|
|
|
|
|
General account |
$ |
31,714 |
|
$ |
32,116 |
|
|
|
|
|
|
|
Separate account |
|
18,010 |
|
|
15,173 |
|
|
|
|
|
|
|
Total account balances |
$ |
49,724 |
|
$ |
47,289 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In-Force Face Amount |
|
|
|
|
|
|
|
|
|
|
|
|
UL and other |
$ |
364,586 |
|
$ |
362,098 |
|
|
|
|
|
|
|
Term insurance |
|
721,927 |
|
|
689,101 |
|
|
|
|
|
|
|
Total in-force face amount |
$ |
1,086,513 |
|
$ |
1,051,199 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Average General Account Balances (1) |
$ |
31,823 |
|
$ |
32,163 |
|
$ |
31,955 |
|
$ |
32,337 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)Net of reinsurance ceded.
Fee income relates only to interest-sensitive products and includes cost of insurance assessments, expense assessments and surrender charges. Both cost of insurance and expense assessments can have deferrals and amortization related to DFEL. Cost of insurance and expense assessments are deducted from our policyholders’ account balances. These amounts are a function of the rates priced into the product and premiums received, face amount in force and account balances.
Sales are not recorded as a component of revenues (other than for traditional products) and do not have a significant effect on current quarter income from operations but are indicators of future profitability. Generally, we have higher sales during the second half of the year with the fourth quarter being our strongest.
Sales in the table above and as discussed above were reported as follows:
UL, IUL and VUL – first-year commissionable premiums plus 5% of excess premiums received;
MoneyGuard® linked-benefit products – MoneyGuard (UL), 15% of total expected premium deposits, and MoneyGuard Market AdvantageSM (VUL), 150% of commissionable premiums;
Executive Benefits – insurance and corporate-owned UL and VUL, first-year commissionable premiums plus 5% of excess premium received, and single premium bank-owned UL and VUL, 15% of single premium deposits; and
Term – 100% of annualized first-year premiums.
We monitor the business environment, including but not limited to the regulatory and interest rate environments, and make changes to our product offerings and in-force products as needed, and as permitted under the terms of the policies, to sustain the future profitability of our segment.
Net Investment Income and Interest Credited
Details underlying net investment income and interest credited (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Net Investment Income |
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities, mortgage loans on real estate |
|
|
|
|
|
|
|
|
|
|
|
|
and other, net of investment expenses |
$ |
603 |
|
$ |
594 |
|
$ |
1,797 |
|
$ |
1,770 |
|
Commercial mortgage loan prepayment |
|
|
|
|
|
|
|
|
|
|
|
|
and bond make-whole premiums (1) |
|
- |
|
|
10 |
|
|
3 |
|
|
31 |
|
Alternative investments (2) |
|
45 |
|
|
(52 |
) |
|
159 |
|
|
38 |
|
Surplus investments (3) |
|
41 |
|
|
33 |
|
|
124 |
|
|
98 |
|
Total net investment income |
$ |
689 |
|
$ |
585 |
|
$ |
2,083 |
|
$ |
1,937 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Credited |
$ |
325 |
|
$ |
329 |
|
$ |
978 |
|
$ |
984 |
|
(1)See “Consolidated Investments – Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.
(2)See “Consolidated Investments – Alternative Investments” below for additional information.
(3)Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities.
A portion of the investment income earned for this segment is credited to policyholder accounts. Statutory reserves will typically grow at a faster rate than account balances because of reserve requirements. Investments allocated to this segment are based upon the statutory reserve liabilities and are affected by various reserve adjustments, including financing transactions providing relief from reserve requirements. These financing transactions lead to a transfer of investments from this segment to Other Operations. We expect to earn a spread between what we earn on the underlying general account investments and what we credit to our policyholders’ accounts. Investment income partially offsets the earnings effect of the associated growth of our policy reserves. Commercial mortgage loan prepayments and bond make-whole premiums and investment income on alternative investments can vary significantly from period to period due to a number of factors, and, therefore, may contribute to investment income results that are not indicative of the underlying trends.
Benefits and Policyholder Remeasurement (Gain) Loss
Details underlying benefits and policyholder remeasurement (gain) loss (dollars in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Benefits and Policyholder Remeasurement (Gain) Loss |
|
|
|
|
|
|
|
|
|
|
|
|
Death claims direct and assumed |
$ |
1,311 |
|
$ |
1,278 |
|
$ |
4,100 |
|
$ |
4,171 |
|
Death claims ceded |
|
(500 |
) |
|
(473 |
) |
|
(1,604 |
) |
|
(1,624 |
) |
Reserves released on death |
|
(158 |
) |
|
(154 |
) |
|
(470 |
) |
|
(475 |
) |
Net death benefits |
|
653 |
|
|
651 |
|
|
2,026 |
|
|
2,072 |
|
Change in secondary guarantee life insurance product |
|
|
|
|
|
|
|
|
|
|
|
|
reserves: |
|
|
|
|
|
|
|
|
|
|
|
|
Change in reserves |
|
204 |
|
|
214 |
|
|
593 |
|
|
482 |
|
Impact from annual assumption review |
|
172 |
|
|
2,438 |
|
|
172 |
|
|
2,438 |
|
Change in MoneyGuard® reserves: |
|
|
|
|
|
|
|
|
|
|
|
|
Change in reserves |
|
143 |
|
|
111 |
|
|
392 |
|
|
333 |
|
Impact from annual assumption review |
|
37 |
|
|
167 |
|
|
37 |
|
|
167 |
|
Change in traditional product reserves: |
|
|
|
|
|
|
|
|
|
|
|
|
Change in reserves |
|
47 |
|
|
52 |
|
|
164 |
|
|
139 |
|
Impact from annual assumption review |
|
(11 |
) |
|
62 |
|
|
(11 |
) |
|
62 |
|
Other benefits (1) |
|
67 |
|
|
54 |
|
|
164 |
|
|
154 |
|
Total benefits and policyholder remeasurement |
|
|
|
|
|
|
|
|
|
|
|
|
(gain) loss |
$ |
1,312 |
|
$ |
3,749 |
|
$ |
3,537 |
|
$ |
5,847 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Death claims per $1,000 of in-force |
|
2.41 |
|
|
2.51 |
|
|
2.50 |
|
|
2.73 |
|
(1)Includes primarily long-term care claims and life surrender benefits.
Benefits for this segment include claims incurred during the period in excess of the associated reserves for its interest-sensitive and traditional products. In addition, benefits include the change in secondary guarantee, linked-benefit and term life insurance product reserves. These reserves are affected by changes in expected future trends of assessments and benefits causing remeasurements. Generally, we experience higher mortality in the first quarter of the year due to the seasonality of claims. We expect COVID-19-related mortality to continue to follow U.S. death trends.
Commissions and Other Expenses
Details underlying commissions and other expenses (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Commissions and Other Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
Commissions |
$ |
129 |
|
$ |
177 |
|
$ |
421 |
|
$ |
509 |
|
General and administrative expenses |
|
154 |
|
|
149 |
|
|
457 |
|
|
416 |
|
Expenses associated with reserve financing |
|
25 |
|
|
26 |
|
|
76 |
|
|
78 |
|
Taxes, licenses and fees |
|
36 |
|
|
33 |
|
|
114 |
|
|
115 |
|
Total expenses incurred |
|
344 |
|
|
385 |
|
|
1,068 |
|
|
1,118 |
|
DAC and VOBA deferrals |
|
(152 |
) |
|
(202 |
) |
|
(496 |
) |
|
(588 |
) |
Total expenses recognized before amortization |
|
192 |
|
|
183 |
|
|
572 |
|
|
530 |
|
DAC and VOBA amortization: |
|
|
|
|
|
|
|
|
|
|
|
|
Amortization |
|
122 |
|
|
123 |
|
|
368 |
|
|
361 |
|
Impact from annual assumption review |
|
- |
|
|
(4 |
) |
|
- |
|
|
(4 |
) |
Other intangible amortization |
|
1 |
|
|
1 |
|
|
3 |
|
|
3 |
|
Total commissions and other expenses |
$ |
315 |
|
$ |
303 |
|
$ |
943 |
|
$ |
890 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DAC and VOBA Deferrals |
|
|
|
|
|
|
|
|
|
|
|
|
As a percentage of sales |
|
105.6% |
|
|
118.1% |
|
|
124.9% |
|
|
113.5% |
|
Commissions and other expenses that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable. For our interest-sensitive and traditional products, DAC and VOBA are amortized on a constant level basis over the expected term of the related contracts using the groupings and actuarial assumptions consistent with those used for calculating the related policyholder liability balances. For more information, see “Critical Accounting Policies and Estimates – DAC, VOBA, DSI and DFEL” above.
RESULTS OF GROUP PROTECTION
Income (Loss) from Operations
Details underlying the results for Group Protection (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Operating Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
Insurance premiums |
$ |
1,251 |
|
$ |
1,200 |
|
$ |
3,765 |
|
$ |
3,556 |
|
Net investment income |
|
84 |
|
|
83 |
|
|
254 |
|
|
253 |
|
Other revenues (1) |
|
53 |
|
|
50 |
|
|
157 |
|
|
149 |
|
Total operating revenues |
|
1,388 |
|
|
1,333 |
|
|
4,176 |
|
|
3,958 |
|
Operating Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
Benefits |
|
979 |
|
|
994 |
|
|
3,036 |
|
|
3,003 |
|
Interest credited |
|
1 |
|
|
1 |
|
|
4 |
|
|
4 |
|
Policyholder liability remeasurement |
|
|
|
|
|
|
|
|
|
|
|
|
(gain) loss |
|
(39 |
) |
|
(22 |
) |
|
(260 |
) |
|
(55 |
) |
Commissions and other expenses |
|
361 |
|
|
345 |
|
|
1,083 |
|
|
987 |
|
Total operating expenses |
|
1,302 |
|
|
1,318 |
|
|
3,863 |
|
|
3,939 |
|
Income (loss) from operations before taxes |
|
86 |
|
|
15 |
|
|
313 |
|
|
19 |
|
Federal income tax expense (benefit) |
|
18 |
|
|
3 |
|
|
66 |
|
|
4 |
|
Income (loss) from operations |
$ |
68 |
|
$ |
12 |
|
$ |
247 |
|
$ |
15 |
|
(1)Consists of revenue from third parties for administrative services performed, which has a corresponding partial offset in commissions and other expenses.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Income (Loss) from Operations by |
|
|
|
|
|
|
|
|
|
|
|
|
Product Line |
|
|
|
|
|
|
|
|
|
|
|
|
Life |
$ |
8 |
|
$ |
27 |
|
$ |
28 |
|
$ |
(10 |
) |
Disability |
|
64 |
|
|
(14 |
) |
|
228 |
|
|
26 |
|
Dental |
|
(4 |
) |
|
(1 |
) |
|
(9 |
) |
|
(1 |
) |
Income (loss) from operations |
$ |
68 |
|
$ |
12 |
|
$ |
247 |
|
$ |
15 |
|
Comparison of the Three Months Ended September 30, 2023 to 2022
Income from operations for this segment increased due primarily to the following:
Higher insurance premiums due to growth in business in force.
Lower total benefits and policyholder liability remeasurement (gain) loss driven by lower disability incidence, new life claim incurrals and the impact from our annual assumption review, partially offset by higher life and disability claims severity.
The increase in income from operations was partially offset by higher commissions and other expenses driven by higher compensation-related expenses and other operating costs pertaining to business operations and higher commissions due to growth in business in force.
Comparison of the Nine Months Ended September 30, 2023 to 2022
Income from operations for this segment increased due primarily to the following:
Higher insurance premiums due to growth in business in force.
Lower total benefits and policyholder liability remeasurement (gain) loss driven by more favorable discount rate impacts on new claims and the impact from our annual assumption review, partially offset by growth in business in force.
The increase in income from operations was partially offset by higher commissions and other expenses driven by higher compensation-related expenses and other operating costs pertaining to business operations and higher commissions due to growth in business in force.
See “Critical Accounting Policies and Estimates – Annual Assumption Review” for information on the impacts from our annual assumption review.
Additional Information
For information about the effect of the loss ratio sensitivity on our income (loss) from operations, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Results of Group Protection – Additional Information” in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K.
For information on the effects of current interest rates on our long-term disability claim reserves, see “Item 3. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk – Effect of Interest Rate Sensitivity” below. For information on the interest rate environment, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary” in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K.
Insurance Premiums Details underlying insurance premiums (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Insurance Premiums by Product Line |
|
|
|
|
|
|
|
|
|
|
|
|
Life |
$ |
487 |
|
$ |
455 |
|
$ |
1,452 |
|
$ |
1,344 |
|
Disability |
|
719 |
|
|
695 |
|
|
2,175 |
|
|
2,063 |
|
Dental |
|
45 |
|
|
50 |
|
|
138 |
|
|
149 |
|
Total insurance premiums |
$ |
1,251 |
|
$ |
1,200 |
|
$ |
3,765 |
|
$ |
3,556 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales by Product Line |
|
|
|
|
|
|
|
|
|
|
|
|
Life |
$ |
30 |
|
$ |
41 |
|
$ |
167 |
|
$ |
157 |
|
Disability |
|
32 |
|
|
37 |
|
|
107 |
|
|
143 |
|
Dental |
|
9 |
|
|
10 |
|
|
21 |
|
|
21 |
|
Total sales |
$ |
71 |
|
$ |
88 |
|
$ |
295 |
|
$ |
321 |
|
Our cost of insurance and policy administration charges are embedded in the premiums charged to our customers. The premiums are a function of the rates priced into the product and our business in force. Business in force, in turn, is driven by sales and persistency experience.
Sales relate to new policyholders and new coverages sold to existing policyholders. We believe that the trend in sales is an important indicator of development of business in force over time. Sales in the table above are the combined annualized premiums for our products. Generally, we have higher sales during the fourth quarter of the year.
Net Investment Income
We use our investment income to offset the earnings effect of the associated build of our reserves, which are a function of our insurance premiums and the yields on our investments. Details underlying net investment income (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Net Investment Income |
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities, mortgage |
|
|
|
|
|
|
|
|
|
|
|
|
loans on real estate and other, |
|
|
|
|
|
|
|
|
|
|
|
|
net of investment expenses |
$ |
66 |
|
$ |
65 |
|
$ |
200 |
|
$ |
188 |
|
Commercial mortgage loan prepayment |
|
|
|
|
|
|
|
|
|
|
|
|
and bond make-whole premiums (1) |
|
- |
|
|
1 |
|
|
1 |
|
|
6 |
|
Surplus investments (2) |
|
18 |
|
|
17 |
|
|
53 |
|
|
59 |
|
Total net investment income |
$ |
84 |
|
$ |
83 |
|
$ |
254 |
|
$ |
253 |
|
(1)See “Consolidated Investments – Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.
(2)Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities. See “Consolidated Investments – Alternative Investments” below for more information on alternative investments.
Benefits, Interest Credited and Policyholder Liability Remeasurement (Gain) Loss
Details underlying benefits, interest credited (in millions), policyholder liability remeasurement (gain) loss and loss ratios by product line were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Benefits, Interest Credited and |
|
|
|
|
|
|
|
|
|
|
|
|
Policyholder Liability Remeasurement |
|
|
|
|
|
|
|
|
|
|
|
|
(Gain) Loss by Product Line |
|
|
|
|
|
|
|
|
|
|
|
|
Life |
$ |
374 |
|
$ |
327 |
|
$ |
1,107 |
|
$ |
1,089 |
|
Disability |
|
533 |
|
|
610 |
|
|
1,568 |
|
|
1,754 |
|
Dental |
|
34 |
|
|
36 |
|
|
105 |
|
|
109 |
|
Total benefits, interest credited and |
|
|
|
|
|
|
|
|
|
|
|
|
policyholder liability remeasurement |
|
|
|
|
|
|
|
|
|
|
|
|
(gain) loss |
$ |
941 |
|
$ |
973 |
|
$ |
2,780 |
|
$ |
2,952 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss Ratios by Product Line |
|
|
|
|
|
|
|
|
|
|
|
|
Life |
|
76.8% |
|
|
71.8% |
|
|
76.3% |
|
|
81.1% |
|
Disability |
|
74.1% |
|
|
87.7% |
|
|
72.1% |
|
|
85.0% |
|
Dental |
|
75.9% |
|
|
72.0% |
|
|
76.4% |
|
|
73.3% |
|
Total |
|
75.2% |
|
|
81.0% |
|
|
73.8% |
|
|
83.0% |
|
Generally, we experience higher mortality in the first quarter of the year and higher disability claims in the fourth quarter of the year due to the seasonality of claims. We expect COVID-19-related mortality to continue to follow U.S. death trends. For additional information on our loss ratios, see “Additional Information” above.
Commissions and Other Expenses
Details underlying commissions and other expenses (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Commissions and Other Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
Commissions |
$ |
109 |
|
$ |
101 |
|
$ |
327 |
|
$ |
291 |
|
General and administrative expenses |
|
212 |
|
|
204 |
|
|
635 |
|
|
574 |
|
Taxes, licenses and fees |
|
33 |
|
|
31 |
|
|
102 |
|
|
95 |
|
Total expenses incurred |
|
354 |
|
|
336 |
|
|
1,064 |
|
|
960 |
|
DAC deferrals |
|
(26 |
) |
|
(23 |
) |
|
(79 |
) |
|
(70 |
) |
Total expenses recognized before amortization |
|
328 |
|
|
313 |
|
|
985 |
|
|
890 |
|
DAC amortization |
|
25 |
|
|
24 |
|
|
73 |
|
|
73 |
|
Other intangible amortization |
|
8 |
|
|
8 |
|
|
25 |
|
|
24 |
|
Total commissions and other expenses |
$ |
361 |
|
$ |
345 |
|
$ |
1,083 |
|
$ |
987 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DAC Deferrals |
|
|
|
|
|
|
|
|
|
|
|
|
As a percentage of insurance premiums |
|
2.1% |
|
|
1.9% |
|
|
2.1% |
|
|
2.0% |
|
Commissions and other costs that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable and are amortized on a constant level basis over the expected term of the related contracts using the groupings and actuarial assumptions consistent with those used for calculating the related policyholder liability balances. Certain broker commissions that vary with and are related to paid premiums are expensed as incurred rather than deferred and amortized. For more information, see “Critical Accounting Policies and Estimates – DAC, VOBA, DSI and DFEL” above.
RESULTS OF RETIREMENT PLAN SERVICES
Income (Loss) from Operations
Details underlying the results for Retirement Plan Services (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Operating Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
Fee income |
$ |
66 |
|
$ |
64 |
|
$ |
195 |
|
$ |
199 |
|
Net investment income |
|
251 |
|
|
244 |
|
|
765 |
|
|
723 |
|
Other revenues (1) |
|
10 |
|
|
8 |
|
|
28 |
|
|
27 |
|
Total operating revenues |
|
327 |
|
|
316 |
|
|
988 |
|
|
949 |
|
Operating Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
Interest credited |
|
165 |
|
|
161 |
|
|
501 |
|
|
469 |
|
Commissions and other expenses |
|
112 |
|
|
102 |
|
|
330 |
|
|
294 |
|
Total operating expenses |
|
277 |
|
|
263 |
|
|
831 |
|
|
763 |
|
Income (loss) from operations before taxes |
|
50 |
|
|
53 |
|
|
157 |
|
|
186 |
|
Federal income tax expense (benefit) |
|
7 |
|
|
6 |
|
|
24 |
|
|
27 |
|
Income (loss) from operations |
$ |
43 |
|
$ |
47 |
|
$ |
133 |
|
$ |
159 |
|
(1)Consists primarily of mutual fund account program revenues from mid to large employers.
Comparison of the Three Months Ended September 30, 2023 to 2022
Income from operations for this segment decreased due primarily to higher commissions and other expenses driven by higher compensation-related expenses and other costs pertaining to business operations and trail commissions resulting from higher average account balances.
The decrease in income from operations was partially offset by the following:
Higher fee income driven by higher average account balances.
Higher net investment income, net of interest credited, driven by investment income in 2023 compared to negative performance in 2022 on alternative investments within our surplus portfolio and impacts to portfolio yields from the current interest rate environment, partially offset by lower average fixed account balances and lower investment income on prepayment and bond make-whole premiums.
Comparison of the Nine Months Ended September 30, 2023 to 2022
Income from operations for this segment decreased due primarily to the following:
Higher commissions and other expenses driven by compensation-related expenses and other costs pertaining to business operations and trail commissions resulting from higher average fixed account balances.
Lower fee income driven by lower average account balances.
The decrease in income from operations was partially offset by higher net investment income, net of interest credited, driven by impacts to portfolio yields from the current interest rate environment, higher average fixed account balances and higher investment income on alternative investments within our surplus portfolio, partially offset by lower investment income on prepayment and bond make-whole premiums.
Additional Information
Net flows in this business fluctuate based on the timing of larger plans being implemented and terminating over the course of the year.
New deposits are an important component of net flows and key to our efforts to grow our business. Although deposits do not significantly affect current period income from operations, they can significantly impact future income from operations. The other component of net flows relates to the retention of the business. An important measure of retention is the reduction in account balances caused by plan sponsor terminations and participant withdrawals. These outflows as a percentage of average account balances were 12% for the three and nine months ended September 30, 2023, and 10% and 11%, respectively, for the corresponding periods in 2022.
Our net flows are negatively affected by the continued net outflows from our oldest blocks of annuities business (as presented on our Net Flows By Market table below as “Multi-Fund® and other”), which are among our higher margin product lines in this segment, due to the fact that they are mature blocks with low distribution and servicing costs. The proportion of these products to our total account balances was 16% and 17% as of September 30, 2023 and 2022, respectively. Due to this overall shift in business mix toward products with lower returns, new deposit production continues to be necessary to maintain earnings at current levels.
Our fixed annuity business includes products with discretionary and index-based crediting rates that are reset on either a quarterly or semi-annual basis. Our ability to retain quarterly or semi-annual reset annuities will be subject to current competitive conditions at the time crediting rates for these products reset. We expect to manage the effects of spreads on near-term income from operations through portfolio management and, to a lesser extent, crediting rate actions, which assumes no significant changes in net flows into or out of our fixed accounts or other changes that may cause interest rate spreads to differ from our expectations. For information on interest rate spreads and interest rate risk, see “Part I – Item 1A. Risk Factors – Market Conditions – Changes in interest rates and sustained low interest rates may cause interest rate spreads to decrease, impacting our profitability, and make it more challenging to meet certain statutory requirements” and “Part I – Item 1A. Risk Factors – Market Conditions – Increases in interest rates may negatively affect our profitability, capital position and the value of our investment portfolio and may also result in increased contract withdrawals” in our 2022 Form 10-K/A; and “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk” in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K and “Item 3. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk” below. For information on the interest rate environment, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary” in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K.
Fee Income
Details underlying fee income (in millions) were as follows:
\
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Fee Income |
|
|
|
|
|
|
|
|
|
|
|
|
Annuity expense assessments |
$ |
49 |
|
$ |
47 |
|
$ |
142 |
|
$ |
147 |
|
Mutual fund fees |
|
16 |
|
|
17 |
|
|
52 |
|
|
52 |
|
Total expense assessments |
|
65 |
|
|
64 |
|
|
194 |
|
|
199 |
|
Surrender charges |
|
1 |
|
|
- |
|
|
1 |
|
|
- |
|
Total fee income |
$ |
66 |
|
$ |
64 |
|
$ |
195 |
|
$ |
199 |
|
Our fee income is primarily composed of expense assessments that we charge to cover insurance and administrative expenses, and mutual fund fees earned for services we provide to our mutual fund programs. Fee income is primarily based on average account balances, both fixed and variable, which are driven by net flows and the equity markets. Fee income is also driven by non-account balance-related items such as participant counts. We may collect surrender charges when our fixed and variable annuity policyholders surrender their contracts during the surrender charge period to protect us from premature withdrawals.
Net Investment Income and Interest Credited
Details underlying net investment income and interest credited (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Net Investment Income |
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities, mortgage loans on real estate |
|
|
|
|
|
|
|
|
|
|
|
|
and other, net of investment expenses |
$ |
231 |
|
$ |
228 |
|
$ |
707 |
|
$ |
647 |
|
Commercial mortgage loan prepayment and |
|
|
|
|
|
|
|
|
|
|
|
|
bond make-whole premiums (1) |
|
- |
|
|
2 |
|
|
1 |
|
|
22 |
|
Surplus investments (2) |
|
20 |
|
|
14 |
|
|
57 |
|
|
54 |
|
Total net investment income |
$ |
251 |
|
$ |
244 |
|
$ |
765 |
|
$ |
723 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Credited |
$ |
165 |
|
$ |
161 |
|
$ |
501 |
|
$ |
469 |
|
(1)See “Consolidated Investments – Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.
(2)Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities. See “Consolidated Investments – Alternative Investments” below for more information on alternative investments.
A portion of our investment income earned is credited to the policyholders of our fixed annuity products, including the fixed portion of variable annuity contracts. We expect to earn a spread between what we earn on the underlying general account investments supporting the fixed annuity product line, including the fixed portion of variable annuity contracts, and what we credit to our fixed annuity policyholders’ accounts, including the fixed portion of variable annuity contracts. Commercial mortgage loan prepayments and bond make-whole premiums, investment income on alternative investments and surplus investment income can vary significantly from period to period due to a number of factors and, therefore, may contribute to investment income results that are not indicative of the underlying trends.
Account Balances
Details underlying account balances (dollars in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of or For the Three |
|
As of or For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Variable Account Balance Information (1) |
|
|
|
|
|
|
|
|
|
|
|
|
Variable annuity deposits |
$ |
476 |
|
$ |
484 |
|
$ |
1,655 |
|
$ |
1,843 |
|
Variable annuity net flows |
|
(192 |
) |
|
29 |
|
|
(129 |
) |
|
41 |
|
Variable annuity account balances |
|
17,908 |
|
|
15,854 |
|
|
17,908 |
|
|
15,854 |
|
Average daily variable annuity account balances |
|
18,686 |
|
|
17,287 |
|
|
18,097 |
|
|
18,331 |
|
Average daily S&P 500® Index |
|
4,456 |
|
|
3,983 |
|
|
4,222 |
|
|
4,185 |
|
Fixed Account Balance Information (2) |
|
|
|
|
|
|
|
|
|
|
|
|
Fixed annuity deposits |
$ |
709 |
|
$ |
994 |
|
$ |
2,026 |
|
$ |
3,225 |
|
Fixed annuity net flows |
|
(459 |
) |
|
121 |
|
|
(1,236 |
) |
|
766 |
|
Fixed annuity account balances |
|
24,099 |
|
|
25,276 |
|
|
24,099 |
|
|
25,276 |
|
Average fixed account balances |
|
24,268 |
|
|
25,077 |
|
|
24,711 |
|
|
24,390 |
|
Mutual Fund Account Balance Information |
|
|
|
|
|
|
|
|
|
|
|
|
Mutual fund deposits |
$ |
1,515 |
|
$ |
1,613 |
|
$ |
5,125 |
|
$ |
4,861 |
|
Mutual fund net flows |
|
379 |
|
|
655 |
|
|
1,829 |
|
|
1,839 |
|
Mutual fund account balances (3) |
|
51,926 |
|
|
43,211 |
|
|
51,926 |
|
|
43,211 |
|
(1)Excludes the fixed portion of variable annuities.
(2)Includes the fixed portion of variable annuities.
(3)Mutual funds are not included in the separate accounts reported on the Consolidated Balance Sheets as we do not have any ownership interest in them.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Net Flows By Market |
|
|
|
|
|
|
|
|
|
|
|
|
Small market |
$ |
21 |
|
$ |
157 |
|
$ |
267 |
|
$ |
121 |
|
Mid – large market |
|
83 |
|
|
899 |
|
|
1,202 |
|
|
3,303 |
|
Multi-Fund® and other |
|
(376 |
) |
|
(251 |
) |
|
(1,005 |
) |
|
(779 |
) |
Total net flows |
$ |
(272 |
) |
$ |
805 |
|
$ |
464 |
|
$ |
2,645 |
|
For more information on account balances, see Notes 10 and 11.
Commissions and Other Expenses
Details underlying commissions and other expenses (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Commissions and Other Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
Commissions: |
|
|
|
|
|
|
|
|
|
|
|
|
Deferrable |
$ |
1 |
|
$ |
1 |
|
$ |
3 |
|
$ |
3 |
|
Non-deferrable |
|
21 |
|
|
19 |
|
|
62 |
|
|
55 |
|
General and administrative expenses |
|
86 |
|
|
80 |
|
|
253 |
|
|
224 |
|
Taxes, licenses and fees |
|
4 |
|
|
3 |
|
|
14 |
|
|
13 |
|
Total expenses incurred |
|
112 |
|
|
103 |
|
|
332 |
|
|
295 |
|
DAC deferrals |
|
(5 |
) |
|
(6 |
) |
|
(15 |
) |
|
(15 |
) |
Total expenses recognized before amortization |
|
107 |
|
|
97 |
|
|
317 |
|
|
280 |
|
DAC amortization |
|
5 |
|
|
5 |
|
|
13 |
|
|
14 |
|
Total commissions and other expenses |
$ |
112 |
|
$ |
102 |
|
$ |
330 |
|
$ |
294 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DAC Deferrals |
|
|
|
|
|
|
|
|
|
|
|
|
As a percentage of annuity sales/deposits |
|
0.4% |
|
|
0.4% |
|
|
0.4% |
|
|
0.3% |
|
Commissions and other costs that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable and are amortized on a constant level basis over the expected term of the related contracts using the groupings and actuarial assumptions consistent with those used for calculating the related policyholder liability balances. Certain types of commissions, such as trail commissions that are based on account balances, are expensed as incurred rather than deferred and amortized. Distribution expenses associated with the sale of mutual fund products are expensed as incurred. For more information, see “Critical Accounting Policies and Estimates – DAC, VOBA, DSI and DFEL” above.
RESULTS OF OTHER OPERATIONS
Income (Loss) from Operations
Details underlying the results for Other Operations (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Operating Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
Insurance premiums (1) |
$ |
1 |
|
$ |
2 |
|
$ |
8 |
|
$ |
6 |
|
Net investment income |
|
37 |
|
|
35 |
|
|
110 |
|
|
117 |
|
Other revenues |
|
- |
|
|
(1 |
) |
|
9 |
|
|
(12 |
) |
Total operating revenues |
|
38 |
|
|
36 |
|
|
127 |
|
|
111 |
|
Operating Expenses |
|
|
|
|
|
|
|
|
|
|
|
|
Benefits |
|
17 |
|
|
20 |
|
|
53 |
|
|
47 |
|
Interest credited |
|
9 |
|
|
9 |
|
|
27 |
|
|
30 |
|
Policyholder liability remeasurement |
|
|
|
|
|
|
|
|
|
|
|
|
(gain) loss |
|
(5 |
) |
|
- |
|
|
(3 |
) |
|
2 |
|
Other expenses |
|
39 |
|
|
28 |
|
|
84 |
|
|
44 |
|
Interest and debt expense |
|
84 |
|
|
71 |
|
|
250 |
|
|
205 |
|
Spark program expense |
|
36 |
|
|
44 |
|
|
101 |
|
|
118 |
|
Total operating expenses |
|
180 |
|
|
172 |
|
|
512 |
|
|
446 |
|
Income (loss) from operations before taxes |
|
(142 |
) |
|
(136 |
) |
|
(385 |
) |
|
(335 |
) |
Federal income tax expense (benefit) |
|
(29 |
) |
|
(24 |
) |
|
(79 |
) |
|
(59 |
) |
Income (loss) from operations |
$ |
(113 |
) |
$ |
(112 |
) |
$ |
(306 |
) |
$ |
(276 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)Includes our disability income business, which has a corresponding offset in benefits for changes in reserves.
Comparison of the Three Months Ended September 30, 2023 to 2022
Loss from operations for Other Operations increased due primarily to the following:
Higher interest and debt expense driven by an increase in average interest rates.
Higher other expenses driven by higher compensation-related expenses and other costs pertaining to business operations.
The increase in loss from operations was partially offset by the following:
Lower Spark program expense as part of our Spark Initiative.
Lower benefits, net of policyholder liability remeasurement (gain) loss, driven by favorable reserve adjustments in our institutional pension and run-off disability income businesses.
Comparison of the Nine Months Ended September 30, 2023 to 2022
Loss from operations for Other Operations increased due primarily to the following:
Higher interest and debt expense driven by an increase in average interest rates.
Higher other expenses due to the effect of changes in our stock price on our deferred compensation plans, as our stock price decreased during the nine months ended September 30, 2023, compared to a more significant decrease during the corresponding period in 2022, and higher compensation-related expenses.
Lower net investment income, net of interest credited, related to lower allocated investments driven by a decrease in excess capital retained by Other Operations.
The increase in loss from operations was partially offset by the following:
Higher other revenues due to the effect of market fluctuations on assets held as part of certain compensation plans, which increased during the nine months ended September 30, 2023, compared to a decrease during the corresponding period in 2022.
More favorable income tax benefit driven by favorable market impacts on tax preferred investment income.
Lower Spark program expense as part of our Spark Initiative.
Additional Information
We expect to continue making investments as part of our Spark Initiative. For more information, see “Introduction – Executive Summary – Significant Operational Matters – Spark Initiative” in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K.
Net Investment Income and Interest Credited
We utilize an internal formula to determine the amount of capital that is allocated to our business segments. Investment income on capital in excess of the calculated amounts is reported in Other Operations. If our business segments require increases in statutory reserves, surplus or investments, the amount of excess capital that is retained by Other Operations would decrease and net investment income would be negatively affected.
Write-downs for impairments decrease the recorded value of investments owned by the business segments. These write-downs are not included in the income from operations of our business segments. When impairment occurs, assets are transferred to the business segments’ portfolios and will reduce the future net investment income for Other Operations. Statutory reserve adjustments for our business segments can also cause allocations of investments between the business segments and Other Operations.
The majority of our interest credited relates to our reinsurance operations sold to Swiss Re Life & Health America, Inc. (“Swiss Re”) in 2001. A substantial amount of the business was sold through indemnity reinsurance transactions, which is still recorded in the consolidated financial statements. The interest credited corresponds to investment income earnings on the assets we continue to hold for this business. There is no effect to income or loss in Other Operations or on a consolidated basis for these amounts because interest earned on the blocks that continue to be reinsured is passed through to Swiss Re in the form of interest credited.
Benefits
Benefits are recognized when incurred for institutional pension products and disability income business.
Other Expenses
Details underlying other expenses (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
General and administrative expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Legal |
$ |
3 |
|
$ |
2 |
|
$ |
(1 |
) |
$ |
2 |
|
Branding |
|
10 |
|
|
12 |
|
|
34 |
|
|
29 |
|
Other (1) |
|
20 |
|
|
12 |
|
|
49 |
|
|
16 |
|
Total general and administrative expenses |
|
33 |
|
|
26 |
|
|
82 |
|
|
47 |
|
Taxes, licenses and fees (2) |
|
7 |
|
|
3 |
|
|
4 |
|
|
(1 |
) |
Other (3) |
|
(1 |
) |
|
(1 |
) |
|
(2 |
) |
|
(2 |
) |
Total other expenses |
$ |
39 |
|
$ |
28 |
|
$ |
84 |
|
$ |
44 |
|
(1)Includes the portion of our deferred compensation plan expense attributable to participants’ selection of LNC stock as the measure for their investment return, expenses that are corporate in nature including charitable contributions and other expenses not allocated to our business segments.
(2)Includes state guaranty funds assessments to cover losses to policyholders of insolvent or rehabilitated insurance companies. Mandatory assessments may be partially recovered through a reduction in future premium taxes in some states.
(3)Consists primarily of reimbursements to Other Operations from the Life Insurance segment for the use of proceeds from certain issuances of senior notes that were used as long-term structured solutions, net of expenses incurred by Other Operations for its access to a financing facility and issuance of letters of credit (“LOCs”).
Interest and Debt Expense
Our current level of interest expense may not be indicative of the future due to, among other things, the timing of the use of cash, the availability of funds from our inter-company cash management program and the future cost of capital. For additional information on our financing activities, see “Liquidity and Capital Resources – Holding Company Sources and Uses of Liquidity and Capital – Debt” below.
CONSOLIDATED INVESTMENTS
Details underlying our consolidated investment balances (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of |
|
|
|||
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
||||
|
|
As of |
|
|
As of |
|
As of |
|
As of |
|
|
||||
|
September 30, |
December 31, |
September 30, |
December 31, |
|
||||||||||
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
|
||
Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities |
|
$ |
97,804 |
|
|
$ |
99,736 |
|
|
73.8% |
|
|
75.8% |
|
|
Trading securities |
|
|
2,788 |
|
|
|
3,498 |
|
|
2.1% |
|
|
2.7% |
|
|
Equity securities |
|
|
383 |
|
|
|
427 |
|
|
0.3% |
|
|
0.3% |
|
|
Mortgage loans on real estate |
|
|
18,751 |
|
|
|
18,301 |
|
|
14.2% |
|
|
13.9% |
|
|
Policy loans |
|
|
2,428 |
|
|
|
2,359 |
|
|
1.7% |
|
|
1.8% |
|
|
Derivative investments |
|
|
5,790 |
|
|
|
3,594 |
|
|
4.4% |
|
|
2.7% |
|
|
Alternative investments |
|
|
3,290 |
|
|
|
3,021 |
|
|
2.5% |
|
|
2.3% |
|
|
Other investments |
|
|
1,261 |
|
|
|
718 |
|
|
1.0% |
|
|
0.5% |
|
|
Total investments |
|
$ |
132,495 |
|
|
$ |
131,654 |
|
|
100.0% |
|
|
100.0% |
|
|
Investment Objective
Investments are an integral part of our operations. We follow a balanced approach to investing for both current income and prudent risk management, with an emphasis on generating sufficient current income, net of income tax, to meet our obligations to customers, as well as other general liabilities. This balanced approach requires the evaluation of expected return and risk of each asset class utilized, while still meeting our income objectives. This approach is important to our asset-liability management because decisions can be made based upon both the economic and current investment income considerations affecting assets and liabilities. For a discussion of our risk management process, see “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K.
Investment Portfolio Composition and Diversification
Fundamental to our investment policy is diversification across asset classes. Our investment portfolio, excluding cash and invested cash, is composed of fixed maturity securities, mortgage loans on real estate, real estate (either wholly-owned or in joint ventures) and other long-term investments. We purchase investments for our segmented portfolios that have yield, duration and other characteristics that take into account the liabilities of the products being supported.
We have the ability to maintain our investment holdings throughout credit cycles because of our capital position, the long-term nature of our liabilities and the matching of our portfolios of investment assets with the liabilities of our various products.
Fixed Maturity and Equity Securities Portfolios
Fixed maturity securities consist of portfolios classified as AFS and trading. Details underlying our fixed maturity AFS securities by industry classification (in millions) are presented in the tables below. These tables agree in total with the presentation of fixed maturity AFS securities in Note 4; however, the categories below represent a more detailed breakout of the fixed maturity AFS portfolio. Therefore, the investment classifications listed below do not agree to the investment categories provided in Note 4.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
||||||||||||
|
Net |
|
|
|
|
|
|
|
|
|
|
% |
|
|
|
Amortized |
|
Gross Unrealized |
|
Fair |
|
Fair |
|
||||||
|
Cost (1) |
|
Gains |
|
Losses |
|
Value |
|
Value |
|
||||
Fixed Maturity AFS Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industry corporate bonds: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial services |
$ |
16,954 |
|
$ |
76 |
|
$ |
2,192 |
|
$ |
14,838 |
|
15.3% |
|
Basic industry |
|
4,173 |
|
|
29 |
|
|
543 |
|
|
3,659 |
|
3.7% |
|
Capital goods |
|
7,082 |
|
|
40 |
|
|
967 |
|
|
6,155 |
|
6.3% |
|
Communications |
|
4,331 |
|
|
41 |
|
|
612 |
|
|
3,760 |
|
3.8% |
|
Consumer cyclical |
|
5,948 |
|
|
25 |
|
|
785 |
|
|
5,188 |
|
5.3% |
|
Consumer non-cyclical |
|
17,395 |
|
|
109 |
|
|
2,830 |
|
|
14,674 |
|
15.0% |
|
Energy |
|
4,518 |
|
|
34 |
|
|
514 |
|
|
4,038 |
|
4.1% |
|
Technology |
|
5,713 |
|
|
16 |
|
|
770 |
|
|
4,959 |
|
5.1% |
|
Transportation |
|
3,729 |
|
|
12 |
|
|
501 |
|
|
3,240 |
|
3.3% |
|
Industrial other |
|
2,301 |
|
|
3 |
|
|
501 |
|
|
1,803 |
|
1.8% |
|
Utilities |
|
14,375 |
|
|
49 |
|
|
2,290 |
|
|
12,134 |
|
12.4% |
|
Government-related entities |
|
1,798 |
|
|
13 |
|
|
258 |
|
|
1,553 |
|
1.6% |
|
Collateralized mortgage and other obligations ("CMOs"): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agency backed |
|
1,415 |
|
|
- |
|
|
207 |
|
|
1,208 |
|
1.2% |
|
Non-agency backed |
|
350 |
|
|
18 |
|
|
15 |
|
|
353 |
|
0.4% |
|
Mortgage pass through securities ("MPTS"): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agency backed |
|
389 |
|
|
- |
|
|
53 |
|
|
336 |
|
0.3% |
|
Non-agency backed |
|
32 |
|
|
- |
|
|
1 |
|
|
31 |
|
0.0% |
|
Commercial mortgage-backed securities ("CMBS"): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agency backed |
|
2 |
|
|
- |
|
|
- |
|
|
2 |
|
0.0% |
|
Non-agency backed |
|
1,961 |
|
|
- |
|
|
262 |
|
|
1,699 |
|
1.7% |
|
Asset-backed securities ("ABS"): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Collateralized loan obligations ("CLOs") |
|
9,216 |
|
|
11 |
|
|
588 |
|
|
8,639 |
|
8.8% |
|
Credit card |
|
78 |
|
|
2 |
|
|
1 |
|
|
79 |
|
0.1% |
|
Home equity |
|
179 |
|
|
22 |
|
|
4 |
|
|
197 |
|
0.2% |
|
Other |
|
3,723 |
|
|
2 |
|
|
247 |
|
|
3,478 |
|
3.6% |
|
Municipals: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Taxable |
|
5,166 |
|
|
67 |
|
|
538 |
|
|
4,695 |
|
4.8% |
|
Tax-exempt |
|
81 |
|
|
- |
|
|
6 |
|
|
75 |
|
0.1% |
|
Government: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
418 |
|
|
3 |
|
|
48 |
|
|
373 |
|
0.4% |
|
Foreign |
|
326 |
|
|
9 |
|
|
62 |
|
|
273 |
|
0.3% |
|
Hybrid and redeemable preferred securities |
|
360 |
|
|
25 |
|
|
20 |
|
|
365 |
|
0.4% |
|
Total fixed maturity AFS securities |
|
112,013 |
|
|
606 |
|
|
14,815 |
|
|
97,804 |
|
100.0% |
|
Trading Securities (2) |
|
3,126 |
|
|
25 |
|
|
363 |
|
|
2,788 |
|
|
|
Equity Securities |
|
360 |
|
|
89 |
|
|
66 |
|
|
383 |
|
|
|
Total fixed maturity AFS, trading and equity securities |
$ |
115,499 |
|
$ |
720 |
|
$ |
15,244 |
|
$ |
100,975 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2022 |
|
||||||||||||
|
Net |
|
|
|
|
|
|
% |
|
|||||
|
Amortized |
|
Gross Unrealized |
|
Fair |
|
Fair |
|
||||||
|
Cost (1) |
|
Gains |
|
Losses |
|
Value |
|
Value |
|
||||
Fixed Maturity AFS Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industry corporate bonds: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial services |
$ |
17,762 |
|
$ |
133 |
|
$ |
1,998 |
|
$ |
15,897 |
|
15.9% |
|
Basic industry |
|
4,352 |
|
|
45 |
|
|
478 |
|
|
3,919 |
|
3.9% |
|
Capital goods |
|
7,374 |
|
|
63 |
|
|
884 |
|
|
6,553 |
|
6.6% |
|
Communications |
|
4,239 |
|
|
72 |
|
|
519 |
|
|
3,792 |
|
3.8% |
|
Consumer cyclical |
|
6,056 |
|
|
40 |
|
|
698 |
|
|
5,398 |
|
5.4% |
|
Consumer non-cyclical |
|
17,080 |
|
|
184 |
|
|
2,395 |
|
|
14,869 |
|
14.9% |
|
Energy |
|
4,776 |
|
|
53 |
|
|
485 |
|
|
4,344 |
|
4.4% |
|
Technology |
|
5,581 |
|
|
27 |
|
|
675 |
|
|
4,933 |
|
4.9% |
|
Transportation |
|
3,666 |
|
|
19 |
|
|
421 |
|
|
3,264 |
|
3.3% |
|
Industrial other |
|
2,330 |
|
|
3 |
|
|
416 |
|
|
1,917 |
|
1.9% |
|
Utilities |
|
14,204 |
|
|
111 |
|
|
1,822 |
|
|
12,493 |
|
12.5% |
|
Government-related entities |
|
1,820 |
|
|
37 |
|
|
213 |
|
|
1,644 |
|
1.6% |
|
CMOs: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agency backed |
|
1,451 |
|
|
3 |
|
|
166 |
|
|
1,288 |
|
1.3% |
|
Non-agency backed |
|
364 |
|
|
18 |
|
|
14 |
|
|
368 |
|
0.4% |
|
MPTS: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agency backed |
|
394 |
|
|
1 |
|
|
42 |
|
|
353 |
|
0.4% |
|
CMBS: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agency backed |
|
15 |
|
|
- |
|
|
- |
|
|
15 |
|
0.0% |
|
Non-agency backed |
|
1,902 |
|
|
3 |
|
|
246 |
|
|
1,659 |
|
1.7% |
|
ABS: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CLOs |
|
8,497 |
|
|
1 |
|
|
671 |
|
|
7,827 |
|
7.8% |
|
Credit card |
|
85 |
|
|
6 |
|
|
1 |
|
|
90 |
|
0.1% |
|
Home equity |
|
196 |
|
|
27 |
|
|
4 |
|
|
219 |
|
0.2% |
|
Other |
|
3,014 |
|
|
4 |
|
|
250 |
|
|
2,768 |
|
2.8% |
|
Municipals: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Taxable |
|
5,319 |
|
|
171 |
|
|
506 |
|
|
4,984 |
|
5.0% |
|
Tax-exempt |
|
91 |
|
|
1 |
|
|
6 |
|
|
86 |
|
0.1% |
|
Government: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
405 |
|
|
5 |
|
|
31 |
|
|
379 |
|
0.4% |
|
Foreign |
|
348 |
|
|
17 |
|
|
47 |
|
|
318 |
|
0.3% |
|
Hybrid and redeemable preferred securities |
|
364 |
|
|
25 |
|
|
30 |
|
|
359 |
|
0.4% |
|
Total fixed maturity AFS securities |
|
111,685 |
|
|
1,069 |
|
|
13,018 |
|
|
99,736 |
|
100.0% |
|
Trading Securities (2) |
|
3,833 |
|
|
44 |
|
|
379 |
|
|
3,498 |
|
|
|
Equity Securities |
|
383 |
|
|
104 |
|
|
60 |
|
|
427 |
|
|
|
Total fixed maturity AFS, trading and equity securities |
$ |
115,901 |
|
$ |
1,217 |
|
$ |
13,457 |
|
$ |
103,661 |
|
|
|
(1)Represents amortized cost, net of the allowance for credit losses.
(2)Certain of our trading securities support our reinsurance funds withheld and modified coinsurance agreements and the investment results are passed directly to the reinsurers. See “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Consolidated Investments – Fixed Maturity and Equity Securities Portfolios – Trading Securities” in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K, for further details.
Fixed Maturity AFS Securities
In accordance with the fixed maturity AFS accounting guidance, we reflect stockholders’ equity as if unrealized gains and losses were actually recognized and consider all related accounting adjustments that would occur upon such a hypothetical recognition of unrealized gains and losses. Such related balance sheet effects include adjustments to future contract benefits, policyholder account balances and deferred income taxes. Adjustments to each of these balances are charged or credited to accumulated other comprehensive income (loss) (“AOCI”). For instance, deferred income tax balances are adjusted because unrealized gains or losses do not affect actual taxes currently paid.
The quality of our fixed maturity AFS securities portfolio, as measured at estimated fair value and by the percentage of fixed maturity AFS securities invested in various ratings categories, relative to the entire fixed maturity AFS security portfolio (in millions) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
As of December 31, 2022 |
|
||||||||||||
|
|
Rating Agency |
|
Net |
|
|
|
|
|
|
Net |
|
|
|
|
|
|
||
NAIC |
|
Equivalent |
|
Amortized |
|
Fair |
|
% of |
|
Amortized |
|
Fair |
|
% of |
|
||||
Designation (1) |
|
Designation (1) |
|
Cost |
|
Value |
|
Total |
|
Cost |
|
Value |
|
Total |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
1 |
|
AAA / AA / A |
|
$ |
65,770 |
|
$ |
57,192 |
|
58.5% |
|
$ |
63,741 |
|
$ |
56,892 |
|
57.0% |
|
2 |
|
BBB |
|
|
42,792 |
|
|
37,358 |
|
38.2% |
|
|
44,103 |
|
|
39,230 |
|
39.4% |
|
Total investment grade securities |
|
|
108,562 |
|
|
94,550 |
|
96.7% |
|
|
107,844 |
|
|
96,122 |
|
96.4% |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Below Investment Grade Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
3 |
|
BB |
|
|
1,602 |
|
|
1,457 |
|
1.5% |
|
|
2,101 |
|
|
1,938 |
|
1.9% |
|
4 |
|
B |
|
|
1,735 |
|
|
1,693 |
|
1.7% |
|
|
1,679 |
|
|
1,620 |
|
1.6% |
|
5 |
|
CCC and lower |
|
|
98 |
|
|
91 |
|
0.1% |
|
|
59 |
|
|
53 |
|
0.1% |
|
6 |
|
In or near default |
|
|
16 |
|
|
13 |
|
0.0% |
|
|
2 |
|
|
3 |
|
0.0% |
|
Total below investment grade securities |
|
|
3,451 |
|
|
3,254 |
|
3.3% |
|
|
3,841 |
|
|
3,614 |
|
3.6% |
|
||
Total fixed maturity AFS securities |
|
$ |
112,013 |
|
$ |
97,804 |
|
100.0% |
|
$ |
111,685 |
|
$ |
99,736 |
|
100.0% |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total securities below investment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
grade as a percentage of total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
fixed maturity AFS securities |
|
|
3.1% |
|
|
3.3% |
|
|
|
|
3.4% |
|
|
3.6% |
|
|
|
||
(1)Based upon the rating designations determined and provided by the National Association of Insurance Commissioners (“NAIC”) or the major credit rating agencies (Fitch Ratings (“Fitch”), Moody’s Investors Service (“Moody’s”) and S&P Global Ratings (“S&P”)). For securities where the ratings assigned by the major credit rating agencies are not equivalent, the second lowest rating assigned is used. For those securities where ratings by the major credit rating agencies are not available, which does not represent a significant amount of our total fixed maturity AFS securities, we base the ratings disclosed upon internal ratings. The average credit quality was A- as of September 30, 2023.
Comparisons between the NAIC designations and rating agency designations are published by the NAIC. The NAIC assigns securities quality designations and uniform valuations, which are used by insurers when preparing their annual statements. The NAIC designations are similar to the rating agency designations of the Nationally Recognized Statistical Rating Organizations for marketable bonds. NAIC designations 1 and 2 include bonds generally considered investment grade (rated Baa3 or higher by Moody’s, or rated BBB- or higher by S&P and Fitch) by such ratings organizations. However, securities designated NAIC 1 and 2 could be deemed below investment grade by the rating agencies as a result of the current risk-based capital (“RBC”) rules for residential mortgage-backed securities (“RMBS”) and CMBS for statutory reporting. NAIC designations 3 through 6 include bonds generally considered below investment grade (rated Ba1 or lower by Moody’s, or rated BB+ or lower by S&P and Fitch).
As of September 30, 2023, and December 31, 2022, 97% of the total fixed maturity AFS securities in an unrealized loss position were investment grade. Our gross unrealized losses recognized in OCI on fixed maturity AFS securities as of September 30, 2023, increased by $1.8 billion since December 31, 2022. For further information on our unrealized losses on fixed maturity AFS securities, see “Composition by Industry Categories of our Unrealized Losses on Fixed Maturity AFS Securities” below.
We regularly review our fixed maturity AFS securities for declines in fair value that we determine to be impairment-related, including those attributable to credit risk factors that may require a credit allowance. Other than with respect to those certain fixed maturity AFS securities intended to be sold as part of the previously announced Fortitude Re reinsurance transaction, we do not believe the unrealized loss position as of September 30, 2023, required an impairment recognized in earnings as: (i) we did not intend to sell these fixed maturity AFS securities; (ii) it is not more likely than not that we will be required to sell the fixed maturity AFS securities before recovery of their amortized cost basis; and (iii) the difference in the fair value compared to the amortized cost was due to factors other than credit loss. This conclusion is consistent with our asset-liability management process. For additional information related to the intent to sell impairments, see Note 4. Management considered the following as part of the evaluation:
The current economic environment and market conditions;
Our business strategy and current business plans;
The nature and type of security, including expected maturities and exposure to general credit, liquidity, market and interest rate risk;
Our analysis of data from financial models and other internal and industry sources to evaluate the current effectiveness of our hedging and overall risk management strategies;
The current and expected timing of contractual maturities of our assets and liabilities, expectations of prepayments on investments and expectations for surrenders and withdrawals of annuity contracts and life insurance policies;
The capital risk limits approved by management; and
Our current financial condition and liquidity demands.
We recognized $(1) million and $(17) million of credit loss benefit (expense) on our fixed maturity AFS securities for the three and nine months ended September 30, 2023, and $(5) million and $(11) million for the corresponding periods in 2022. In order to determine the amount of credit loss, we calculated the recovery value by performing a discounted cash flow analysis based on the current cash flows and future cash flows we expect to recover. To determine the recoverability, we considered the facts and circumstances surrounding the underlying issuer including, but not limited to, the following:
Historical and implied volatility of the security;
The extent to which the fair value has been less than amortized cost;
Adverse conditions specifically related to the security or to specific conditions in an industry or geographic area;
Failure, if any, of the issuer of the security to make scheduled payments; and
Recoveries or additional declines in fair value subsequent to the balance sheet date.
For information on credit loss impairment on fixed maturity AFS securities, see Notes 1, 4 and 17 herein.
As reported on the Consolidated Balance Sheets, we had $141.1 billion of liabilities for future obligations under insurance policies and contracts, net of amounts recoverable from reinsurers, which exceeded investments and cash and invested cash, which totaled $135.0 billion as of September 30, 2023. If it were necessary to liquidate fixed maturity AFS securities prior to maturity or call to meet cash flow needs, we would first look to those fixed maturity AFS securities that are in an unrealized gain position, which had a fair value of $12.8 billion as of September 30, 2023, rather than selling fixed maturity AFS securities in an unrealized loss position. The amount of cash that we have on hand at any point in time takes into account our liquidity needs in the future, other sources of cash, such as the maturities of investments, interest and dividends we earn on our investments and the ongoing cash flows from new and existing business. For additional information, see “Liquidity and Capital Resources” below.
As of September 30, 2023, and December 31, 2022, the estimated fair value for all private placement securities was $19.2 billion and $19.0 billion, respectively, representing 14% of total investments.
Mortgage-Backed Securities (Included in Fixed Maturity AFS and Trading Securities)
See “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Consolidated Investments – Mortgage-Backed Securities” in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K, for a discussion of our mortgage-backed securities.
The market value of fixed maturity AFS and trading securities backed by subprime loans was $172 million and represented less than 1% of our total investment portfolio as of September 30, 2023. Fixed maturity AFS securities represented $165 million, or 96%, and trading securities represented $7 million, or 4%, of the subprime exposure as of September 30, 2023. The table below summarizes our investments in fixed maturity AFS securities backed by pools of residential mortgages (in millions) as of September 30, 2023:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subprime/ |
|
|
|
|
|
|
|
||||
|
Agency |
|
Prime |
|
Alt-A |
|
Option ARM (1) |
|
Total |
|
||||||||||||||||||||
|
Net |
|
|
|
|
Net |
|
|
|
|
Net |
|
|
|
|
Net |
|
|
|
|
Net |
|
|
|
|
|||||
|
Amortized |
Fair |
Amortized |
Fair |
Amortized |
Fair |
Amortized |
Fair |
Amortized |
Fair |
||||||||||||||||||||
|
Cost |
|
Value |
|
Cost |
|
Value |
|
Cost |
|
Value |
|
Cost |
|
Value |
|
Cost |
|
Value |
|
||||||||||
Type |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RMBS |
$ |
1,803 |
|
$ |
1,544 |
|
$ |
226 |
|
$ |
215 |
|
$ |
58 |
|
$ |
63 |
|
$ |
99 |
|
$ |
106 |
|
$ |
2,186 |
|
$ |
1,928 |
|
ABS home equity |
|
1 |
|
|
1 |
|
|
17 |
|
|
17 |
|
|
14 |
|
|
20 |
|
|
147 |
|
|
159 |
|
|
179 |
|
|
197 |
|
Total by type (2)(3) |
$ |
1,804 |
|
$ |
1,545 |
|
$ |
243 |
|
$ |
232 |
|
$ |
72 |
|
$ |
83 |
|
$ |
246 |
|
$ |
265 |
|
$ |
2,365 |
|
$ |
2,125 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rating |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AAA |
$ |
1,768 |
|
$ |
1,517 |
|
$ |
120 |
|
$ |
114 |
|
$ |
1 |
|
$ |
1 |
|
$ |
6 |
|
$ |
6 |
|
$ |
1,895 |
|
$ |
1,638 |
|
AA |
|
36 |
|
|
28 |
|
|
33 |
|
|
32 |
|
|
3 |
|
|
3 |
|
|
2 |
|
|
2 |
|
|
74 |
|
|
65 |
|
A |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
1 |
|
|
1 |
|
|
6 |
|
|
6 |
|
|
7 |
|
|
7 |
|
BBB |
|
- |
|
|
- |
|
|
31 |
|
|
26 |
|
|
2 |
|
|
2 |
|
|
5 |
|
|
5 |
|
|
38 |
|
|
33 |
|
BB and below |
|
- |
|
|
- |
|
|
59 |
|
|
60 |
|
|
65 |
|
|
76 |
|
|
227 |
|
|
246 |
|
|
351 |
|
|
382 |
|
Total by rating (2)(3)(4) |
$ |
1,804 |
|
$ |
1,545 |
|
$ |
243 |
|
$ |
232 |
|
$ |
72 |
|
$ |
83 |
|
$ |
246 |
|
$ |
265 |
|
$ |
2,365 |
|
$ |
2,125 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Origination Year |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2013 and prior |
$ |
411 |
|
$ |
386 |
|
$ |
78 |
|
$ |
77 |
|
$ |
72 |
|
$ |
83 |
|
$ |
246 |
|
$ |
265 |
|
$ |
807 |
|
$ |
811 |
|
2014 |
|
50 |
|
|
44 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
50 |
|
|
44 |
|
2015 |
|
144 |
|
|
124 |
|
|
15 |
|
|
14 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
159 |
|
|
138 |
|
2016 |
|
445 |
|
|
361 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
445 |
|
|
361 |
|
2017 |
|
202 |
|
|
173 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
202 |
|
|
173 |
|
2018 |
|
170 |
|
|
153 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
170 |
|
|
153 |
|
2019 |
|
158 |
|
|
121 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
158 |
|
|
121 |
|
2020 |
|
64 |
|
|
49 |
|
|
3 |
|
|
3 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
67 |
|
|
52 |
|
2021 |
|
109 |
|
|
87 |
|
|
33 |
|
|
27 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
142 |
|
|
114 |
|
2022 |
|
50 |
|
|
46 |
|
|
68 |
|
|
66 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
118 |
|
|
112 |
|
2023 |
|
1 |
|
|
1 |
|
|
46 |
|
|
45 |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
47 |
|
|
46 |
|
Total by origination |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
year (2)(3) |
$ |
1,804 |
|
$ |
1,545 |
|
$ |
243 |
|
$ |
232 |
|
$ |
72 |
|
$ |
83 |
|
$ |
246 |
|
$ |
265 |
|
$ |
2,365 |
|
$ |
2,125 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity AFS securities backed by pools of |
|
|
|
|
|
|
|
|||||||||||||||||||||||
residential mortgages as a percentage of total fixed maturity AFS securities |
|
|
2.1% |
|
|
2.2% |
|
|||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total prime, Alt-A and subprime/option ARM as a percentage of total fixed maturity AFS securities |
|
|
0.5% |
|
|
0.6% |
|
|||||||||||||||||||||||
(1)Includes the net amortized cost and fair value of option adjustable rate mortgages (“ARM”) within RMBS, totaling $94 million and $100 million, respectively.
(2)Does not include the amortized cost of trading securities totaling $85 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $85 million in trading securities consisted of $76 million prime, $1 million Alt-A and $8 million subprime.
(3)Does not include the fair value of trading securities totaling $71 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $71 million in trading securities consisted of $63 million prime, $1 million Alt-A and $7 million subprime.
(4)Based upon the rating designations determined and provided by the major credit rating agencies (Fitch, Moody’s and S&P). For securities where the ratings assigned by the major credit rating agencies are not equivalent, the second lowest rating assigned is used. For those securities where ratings by the major credit rating agencies are not available, which does not represent a significant amount of our total fixed maturity AFS securities, we base the ratings disclosed upon internal ratings.
None of these investments included any direct investments in subprime lenders or mortgages. We are not aware of material exposure to subprime loans in our alternative investment portfolio.
The following summarizes our investments in fixed maturity AFS securities backed by pools of commercial mortgages (in millions) as of September 30, 2023:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Multiple Property |
|
Single Property |
|
Total |
|
||||||||||||
|
Net |
|
|
|
|
Net |
|
|
|
|
Net |
|
|
|
|
|||
|
Amortized |
|
Fair |
|
Amortized |
|
Fair |
|
Amortized |
|
Fair |
|
||||||
|
Cost |
|
Value |
|
Cost |
|
Value |
|
Cost |
|
Value |
|
||||||
Type |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CMBS (1)(2) |
$ |
1,887 |
|
$ |
1,640 |
|
$ |
76 |
|
$ |
61 |
|
$ |
1,963 |
|
$ |
1,701 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rating |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AAA |
$ |
1,371 |
|
$ |
1,233 |
|
$ |
20 |
|
$ |
18 |
|
$ |
1,391 |
|
$ |
1,251 |
|
AA |
|
512 |
|
|
403 |
|
|
52 |
|
|
39 |
|
|
564 |
|
|
442 |
|
A |
|
4 |
|
|
4 |
|
|
4 |
|
|
4 |
|
|
8 |
|
|
8 |
|
Total by rating (1)(2)(3) |
$ |
1,887 |
|
$ |
1,640 |
|
$ |
76 |
|
$ |
61 |
|
$ |
1,963 |
|
$ |
1,701 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Origination Year |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2013 and prior |
$ |
14 |
|
$ |
14 |
|
$ |
10 |
|
$ |
9 |
|
$ |
24 |
|
$ |
23 |
|
2014 |
|
15 |
|
|
14 |
|
|
- |
|
|
- |
|
|
15 |
|
|
14 |
|
2015 |
|
27 |
|
|
24 |
|
|
- |
|
|
- |
|
|
27 |
|
|
24 |
|
2016 |
|
107 |
|
|
99 |
|
|
4 |
|
|
4 |
|
|
111 |
|
|
103 |
|
2017 |
|
344 |
|
|
324 |
|
|
- |
|
|
- |
|
|
344 |
|
|
324 |
|
2018 |
|
206 |
|
|
194 |
|
|
- |
|
|
- |
|
|
206 |
|
|
194 |
|
2019 |
|
353 |
|
|
305 |
|
|
- |
|
|
- |
|
|
353 |
|
|
305 |
|
2020 |
|
257 |
|
|
198 |
|
|
5 |
|
|
4 |
|
|
262 |
|
|
202 |
|
2021 |
|
246 |
|
|
180 |
|
|
39 |
|
|
29 |
|
|
285 |
|
|
209 |
|
2022 |
|
205 |
|
|
180 |
|
|
14 |
|
|
11 |
|
|
219 |
|
|
191 |
|
2023 |
|
113 |
|
|
108 |
|
|
4 |
|
|
4 |
|
|
117 |
|
|
112 |
|
Total by origination year (1)(2) |
$ |
1,887 |
|
$ |
1,640 |
|
$ |
76 |
|
$ |
61 |
|
$ |
1,963 |
|
$ |
1,701 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity AFS securities backed by pools of |
|
|
|
|
|
|
||||||||||||
commercial mortgages as a percentage of total fixed maturity AFS securities |
|
1.8% |
|
|
1.7% |
|
||||||||||||
(1)Does not include the amortized cost of trading securities totaling $142 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $142 million in trading securities consisted of $102 million of multiple property CMBS and $40 million of single property CMBS.
(2)Does not include the fair value of trading securities totaling $116 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $116 million in trading securities consisted of $82 million of multiple property CMBS and $34 million of single property CMBS.
(3)Based upon the rating designations determined and provided by the major credit rating agencies (Fitch, Moody’s and S&P). For securities where the ratings assigned by the major credit rating agencies are not equivalent, the second lowest rating assigned is used. For those securities where ratings by the major credit rating agencies are not available, which does not represent a significant amount of our total fixed maturity AFS securities, we base the ratings disclosed upon internal ratings.
As of September 30, 2023, the net amortized cost and fair value of our fixed maturity AFS exposure to monoline insurers was $288 million and $270 million, respectively.
Composition by Industry Categories of our Unrealized Losses on Fixed Maturity AFS Securities
When considering unrealized gain and loss information, it is important to recognize that the information relates to the position of securities at a particular point in time and may not be indicative of the position of our investment portfolios subsequent to the balance sheet date. Further, because the timing of the recognition of realized investment gains and losses through the selection of which securities are sold is largely at management’s discretion, it is important to consider the information provided below within the context of the overall unrealized gain or loss position of our investment portfolios. These are important considerations that should be included in any evaluation of the potential effect of securities in an unrealized loss position on our future earnings.
The composition by industry categories of all fixed maturity AFS securities in an unrealized loss position (in millions) as of September 30, 2023, was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% |
|
|
|
% |
|
|
|
|
|
|||
|
Net |
|
Net |
|
Gross |
|
Gross |
|
|
|
% |
|
|||
|
Amortized |
|
Amortized |
|
Unrealized |
|
Unrealized |
|
Fair |
|
Fair |
|
|||
|
Cost |
|
Cost |
|
Losses |
|
Losses |
|
Value |
|
Value |
|
|||
Electric |
$ |
9,118 |
|
9.1% |
|
$ |
1,566 |
|
10.7% |
|
$ |
7,552 |
|
8.9% |
|
Healthcare |
|
6,721 |
|
6.7% |
|
|
1,481 |
|
10.0% |
|
|
5,240 |
|
6.2% |
|
ABS |
|
10,537 |
|
10.6% |
|
|
821 |
|
5.5% |
|
|
9,716 |
|
11.4% |
|
Banking |
|
6,453 |
|
6.5% |
|
|
781 |
|
5.3% |
|
|
5,672 |
|
6.7% |
|
Technology |
|
5,313 |
|
5.3% |
|
|
770 |
|
5.2% |
|
|
4,543 |
|
5.3% |
|
Food and beverage |
|
4,458 |
|
4.5% |
|
|
695 |
|
4.7% |
|
|
3,763 |
|
4.4% |
|
Local authorities |
|
3,594 |
|
3.6% |
|
|
550 |
|
3.7% |
|
|
3,044 |
|
3.6% |
|
Industrial – other |
|
2,195 |
|
2.2% |
|
|
507 |
|
3.4% |
|
|
1,688 |
|
2.0% |
|
Diversified manufacturing |
|
2,895 |
|
2.9% |
|
|
436 |
|
2.9% |
|
|
2,459 |
|
2.9% |
|
Pharmaceuticals |
|
2,765 |
|
2.8% |
|
|
384 |
|
2.6% |
|
|
2,381 |
|
2.8% |
|
Natural gas |
|
2,133 |
|
2.1% |
|
|
363 |
|
2.5% |
|
|
1,770 |
|
2.1% |
|
Chemicals |
|
2,321 |
|
2.3% |
|
|
358 |
|
2.4% |
|
|
1,963 |
|
2.3% |
|
Brokerage asset management |
|
2,080 |
|
2.1% |
|
|
348 |
|
2.3% |
|
|
1,732 |
|
2.0% |
|
Retail |
|
1,986 |
|
2.0% |
|
|
333 |
|
2.2% |
|
|
1,653 |
|
1.9% |
|
Transportation services |
|
2,395 |
|
2.4% |
|
|
312 |
|
2.1% |
|
|
2,083 |
|
2.4% |
|
Property and casualty |
|
1,954 |
|
2.0% |
|
|
303 |
|
2.0% |
|
|
1,651 |
|
1.9% |
|
Life insurance |
|
1,692 |
|
1.7% |
|
|
285 |
|
1.9% |
|
|
1,407 |
|
1.7% |
|
Non-agency CMBS |
|
1,945 |
|
1.9% |
|
|
262 |
|
1.8% |
|
|
1,683 |
|
2.0% |
|
Midstream |
|
1,931 |
|
1.9% |
|
|
248 |
|
1.7% |
|
|
1,683 |
|
2.0% |
|
Aerospace and defense |
|
1,570 |
|
1.6% |
|
|
241 |
|
1.6% |
|
|
1,329 |
|
1.6% |
|
Utility – other |
|
1,156 |
|
1.2% |
|
|
228 |
|
1.5% |
|
|
928 |
|
1.1% |
|
Consumer products |
|
1,297 |
|
1.3% |
|
|
209 |
|
1.4% |
|
|
1,088 |
|
1.3% |
|
Wirelines |
|
1,227 |
|
1.2% |
|
|
205 |
|
1.4% |
|
|
1,022 |
|
1.2% |
|
Railroads |
|
978 |
|
1.0% |
|
|
183 |
|
1.2% |
|
|
795 |
|
0.9% |
|
Automotive |
|
1,590 |
|
1.6% |
|
|
182 |
|
1.2% |
|
|
1,408 |
|
1.7% |
|
Wireless |
|
938 |
|
0.9% |
|
|
165 |
|
1.1% |
|
|
773 |
|
0.9% |
|
Government sponsored |
|
716 |
|
0.7% |
|
|
153 |
|
1.0% |
|
|
563 |
|
0.7% |
|
Integrated |
|
920 |
|
0.9% |
|
|
146 |
|
1.0% |
|
|
774 |
|
0.9% |
|
Project finance |
|
998 |
|
1.0% |
|
|
135 |
|
0.9% |
|
|
863 |
|
1.0% |
|
Other real estate investment trust |
|
823 |
|
0.8% |
|
|
126 |
|
0.9% |
|
|
697 |
|
0.8% |
|
Entertainment |
|
916 |
|
0.9% |
|
|
126 |
|
0.9% |
|
|
790 |
|
0.9% |
|
Industries with unrealized losses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
less than $125 million |
|
14,238 |
|
14.3% |
|
|
1,913 |
|
13.0% |
|
|
12,325 |
|
14.5% |
|
Total by industry |
$ |
99,853 |
|
100.0% |
|
$ |
14,815 |
|
100.0% |
|
$ |
85,038 |
|
100.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total by industry as a percentage of |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
total fixed maturity AFS securities |
|
89.1% |
|
|
|
|
100.0% |
|
|
|
|
86.9% |
|
|
|
As of September 30, 2023, the net amortized cost and fair value of securities subject to enhanced analysis and monitoring for potential changes in unrealized loss position was $54 million and $46 million, respectively.
Mortgage Loans on Real Estate
The following tables summarize key information on mortgage loans on real estate (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
|||||||||
|
Commercial |
|
Residential |
|
Total |
|
% |
|
|||
Credit Quality Indicator |
|
|
|
|
|
|
|
|
|
|
|
Current |
$ |
17,187 |
|
$ |
1,631 |
|
$ |
18,818 |
|
99.7% |
|
Delinquent (1) |
|
- |
|
|
14 |
|
|
14 |
|
0.1% |
|
Foreclosure (2) |
|
- |
|
|
32 |
|
|
32 |
|
0.2% |
|
Total mortgage loans on real estate before allowance |
|
17,187 |
|
|
1,677 |
|
|
18,864 |
|
100.0% |
|
Allowance for credit losses |
|
(89 |
) |
|
(24 |
) |
|
(113 |
) |
|
|
Total mortgage loans on real estate |
$ |
17,098 |
|
$ |
1,653 |
|
$ |
18,751 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2022 |
|
|||||||||
|
Commercial |
|
Residential |
|
Total |
|
% |
|
|||
Credit Quality Indicator |
|
|
|
|
|
|
|
|
|
|
|
Current |
$ |
16,987 |
|
$ |
1,379 |
|
$ |
18,366 |
|
99.8% |
|
Delinquent (1) |
|
- |
|
|
13 |
|
|
13 |
|
0.1% |
|
Foreclosure (2) |
|
- |
|
|
21 |
|
|
21 |
|
0.1% |
|
Total mortgage loans on real estate before allowance |
|
16,987 |
|
|
1,413 |
|
|
18,400 |
|
100.0% |
|
Allowance for credit losses |
|
(84 |
) |
|
(15 |
) |
|
(99 |
) |
|
|
Total mortgage loans on real estate |
$ |
16,903 |
|
$ |
1,398 |
|
$ |
18,301 |
|
|
|
(1)As of September 30, 2023, and December 31, 2022, no commercial mortgage loans and 21 and 24 residential mortgage loans, respectively, were delinquent.
(2)As of September 30, 2023, and December 31, 2022, no commercial mortgage loans and 66 and 49 residential mortgage loans, respectively, were in foreclosure.
As of September 30, 2023, there were 3 specifically identified impaired commercial mortgage loans on real estate with an aggregate carrying value of $3 million and 67 specifically identified impaired residential mortgage loans on real estate with an aggregate carrying value of $34 million. As of December 31, 2022, there were 2 specifically identified impaired commercial mortgage loans on real estate with an aggregate carrying value of less than $1 million and 37 specifically identified impaired residential mortgage loans on real estate with an aggregate carrying value of $16 million.
The total outstanding principal and interest on commercial mortgage loans on real estate that were two or more payments delinquent, excluding foreclosures, as of September 30, 2023, and December 31, 2022, was less than $1 million. The total outstanding principal and interest on residential mortgage loans on real estate that were three or more payments delinquent, excluding foreclosures, as of September 30, 2023, and December 31, 2022, was $15 million and $13 million, respectively.
The carrying value of mortgage loans on real estate by business segment (in millions) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
As of |
|
|
||
|
September 30, |
December 31, |
|
||||||
|
|
2023 |
|
|
2022 |
|
|
||
Segment |
|
|
|
|
|
|
|
|
|
Annuities |
|
$ |
7,466 |
|
|
$ |
7,008 |
|
|
Life Insurance |
|
|
3,448 |
|
|
|
3,536 |
|
|
Group Protection |
|
|
1,434 |
|
|
|
1,417 |
|
|
Retirement Plan Services |
|
|
4,142 |
|
|
|
4,253 |
|
|
Other Operations |
|
|
2,261 |
|
|
|
2,087 |
|
|
Total mortgage loans on real estate |
|
$ |
18,751 |
|
|
$ |
18,301 |
|
|
The composition of commercial mortgage loans (in millions) by property type, geographic region and state is shown below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
|
As of September 30, 2023 |
|
||||||
|
Carrying |
|
|
|
|
Carrying |
|
|
|
||
|
Value |
|
% |
|
|
Value |
|
% |
|
||
Property Type |
|
|
|
|
|
State |
|
|
|
|
|
Apartment |
$ |
5,562 |
|
32.6% |
|
CA |
$ |
4,722 |
|
27.6% |
|
Industrial |
|
4,406 |
|
25.8% |
|
TX |
|
1,614 |
|
9.4% |
|
Office building |
|
3,478 |
|
20.3% |
|
FL |
|
917 |
|
5.4% |
|
Retail |
|
2,571 |
|
15.0% |
|
NY |
|
873 |
|
5.0% |
|
Other commercial |
|
763 |
|
4.5% |
|
PA |
|
829 |
|
4.8% |
|
Mixed use |
|
176 |
|
1.0% |
|
MD |
|
715 |
|
4.2% |
|
Hotel/motel |
|
142 |
|
0.8% |
|
AZ |
|
702 |
|
4.1% |
|
Total |
$ |
17,098 |
|
100.0% |
|
GA |
|
685 |
|
4.0% |
|
Geographic Region |
|
|
|
|
|
WA |
|
661 |
|
3.9% |
|
Pacific |
$ |
5,706 |
|
33.4% |
|
TN |
|
556 |
|
3.3% |
|
South Atlantic |
|
3,600 |
|
21.1% |
|
OH |
|
426 |
|
2.5% |
|
Middle Atlantic |
|
1,991 |
|
11.6% |
|
NC |
|
388 |
|
2.3% |
|
West South Central |
|
1,756 |
|
10.2% |
|
VA |
|
388 |
|
2.3% |
|
Mountain |
|
1,315 |
|
7.7% |
|
WI |
|
345 |
|
2.0% |
|
East North Central |
|
1,203 |
|
7.0% |
|
OR |
|
323 |
|
1.9% |
|
East South Central |
|
678 |
|
4.0% |
|
SC |
|
301 |
|
1.8% |
|
West North Central |
|
461 |
|
2.7% |
|
IL |
|
296 |
|
1.7% |
|
New England |
|
359 |
|
2.1% |
|
Non U.S. |
|
29 |
|
0.2% |
|
Non U.S. |
|
29 |
|
0.2% |
|
All other states |
|
2,328 |
|
13.6% |
|
Total |
$ |
17,098 |
|
100.0% |
|
Total |
$ |
17,098 |
|
100.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table shows the principal amount (in millions) of our commercial and residential mortgage loans by year in which the principal is contractually obligated to be repaid:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2023 |
|
|||||||||
|
Commercial |
|
Residential |
|
Total |
|
% |
|
|||
Principal Repayment Year |
|
|
|
|
|
|
|
|
|
|
|
2023 |
$ |
185 |
|
$ |
5 |
|
$ |
190 |
|
1.1% |
|
2024 |
|
907 |
|
|
20 |
|
|
927 |
|
4.9% |
|
2025 |
|
1,041 |
|
|
21 |
|
|
1,062 |
|
5.6% |
|
2026 |
|
1,412 |
|
|
22 |
|
|
1,434 |
|
7.6% |
|
2027 |
|
1,735 |
|
|
24 |
|
|
1,759 |
|
9.3% |
|
2028 and thereafter |
|
11,941 |
|
|
1,544 |
|
|
13,485 |
|
71.5% |
|
Total |
$ |
17,221 |
|
$ |
1,636 |
|
$ |
18,857 |
|
100.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
See Note 4 for information regarding our loan-to-value and debt-service coverage ratios and our allowance for credit losses.
Alternative Investments
Investment income (loss) on alternative investments by business segment (in millions) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Segment |
|
|
|
|
|
|
|
|
|
|
|
|
Annuities |
$ |
4 |
|
$ |
(4 |
) |
$ |
13 |
|
$ |
6 |
|
Life Insurance |
|
44 |
|
|
(51 |
) |
|
158 |
|
|
38 |
|
Group Protection |
|
2 |
|
|
(2 |
) |
|
7 |
|
|
4 |
|
Retirement Plan Services |
|
2 |
|
|
(2 |
) |
|
7 |
|
|
4 |
|
Other Operations |
|
- |
|
|
(1 |
) |
|
- |
|
|
1 |
|
Total (1) |
$ |
52 |
|
$ |
(60 |
) |
$ |
185 |
|
$ |
53 |
|
(1)Includes net investment income on the alternative investments supporting the required statutory surplus of our insurance businesses.
As of September 30, 2023, and December 31, 2022, alternative investments included investments in 348 and 337 different partnerships, respectively, and the portfolio represented approximately 2% of total investments. The partnerships do not represent off-balance sheet financing and generally involve several third-party partners. Some of our partnerships contain capital calls, which require us to contribute capital upon notification by the general partner. These capital calls are contemplated during the initial investment decision and are planned for well in advance of the call date. The capital calls are not material in size and are not material to our liquidity. Alternative investments are accounted for using the equity method of accounting and are included in other investments on the Consolidated Balance Sheets.
Non-Income Producing Investments
As of September 30, 2023, and December 31, 2022, the carrying amount of fixed maturity securities, mortgage loans on real estate and real estate that were non-income producing was $74 million and $11 million, respectively.
Net Investment Income
Details underlying net investment income (in millions) and our investment yield were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
|
For the Nine |
|
||||||||
|
Months Ended |
|
|
Months Ended |
|
||||||||
|
September 30, |
|
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
|
2023 |
|
2022 |
|
||||
Net Investment Income |
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities |
$ |
1,237 |
|
$ |
1,131 |
|
|
$ |
3,659 |
|
$ |
3,279 |
|
Trading securities |
|
40 |
|
|
48 |
|
|
|
123 |
|
|
134 |
|
Equity securities |
|
3 |
|
|
4 |
|
|
|
9 |
|
|
9 |
|
Mortgage loans on real estate |
|
188 |
|
|
173 |
|
|
|
553 |
|
|
511 |
|
Policy loans |
|
27 |
|
|
26 |
|
|
|
79 |
|
|
76 |
|
Cash and invested cash |
|
39 |
|
|
5 |
|
|
|
100 |
|
|
7 |
|
Commercial mortgage loan prepayment |
|
|
|
|
|
|
|
|
|
|
|
|
|
and bond make-whole premiums (1) |
|
1 |
|
|
14 |
|
|
|
6 |
|
|
96 |
|
Alternative investments (2) |
|
52 |
|
|
(60 |
) |
|
|
185 |
|
|
53 |
|
Consent fees |
|
- |
|
|
2 |
|
|
|
3 |
|
|
4 |
|
Other investments |
|
(14 |
) |
|
7 |
|
|
|
(24 |
) |
|
76 |
|
Investment income |
|
1,573 |
|
|
1,350 |
|
|
|
4,693 |
|
|
4,245 |
|
Investment expense |
|
(79 |
) |
|
(55 |
) |
|
|
(225 |
) |
|
(140 |
) |
Net investment income |
$ |
1,494 |
|
$ |
1,295 |
|
|
$ |
4,468 |
|
$ |
4,105 |
|
(1)See “Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.
(2)See “Alternative Investments” above for additional information.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
|
For the Nine |
|
||||
|
Months Ended |
|
|
Months Ended |
|
||||
|
September 30, |
|
|
September 30, |
|
||||
|
2023 |
|
2022 |
|
|
2023 |
|
2022 |
|
Interest Rate Yield |
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities, mortgage loans on |
|
|
|
|
|
|
|
|
|
real estate and other, net of investment expenses |
4.08% |
|
3.88% |
|
|
4.05% |
|
3.84% |
|
Commercial mortgage loan prepayment and |
|
|
|
|
|
|
|
|
|
bond make-whole premiums |
0.00% |
|
0.04% |
|
|
0.01% |
|
0.10% |
|
Alternative investments |
0.15% |
|
-0.18% |
|
|
0.18% |
|
0.05% |
|
Net investment income yield on invested assets |
4.23% |
|
3.74% |
|
|
4.24% |
|
3.99% |
|
|
|
|
|
|
|
|
|
|
|
We earn investment income on our general account assets supporting fixed annuity, term life, whole life, UL, interest-sensitive whole life and the fixed portion of retirement plan and VUL products. The profitability of our fixed annuity and life insurance products is affected by our ability to achieve target spreads, or margins, between the interest income earned on the general account assets and the interest credited to the policyholder on our average fixed account balances, including the fixed portion of variable. Net investment income and the interest rate yield table each include commercial mortgage loan prepayments and bond make-whole premiums, alternative investments and contingent interest and standby real estate equity commitments. These items can vary significantly from period to period due to a number of factors and, therefore, can provide results that are not indicative of the underlying trends.
Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums
Prepayment and make-whole premiums are collected when borrowers elect to call or prepay their debt prior to the stated maturity. A prepayment or make-whole premium allows investors to attain the same yield as if the borrower made all scheduled interest payments until maturity. These premiums are designed to make investors indifferent to prepayment.
LIQUIDITY AND CAPITAL RESOURCES
Overview
Liquidity
Liquidity refers to our ability to generate adequate amounts of cash from our normal operations to meet cash requirements with a prudent margin of safety. Our ability to generate and maintain sufficient liquidity depends on the profitability of our businesses, general economic conditions and access to the capital markets and other sources of liquidity and capital as described below.
When considering our liquidity, it is important to distinguish between the needs of our insurance subsidiaries and the needs of the holding company, LNC. As a holding company with no operations of its own, LNC is largely dependent upon the dividend capacity of its insurance subsidiaries as well as their ability to advance or repay funds to it through inter-company borrowing arrangements, which may be affected by factors influencing the insurance subsidiaries’ RBC and statutory earnings performance. Based on the sources of liquidity available to us as discussed below, we currently expect to be able to meet the holding company’s ongoing cash needs.
Capital
Capital refers to our long-term financial resources to support the operations of our businesses, to fund long-term growth strategies and to support our operations during adverse conditions. Our ability to generate and maintain sufficient capital depends on the profitability of our businesses, general economic conditions and access to the capital markets and other sources of liquidity and capital as described below. Disruptions, uncertainty or volatility in the capital and credit markets may materially affect our business operations and results of operations and may adversely affect our insurance subsidiaries’ statutory surplus and RBC.
Reductions to our subsidiaries’ statutory surplus and RBC may cause them to retain more capital, which may pressure their ability to pay dividends to LNC, which may lead us to take steps to preserve or raise additional capital. We believe we have adequate capital to operate our business as we replenish statutory capital back to our targeted levels. For more information, see “Subsidiaries’ Capital” below.
For factors that could cause actual results to differ materially from those set forth in this section and that could affect our expectations for liquidity and capital, see “Part I – Item 1A. Risk Factors” in our 2022 Form 10-K/A and “Forward-Looking Statements – Cautionary Language” above.
Consolidated Sources and Uses of Liquidity and Capital
Our primary sources of liquidity and capital are insurance premiums and fees, investment income, maturities and sales of investments, issuance of debt or other types of securities and policyholder deposits. We also have access to alternative sources of liquidity as discussed below. Our primary uses are to pay policy claims and benefits, to fund commissions and other general operating expenses, to purchase investments, to fund policy surrenders and withdrawals, to pay dividends to our common and preferred stockholders, to repurchase our common stock and to repay debt. Our operating activities provided (used) cash of $(206) million and $3.0 billion for the nine months ended September 30, 2023 and 2022, respectively.
Holding Company Sources and Uses of Liquidity and Capital
The primary sources of liquidity and capital at the holding company level are dividends and interest payments from subsidiaries, augmented by holding company short-term investments, bank lines of credit and the ongoing availability of long-term public financing under an effective shelf registration statement, which allows us to issue, in unlimited amounts, securities, including debt securities, preferred stock, common stock, warrants, stock purchase contracts, stock purchase units and depository shares. These sources support the general corporate needs of the holding company, including its common and preferred stock dividends, common stock repurchases, interest and debt service, funding of callable securities, acquisitions and investment in core businesses.
Details underlying the primary sources of the holding company’s liquidity (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Dividends from Subsidiaries |
|
|
|
|
|
|
|
|
|
|
|
|
LNL |
$ |
105 |
|
$ |
275 |
|
$ |
365 |
|
$ |
580 |
|
Lincoln Investment Management Company |
|
- |
|
|
- |
|
|
- |
|
|
16 |
|
Lincoln National Management Corporation |
|
- |
|
|
- |
|
|
- |
|
|
7 |
|
Lincoln National Reinsurance Company (Barbados) Limited |
|
50 |
|
|
- |
|
|
150 |
|
|
85 |
|
Total dividends from subsidiaries |
$ |
155 |
|
$ |
275 |
|
$ |
515 |
|
$ |
688 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest from Subsidiaries |
|
|
|
|
|
|
|
|
|
|
|
|
Interest on inter-company notes |
$ |
39 |
|
$ |
31 |
|
$ |
111 |
|
$ |
87 |
|
The table above focuses on significant and recurring cash flow items and excludes the effects of certain financing activities, including the periodic issuance and retirement of debt, issuance of preferred stock, cash flows related to our inter-company cash management program and certain investing activities, including capital contributions to subsidiaries. These activities are discussed below. Taxes have been eliminated from the analysis due to a tax sharing agreement among our primary subsidiaries resulting in a modest effect on net cash flows at the holding company. Also excluded from this analysis is the modest amount of investment income on short-term investments of the holding company and employee stock exercise activity related to our stock-based incentive compensation plans. See “Part IV – Item 15(a)(2) Financial Statement Schedules – Schedule II – Condensed Financial Information of Registrant” in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K, for the holding company cash flow statement. For information regarding limits on the dividends that our insurance subsidiaries may pay without prior approval, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources – Holding Company Sources and Uses of Liquidity and Capital – Restrictions on Subsidiaries’ Dividends” in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K.
Subsidiaries’ Capital
Our insurance subsidiaries must maintain certain regulatory capital levels. We utilize the RBC ratio as a primary measure of the capital adequacy of our insurance subsidiaries. The RBC ratio is an important factor in the determination of the credit and financial strength ratings of LNC and its subsidiaries, as a reduction in our insurance subsidiaries’ surplus will affect their RBC ratios and dividend-paying capacity. For additional information on RBC ratios, see “Part I – Item 1. Business – Regulatory – Insurance Regulation – Risk-Based Capital” in our 2022 Form 10-K/A.
Our insurance subsidiaries’ regulatory capital levels are affected by statutory accounting rules, which are subject to change by each applicable insurance regulator. For instance, our term products and UL products containing secondary guarantees require reserves calculated pursuant to the Valuation of Life Insurance Policies Model Regulation (“XXX”) and Actuarial Guideline XXXVIII (“AG38”), respectively. Our insurance subsidiaries employ strategies to reduce the strain caused by XXX and AG38 by reinsuring the business to reinsurance captives. Our captive reinsurance and reinsurance subsidiaries provide a mechanism for financing a portion of the excess reserve amounts in a more efficient manner and free up capital the insurance subsidiaries can use for any number of purposes, including paying dividends to the holding company. We use long-dated LOCs and debt financing as well as other financing strategies to finance those reserves. Included in the LOCs issued as of September 30, 2023, was $1.8 billion of long-dated LOCs issued to support inter-company reinsurance agreements for UL products containing secondary guarantees. For information on the LOCs, see the credit facilities table in Note 12 in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K. Our captive reinsurance and reinsurance subsidiaries have also issued long-term notes of $3.9 billion to finance a portion of the excess reserves associated with our term and UL products with secondary guarantees as of September 30, 2023; of this amount, $3.1 billion involve exposure to variable interest entities. For information on these long-term notes issued by our captive reinsurance and reinsurance subsidiaries, see Note 3 in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K. We have also used the proceeds from senior note issuances of $875 million to execute long-term structured solutions primarily supporting reinsurance of UL products containing secondary guarantees. LOCs and related capital market solutions lower the capital effect of term products and UL products containing secondary guarantees.
Statutory reserves established for variable annuity guaranteed benefit riders are sensitive to changes in the equity markets and interest rates and are affected by the level of account balances relative to the level of any guarantees, product design and reinsurance arrangements. As a result, the relationship between reserve changes and equity market performance is non-linear during any given reporting period. Our insurance subsidiaries’ cede a portion of the guaranteed benefit riders to Lincoln National Reinsurance Company (Barbados) Limited (“LNBAR”) through a modified coinsurance agreement. Our variable annuity hedge program mitigates the risk to LNBAR from guaranteed benefit riders and continues to focus on generating sufficient assets to fund future claims with a goal of maximizing distributable earnings and explicitly protecting capital. Market conditions greatly influence the ultimate capital required due to its effect on the valuation of reserves and supporting derivatives. In December 2022, LNC issued a long-term note to a non-affiliated variable interest entity in exchange for notes of like principal and duration classified as AFS securities. LNC contributed the securities to LNBAR to address asset value volatility based on market conditions. Under the current terms of the note facility, the maximum permissible principal amount of the note is $1.25 billion, the full amount of which was outstanding as of September 30, 2023.
There are no impacts to the LNC Consolidated Balance Sheets based on the set-off right provided in the note facility. For more information, see Note 3 in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K.
Changes in equity markets may also affect the capital position of our insurance subsidiaries. We may decide to reallocate available capital among our insurance subsidiaries, including our captive reinsurance subsidiaries, which would result in different RBC ratios for our insurance subsidiaries. In addition, changes in the equity markets can affect the value of our variable annuity and variable universal life insurance separate accounts. When the market value of our separate account assets increases, the statutory surplus within our insurance subsidiaries also increases. Contrarily, when the market value of our separate account assets decreases, the statutory surplus within our insurance subsidiaries may also decrease, which will affect RBC ratios, and in the case of our separate account assets becoming less than the related product liabilities, we must allocate additional capital to fund the difference.
We continue to analyze the use of our existing captive reinsurance structures, as well as additional third-party reinsurance arrangements, and our hedging strategies relative to managing the effects of equity markets and interest rates on the statutory reserves, statutory capital and the dividend capacity of our life insurance subsidiaries. On May 2, 2023, we entered into a reinsurance agreement with Fortitude Re expected to reduce balance sheet risk, strengthen our capital position and improve free cash flow. For more information, see Note 8.
Debt
Although our subsidiaries currently generate adequate cash flow to meet the needs of our normal operations, periodically LNC may issue debt to maintain ratings and increase liquidity, as well as to fund internal growth, acquisitions and the retirement of its debt.
Details underlying our debt activities (in millions) for the nine months ended September 30, 2023, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maturities, |
|
Change |
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
Repayments |
|
in Fair |
|
|
|
|
|
|
|
|
||||
|
Beginning |
|
|
|
|
and |
|
Value |
|
|
Other |
|
|
Ending |
|||||||
|
Balance |
|
Issuance |
|
Refinancing |
|
Hedges |
|
Changes (1) |
|
Balance |
||||||||||
Short-Term Debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current maturities of long-term debt (2) |
$ |
500 |
|
$ |
- |
|
|
$ |
(500 |
) |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-Term Debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Senior notes |
$ |
4,497 |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
(41 |
) |
|
$ |
(9 |
) |
|
$ |
4,447 |
Term loans |
|
250 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
250 |
Subordinated notes (3) |
|
995 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
995 |
Capital securities (3) |
|
213 |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
213 |
Total long-term debt |
$ |
5,955 |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
(41 |
) |
|
$ |
(9 |
) |
|
$ |
5,905 |
(1)Includes the non-cash reclassification of long-term debt to current maturities of long-term debt, accretion (amortization) of discounts and premiums, amortization of debt issuance costs and amortization of adjustments from discontinued hedges, as applicable.
(2)Consisted of $500 million principal amount of our 4.00% Senior Notes that was repaid on September 1, 2023.
(3)To hedge the variability in rates, we purchased interest rate swaps to lock in a fixed rate of approximately 5% over the remaining terms of the subordinated notes and capital securities.
LNC made interest payments to service debt of $75 million and $246 million for the three and nine months ended September 30, 2023, respectively, compared to $73 million and $216 million, respectively, for the corresponding periods in 2022.
For additional information about our short-term and long-term debt and our credit facilities, see Note 12 in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K.
Preferred Stock
In November 2022, we raised approximately $1 billion through the issuance of preferred stock, $780 million of which was contributed to The Lincoln National Life Insurance Company (“LNL”) in the fourth quarter of 2022 to strengthen LNL’s statutory capital. We used the remaining proceeds to fund part of the repayment upon maturity of our 4.00% Senior Notes due September 1, 2023.
Details underlying preferred stock dividends paid (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Series C preferred stock dividends |
$ |
23 |
|
$ |
- |
|
$ |
36 |
|
$ |
- |
|
Series D preferred stock dividends |
|
11 |
|
|
- |
|
|
35 |
|
|
- |
|
Total preferred stock dividends |
$ |
34 |
|
$ |
- |
|
$ |
71 |
|
$ |
- |
|
Capital Contributions to Subsidiaries
LNC made capital contributions to subsidiaries of zero and $5 million for the three and nine months ended September 30, 2023, respectively, compared to $80 million and $145 million for the corresponding periods in 2022.
Return of Capital to Common Stockholders
One of our primary goals is to provide a return to our common stockholders through share price accretion, dividends and stock repurchases. In determining dividends, the Board of Directors takes into consideration items such as current and expected earnings, capital needs, rating agency considerations and requirements for financial flexibility. The amount and timing of share repurchases depends on key capital ratios, rating agency expectations, the generation of dividends from our subsidiaries and an evaluation of the costs and benefits associated with alternative uses of capital. For additional information regarding share repurchases, see “Part II – Item 2(c)” below.
Details underlying return of capital to common stockholders (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three |
|
For the Nine |
|
||||||||
|
Months Ended |
|
Months Ended |
|
||||||||
|
September 30, |
|
September 30, |
|
||||||||
|
2023 |
|
2022 |
|
2023 |
|
2022 |
|
||||
Dividends to common stockholders |
$ |
76 |
|
$ |
77 |
|
$ |
229 |
|
$ |
234 |
|
Repurchase and cancellation of common stock warrants |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
Repurchase of common stock |
|
- |
|
|
50 |
|
|
- |
|
|
550 |
|
Total cash returned to common stockholders |
$ |
76 |
|
$ |
127 |
|
$ |
229 |
|
$ |
784 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares repurchased |
|
- |
|
|
1.0 |
|
|
- |
|
|
8.7 |
|
Alternative Sources of Liquidity
Inter-Company Cash Management Program
To promote effective short-term cash management strategies, we utilize an inter-company cash management program between LNC and participating subsidiaries where each entity can lend to or borrow from the holding company to meet short-term borrowing needs. As of September 30, 2023, the holding company had a net receivable of $344 million due from certain subsidiaries in the inter-company cash
management program. Loans under the cash management program are permitted under applicable insurance laws subject to certain restrictions. For our Indiana-domiciled insurance subsidiary, the borrowing and lending limit is currently 3% of the insurance company’s admitted assets as of its most recent year end. For our New York-domiciled insurance subsidiary, it may borrow from LNC less than 2% of its admitted assets as of its most recent year end but may not lend any amounts to LNC.
Facility Agreement for Senior Notes Issuance
LNC entered into a facility agreement in 2020 with a Delaware trust that gives LNC the right over a 10-year period to issue, from time to time, up to $500 million of 2.330% senior notes to the trust in exchange for a corresponding amount of U.S. Treasury securities held by the trust. By agreeing to purchase the 2.330% senior notes in exchange for U.S. Treasury securities upon exercise of the issuance right, the trust will provide a source of liquid assets for the Company. The issuance right will be exercised automatically in full upon our failure to make certain payments to the trust, if the failure to pay is not cured within 30 days, or upon certain bankruptcy events involving LNC. We are also required to exercise the issuance right in full if our consolidated stockholders’ equity (excluding AOCI) falls below a minimum threshold (which was $2.75 billion as of September 30, 2023, and is subject to adjustment from time to time in certain cases) and upon certain other events described in the facility agreement. For additional information, see Note 12 in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K.
Federal Home Loan Bank
Our primary insurance subsidiary, LNL, is a member of the Federal Home Loan Bank (“FHLB”) of Indianapolis (“FHLBI”). Membership allows LNL access to the FHLBI’s financial services, including the ability to obtain loans and to issue funding agreements as an alternative source of liquidity that are collateralized by qualifying mortgage-related assets, agency securities or U.S. Treasury securities. Borrowings under this facility are subject to the FHLBI’s discretion and require the availability of qualifying assets at LNL. As of September 30, 2023, LNL had an estimated maximum borrowing capacity of $7.0 billion under the FHLBI facility and maximum available borrowing based on qualifying assets of $5.1 billion. As of September 30, 2023, LNL had outstanding borrowings of $2.9 billion under this facility reported within payables for collateral on investments on the Consolidated Balance Sheets. Lincoln Life & Annuity Company of New York (“LLANY”) is a member of the Federal Home Loan Bank of New York (“FHLBNY”) with an estimated maximum borrowing capacity of $750 million. Borrowings under this facility are subject to the FHLBNY’s discretion and require the availability of qualifying assets at LLANY. As of September 30, 2023, LLANY had no outstanding borrowings under this facility. For additional information, see “Payables for Collateral on Investments” in Note 4.
Securities Lending Programs and Repurchase Agreements
Our insurance subsidiaries, by virtue of their general account fixed-income investment holdings, can access liquidity through securities lending programs and repurchase agreements. As of September 30, 2023, our insurance subsidiaries had securities pledged under securities lending agreements with a carrying value of $290 million. In addition, our insurance and reinsurance subsidiaries had access to $2.25 billion through committed repurchase agreements, of which $25 million was utilized as of September 30, 2023. The cash received in our securities lending programs and repurchase agreements is typically invested in cash and invested cash or fixed maturity AFS securities. For additional information, see “Payables for Collateral on Investments” in Note 4.
Collateral on Derivative Contracts
Our cash flows associated with collateral received from counterparties (when we are in a net collateral payable position) and posted with counterparties (when we are in a net collateral receivable position) change as the market value of the underlying derivative contract changes. The net collateral position depends on changes in interest rates and equity markets related to the amount of the exposures hedged. As of September 30, 2023, we were in a net collateral payable position of $4.3 billion compared to $3.1 billion as of December 31, 2022. In the event of adverse changes in fair value of our derivative instruments, we may need to post collateral with a counterparty. If we do not have sufficient high-quality securities or cash and invested cash to provide as collateral, we have committed liquidity sources through facilities that can provide up to $1.25 billion of additional liquidity to help meet collateral needs. Access to such facilities is contingent upon interest rates having achieved certain threshold levels. In addition to these facilities, we have the facility agreement for senior notes issuance, the FHLB facilities and the repurchase agreements discussed above as well as the five-year revolving credit facility discussed in Note 12 in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K, to leverage that would be eligible for collateral posting. For additional information, see “Credit Risk” in Note 6.
Ratings
Financial Strength Ratings
See “Part I – Item 1. Business – Financial Strength Ratings” in our 2022 Form 10-K/A for information on our financial strength ratings.
Credit Ratings
See “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources – Ratings” in our 2022 Form 10-K/A for information on our credit ratings.
If our current financial strength ratings or credit ratings were downgraded in the future, terms in our derivative agreements may be triggered, which could negatively affect overall liquidity. For the majority of our derivative counterparties, there is a termination event with respect to LNC if its long-term senior debt ratings drop below BBB-/Baa3 (S&P/Moody’s); or with respect to LNL if its financial strength ratings drop below BBB-/Baa3 (S&P/Moody’s). Our long-term senior debt held a rating of BBB+/Baa1 (S&P/Moody’s) as of September 30, 2023. On October 9, 2023, Moody’s downgraded LNC’s long-term issuer credit rating to Baa2 (9th highest of 21) and downgraded the financial strength ratings of LNL, LLANY and FPP from A1 to A2 (6th highest of 21), due in part to a decrease in our capital from the third quarter 2022 annual assumption review, and revised its ratings outlook from negative to stable for LNC and its insurance subsidiaries. In addition, contractual selling agreements with intermediaries could be negatively affected, which could have an adverse effect on overall sales of annuities, life insurance and investment products. See “Part I – Item 1A. Risk Factors – Covenants and Ratings – A downgrade in our financial strength or credit ratings could limit our ability to market products, increase the number or value of policies being surrendered and/or hurt our relationships with creditors” in our 2022 Form 10-K/A for more information.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We analyze and manage the risks arising from market exposures of financial instruments, as well as other risks, in an integrated asset-liability management process that considers diversification. We have exposures to several market risks including interest rate risk, equity market risk, credit risk and, to a lesser extent, foreign currency exchange risk. The MD&A included in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K, contains a detailed discussion of our quantitative and qualitative disclosures about market risk. Set forth below are material updates to the disclosure contained in “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K, which should be read in conjunction with that disclosure.
Market Risk Related to Certain Variable Annuity and Fixed Indexed Annuity Products
Our variable annuity and fixed indexed annuity contracts are exposed to market risks related to changes in the assumptions used in the original pricing of these products, including equity market, interest rate, and non-market actuarial assumptions. For additional information, see Note 10. We manage our exposure to market risks created by these fluctuations through a combination of product design elements and our hedge program. In addition, we utilize reinsurance to mitigate risk. For additional information, see Note 10 and “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Reinsurance” in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K. Certain variable annuity GLB and GDB riders are accounted for as MRBs and recorded at fair value. For more information on the market risk sensitivities associated with MRBs, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates – Market Risk Benefits.”
Interest Rate Risk
Interest rate risk is the risk of financial loss due to adverse changes in the value of assets and liabilities due to movements in interest rates. We are exposed to interest rate risk arising from our fixed maturity securities and interest rate sensitive liabilities.
With respect to accumulation and investment-oriented products, we seek to earn a stable and profitable spread, or margin, between investment income we earn on our investments and interest credited to the account balances of our policyholders. If we have adverse experience on investments that cannot be passed on to customers, our spreads are reduced. The combination of a probable range of interest rate changes over the next 12 months, asset-liability management strategies, flexibility in adjusting policy crediting rate levels and protection afforded by policy surrender charges all work together to mitigate this risk. The interest rate scenarios of concern are those in which there is a substantial, relatively prolonged decrease in interest rates that is sustained over a long period or a rapid increase in interest rates. For additional information, see “Part II – Item 7A. Quantitative and Qualitive Disclosures About Market Risk – Interest Rate Risk” in our 2022 Form 10-K/A, as updated by the May 2023 Form 8-K.
Effect of Interest Rate Sensitivity
The following table presents our estimate of the effect on income (loss) from operations by segment (in millions) for the next 12-month period if the level of interest rates were to instantaneously increase or decrease by 1% and remain at those levels immediately after September 30, 2023, relative to interest rates remaining flat.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1% |
|
1% |
|
||
|
Increase |
|
Decrease |
|
||
Segment |
|
|
|
|
|
|
Annuities (1) |
$ |
(21 |
) |
$ |
21 |
|
Life Insurance |
|
7 |
|
|
(7 |
) |
Group Protection |
|
6 |
|
|
(5 |
) |
Retirement Plan Services |
|
(3 |
) |
|
(3 |
) |
Other Operations |
|
(7 |
) |
|
7 |
|
Income (loss) from operations |
$ |
(18 |
) |
$ |
13 |
|
(1)Includes the impact on bond funds in our separate accounts, which move in the opposite direction of interest rates.
We have updated estimated impacts to income (loss) from operations for changes primarily related to new money rates. For purposes of this estimate, we assumed asset purchases are made at prevailing new money rates and exclude the impact of new business, persistency, hedge program performance or customer behavior caused by the interest rate changes.
Item 4. Controls and Procedures
Conclusions Regarding Disclosure Controls and Procedures
We maintain disclosure controls and procedures, which are designed to ensure that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. As of the end of the period required by this report, we, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were ineffective as of September 30, 2023, as a result of the material weakness disclosed in our 2022 Form 10-K/A.
Remediation Plan for Previously Reported Material Weakness
Since identifying the material weakness related to management’s review controls over significant reinsurance transactions, management has taken the following steps towards remediating the material weakness:
The formation of a technical review committee comprising cross-functional accounting, business, legal, and risk personnel that is in place and operating with a dedicated charter in overseeing the technical accounting and reporting implications of complex significant transactions;
The establishment of protocols that are in place and operating, enabling the involvement of external subject matter experts providing support and insights to management from third party firms;
Formalization of the documentation and review of key considerations and critical decision matters resulting from significant reinsurance transactions by the aforementioned technical review committee; and
Communication across the organization to reinforce the steps taken to strengthen the control environment related to significant reinsurance transactions.
Our management has monitored the effectiveness of these and other processes, procedures and controls and these controls have functioned or are functioning now as part of the reinsurance transaction with Fortitude Re described in Note 8 and announced on May 2, 2023. The material weakness will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. We are on track with our plan to complete our testing procedures and complete remediation of this material weakness prior to the end of 2023.
Changes in Internal Control Over Financial Reporting
Except for the implementation of the remediation steps described above, there have not been any material changes in the Company’s internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act) during the quarter ended September 30, 2023, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
A control system, no matter how well designed and operated, can provide only reasonable assurance that the control system’s objectives will be met. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.
PART II – OTHER INFORMATION
Item 1. Legal Proceedings
Reference is made to Glover v. Connecticut General Life Insurance Company and The Lincoln National Life Insurance Company, previously disclosed in our Annual Report on Form 10-K/A for the year ended December 31, 2022 (“2022 Form 10-K/A”). On September 25, 2023, the court granted in part and denied in part plaintiff’s motion for leave to amend the complaint, and on October 10, 2023, plaintiff filed an amended complaint.
Reference is made to In re: Lincoln National COI Litigation and In re: Lincoln National 2017 COI Rate Litigation, both previously disclosed in the 2022 Form 10-K/A, our Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (“First Quarter 2023 Form 10-Q”) and our Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (“Second Quarter 2023 Form 10-Q”). After certain policyholders timely opted out or otherwise excluded themselves from the settlement class with respect to certain policies, the pre-tax cash settlement fund was reduced from $117.75 million to $109.96 million. The court granted final approval of the settlement on October 5, 2023. Certain of the policyholders who did not participate in the settlement are plaintiffs in the Brighton Trustees, LLC, et al. v. The Lincoln National Life Insurance Company (discussed in the First Quarter 2023 Form 10-Q and the Second Quarter 2023 Form 10-Q).
The remaining policyholders who did not participate in the settlement may bring individual actions in the future to the extent they have not already done so.
Reference is made to Andrew Nitkewicz v. Lincoln Life & Annuity Company of New York, previously disclosed in in our 2022 Form 10-K/A. With respect to the question that was certified to the New York Court of Appeals, on October 19, 2023, the New York Court of Appeals answered the question in Lincoln Life & Annuity Company of New York’s favor and transmitted the decision to the U.S. Court of Appeals for the Second Circuit.
See Note 15 in “Part I – Item 1. Financial Statements” for further discussion regarding these matters and other contingencies.
Item 1A. Risk Factors
In addition to the factors set forth in “Part I – Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Forward-Looking Statements – Cautionary Language,” you should carefully consider the risks described under “Part I – Item 1A. Risk Factors” in our 2022 Form 10-K/A. Such risks and uncertainties are not the only ones facing our Company. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business operations. If any of these risks actually occur, our business, financial condition and results of operations could be materially affected. In that case, the value of our securities could decline substantially.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
(c) The following summarizes purchases of equity securities by the Company during the quarter ended September 30, 2023 (dollars in millions, except per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(c) Total Number |
|
(d) Approximate Dollar |
|
|||
|
|
(a) Total |
|
|
|
of Shares |
|
Value of Shares |
|
||||
|
|
Number |
|
(b) Average |
|
Purchased as Part of |
|
that May Yet Be |
|
||||
|
|
of Shares |
|
Price Paid |
|
Publicly Announced |
|
Purchased Under the |
|
||||
Period |
|
Purchased |
|
per Share |
|
Plans or Programs (1) |
|
Plans or Programs (1) |
|
||||
7/1/23 – 7/31/23 |
|
|
- |
|
$ |
- |
|
|
- |
|
$ |
714 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8/1/23 – 8/31/23 |
|
|
- |
|
|
- |
|
|
- |
|
|
714 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9/1/23 – 9/30/23 |
|
|
- |
|
|
- |
|
|
- |
|
|
714 |
|
(1)On November 10, 2021, our Board of Directors authorized an increase in our securities repurchase authorization, bringing the total aggregate repurchase authorization to $1.5 billion. As of September 30, 2023, our remaining security repurchase authorization was $714 million. The security repurchase authorization does not have an expiration date. The amount and timing of share repurchases depends on key capital ratios, rating agency expectations, the generation of free cash flow and an evaluation of the costs and benefits associated with alternative uses of capital. Our stock repurchases may be effected from time to time through open market purchases or in privately negotiated transactions and may be made pursuant to an accelerated share repurchase agreement or Rule 10b5-1 plan.
Item 5. Other Information
Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements
During the three months ended September 30, 2023, none of our directors or officers (as defined in Exchange Act Rule 16a-1(f)) adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.
Item 6. Exhibits
The Exhibits included in this report are listed in the Exhibit Index beginning on page 143, which is incorporated herein by reference.
LINCOLN NATIONAL CORPORATION
Exhibit Index for the Report on Form 10-Q
For the Quarter Ended September 30, 2023
|
|
|
|
101.INS |
XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
101.SCH |
XBRL Taxonomy Extension Schema Document. |
101.CAL |
XBRL Taxonomy Extension Calculation Linkbase Document. |
101.LAB |
XBRL Taxonomy Extension Label Linkbase Document. |
101.PRE |
XBRL Taxonomy Extension Presentation Linkbase Document. |
101.DEF |
XBRL Taxonomy Extension Definition Linkbase Document. |
104 |
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
LINCOLN NATIONAL CORPORATION |
|
|
|
|
By: |
/s/ Christopher Neczypor |
|
|
Christopher Neczypor Executive Vice President and Chief Financial Officer |
|
|
|
|
By: |
/s/ Adam Cohen |
|
|
Adam Cohen Senior Vice President and Chief Accounting Officer |
Dated: November 2, 2023 |
|
|
Exhibit 31.1
Certification Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
I, Ellen G. Cooper, President and Chief Executive Officer, certify that:
|
1. |
I have reviewed this quarterly report on Form 10-Q of Lincoln National Corporation; |
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
c) |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
d) |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
|
5. |
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
|
|
||
|
Dated: November 2, 2023 |
/s/ Ellen G. Cooper |
|
|
|
Name: Ellen G. Cooper |
|
|
|
Title: President and Chief Executive Officer |
Exhibit 31.2
Certification Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
I, Christopher Neczypor, Executive Vice President and Chief Financial Officer, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Lincoln National Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
|
||
|
|
||
|
Dated: November 2, 2023 |
/s/ Christopher Neczypor |
|
|
|
Name: Christopher Neczypor |
|
|
|
Title: Executive Vice President and Chief Financial Officer |
Exhibit 32.1
Certification Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906
of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. § 1350, the undersigned officer of Lincoln National Corporation (the “Company”), hereby certifies that the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
||
|
Dated: November 2, 2023 |
/s/ Ellen G. Cooper |
|
|
|
Name: Ellen G. Cooper |
|
|
|
Title: President and Chief Executive Officer |
The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.
A signed original of this written statement required under Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit 32.2
Certification Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906
of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. § 1350, the undersigned officer of Lincoln National Corporation (the “Company”), hereby certifies that the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
||
|
|
||
|
Dated: November 2, 2023 |
/s/ Christopher Neczypor |
|
|
|
Name: Christopher Neczypor |
|
|
|
Title: Executive Vice President and Chief Financial Officer |
The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.
A signed original of this written statement required under Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.